Sentence,class,file
Acommercial wheat aleurone (Grainwise TMwheat aleurone) was a gift from Cargill Article No~e00106 3 http://dx.doi.org/10.1016/j.heliyon.2016.e00106 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/20/38/main.PMC4946213.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/20/38/main.PMC4946213.pdf
Article No~e00106 4 http://dx.doi.org/10.1016/j.heliyon.2016.e00106 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/20/38/main.PMC4946213.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/20/38/main.PMC4946213.pdf
The reconstituted samples in Article No~e00106 5 http://dx.doi.org/10.1016/j.heliyon.2016.e00106 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/20/38/main.PMC4946213.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/20/38/main.PMC4946213.pdf
"The operating conditionswere set as follows: desolvation temperature 300 Â°C; source temperature, 120 Â°C Article No~e00106 6 http://dx.doi.org/10.1016/j.heliyon.2016.e00106 2405-8440/Â© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/20/38/main.PMC4946213.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/20/38/main.PMC4946213.pdf
Article No~e00106 7 http://dx.doi.org/10.1016/j.heliyon.2016.e00106 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/20/38/main.PMC4946213.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/20/38/main.PMC4946213.pdf
The generally Article No~e00106 8 http://dx.doi.org/10.1016/j.heliyon.2016.e00106 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/20/38/main.PMC4946213.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/20/38/main.PMC4946213.pdf
Article No~e00106 9 http://dx.doi.org/10.1016/j.heliyon.2016.e00106 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/20/38/main.PMC4946213.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/20/38/main.PMC4946213.pdf
Article No~e00106 10 http://dx.doi.org/10.1016/j.heliyon.2016.e00106 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/20/38/main.PMC4946213.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/20/38/main.PMC4946213.pdf
Article No~e00106 11 http://dx.doi.org/10.1016/j.heliyon.2016.e00106 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/20/38/main.PMC4946213.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/20/38/main.PMC4946213.pdf
Article No~e00106 12 http://dx.doi.org/10.1016/j.heliyon.2016.e00106 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/20/38/main.PMC4946213.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/20/38/main.PMC4946213.pdf
Article No~e00106 13 http://dx.doi.org/10.1016/j.heliyon.2016.e00106 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/20/38/main.PMC4946213.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/20/38/main.PMC4946213.pdf
Article No~e00106 14 http://dx.doi.org/10.1016/j.heliyon.2016.e00106 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/20/38/main.PMC4946213.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/20/38/main.PMC4946213.pdf
Article No~e00106 15 http://dx.doi.org/10.1016/j.heliyon.2016.e00106 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/20/38/main.PMC4946213.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/20/38/main.PMC4946213.pdf
Article No~e00106 16 http://dx.doi.org/10.1016/j.heliyon.2016.e00106 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/20/38/main.PMC4946213.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/20/38/main.PMC4946213.pdf
Structural features and feruloylationmodulate the fermentability and evolution of antioxidant properties of Article No~e00106 17 http://dx.doi.org/10.1016/j.heliyon.2016.e00106 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/20/38/main.PMC4946213.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/20/38/main.PMC4946213.pdf
Article No~e00106 18 http://dx.doi.org/10.1016/j.heliyon.2016.e00106 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/20/38/main.PMC4946213.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/20/38/main.PMC4946213.pdf
"Of these, cassiterite (from the Greek word for tin, Kassiteros âˆ’SnO 2) is the best known, having a rutile-type, tetragonal crystalReceived: 26 February 2016 Revised: 2 May 2016 Accepted: 9 May 2016 Heliyon 2 (2016) e00112 http://dx.doi.org/10.1016/j.heliyon.2016.e00112 2405-8440/Â© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/c4/65/main.PMC4946215.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/c4/65/main.PMC4946215.pdf
"Even in the absence of oxygen, this oxide undergoes a disproportionation reaction of a spontaneous nature with aÎ”GÂ° 298(2) =âˆ’5.9 KJ molâˆ’1[16,17]; given by: Article No~e00112 2 http://dx.doi.org/10.1016/j.heliyon.2016.e00112 2405-8440/Â© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/c4/65/main.PMC4946215.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/c4/65/main.PMC4946215.pdf
"During the indirect phase transformation, one of the phases that appeared in the sample was Article No~e00112 3 http://dx.doi.org/10.1016/j.heliyon.2016.e00112 2405-8440/Â© 2016 The Authors.",OADS,/arxiv_data1/oa_pdf/c4/65/main.PMC4946215.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/c4/65/main.PMC4946215.pdf
TGA-DSC The thermal behavior of the SnO was determined using thermogravimetric analysis (TGA) and differential scanning calorimetry (DSC) in two different atmospheres: Article No~e00112 4 http://dx.doi.org/10.1016/j.heliyon.2016.e00112 2405-8440/Â© 2016 The Authors.,OADS,/arxiv_data1/oa_pdf/c4/65/main.PMC4946215.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/c4/65/main.PMC4946215.pdf
Article No~e00112 5 http://dx.doi.org/10.1016/j.heliyon.2016.e00112 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/c4/65/main.PMC4946215.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/c4/65/main.PMC4946215.pdf
Article No~e00112 6 http://dx.doi.org/10.1016/j.heliyon.2016.e00112 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/c4/65/main.PMC4946215.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/c4/65/main.PMC4946215.pdf
Total surface area (m2gâˆ’1) Total pore volume 10âˆ’3(cm3gâˆ’1)Mesopore volume 10âˆ’3(cm3gâˆ’1) Pore diameter (Ã…) 22.39 22.96 22.18 65.25 Article No~e00112 7 http://dx.doi.org/10.1016/j.heliyon.2016.e00112 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/c4/65/main.PMC4946215.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/c4/65/main.PMC4946215.pdf
Article No~e00112 8 http://dx.doi.org/10.1016/j.heliyon.2016.e00112 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/c4/65/main.PMC4946215.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/c4/65/main.PMC4946215.pdf
Article No~e00112 9 http://dx.doi.org/10.1016/j.heliyon.2016.e00112 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/c4/65/main.PMC4946215.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/c4/65/main.PMC4946215.pdf
Article No~e00112 10 http://dx.doi.org/10.1016/j.heliyon.2016.e00112 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/c4/65/main.PMC4946215.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/c4/65/main.PMC4946215.pdf
Article No~e00112 11 http://dx.doi.org/10.1016/j.heliyon.2016.e00112 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/c4/65/main.PMC4946215.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/c4/65/main.PMC4946215.pdf
Article No~e00112 12 http://dx.doi.org/10.1016/j.heliyon.2016.e00112 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/c4/65/main.PMC4946215.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/c4/65/main.PMC4946215.pdf
Article No~e00112 13 http://dx.doi.org/10.1016/j.heliyon.2016.e00112 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/c4/65/main.PMC4946215.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/c4/65/main.PMC4946215.pdf
Main methods: Anticancer activity of the I. obliquus extract was examined in mouse models of Lewis lung carcinoma growth and spontaneous metastasis afterReceived: 15 March 2016 Revised: 20 April 2016 Accepted: 6 May 2016 Heliyon 2 (2016) e00111 http://dx.doi.org/10.1016/j.heliyon.2016.e00111 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/31/65/main.PMC4946216.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/31/65/main.PMC4946216.pdf
"The extracts of I. obliquus have been used in China, Korea, Japan, Russia, and the Baltics for their favorable effects on Article No~e00111 2 http://dx.doi.org/10.1016/j.heliyon.2016.e00111 2405-8440/Â© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/31/65/main.PMC4946216.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/31/65/main.PMC4946216.pdf
"101, Advantec, Tokyo, Japan) and freeze-dried, yielding 1.3 g (4.1% of raw Article No~e00111 3 http://dx.doi.org/10.1016/j.heliyon.2016.e00111 2405-8440/Â© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/31/65/main.PMC4946216.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/31/65/main.PMC4946216.pdf
"For immunostaining, Article No~e00111 4 http://dx.doi.org/10.1016/j.heliyon.2016.e00111 2405-8440/Â© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/31/65/main.PMC4946216.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/31/65/main.PMC4946216.pdf
Article No~e00111 5 http://dx.doi.org/10.1016/j.heliyon.2016.e00111 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/31/65/main.PMC4946216.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/31/65/main.PMC4946216.pdf
Article No~e00111 6 http://dx.doi.org/10.1016/j.heliyon.2016.e00111 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/31/65/main.PMC4946216.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/31/65/main.PMC4946216.pdf
Article No~e00111 7 http://dx.doi.org/10.1016/j.heliyon.2016.e00111 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/31/65/main.PMC4946216.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/31/65/main.PMC4946216.pdf
Article No~e00111 8 http://dx.doi.org/10.1016/j.heliyon.2016.e00111 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/31/65/main.PMC4946216.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/31/65/main.PMC4946216.pdf
Article No~e00111 9 http://dx.doi.org/10.1016/j.heliyon.2016.e00111 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/31/65/main.PMC4946216.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/31/65/main.PMC4946216.pdf
Article No~e00111 10 http://dx.doi.org/10.1016/j.heliyon.2016.e00111 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/31/65/main.PMC4946216.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/31/65/main.PMC4946216.pdf
Article No~e00111 11 http://dx.doi.org/10.1016/j.heliyon.2016.e00111 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/31/65/main.PMC4946216.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/31/65/main.PMC4946216.pdf
Article No~e00111 12 http://dx.doi.org/10.1016/j.heliyon.2016.e00111 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/31/65/main.PMC4946216.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/31/65/main.PMC4946216.pdf
Article No~e00111 13 http://dx.doi.org/10.1016/j.heliyon.2016.e00111 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/31/65/main.PMC4946216.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/31/65/main.PMC4946216.pdf
Article No~e00111 14 http://dx.doi.org/10.1016/j.heliyon.2016.e00111 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/31/65/main.PMC4946216.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/31/65/main.PMC4946216.pdf
"Kim, et al., Potential anticancer properties of the water extract of Inonotus [corrected] obliquus by Article No~e00111 15 http://dx.doi.org/10.1016/j.heliyon.2016.e00111 2405-8440/Â© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/31/65/main.PMC4946216.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/31/65/main.PMC4946216.pdf
Article No~e00111 16 http://dx.doi.org/10.1016/j.heliyon.2016.e00111 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/31/65/main.PMC4946216.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/31/65/main.PMC4946216.pdf
FOXP1 was expressed in normal and malignantReceived: 14 January 2016 Revised: 6 April 2016 Accepted: 18 May 2016 Heliyon 2 (2016) e00116 http://dx.doi.org/10.1016/j.heliyon.2016.e00116 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/16/22/main.PMC4946217.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/16/22/main.PMC4946217.pdf
found that the pattern of expression of FOXP1 protein was similar to the pattern of expression of Article No~e00116 2 http://dx.doi.org/10.1016/j.heliyon.2016.e00116 2405-8440/Â© 2016 The Authors.,OADS,/arxiv_data1/oa_pdf/16/22/main.PMC4946217.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/16/22/main.PMC4946217.pdf
Article No~e00116 3 http://dx.doi.org/10.1016/j.heliyon.2016.e00116 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/16/22/main.PMC4946217.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/16/22/main.PMC4946217.pdf
"The Ishikawa cell line established from well differentiated endometrioid adenocarcinoma cells (JCRB1505, the Japanese Collection of Research Bioresources, Osaka, Japan) [28] and the HEC-50B cell line derived from poorly differentiated endometrioid adenocarcinoma (JCRB1145, the Japanese Collection of Research Article No~e00116 4 http://dx.doi.org/10.1016/j.heliyon.2016.e00116 2405-8440/Â© 2016 The Authors.",OADS,/arxiv_data1/oa_pdf/16/22/main.PMC4946217.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/16/22/main.PMC4946217.pdf
Article No~e00116 5 http://dx.doi.org/10.1016/j.heliyon.2016.e00116 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/16/22/main.PMC4946217.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/16/22/main.PMC4946217.pdf
The membranes were incubated overnight at 4 Â°C with the Article No~e00116 6 http://dx.doi.org/10.1016/j.heliyon.2016.e00116 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/16/22/main.PMC4946217.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/16/22/main.PMC4946217.pdf
Article No~e00116 7 http://dx.doi.org/10.1016/j.heliyon.2016.e00116 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/16/22/main.PMC4946217.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/16/22/main.PMC4946217.pdf
Article No~e00116 8 http://dx.doi.org/10.1016/j.heliyon.2016.e00116 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/16/22/main.PMC4946217.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/16/22/main.PMC4946217.pdf
Article No~e00116 9 http://dx.doi.org/10.1016/j.heliyon.2016.e00116 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/16/22/main.PMC4946217.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/16/22/main.PMC4946217.pdf
Article No~e00116 10 http://dx.doi.org/10.1016/j.heliyon.2016.e00116 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/16/22/main.PMC4946217.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/16/22/main.PMC4946217.pdf
Article No~e00116 11 http://dx.doi.org/10.1016/j.heliyon.2016.e00116 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/16/22/main.PMC4946217.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/16/22/main.PMC4946217.pdf
Article No~e00116 12 http://dx.doi.org/10.1016/j.heliyon.2016.e00116 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/16/22/main.PMC4946217.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/16/22/main.PMC4946217.pdf
Article No~e00116 13 http://dx.doi.org/10.1016/j.heliyon.2016.e00116 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/16/22/main.PMC4946217.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/16/22/main.PMC4946217.pdf
Article No~e00116 14 http://dx.doi.org/10.1016/j.heliyon.2016.e00116 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/16/22/main.PMC4946217.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/16/22/main.PMC4946217.pdf
Article No~e00116 15 http://dx.doi.org/10.1016/j.heliyon.2016.e00116 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/16/22/main.PMC4946217.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/16/22/main.PMC4946217.pdf
doi.org/10.1016/j.heliyon.2016.e00116 Article No~e00116 16 http://dx.doi.org/10.1016/j.heliyon.2016.e00116 2405-8440/Â© 2016 The Authors.,OADS,/arxiv_data1/oa_pdf/16/22/main.PMC4946217.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/16/22/main.PMC4946217.pdf
Article No~e00116 17 http://dx.doi.org/10.1016/j.heliyon.2016.e00116 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/16/22/main.PMC4946217.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/16/22/main.PMC4946217.pdf
Article No~e00116 18 http://dx.doi.org/10.1016/j.heliyon.2016.e00116 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/16/22/main.PMC4946217.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/16/22/main.PMC4946217.pdf
Article No~e00116 19 http://dx.doi.org/10.1016/j.heliyon.2016.e00116 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/16/22/main.PMC4946217.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/16/22/main.PMC4946217.pdf
Article No~e00116 20 http://dx.doi.org/10.1016/j.heliyon.2016.e00116 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/16/22/main.PMC4946217.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/16/22/main.PMC4946217.pdf
"Keywords: Biological sciences, Cell biologyReceived: 22 January 2016 Revised: 24 March 2016 Accepted: 5 May 2016 Heliyon 2 (2016) e00109 http://dx.doi.org/10.1016/j.heliyon.2016.e00109 2405-8440/Â© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/d7/17/main.PMC4946219.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d7/17/main.PMC4946219.pdf
"The expression of GLI1, an activator of transcription, is induced by Article No~e00109 2 http://dx.doi.org/10.1016/j.heliyon.2016.e00109 2405-8440/Â© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/d7/17/main.PMC4946219.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d7/17/main.PMC4946219.pdf
Article No~e00109 3 http://dx.doi.org/10.1016/j.heliyon.2016.e00109 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d7/17/main.PMC4946219.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d7/17/main.PMC4946219.pdf
Article No~e00109 4 http://dx.doi.org/10.1016/j.heliyon.2016.e00109 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d7/17/main.PMC4946219.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d7/17/main.PMC4946219.pdf
Representative high magnifications of resection Article No~e00109 5 http://dx.doi.org/10.1016/j.heliyon.2016.e00109 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d7/17/main.PMC4946219.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d7/17/main.PMC4946219.pdf
Article No~e00109 6 http://dx.doi.org/10.1016/j.heliyon.2016.e00109 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d7/17/main.PMC4946219.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d7/17/main.PMC4946219.pdf
Article No~e00109 7 http://dx.doi.org/10.1016/j.heliyon.2016.e00109 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d7/17/main.PMC4946219.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d7/17/main.PMC4946219.pdf
Article No~e00109 8 http://dx.doi.org/10.1016/j.heliyon.2016.e00109 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d7/17/main.PMC4946219.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d7/17/main.PMC4946219.pdf
Article No~e00109 9 http://dx.doi.org/10.1016/j.heliyon.2016.e00109 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d7/17/main.PMC4946219.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d7/17/main.PMC4946219.pdf
Article No~e00109 10 http://dx.doi.org/10.1016/j.heliyon.2016.e00109 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d7/17/main.PMC4946219.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d7/17/main.PMC4946219.pdf
Article No~e00109 11 http://dx.doi.org/10.1016/j.heliyon.2016.e00109 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d7/17/main.PMC4946219.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d7/17/main.PMC4946219.pdf
Article No~e00109 12 http://dx.doi.org/10.1016/j.heliyon.2016.e00109 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d7/17/main.PMC4946219.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d7/17/main.PMC4946219.pdf
"Analysis of the various components of the HH pathway in CRC cell lines showed that in addition to the two HH ligands SHH and IHH, known to be produced by normal intestinal epithelial cells [ 2,47], expression of PC components PTCH, SMO and GLI1 was also observed in CRC cells in agreement with previousobservations [ 32,33,34,35,36,37], although a recent study suggests a loss of the Article No~e00109 13 http://dx.doi.org/10.1016/j.heliyon.2016.e00109 2405-8440/Â© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/d7/17/main.PMC4946219.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d7/17/main.PMC4946219.pdf
Article No~e00109 14 http://dx.doi.org/10.1016/j.heliyon.2016.e00109 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d7/17/main.PMC4946219.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d7/17/main.PMC4946219.pdf
Article No~e00109 15 http://dx.doi.org/10.1016/j.heliyon.2016.e00109 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d7/17/main.PMC4946219.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d7/17/main.PMC4946219.pdf
Article No~e00109 16 http://dx.doi.org/10.1016/j.heliyon.2016.e00109 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d7/17/main.PMC4946219.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d7/17/main.PMC4946219.pdf
Article No~e00109 17 http://dx.doi.org/10.1016/j.heliyon.2016.e00109 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d7/17/main.PMC4946219.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d7/17/main.PMC4946219.pdf
"Beaulieu, Gene expression profiles of normal proliferating and differentiating human Article No~e00109 18 http://dx.doi.org/10.1016/j.heliyon.2016.e00109 2405-8440/Â© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/d7/17/main.PMC4946219.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d7/17/main.PMC4946219.pdf
Article No~e00109 19 http://dx.doi.org/10.1016/j.heliyon.2016.e00109 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d7/17/main.PMC4946219.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d7/17/main.PMC4946219.pdf
Article No~e00109 20 http://dx.doi.org/10.1016/j.heliyon.2016.e00109 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d7/17/main.PMC4946219.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d7/17/main.PMC4946219.pdf
http://dx.doi.org/10.1016/j.heliyon.2016.e00101 2405-8440/ Â©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/dd/4c/main.PMC4946220.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/dd/4c/main.PMC4946220.pdf
The very recent paper [14] 2 http://dx.doi.org/10.1016/j.heliyon.2016.e00101 2405-8440/ Â©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/dd/4c/main.PMC4946220.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/dd/4c/main.PMC4946220.pdf
Because of the very high population  3 http://dx.doi.org/10.1016/j.heliyon.2016.e00101 2405-8440/ Â©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/dd/4c/main.PMC4946220.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/dd/4c/main.PMC4946220.pdf
"However,  when injected  into the open circulatory system  of the insects,  in which the heart pumps  blood into  the space in between the organs  rather  than in closed vessels  as in v ertebrates,  these  4 http://dx.doi.org/10.1016/j.heliyon.2016.e00101 2405-8440/ Â©2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/dd/4c/main.PMC4946220.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/dd/4c/main.PMC4946220.pdf
5 http://dx.doi.org/10.1016/j.heliyon.2016.e00101 2405-8440/ Â©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/dd/4c/main.PMC4946220.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/dd/4c/main.PMC4946220.pdf
The second and third terms  account for the new recruits   6 http://dx.doi.org/10.1016/j.heliyon.2016.e00101 2405-8440/ Â©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/dd/4c/main.PMC4946220.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/dd/4c/main.PMC4946220.pdf
"Therefore,  system (2)reduces  to the following one, written in shorthand  as ğ‘‹â€²=ğ‘“(ğ‘‹)=(ğ‘“ğµ,ğ‘“ğ¼,ğ‘“ğ‘€,ğ‘“ğ‘)ğ‘‡,ğ‘“âˆ¶îˆ°0â†’â„4 +, (5) 7 http://dx.doi.org/10.1016/j.heliyon.2016.e00101 2405-8440/ Â©2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/dd/4c/main.PMC4946220.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/dd/4c/main.PMC4946220.pdf
8 http://dx.doi.org/10.1016/j.heliyon.2016.e00101 2405-8440/ Â©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/dd/4c/main.PMC4946220.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/dd/4c/main.PMC4946220.pdf
9 http://dx.doi.org/10.1016/j.heliyon.2016.e00101 2405-8440/ Â©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/dd/4c/main.PMC4946220.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/dd/4c/main.PMC4946220.pdf
10 http://dx.doi.org/10.1016/j.heliyon.2016.e00101 2405-8440/ Â©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/dd/4c/main.PMC4946220.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/dd/4c/main.PMC4946220.pdf
"The conic  section  ğğŸ For the second conic section,  the second invariant is always  negative, âˆ’1 4( ğ›¿âˆ’ğ‘Ÿ ğ¾)2 <0, 11 http://dx.doi.org/10.1016/j.heliyon.2016.e00101 2405-8440/ Â©2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/dd/4c/main.PMC4946220.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/dd/4c/main.PMC4946220.pdf
12 http://dx.doi.org/10.1016/j.heliyon.2016.e00101 2405-8440/ Â©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/dd/4c/main.PMC4946220.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/dd/4c/main.PMC4946220.pdf
The transition  among them occurs  when the hyperbola  13 http://dx.doi.org/10.1016/j.heliyon.2016.e00101 2405-8440/ Â©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/dd/4c/main.PMC4946220.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/dd/4c/main.PMC4946220.pdf
14 http://dx.doi.org/10.1016/j.heliyon.2016.e00101 2405-8440/ Â©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/dd/4c/main.PMC4946220.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/dd/4c/main.PMC4946220.pdf
15 http://dx.doi.org/10.1016/j.heliyon.2016.e00101 2405-8440/ Â©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/dd/4c/main.PMC4946220.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/dd/4c/main.PMC4946220.pdf
"The ï¬rst is Î›2âˆ’trğ½âˆ—(ğ¸4)Î›+detğ½âˆ—(ğ¸4)=0, (29) where  ğ½âˆ—(ğ¸4)is the submatrix 16 http://dx.doi.org/10.1016/j.heliyon.2016.e00101 2405-8440/ Â©2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/dd/4c/main.PMC4946220.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/dd/4c/main.PMC4946220.pdf
17 http://dx.doi.org/10.1016/j.heliyon.2016.e00101 2405-8440/ Â©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/dd/4c/main.PMC4946220.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/dd/4c/main.PMC4946220.pdf
There  is thus a transcritical   18 http://dx.doi.org/10.1016/j.heliyon.2016.e00101 2405-8440/ Â©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/dd/4c/main.PMC4946220.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/dd/4c/main.PMC4946220.pdf
19 http://dx.doi.org/10.1016/j.heliyon.2016.e00101 2405-8440/ Â©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/dd/4c/main.PMC4946220.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/dd/4c/main.PMC4946220.pdf
"Hence,  when transmitted  by Varroa mites,  20 http://dx.doi.org/10.1016/j.heliyon.2016.e00101 2405-8440/ Â©2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/dd/4c/main.PMC4946220.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/dd/4c/main.PMC4946220.pdf
"Indeed,  note  that solving for ğ‘›the equation (38), we ï¬nd ğ‘›=ğ‘Ÿâˆ’ğ›½(ğ‘ğ›¾âˆ’ğ‘šğœ‡) ğœ‡ğ›¾+2ğ‘’(ğ‘ğ›¾âˆ’ğ‘šğœ‡âˆ’ğœ‡2) ğœ‡ğ›¾, (39) and the second inequality in(34) becomes âˆ’( ğ‘Ÿâˆ’ğ›½(ğ‘ğ›¾âˆ’ğ‘šğœ‡)âˆ’ğ‘’(ğ‘ğ›¾âˆ’ğ‘šğœ‡âˆ’ğœ‡2) ğœ‡ğ›¾)2 âˆ’ğ›½(ğ‘Ÿ+ğ‘›)(ğ‘ğ›¾âˆ’ğ‘šğœ‡) ğœ‡ğ›¾>0, 21 http://dx.doi.org/10.1016/j.heliyon.2016.e00101 2405-8440/ Â©2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/dd/4c/main.PMC4946220.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/dd/4c/main.PMC4946220.pdf
"Introducing ğ‘ˆ(1)=(ğµâˆ’ğµ1, ğ¼, ğ‘€, ğ‘)ğ‘‡and requiring ğœ‚(1)ğœ†ğµ1+ğœŒ(1)ğ‘Ÿâ‰¤ğ‘›ğœ(1)+ğ‘’ğœ(1)ğµ1,ğ‘Ÿ+ğ‘›â‰¤ğ‘’ğµ1,ğ›¾ ğµ1+ğ‘ ğµ1â‰¤ğ‘š+ğœ‡, (43) it is possible then to write the estimate 22 http://dx.doi.org/10.1016/j.heliyon.2016.e00101 2405-8440/ Â©2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/dd/4c/main.PMC4946220.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/dd/4c/main.PMC4946220.pdf
"(45) Taking upper  bounds  for each term we have ğ‘‡(4) 1=âˆ’ğœ™(4)ğ‘(ğµâˆ’ğµ4)2 (ğµ+ğ¼)(ğµ4+ğ¼4)âˆ’ğœ†ğœ™(4)(ğµâˆ’ğµ4)ğ‘âˆ’ğ›¾ğœ™(4)(ğµâˆ’ğµ4)(ğ¼âˆ’ğ¼4), (46) ğ‘‡(4) 2=âˆ’(ğ¼âˆ’ğ¼4)2ğœ‚(4)ğ‘ (ğµ+ğ¼)(ğµ4+ğ¼4)âˆ’ğœ‚(4)ğ‘ (ğµ+ğ¼)(ğµ4+ğ¼4)(ğµâˆ’ğµ4)(ğ¼âˆ’ğ¼4) +( ğœ†ğœ‚(4)ğ‘ ğ¼+ğ›¾ğœ‚(4)) (ğµâˆ’ğµ4)(ğ¼âˆ’ğ¼4)+ğœ‚(4)ğœ† ğ¼ğµ4(ğ¼âˆ’ğ¼4)ğ‘,(47) 23 http://dx.doi.org/10.1016/j.heliyon.2016.e00101 2405-8440/ Â©2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/dd/4c/main.PMC4946220.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/dd/4c/main.PMC4946220.pdf
24 http://dx.doi.org/10.1016/j.heliyon.2016.e00101 2405-8440/ Â©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/dd/4c/main.PMC4946220.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/dd/4c/main.PMC4946220.pdf
25 http://dx.doi.org/10.1016/j.heliyon.2016.e00101 2405-8440/ Â©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/dd/4c/main.PMC4946220.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/dd/4c/main.PMC4946220.pdf
"For the remaining terms  we have the following bounds ğ‘‡âˆ— 3=âˆ’ğœŒâˆ—(ğ‘€âˆ’ğ‘€âˆ—)2[(ğ‘Ÿ+ğ‘›)ğ‘ ğ‘€ğ‘€âˆ—+ğ‘Ÿ ğ¾] +ğœŒâˆ—(ğ‘€âˆ’ğ‘€âˆ—)[ (ğ‘âˆ’ğ‘âˆ—)((ğ‘Ÿ+ğ‘›) ğ‘€âˆ—âˆ’ğ‘Ÿ ğ¾âˆ’ğ›¿) âˆ’ğ›½(ğ¼âˆ’ğ¼âˆ—)âˆ’ğ‘’(ğµâˆ’ğµâˆ—)] â‰¤âˆ’ğœŒâˆ—(ğ‘€âˆ’ğ‘€âˆ—)2ğ‘Ÿ ğ¾+ğœŒâˆ—(ğ‘€âˆ’ğ‘€âˆ—)(ğ‘âˆ’ğ‘âˆ—)[(ğ‘Ÿ+ğ‘›) ğ‘€âˆ—âˆ’ğ‘Ÿ ğ¾âˆ’ğ›¿] âˆ’ğœŒâˆ—(ğ‘€âˆ’ğ‘€âˆ—)[ğ›½(ğ¼âˆ’ğ¼âˆ—)+ğ‘’(ğµâˆ’ğµâˆ—)], 26 http://dx.doi.org/10.1016/j.heliyon.2016.e00101 2405-8440/ Â©2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/dd/4c/main.PMC4946220.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/dd/4c/main.PMC4946220.pdf
27 http://dx.doi.org/10.1016/j.heliyon.2016.e00101 2405-8440/ Â©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/dd/4c/main.PMC4946220.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/dd/4c/main.PMC4946220.pdf
Healthy and infected mites  are wiped out while the healthy bee population  28 http://dx.doi.org/10.1016/j.heliyon.2016.e00101 2405-8440/ Â©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/dd/4c/main.PMC4946220.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/dd/4c/main.PMC4946220.pdf
29 http://dx.doi.org/10.1016/j.heliyon.2016.e00101 2405-8440/ Â©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/dd/4c/main.PMC4946220.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/dd/4c/main.PMC4946220.pdf
30 http://dx.doi.org/10.1016/j.heliyon.2016.e00101 2405-8440/ Â©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/dd/4c/main.PMC4946220.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/dd/4c/main.PMC4946220.pdf
31 http://dx.doi.org/10.1016/j.heliyon.2016.e00101 2405-8440/ Â©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/dd/4c/main.PMC4946220.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/dd/4c/main.PMC4946220.pdf
"To make a valid comparison of the eï¬€ect  that parameters   with diï¬€erent  units have on the solution,  the sensitivity solution is multiplied by  the parame ter  under  consideration,  obtaining the  so-called semi-relative sensitivity  32 http://dx.doi.org/10.1016/j.heliyon.2016.e00101 2405-8440/ Â©2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/dd/4c/main.PMC4946220.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/dd/4c/main.PMC4946220.pdf
"Indeed,  the shor ter  survival time means   33 http://dx.doi.org/10.1016/j.heliyon.2016.e00101 2405-8440/ Â©2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/dd/4c/main.PMC4946220.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/dd/4c/main.PMC4946220.pdf
34 http://dx.doi.org/10.1016/j.heliyon.2016.e00101 2405-8440/ Â©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/dd/4c/main.PMC4946220.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/dd/4c/main.PMC4946220.pdf
35 http://dx.doi.org/10.1016/j.heliyon.2016.e00101 2405-8440/ Â©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/dd/4c/main.PMC4946220.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/dd/4c/main.PMC4946220.pdf
"Looking at  the peaks  in the logarithmic sensitivity solutions,  we discover  that ğ‘’inï¬‚uences   the transient dynamics  of all the populations  more than ğ›¾, while at the end of the  36 http://dx.doi.org/10.1016/j.heliyon.2016.e00101 2405-8440/ Â©2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/dd/4c/main.PMC4946220.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/dd/4c/main.PMC4946220.pdf
37 http://dx.doi.org/10.1016/j.heliyon.2016.e00101 2405-8440/ Â©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/dd/4c/main.PMC4946220.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/dd/4c/main.PMC4946220.pdf
38 http://dx.doi.org/10.1016/j.heliyon.2016.e00101 2405-8440/ Â©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/dd/4c/main.PMC4946220.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/dd/4c/main.PMC4946220.pdf
"However,  in agreement  with the fact that the presence of V. destructor 39 http://dx.doi.org/10.1016/j.heliyon.2016.e00101 2405-8440/ Â©2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/dd/4c/main.PMC4946220.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/dd/4c/main.PMC4946220.pdf
40 http://dx.doi.org/10.1016/j.heliyon.2016.e00101 2405-8440/ Â©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/dd/4c/main.PMC4946220.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/dd/4c/main.PMC4946220.pdf
41 http://dx.doi.org/10.1016/j.heliyon.2016.e00101 2405-8440/ Â©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/dd/4c/main.PMC4946220.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/dd/4c/main.PMC4946220.pdf
"Skinner,  Honey Bee Viruses, the Deadly  Varroa  Mite Associates,  Department of Entomology and Plant Pathology,  the  University of Tennessee,  Knoxville, TN,  2014,  http://www.extension.org/ pages/71172/honeybee-viruses-the-deadly-varroa-mite-associates#.",Non-OADS,/arxiv_data1/oa_pdf/dd/4c/main.PMC4946220.pdf
42 http://dx.doi.org/10.1016/j.heliyon.2016.e00101 2405-8440/ Â©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/dd/4c/main.PMC4946220.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/dd/4c/main.PMC4946220.pdf
43 http://dx.doi.org/10.1016/j.heliyon.2016.e00101 2405-8440/ Â©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/dd/4c/main.PMC4946220.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/dd/4c/main.PMC4946220.pdf
"Keywords: Biological sciences, Plant biology, BiochemistryReceived: 7 April 2016 Revised: 27 April 2016 Accepted: 13 May 2016 Heliyon 2 (2016) e00115 http://dx.doi.org/10.1016/j.heliyon.2016.e00115 2405-8440/Â© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/bf/e3/main.PMC4946221.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/bf/e3/main.PMC4946221.pdf
"Therefore, we hypothesized that KPE may improve physical Article No~e00115 2 http://dx.doi.org/10.1016/j.heliyon.2016.e00115 2405-8440/Â© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/bf/e3/main.PMC4946221.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/bf/e3/main.PMC4946221.pdf
PMF standards including Article No~e00115 3 http://dx.doi.org/10.1016/j.heliyon.2016.e00115 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/bf/e3/main.PMC4946221.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/bf/e3/main.PMC4946221.pdf
Article No~e00115 4 http://dx.doi.org/10.1016/j.heliyon.2016.e00115 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/bf/e3/main.PMC4946221.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/bf/e3/main.PMC4946221.pdf
Article No~e00115 5 http://dx.doi.org/10.1016/j.heliyon.2016.e00115 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/bf/e3/main.PMC4946221.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/bf/e3/main.PMC4946221.pdf
"Then, the extract was centrifuged (500 Ã— g, 4 Â°C, Article No~e00115 6 http://dx.doi.org/10.1016/j.heliyon.2016.e00115 2405-8440/Â© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/bf/e3/main.PMC4946221.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/bf/e3/main.PMC4946221.pdf
"The significance of differences from the initial data (0 weeks)was indicated as *: P <0.05, **: P <0.01, while that from the control was Article No~e00115 7 http://dx.doi.org/10.1016/j.heliyon.2016.e00115 2405-8440/Â© 2016 The Authors.",OADS,/arxiv_data1/oa_pdf/bf/e3/main.PMC4946221.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/bf/e3/main.PMC4946221.pdf
Article No~e00115 8 http://dx.doi.org/10.1016/j.heliyon.2016.e00115 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/bf/e3/main.PMC4946221.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/bf/e3/main.PMC4946221.pdf
Article No~e00115 9 http://dx.doi.org/10.1016/j.heliyon.2016.e00115 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/bf/e3/main.PMC4946221.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/bf/e3/main.PMC4946221.pdf
Regarding mitochondrial Article No~e00115 10 http://dx.doi.org/10.1016/j.heliyon.2016.e00115 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/bf/e3/main.PMC4946221.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/bf/e3/main.PMC4946221.pdf
Article No~e00115 11 http://dx.doi.org/10.1016/j.heliyon.2016.e00115 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/bf/e3/main.PMC4946221.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/bf/e3/main.PMC4946221.pdf
Article No~e00115 12 http://dx.doi.org/10.1016/j.heliyon.2016.e00115 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/bf/e3/main.PMC4946221.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/bf/e3/main.PMC4946221.pdf
Article No~e00115 13 http://dx.doi.org/10.1016/j.heliyon.2016.e00115 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/bf/e3/main.PMC4946221.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/bf/e3/main.PMC4946221.pdf
Article No~e00115 14 http://dx.doi.org/10.1016/j.heliyon.2016.e00115 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/bf/e3/main.PMC4946221.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/bf/e3/main.PMC4946221.pdf
Article No~e00115 15 http://dx.doi.org/10.1016/j.heliyon.2016.e00115 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/bf/e3/main.PMC4946221.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/bf/e3/main.PMC4946221.pdf
Article No~e00115 16 http://dx.doi.org/10.1016/j.heliyon.2016.e00115 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/bf/e3/main.PMC4946221.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/bf/e3/main.PMC4946221.pdf
Article No~e00115 17 http://dx.doi.org/10.1016/j.heliyon.2016.e00115 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/bf/e3/main.PMC4946221.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/bf/e3/main.PMC4946221.pdf
Article No~e00115 18 http://dx.doi.org/10.1016/j.heliyon.2016.e00115 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/bf/e3/main.PMC4946221.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/bf/e3/main.PMC4946221.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8c/71/nihms-798468.PMC4946246.pdf
Available: http://www.bt.cdc.gov/agent/benzene/basics/ facts.asp  (accessed 13.11.14) [8].,Non-OADS,/arxiv_data1/oa_pdf/8c/71/nihms-798468.PMC4946246.pdf
Available: http://www2.epa.gov/toxics-release-inventory-tri-program/basics-tri- reporting  (accessed 12.03.15) [33].,OADS,/arxiv_data1/oa_pdf/8c/71/nihms-798468.PMC4946246.pdf
"Background Species C adenoviruses infect most people asymptomatically in the first few years of life  (Garnett et al., 2002 , 2009 ), and appear to be the most common prenatal viral infection in  This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/b4/e9/nihms793913.PMC4946252.pdf
Supporting information Supplementary data associated with this article can be found in the online version at http://dx.doi.org/10.1016/10.1016/j.virol.,OADS,/arxiv_data1/oa_pdf/b4/e9/nihms793913.PMC4946252.pdf
"Functional analysis of coordinately regulated genes Genes that showed a common pattern by the EPIG analysis were evaluated with the  Functional Annotation Clustering tool of the Database for Annotation, Visualization and  Integrated Discovery (DA VID), version 6.7 http://david.abcc.ncifcrf.gov .",OADS,/arxiv_data1/oa_pdf/b4/e9/nihms793913.PMC4946252.pdf
"To see if the coordinately regulated genes share common transcriptional regulators, genes  identified in patterns 1 through 4 were analyzed with the Distant Regulatory Elements  (Gotea and Ovcharenko, 2008 ) or DiRE tool ( http://dire.dcode.org/ ).",OADS,/arxiv_data1/oa_pdf/b4/e9/nihms793913.PMC4946252.pdf
Available from: http://www.who.int/ageing/publications/ active/en/.,Non-OADS,/arxiv_data1/oa_pdf/61/6f/JEHP-4-103.PMC4946259.pdf
Available from: http://www.who.int/nmh/ publications/9789241597418/en.,Non-OADS,/arxiv_data1/oa_pdf/61/6f/JEHP-4-103.PMC4946259.pdf
"Editor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.com Â© 2016 Surgical Neurology International | Published by Wolters Kluwer - MedknowAbstract Background:  Despite the use of electromagnetic waves in the treatment of some  acute and chronic diseases, application of these waves in everyday life has created  several problems for humans, especially the nerve system.",Non-OADS,/arxiv_data1/oa_pdf/0e/c4/SNI-7-70.PMC4946261.pdf
"Surg Neurol  Int 2016;7:70. http://surgicalneurologyint.com/The-effects-of-30-mT -electromagnetic-fields-on- hippocampus-cells-of-rats/This is an open access article distributed under the terms of the Creative Commons  Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix,  tweak, and build upon the work non-commercially, as long as the author is credited and  the new creations are licensed under the identical terms.",Non-OADS,/arxiv_data1/oa_pdf/0e/c4/SNI-7-70.PMC4946261.pdf
"Surgical Neurology International 2016, 7:70  http://www.surgicalneurologyint.com/content/7/1/70ionizing and nonâ€‘ionizing parts.",Non-OADS,/arxiv_data1/oa_pdf/0e/c4/SNI-7-70.PMC4946261.pdf
"Surgical Neurology International 2016, 7:70  http://www.surgicalneurologyint.com/content/7/1/70and swallowed by macrophages.",Non-OADS,/arxiv_data1/oa_pdf/0e/c4/SNI-7-70.PMC4946261.pdf
"Surgical Neurology International 2016, 7:70  http://www.surgicalneurologyint.com/content/7/1/70photomicrograph of hippocampus parenchyma after  EMF exposure by TUNEL method shows the number of  apoptotic cells, which compared to the control group has  a significant increase [Figure 6].",Non-OADS,/arxiv_data1/oa_pdf/0e/c4/SNI-7-70.PMC4946261.pdf
"Surgical Neurology International 2016, 7:70  http://www.surgicalneurologyint.com/content/7/1/70and duration of exposure to electromagnetic waves  and the number of damaged neurons and its biological  effects.",Non-OADS,/arxiv_data1/oa_pdf/0e/c4/SNI-7-70.PMC4946261.pdf
"Surgical Neurology International 2016, 7:70  http://www.surgicalneurologyint.com/content/7/1/70cord are our other findings that were recognized by light  microscopic and TEM examination.",Non-OADS,/arxiv_data1/oa_pdf/0e/c4/SNI-7-70.PMC4946261.pdf
"Surgical Neurology International 2016, 7:70  http://www.surgicalneurologyint.com/content/7/1/70REFERENCES 1.",Non-OADS,/arxiv_data1/oa_pdf/0e/c4/SNI-7-70.PMC4946261.pdf
Available from:  http://nces.ed.gov/pubsearch/pubsinfo.asp?pubid=2006483.,Non-OADS,/arxiv_data1/oa_pdf/dd/b7/JEHP-4-91.PMC4946262.pdf
Available from: http://www.siasat.behdasht.,Non-OADS,/arxiv_data1/oa_pdf/dd/b7/JEHP-4-91.PMC4946262.pdf
"Editor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.com Â© 2016 Surgical Neurology International | Published by Wolters Kluwer - MedknowAbstract Background:  The membranous structure of vestibular schwannoma is an important  factor in its surgical treatment.",Non-OADS,/arxiv_data1/oa_pdf/50/35/SNI-7-71.PMC4946263.pdf
"Surg Neurol Int  2016;7:71. http://surgicalneurologyint.com/The-outermost-""dura-like-membrane""-of-vestibular- schwannoma/This is an open access article distributed under the terms of the Creative Commons  Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix,  tweak, and build upon the work non-commercially, as long as the author is credited and  the new creations are licensed under the identical terms.",Non-OADS,/arxiv_data1/oa_pdf/50/35/SNI-7-71.PMC4946263.pdf
"Surgical Neurology International 2016, 7:71  http://www.surgicalneurologyint.com/content/7/1/71membranous structure of vestibular schwannoma has  been reported by many authors to date.",Non-OADS,/arxiv_data1/oa_pdf/50/35/SNI-7-71.PMC4946263.pdf
"Surgical Neurology International 2016, 7:71  http://www.surgicalneurologyint.com/content/7/1/71tumor.",Non-OADS,/arxiv_data1/oa_pdf/50/35/SNI-7-71.PMC4946263.pdf
"Surgical Neurology International 2016, 7:71  http://www.surgicalneurologyint.com/content/7/1/71located structures in this surgery.",Non-OADS,/arxiv_data1/oa_pdf/50/35/SNI-7-71.PMC4946263.pdf
"Surgical Neurology International 2016, 7:71  http://www.surgicalneurologyint.com/content/7/1/71induced by the tumor.",Non-OADS,/arxiv_data1/oa_pdf/50/35/SNI-7-71.PMC4946263.pdf
Available from: http://www.webda.,Non-OADS,/arxiv_data1/oa_pdf/a5/36/JEHP-4-94.PMC4946264.pdf
Available from: http://www.Sciencedirect.,Non-OADS,/arxiv_data1/oa_pdf/a5/36/JEHP-4-94.PMC4946264.pdf
Available from:  http://www.ssw.unc.edu/mch/default.asp [Last accessed on 2009  Oct  07].,Non-OADS,/arxiv_data1/oa_pdf/a5/36/JEHP-4-94.PMC4946264.pdf
Available from: http://www.cna â€‘aiic.,Non-OADS,/arxiv_data1/oa_pdf/dd/19/JEHP-4-88.PMC4946265.pdf
Available  from: http://www.who.int/mediacentre/factsheets/fs297/en/index.,Non-OADS,/arxiv_data1/oa_pdf/e3/f3/JEHP-4-102.PMC4946266.pdf
Available from: http://crc.sbmu.,Non-OADS,/arxiv_data1/oa_pdf/e3/f3/JEHP-4-102.PMC4946266.pdf
Available from: http://www.cdc.gov/nutrition/ everyone/basics/foodgroups.html.,Non-OADS,/arxiv_data1/oa_pdf/e3/f3/JEHP-4-102.PMC4946266.pdf
Available from: https://www.iom.edu/Reports/2008/ Residentâ€‘Dutyâ€‘Hoursâ€‘Enhancingâ€‘Sleepâ€‘Supervisionâ€‘andâ€‘Safety.,Non-OADS,/arxiv_data1/oa_pdf/a5/40/JEHP-4-98.PMC4946269.pdf
Available from: http://www.behdasht.gov.ir/uploads/1_94_29.pdf.,Non-OADS,/arxiv_data1/oa_pdf/c9/3b/JEHP-4-106.PMC4946271.pdf
Available from: http://www.hepatitiscentral.com/hepatitis-c/ what-is-hepatitis-c.html.,Non-OADS,/arxiv_data1/oa_pdf/75/bb/JEHP-4-93.PMC4946275.pdf
Feb 2014  Available from: http://www.hepatitisscotland.org.uk/index.php/ what -s-the -difference -between -hepatitis- b-and-c/.,Non-OADS,/arxiv_data1/oa_pdf/75/bb/JEHP-4-93.PMC4946275.pdf
"Editor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.com Â© 2016 Surgical Neurology International | Published by Wolters Kluwer - MedknowSir, Preoperative diversion of cerebrospinal fluid (CSF) is a  common procedure for posterior fossa lesions.",Non-OADS,/arxiv_data1/oa_pdf/95/af/SNI-7-72.PMC4946276.pdf
"Surg Neurol Int 2016;7:72. http://surgicalneurologyint.com/Diagnosing-early-upward-cerebellar-herniation-by- computed-tomography:-A-diagnostic-boom,-a-savior/",Non-OADS,/arxiv_data1/oa_pdf/95/af/SNI-7-72.PMC4946276.pdf
"Surgical Neurology International 2016, 7:72  http://www.surgicalneurologyint.com/content/7/1/72Although the incidence of upward cerebellar herniation  is reported to be 3%, sudden clinical deterioration  after shunt surgery is observed more often.",Non-OADS,/arxiv_data1/oa_pdf/95/af/SNI-7-72.PMC4946276.pdf
Available from:  http://www.commonwealthfund.org/Content/Newsletters/ Qualityâ€‘Matters/2010/Februaryâ€‘Marchâ€‘2010/Inâ€‘Focus.aspx.,Non-OADS,/arxiv_data1/oa_pdf/5c/77/JEHP-4-104.PMC4946280.pdf
Available  from: http://www.who.int/nutrition/en/.,Non-OADS,/arxiv_data1/oa_pdf/4e/c6/JEHP-4-95.PMC4946281.pdf
Available from: http://daa.asn.au/wpâ€‘content/ uploads/2011/11/Enteralâ€‘nutritionâ€‘manualâ€‘Octâ€‘2011.pdf.,Non-OADS,/arxiv_data1/oa_pdf/4e/c6/JEHP-4-95.PMC4946281.pdf
Available from: http://www.jcu.edu.au/teaching/idc/groups/ public/documents/statistics/jcuprd_025473.pdf.,Non-OADS,/arxiv_data1/oa_pdf/a5/7b/JEHP-4-101.PMC4946282.pdf
Available from: http://mams.rmit.edu.au/kfj8j9ypwtynz.,Non-OADS,/arxiv_data1/oa_pdf/a5/7b/JEHP-4-101.PMC4946282.pdf
Available from: http://hca.ltsn.ac.uk/assets/ York/documents/ourwork/research/surveys/pres/PRES Executive  Summary.,OADS,/arxiv_data1/oa_pdf/a5/7b/JEHP-4-101.PMC4946282.pdf
"Methods: We evaluated activity and/or expression of cellular markers of oxidative stress, inflammation, and apoptosis in rat liver, following treatment with VPA (500 mg/kg/day) with and without concurrent treatment with DHA (250 mg/kg/day) fortwo weeks.Received: 2 March 2016 Revised: 23 May 2016 Accepted: 24 June 2016 Heliyon 2 (2016) e00130 http://dx.doi.org/10.1016/j.heliyon.2016.e00130 2405-8440/Â© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/92/ac/main.PMC4946287.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/92/ac/main.PMC4946287.pdf
"VPA is extensively metabolized in the liver viaglucuronic acid conjugation, mitochondrial Î²-oxidation and cytosolic Ï‰-oxidation to produce multiple metabolites; some of them are biologically active and could mediate VPA-induced hepatotoxicity.For instance, 4-ene-valproic (4-ene-VPA) is a more potent hepatotoxic than VPA and Article No~e00130 2 http://dx.doi.org/10.1016/j.heliyon.2016.e00130 2405-8440/Â© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/92/ac/main.PMC4946287.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/92/ac/main.PMC4946287.pdf
"Animal studies All procedures with animals were performed in accordance with the Public HealthService Guide for the Care and Use of Laboratory Animals and Augusta Universityguidelines, and approved by the Institutional Animal Care and Use Committee of Article No~e00130 3 http://dx.doi.org/10.1016/j.heliyon.2016.e00130 2405-8440/Â© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/92/ac/main.PMC4946287.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/92/ac/main.PMC4946287.pdf
Band Article No~e00130 4 http://dx.doi.org/10.1016/j.heliyon.2016.e00130 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/92/ac/main.PMC4946287.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/92/ac/main.PMC4946287.pdf
Article No~e00130 5 http://dx.doi.org/10.1016/j.heliyon.2016.e00130 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/92/ac/main.PMC4946287.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/92/ac/main.PMC4946287.pdf
Article No~e00130 6 http://dx.doi.org/10.1016/j.heliyon.2016.e00130 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/92/ac/main.PMC4946287.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/92/ac/main.PMC4946287.pdf
Article No~e00130 7 http://dx.doi.org/10.1016/j.heliyon.2016.e00130 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/92/ac/main.PMC4946287.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/92/ac/main.PMC4946287.pdf
Article No~e00130 8 http://dx.doi.org/10.1016/j.heliyon.2016.e00130 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/92/ac/main.PMC4946287.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/92/ac/main.PMC4946287.pdf
Article No~e00130 9 http://dx.doi.org/10.1016/j.heliyon.2016.e00130 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/92/ac/main.PMC4946287.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/92/ac/main.PMC4946287.pdf
"Notably, NOX, in the liver, has been shown as a crucial mediator of diverse deleterious reactions,including inflammation, mitogenesis, fibrosis, apoptosis and steatosis ( Li et al., Article No~e00130 10 http://dx.doi.org/10.1016/j.heliyon.2016.e00130 2405-8440/Â© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/92/ac/main.PMC4946287.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/92/ac/main.PMC4946287.pdf
"However, beyond that, omega-3 fatty-acids displayed an array of favorable Article No~e00130 11 http://dx.doi.org/10.1016/j.heliyon.2016.e00130 2405-8440/Â© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/92/ac/main.PMC4946287.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/92/ac/main.PMC4946287.pdf
Article No~e00130 12 http://dx.doi.org/10.1016/j.heliyon.2016.e00130 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/92/ac/main.PMC4946287.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/92/ac/main.PMC4946287.pdf
Article No~e00130 13 http://dx.doi.org/10.1016/j.heliyon.2016.e00130 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/92/ac/main.PMC4946287.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/92/ac/main.PMC4946287.pdf
Article No~e00130 14 http://dx.doi.org/10.1016/j.heliyon.2016.e00130 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/92/ac/main.PMC4946287.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/92/ac/main.PMC4946287.pdf
Article No~e00130 15 http://dx.doi.org/10.1016/j.heliyon.2016.e00130 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/92/ac/main.PMC4946287.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/92/ac/main.PMC4946287.pdf
Article No~e00130 16 http://dx.doi.org/10.1016/j.heliyon.2016.e00130 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/92/ac/main.PMC4946287.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/92/ac/main.PMC4946287.pdf
Article No~e00130 17 http://dx.doi.org/10.1016/j.heliyon.2016.e00130 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/92/ac/main.PMC4946287.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/92/ac/main.PMC4946287.pdf
"The first mathematical formulation of the second law is credited to Clausius, who showed that in a reversible Carnot cycle operatingReceived: 20 March 2016 Accepted: 9 May 2016 Heliyon 2 (2016) e00113 http://dx.doi.org/10.1016/j.heliyon.2016.e00113 2405-8440/Â© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/92/79/main.PMC4946288.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/92/79/main.PMC4946288.pdf
Unlike many articles appeared in the Article No~e00113 2 http://dx.doi.org/10.1016/j.heliyon.2016.e00113 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/92/79/main.PMC4946288.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/92/79/main.PMC4946288.pdf
Article No~e00113 3 http://dx.doi.org/10.1016/j.heliyon.2016.e00113 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/92/79/main.PMC4946288.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/92/79/main.PMC4946288.pdf
Article No~e00113 4 http://dx.doi.org/10.1016/j.heliyon.2016.e00113 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/92/79/main.PMC4946288.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/92/79/main.PMC4946288.pdf
Article No~e00113 5 http://dx.doi.org/10.1016/j.heliyon.2016.e00113 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/92/79/main.PMC4946288.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/92/79/main.PMC4946288.pdf
Article No~e00113 6 http://dx.doi.org/10.1016/j.heliyon.2016.e00113 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/92/79/main.PMC4946288.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/92/79/main.PMC4946288.pdf
Article No~e00113 7 http://dx.doi.org/10.1016/j.heliyon.2016.e00113 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/92/79/main.PMC4946288.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/92/79/main.PMC4946288.pdf
Article No~e00113 8 http://dx.doi.org/10.1016/j.heliyon.2016.e00113 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/92/79/main.PMC4946288.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/92/79/main.PMC4946288.pdf
Article No~e00113 9 http://dx.doi.org/10.1016/j.heliyon.2016.e00113 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/92/79/main.PMC4946288.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/92/79/main.PMC4946288.pdf
Article No~e00113 10 http://dx.doi.org/10.1016/j.heliyon.2016.e00113 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/92/79/main.PMC4946288.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/92/79/main.PMC4946288.pdf
Article No~e00113 11 http://dx.doi.org/10.1016/j.heliyon.2016.e00113 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/92/79/main.PMC4946288.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/92/79/main.PMC4946288.pdf
Article No~e00113 12 http://dx.doi.org/10.1016/j.heliyon.2016.e00113 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/92/79/main.PMC4946288.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/92/79/main.PMC4946288.pdf
"So, it would be rational to treat this parameter Article No~e00113 13 http://dx.doi.org/10.1016/j.heliyon.2016.e00113 2405-8440/Â© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/92/79/main.PMC4946288.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/92/79/main.PMC4946288.pdf
Article No~e00113 14 http://dx.doi.org/10.1016/j.heliyon.2016.e00113 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/92/79/main.PMC4946288.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/92/79/main.PMC4946288.pdf
Article No~e00113 15 http://dx.doi.org/10.1016/j.heliyon.2016.e00113 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/92/79/main.PMC4946288.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/92/79/main.PMC4946288.pdf
Article No~e00113 16 http://dx.doi.org/10.1016/j.heliyon.2016.e00113 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/92/79/main.PMC4946288.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/92/79/main.PMC4946288.pdf
"Further, the expression profile of NtPGIP was examined in tobacco leaves following stimulation with the oomycete Phytophthora nicotianae and other stressors, including salicylic acid (SA), abscisic acid (ABA), salt, and coldReceived: 30 November 2015 Revised: 14 March 2016 Accepted: 6 May 2016 Heliyon 2 (2016) e00110 http://dx.doi.org/10.1016/j.heliyon.2016.e00110 2405-8440/Â© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/0f/de/main.PMC4946289.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/0f/de/main.PMC4946289.pdf
"Each LRR motif consists of a consensus GxIPxxLGxLxxLxxLxLxxNxLT/S sequence, with the hypervariable xxLxLxx region predicted to form a beta-strand Article No~e00110 2 http://dx.doi.org/10.1016/j.heliyon.2016.e00110 2405-8440/Â© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/0f/de/main.PMC4946289.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/0f/de/main.PMC4946289.pdf
The recombinant Article No~e00110 3 http://dx.doi.org/10.1016/j.heliyon.2016.e00110 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/0f/de/main.PMC4946289.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/0f/de/main.PMC4946289.pdf
5 â€²- and 3 â€²-RACE-PCR amplifications of the NtPGIP gene were performed using a Smart RACE cDNA amplification kit Article No~e00110 4 http://dx.doi.org/10.1016/j.heliyon.2016.e00110 2405-8440/Â© 2016 The Authors.,OADS,/arxiv_data1/oa_pdf/0f/de/main.PMC4946289.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/0f/de/main.PMC4946289.pdf
The PGIP LRR domains werepredicated using the SMART server ( http://smart.embl-eidelberg.de ) and signalingTable 1.,OADS,/arxiv_data1/oa_pdf/0f/de/main.PMC4946289.pdf
Article No~e00110 5 http://dx.doi.org/10.1016/j.heliyon.2016.e00110 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/0f/de/main.PMC4946289.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/0f/de/main.PMC4946289.pdf
peptide sequence were predicted using SignalP 4.1 ( http://www.cbs.dtu.dk/ services/SignalP/ ).,OADS,/arxiv_data1/oa_pdf/0f/de/main.PMC4946289.pdf
The threshold cycle (CT) values Article No~e00110 6 http://dx.doi.org/10.1016/j.heliyon.2016.e00110 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/0f/de/main.PMC4946289.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/0f/de/main.PMC4946289.pdf
The purity of the refolded Article No~e00110 7 http://dx.doi.org/10.1016/j.heliyon.2016.e00110 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/0f/de/main.PMC4946289.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/0f/de/main.PMC4946289.pdf
One unit of PGIP was defined as the amount of inhibitor required to reduce Article No~e00110 8 http://dx.doi.org/10.1016/j.heliyon.2016.e00110 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/0f/de/main.PMC4946289.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/0f/de/main.PMC4946289.pdf
Article No~e00110 9 http://dx.doi.org/10.1016/j.heliyon.2016.e00110 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/0f/de/main.PMC4946289.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/0f/de/main.PMC4946289.pdf
Article No~e00110 10 http://dx.doi.org/10.1016/j.heliyon.2016.e00110 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/0f/de/main.PMC4946289.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/0f/de/main.PMC4946289.pdf
Article No~e00110 11 http://dx.doi.org/10.1016/j.heliyon.2016.e00110 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/0f/de/main.PMC4946289.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/0f/de/main.PMC4946289.pdf
Article No~e00110 12 http://dx.doi.org/10.1016/j.heliyon.2016.e00110 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/0f/de/main.PMC4946289.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/0f/de/main.PMC4946289.pdf
Article No~e00110 13 http://dx.doi.org/10.1016/j.heliyon.2016.e00110 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/0f/de/main.PMC4946289.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/0f/de/main.PMC4946289.pdf
Article No~e00110 14 http://dx.doi.org/10.1016/j.heliyon.2016.e00110 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/0f/de/main.PMC4946289.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/0f/de/main.PMC4946289.pdf
Article No~e00110 15 http://dx.doi.org/10.1016/j.heliyon.2016.e00110 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/0f/de/main.PMC4946289.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/0f/de/main.PMC4946289.pdf
Article No~e00110 16 http://dx.doi.org/10.1016/j.heliyon.2016.e00110 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/0f/de/main.PMC4946289.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/0f/de/main.PMC4946289.pdf
"However, there are many specific PGIPs that are highly specific (Desiderio et al., 1997 ;Cook et al., 1999 ;Leckie et al., 1999 ), such as four P. vulgaris PGIPs that display different inhibitory activities and specific recognition abilities against endoPGs from various sources ( Leckie et al., 1999 ;Dâ€™Ovidio Article No~e00110 17 http://dx.doi.org/10.1016/j.heliyon.2016.e00110 2405-8440/Â© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/0f/de/main.PMC4946289.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/0f/de/main.PMC4946289.pdf
Article No~e00110 18 http://dx.doi.org/10.1016/j.heliyon.2016.e00110 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/0f/de/main.PMC4946289.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/0f/de/main.PMC4946289.pdf
Article No~e00110 19 http://dx.doi.org/10.1016/j.heliyon.2016.e00110 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/0f/de/main.PMC4946289.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/0f/de/main.PMC4946289.pdf
Floral transcription factor AGAMOUS interacts in vitro with a Article No~e00110 20 http://dx.doi.org/10.1016/j.heliyon.2016.e00110 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/0f/de/main.PMC4946289.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/0f/de/main.PMC4946289.pdf
Article No~e00110 21 http://dx.doi.org/10.1016/j.heliyon.2016.e00110 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/0f/de/main.PMC4946289.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/0f/de/main.PMC4946289.pdf
"Polygalacturonase-inhibiting protein 2 of Phaseolus vulgaris inhibits BcPG1, a Article No~e00110 22 http://dx.doi.org/10.1016/j.heliyon.2016.e00110 2405-8440/Â© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/0f/de/main.PMC4946289.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/0f/de/main.PMC4946289.pdf
Article No~e00110 23 http://dx.doi.org/10.1016/j.heliyon.2016.e00110 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/0f/de/main.PMC4946289.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/0f/de/main.PMC4946289.pdf
Article No~e00110 24 http://dx.doi.org/10.1016/j.heliyon.2016.e00110 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/0f/de/main.PMC4946289.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/0f/de/main.PMC4946289.pdf
"Results: Although the predictive model utilising VPDC data had a low overall prediction performance, it had a reasonable discrimination (c statistic 0.646 [95%Received: 30 December 2015 Revised: 31 March 2016 Accepted: 23 May 2016 Heliyon 2 (2016) e00119 http://dx.doi.org/10.1016/j.heliyon.2016.e00119 2405-8440/Â© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/b3/c7/main.PMC4946290.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/b3/c7/main.PMC4946290.pdf
"For many regional or remote areas, the minimum data items required in routine reports to the Article No~e00119 2 http://dx.doi.org/10.1016/j.heliyon.2016.e00119 2405-8440/Â© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/b3/c7/main.PMC4946290.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/b3/c7/main.PMC4946290.pdf
In Article No~e00119 3 http://dx.doi.org/10.1016/j.heliyon.2016.e00119 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/b3/c7/main.PMC4946290.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/b3/c7/main.PMC4946290.pdf
(yes/no/unknown) Birth plurality Article No~e00119 4 http://dx.doi.org/10.1016/j.heliyon.2016.e00119 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/b3/c7/main.PMC4946290.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/b3/c7/main.PMC4946290.pdf
Article No~e00119 5 http://dx.doi.org/10.1016/j.heliyon.2016.e00119 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/b3/c7/main.PMC4946290.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/b3/c7/main.PMC4946290.pdf
Records with missing data were excluded Article No~e00119 6 http://dx.doi.org/10.1016/j.heliyon.2016.e00119 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/b3/c7/main.PMC4946290.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/b3/c7/main.PMC4946290.pdf
Number of patients (percentage) Percentage of preterm <34 weeks <37 weeks Age distribution 15â€“20 468 (5.8%) 2.6% 7.3% 20â€“30 4009 (49.5%) 1.4% 6.4% 30â€“40 3417 (42.2%) 1.6% 6.7% 40â€“55 200 (2.5%) 1.5% 7.5% Indigenous status Indigenous Australians 104 (1.3%) 1.9% 6.7%Nonindigenous 7996 (98.7) 1.6% 6.6% Plurality 1 8007 (98.9%) 1.4% 6.0% >=2 93 (1.1%) 20.4% 58.1% BMI <18.5 176 (2.2%) 1.1% 9.1% 18.5â€“25 3759 (46.4%) 1.5% 6.5% 25â€“30 2239 (27.6%) 1.8% 5.9% >30 1926 (23.8%) 1.7% 7.4% Care Provider Obstetrician 1870 (23%) 3.6% 12.8% Midwife 5405 (67%) 0.8% 4.6% GP 807 (10%) 1.5% 5.3% Article No~e00119 7 http://dx.doi.org/10.1016/j.heliyon.2016.e00119 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/b3/c7/main.PMC4946290.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/b3/c7/main.PMC4946290.pdf
"Performance measure VPDC alone With information on previous preterm and partner smoking Overall prediction performance Brier 0.059 0.060Scaled Brier 4.1% 3.6% Nagelkerke â€™sR 26.7% 6.4% Discrimination c statistics [95% CI] 0.646 [0.596 â€“0.697] 0.645 [0.595 â€“0.697] Discrimination slope 0.060 0.060 Calibration Calibration in the large -0.027 -0.020 Calibration slop 0.804 0.753 Hosmer â€“Lemeshow test Chi-square 7.3, p = 0.61 Chi-square 12.0, p = 0.21 Article No~e00119 8 http://dx.doi.org/10.1016/j.heliyon.2016.e00119 2405-8440/Â© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/b3/c7/main.PMC4946290.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/b3/c7/main.PMC4946290.pdf
Decision threshold based on predicted probability ^pSensitivity Specificity PPV NPV 0.2 12.7% 98.2% 33.3% 94.1% 0.16 16.4% 96.9% 27.8% 94.2% 0.13 20.1% 95.3% 23.4% 94.4% Article No~e00119 9 http://dx.doi.org/10.1016/j.heliyon.2016.e00119 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/b3/c7/main.PMC4946290.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/b3/c7/main.PMC4946290.pdf
Article No~e00119 10 http://dx.doi.org/10.1016/j.heliyon.2016.e00119 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/b3/c7/main.PMC4946290.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/b3/c7/main.PMC4946290.pdf
The significant morbidity and mortality associated with preterm birth have made prevention of preterm birth a global priority for medical research and innovation.Reducing the rate of preterm birth will require accurate identification of those at Article No~e00119 11 http://dx.doi.org/10.1016/j.heliyon.2016.e00119 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/b3/c7/main.PMC4946290.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/b3/c7/main.PMC4946290.pdf
Article No~e00119 12 http://dx.doi.org/10.1016/j.heliyon.2016.e00119 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/b3/c7/main.PMC4946290.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/b3/c7/main.PMC4946290.pdf
Article No~e00119 13 http://dx.doi.org/10.1016/j.heliyon.2016.e00119 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/b3/c7/main.PMC4946290.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/b3/c7/main.PMC4946290.pdf
Viewed 25 November 2013 http://www.aihw.gov.au/publication-detail/ ?id=10737420870 .,Non-OADS,/arxiv_data1/oa_pdf/b3/c7/main.PMC4946290.pdf
Viewed 20 November 2013 http://www.aihw.gov.au/publication-detail/?id=10737420870 .,Non-OADS,/arxiv_data1/oa_pdf/b3/c7/main.PMC4946290.pdf
Article No~e00119 14 http://dx.doi.org/10.1016/j.heliyon.2016.e00119 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/b3/c7/main.PMC4946290.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/b3/c7/main.PMC4946290.pdf
Article No~e00119 15 http://dx.doi.org/10.1016/j.heliyon.2016.e00119 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/b3/c7/main.PMC4946290.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/b3/c7/main.PMC4946290.pdf
The major task of any dictionary in this respect is to create a consistent picture of word useReceived: 27 May 2015 Revised: 10 October 2015 Accepted: 7 January 2016 Heliyon (2016) e00065 http://dx.doi.org/10.1016/j.heliyon.2016.e00065 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/46/3c/main.PMC4946291.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/46/3c/main.PMC4946291.pdf
"In this respect it is not quite clear from the dictionary entry in what way such senses of the word bank asâ€œbusiness that keeps and lends money and provides other financial services â€,â€œland along the side of a river or lake â€orâ€œa large number Article No~e00065 2 http://dx.doi.org/10.1016/j.heliyon.2016.e00065 2405-8440/Â© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/46/3c/main.PMC4946291.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/46/3c/main.PMC4946291.pdf
"For example, in the CCLD edited by John Sinclair - who is known as an Article No~e00065 3 http://dx.doi.org/10.1016/j.heliyon.2016.e00065 2405-8440/Â© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/46/3c/main.PMC4946291.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/46/3c/main.PMC4946291.pdf
"For example, in the following sentences the verb and the noun bank definitely refer to the same situational model: Article No~e00065 4 http://dx.doi.org/10.1016/j.heliyon.2016.e00065 2405-8440/Â© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/46/3c/main.PMC4946291.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/46/3c/main.PMC4946291.pdf
"Meaning as word use The nature of word meaning has always been one of the key questions in linguistics and philosophy of language, which has been treated differently by Article No~e00065 5 http://dx.doi.org/10.1016/j.heliyon.2016.e00065 2405-8440/Â© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/46/3c/main.PMC4946291.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/46/3c/main.PMC4946291.pdf
"In our opinion, all ideas are compositelinguistic structures, which means that relation to a certain (non-linguistic) idea Article No~e00065 6 http://dx.doi.org/10.1016/j.heliyon.2016.e00065 2405-8440/Â© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/46/3c/main.PMC4946291.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/46/3c/main.PMC4946291.pdf
Article No~e00065 7 http://dx.doi.org/10.1016/j.heliyon.2016.e00065 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/46/3c/main.PMC4946291.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/46/3c/main.PMC4946291.pdf
It is much more difficult to imagine how suchabstract nouns as love orjustice can be interpreted in terms of a formalized Article No~e00065 8 http://dx.doi.org/10.1016/j.heliyon.2016.e00065 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/46/3c/main.PMC4946291.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/46/3c/main.PMC4946291.pdf
Article No~e00065 9 http://dx.doi.org/10.1016/j.heliyon.2016.e00065 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/46/3c/main.PMC4946291.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/46/3c/main.PMC4946291.pdf
Basic word senses The first important question that should be answered is how to define relations that hold between such instances of use of the lexeme bank asar i v e r [306_TD$DIFF]bank Article No~e00065 10 http://dx.doi.org/10.1016/j.heliyon.2016.e00065 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/46/3c/main.PMC4946291.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/46/3c/main.PMC4946291.pdf
In this way the word Article No~e00065 11 http://dx.doi.org/10.1016/j.heliyon.2016.e00065 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/46/3c/main.PMC4946291.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/46/3c/main.PMC4946291.pdf
It's Article No~e00065 12 http://dx.doi.org/10.1016/j.heliyon.2016.e00065 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/46/3c/main.PMC4946291.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/46/3c/main.PMC4946291.pdf
Article No~e00065 13 http://dx.doi.org/10.1016/j.heliyon.2016.e00065 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/46/3c/main.PMC4946291.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/46/3c/main.PMC4946291.pdf
Article No~e00065 14 http://dx.doi.org/10.1016/j.heliyon.2016.e00065 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/46/3c/main.PMC4946291.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/46/3c/main.PMC4946291.pdf
Article No~e00065 15 http://dx.doi.org/10.1016/j.heliyon.2016.e00065 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/46/3c/main.PMC4946291.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/46/3c/main.PMC4946291.pdf
Article No~e00065 16 http://dx.doi.org/10.1016/j.heliyon.2016.e00065 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/46/3c/main.PMC4946291.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/46/3c/main.PMC4946291.pdf
"In the first sentence we are definitely dealing with the institution sense, its marker Article No~e00065 17 http://dx.doi.org/10.1016/j.heliyon.2016.e00065 2405-8440/Â© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/46/3c/main.PMC4946291.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/46/3c/main.PMC4946291.pdf
PHYSICAL SPACE [406_TD$DIFF]SENSE I NOUN [C]: an elevated surface ensuring a steady and consistent process within the space it encompasses Article No~e00065 18 http://dx.doi.org/10.1016/j.heliyon.2016.e00065 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/46/3c/main.PMC4946291.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/46/3c/main.PMC4946291.pdf
Article No~e00065 19 http://dx.doi.org/10.1016/j.heliyon.2016.e00065 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/46/3c/main.PMC4946291.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/46/3c/main.PMC4946291.pdf
(COCA: [32]) Article No~e00065 20 http://dx.doi.org/10.1016/j.heliyon.2016.e00065 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/46/3c/main.PMC4946291.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/46/3c/main.PMC4946291.pdf
"However, some Article No~e00065 21 http://dx.doi.org/10.1016/j.heliyon.2016.e00065 2405-8440/Â© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/46/3c/main.PMC4946291.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/46/3c/main.PMC4946291.pdf
Article No~e00065 22 http://dx.doi.org/10.1016/j.heliyon.2016.e00065 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/46/3c/main.PMC4946291.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/46/3c/main.PMC4946291.pdf
"[10] A Banked Turn [384_TD$DIFF]â€“No Friction, available at: http://www.batesville.k12.in.us/ physics/phynet/mechanics/circular%20motion/banked_no_friction.htm (accessed on 12 August 2015).",Non-OADS,/arxiv_data1/oa_pdf/46/3c/main.PMC4946291.pdf
"Akers, The Krozair Cycle: The Saga of Dray Prescot Omnibus, Bladud Books, 2010 Available at: https://books.google.fr (accessed on 05March 2015) .",Non-OADS,/arxiv_data1/oa_pdf/46/3c/main.PMC4946291.pdf
Article No~e00065 23 http://dx.doi.org/10.1016/j.heliyon.2016.e00065 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/46/3c/main.PMC4946291.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/46/3c/main.PMC4946291.pdf
"[13] Baby Center, Available at: http://www.babycenter.com/400_should-i-bank- my-babys-cord-blood_500601_0.bc?startIndex=20&sortFieldName (accessed on 30 August 2014).",Non-OADS,/arxiv_data1/oa_pdf/46/3c/main.PMC4946291.pdf
"[19] Davies, M. The Corpus of Contemporary American English (COCA), available at: http://corpus.byu.edu/coca/ (accessed on 4 April 2015).",Non-OADS,/arxiv_data1/oa_pdf/46/3c/main.PMC4946291.pdf
Article No~e00065 24 http://dx.doi.org/10.1016/j.heliyon.2016.e00065 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/46/3c/main.PMC4946291.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/46/3c/main.PMC4946291.pdf
Article No~e00065 25 http://dx.doi.org/10.1016/j.heliyon.2016.e00065 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/46/3c/main.PMC4946291.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/46/3c/main.PMC4946291.pdf
"[51] Hall L. Pool Table, Available at: http://www.madehow.com/Volume-6/ Pool-Table.html (accessed on 02 April 2015).",Non-OADS,/arxiv_data1/oa_pdf/46/3c/main.PMC4946291.pdf
"[59] How Stuff Works, available at: http://auto.howstuffworks.com/auto-racing/ nascar/race-tracks/daytona-5003.htm (accessed on 12 August 2014) [60] A. Kilgarriff, I don't believe in word senses, Comput.",Non-OADS,/arxiv_data1/oa_pdf/46/3c/main.PMC4946291.pdf
Article No~e00065 26 http://dx.doi.org/10.1016/j.heliyon.2016.e00065 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/46/3c/main.PMC4946291.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/46/3c/main.PMC4946291.pdf
"[66] G. Mogridge, The Old Sea Captain, Facsimile Publisher, 1842 Available at:https://books.google.fr (accessed on 05 March 2015) .",Non-OADS,/arxiv_data1/oa_pdf/46/3c/main.PMC4946291.pdf
"Universidad AutÃ³noma de Madrid, available at:http://web.uam.es/departamentos/filoyletras/filoinglesa/Courses/LFC11/LFC- 2011-Week1.pdf (accessed 27 March 2015) [69] C.K.",Non-OADS,/arxiv_data1/oa_pdf/46/3c/main.PMC4946291.pdf
Article No~e00065 27 http://dx.doi.org/10.1016/j.heliyon.2016.e00065 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/46/3c/main.PMC4946291.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/46/3c/main.PMC4946291.pdf
"[79] Second Life, available at: http://community.secondlife.com/t5/LSL- Scripting/How-to-make-a-car-bank-on-a-banked-turn-on-a-race-track/td-p/2720316 (accessed on 12 August 2014) [80] A.Yu.",Non-OADS,/arxiv_data1/oa_pdf/46/3c/main.PMC4946291.pdf
"[83] The Singapore River, available at: http://comesingapore.com/travel-guide/ article/541/the-singapore-river (accessed on 25 January 2016).",Non-OADS,/arxiv_data1/oa_pdf/46/3c/main.PMC4946291.pdf
"Pulling Boat Oar Commands 1775 [386_TD$DIFF][1_TD$DIFF]â€“1783, available at: http://www.hmsrichmond.org/oarcmd.htm (accessed on 10 September 2014) Article No~e00065 28 http://dx.doi.org/10.1016/j.heliyon.2016.e00065 2405-8440/Â© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/46/3c/main.PMC4946291.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/46/3c/main.PMC4946291.pdf
"Bank Pool, Available at: http://en.wikipedia.org/wiki/Bank_pool (accessed on 03 April 2015).",Non-OADS,/arxiv_data1/oa_pdf/46/3c/main.PMC4946291.pdf
"Elevator, Available at: http://en.wikipedia.org/wiki/Elevator (accessed on 04 April 2015).",Non-OADS,/arxiv_data1/oa_pdf/46/3c/main.PMC4946291.pdf
"River Time: the Way of the James, available at: http://www.vcu.edu/engweb/Rivertime/chp7.htm (accessed on 15 September 2014).",Non-OADS,/arxiv_data1/oa_pdf/46/3c/main.PMC4946291.pdf
"[92] Yahoo!Answers, available at: https://answers.yahoo.com/question/index?",Non-OADS,/arxiv_data1/oa_pdf/46/3c/main.PMC4946291.pdf
Article No~e00065 29 http://dx.doi.org/10.1016/j.heliyon.2016.e00065 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/46/3c/main.PMC4946291.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/46/3c/main.PMC4946291.pdf
"Animals were treated with doses of the antibiotics to simulate the human exposure of meropenem 2 g q8 h 30-min infusion, cefepime 2 g q8 h 30-min infusion and levofloxacin 500 mg q24 h. After 24 hours, the animals were euthanized and efficacy wasReceived: 22 March 2016 Revised: 3 June 2016 Accepted: 8 June 2016 Heliyon 2 (2016) e00121 http://dx.doi.org/10.1016/j.heliyon.2016.e00121 2405-8440/Â© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/ea/4a/main.PMC4946293.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ea/4a/main.PMC4946293.pdf
Article No~e00121 2 http://dx.doi.org/10.1016/j.heliyon.2016.e00121 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ea/4a/main.PMC4946293.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ea/4a/main.PMC4946293.pdf
Article No~e00121 3 http://dx.doi.org/10.1016/j.heliyon.2016.e00121 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ea/4a/main.PMC4946293.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ea/4a/main.PMC4946293.pdf
Article No~e00121 4 http://dx.doi.org/10.1016/j.heliyon.2016.e00121 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ea/4a/main.PMC4946293.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ea/4a/main.PMC4946293.pdf
Article No~e00121 5 http://dx.doi.org/10.1016/j.heliyon.2016.e00121 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ea/4a/main.PMC4946293.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ea/4a/main.PMC4946293.pdf
Article No~e00121 6 http://dx.doi.org/10.1016/j.heliyon.2016.e00121 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ea/4a/main.PMC4946293.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ea/4a/main.PMC4946293.pdf
Article No~e00121 7 http://dx.doi.org/10.1016/j.heliyon.2016.e00121 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ea/4a/main.PMC4946293.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ea/4a/main.PMC4946293.pdf
"Waterman, Article No~e00121 8 http://dx.doi.org/10.1016/j.heliyon.2016.e00121 2405-8440/Â© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/ea/4a/main.PMC4946293.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ea/4a/main.PMC4946293.pdf
Article No~e00121 9 http://dx.doi.org/10.1016/j.heliyon.2016.e00121 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ea/4a/main.PMC4946293.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ea/4a/main.PMC4946293.pdf
Article No~e00121 10 http://dx.doi.org/10.1016/j.heliyon.2016.e00121 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ea/4a/main.PMC4946293.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ea/4a/main.PMC4946293.pdf
A planning process seeking more ecosystem services fromReceived: 22 April 2016 Revised: 16 June 2016 Accepted: 20 June 2016 Heliyon 2 (2016) e00127 http://dx.doi.org/10.1016/j.heliyon.2016.e00127 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/74/7a/main.PMC4946306.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/74/7a/main.PMC4946306.pdf
One approach asks (verbally) about perceptions of lawn attributes such as chemical use Article No~e00127 2 http://dx.doi.org/10.1016/j.heliyon.2016.e00127 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/74/7a/main.PMC4946306.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/74/7a/main.PMC4946306.pdf
"Final ES impacts represent statements in terms that are most understandable by thegeneral public and include flood control, improved water quality, increased plant Article No~e00127 3 http://dx.doi.org/10.1016/j.heliyon.2016.e00127 2405-8440/Â© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/74/7a/main.PMC4946306.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/74/7a/main.PMC4946306.pdf
â€In Article No~e00127 4 http://dx.doi.org/10.1016/j.heliyon.2016.e00127 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/74/7a/main.PMC4946306.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/74/7a/main.PMC4946306.pdf
Article No~e00127 5 http://dx.doi.org/10.1016/j.heliyon.2016.e00127 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/74/7a/main.PMC4946306.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/74/7a/main.PMC4946306.pdf
Article No~e00127 6 http://dx.doi.org/10.1016/j.heliyon.2016.e00127 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/74/7a/main.PMC4946306.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/74/7a/main.PMC4946306.pdf
Article No~e00127 7 http://dx.doi.org/10.1016/j.heliyon.2016.e00127 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/74/7a/main.PMC4946306.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/74/7a/main.PMC4946306.pdf
The study site was somewhat atypical for the region in that its development had comparatively larger Article No~e00127 8 http://dx.doi.org/10.1016/j.heliyon.2016.e00127 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/74/7a/main.PMC4946306.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/74/7a/main.PMC4946306.pdf
"Driver â€™s licenses were the randomizing mechanism used to sample the target population, an approach successfully used in other research to intercept an Article No~e00127 9 http://dx.doi.org/10.1016/j.heliyon.2016.e00127 2405-8440/Â© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/74/7a/main.PMC4946306.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/74/7a/main.PMC4946306.pdf
Article No~e00127 10 http://dx.doi.org/10.1016/j.heliyon.2016.e00127 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/74/7a/main.PMC4946306.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/74/7a/main.PMC4946306.pdf
Occupational Employment Statistics: 37â€“3011 Landscaping and Groundskeeping Workers http://www.bls.gov/oes/current/oes373011.htm .,OADS,/arxiv_data1/oa_pdf/74/7a/main.PMC4946306.pdf
Article No~e00127 11 http://dx.doi.org/10.1016/j.heliyon.2016.e00127 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/74/7a/main.PMC4946306.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/74/7a/main.PMC4946306.pdf
Male Female Total Respondents Intercepted 199 124 323 Participants 73 48 121Refusals 126 76 202 Response Rate 36.7% 38.7% 37.5% Self-Selectors 8 12 20 Percent Of Participants Self-Selecting 11.0% 25.0% 16.5% Usable Surveys 60 45 105 Article No~e00127 12 http://dx.doi.org/10.1016/j.heliyon.2016.e00127 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/74/7a/main.PMC4946306.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/74/7a/main.PMC4946306.pdf
Positive curb appeal was anticipated because respondents viewed pictures to provide confidence in the intervention â€™s Article No~e00127 13 http://dx.doi.org/10.1016/j.heliyon.2016.e00127 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/74/7a/main.PMC4946306.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/74/7a/main.PMC4946306.pdf
"A majority rated curb appeal, looks different, no sheering, and no mulch as positive.Less lawn for sports and more weeding were the only two impacts where the â€œbadâ€ Article No~e00127 14 http://dx.doi.org/10.1016/j.heliyon.2016.e00127 2405-8440/Â© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/74/7a/main.PMC4946306.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/74/7a/main.PMC4946306.pdf
Article No~e00127 15 http://dx.doi.org/10.1016/j.heliyon.2016.e00127 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/74/7a/main.PMC4946306.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/74/7a/main.PMC4946306.pdf
Note Article No~e00127 16 http://dx.doi.org/10.1016/j.heliyon.2016.e00127 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/74/7a/main.PMC4946306.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/74/7a/main.PMC4946306.pdf
Article No~e00127 17 http://dx.doi.org/10.1016/j.heliyon.2016.e00127 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/74/7a/main.PMC4946306.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/74/7a/main.PMC4946306.pdf
These Article No~e00127 18 http://dx.doi.org/10.1016/j.heliyon.2016.e00127 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/74/7a/main.PMC4946306.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/74/7a/main.PMC4946306.pdf
Article No~e00127 19 http://dx.doi.org/10.1016/j.heliyon.2016.e00127 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/74/7a/main.PMC4946306.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/74/7a/main.PMC4946306.pdf
Article No~e00127 20 http://dx.doi.org/10.1016/j.heliyon.2016.e00127 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/74/7a/main.PMC4946306.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/74/7a/main.PMC4946306.pdf
"Second, developments have restrictive covenants that prevent some sustainable Article No~e00127 21 http://dx.doi.org/10.1016/j.heliyon.2016.e00127 2405-8440/Â© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/74/7a/main.PMC4946306.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/74/7a/main.PMC4946306.pdf
"Theaffluent neighborhood has houses with large yards, but the intervention reduced Article No~e00127 22 http://dx.doi.org/10.1016/j.heliyon.2016.e00127 2405-8440/Â© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/74/7a/main.PMC4946306.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/74/7a/main.PMC4946306.pdf
Article No~e00127 23 http://dx.doi.org/10.1016/j.heliyon.2016.e00127 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/74/7a/main.PMC4946306.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/74/7a/main.PMC4946306.pdf
Article No~e00127 24 http://dx.doi.org/10.1016/j.heliyon.2016.e00127 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/74/7a/main.PMC4946306.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/74/7a/main.PMC4946306.pdf
Article No~e00127 25 http://dx.doi.org/10.1016/j.heliyon.2016.e00127 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/74/7a/main.PMC4946306.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/74/7a/main.PMC4946306.pdf
NowData â€”NOAA Online Weather Data http://www.weather.gov/ climate/xmacis.php?wfo=phi .,OADS,/arxiv_data1/oa_pdf/74/7a/main.PMC4946306.pdf
Article No~e00127 26 http://dx.doi.org/10.1016/j.heliyon.2016.e00127 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/74/7a/main.PMC4946306.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/74/7a/main.PMC4946306.pdf
Article No~e00127 27 http://dx.doi.org/10.1016/j.heliyon.2016.e00127 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/74/7a/main.PMC4946306.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/74/7a/main.PMC4946306.pdf
Keywords: Food ScienceReceived: 12 January 2016 Revised: 19 April 2016 Accepted: 14 June 2016 Heliyon 2 (2016) e00124 http://dx.doi.org/10.1016/j.heliyon.2016.e00124 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/be/e8/main.PMC4946307.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/be/e8/main.PMC4946307.pdf
Article No~e00124 2 http://dx.doi.org/10.1016/j.heliyon.2016.e00124 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/be/e8/main.PMC4946307.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/be/e8/main.PMC4946307.pdf
Article No~e00124 3 http://dx.doi.org/10.1016/j.heliyon.2016.e00124 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/be/e8/main.PMC4946307.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/be/e8/main.PMC4946307.pdf
Keys Common Name (Spanish) Common name Scientific name Specimens Origin Provided by Accession number EENC Anchoa European anchovy Engraulis encrasicolus EENC1 Spain Alfageme KX062193 EENC4 Spain Alfageme KX062194EENC6 Spain Alfageme KX062195 EENC5 Spain Alfageme KX062196 EENC3 Spain Alfageme KX062197 EJAP Anchoa japonesa Japanese anchovy Engraulis japonicus EJAP2 Japan A. Takasuka KX062166 EJAP4 Japan A. Takasuka KX062167EJAP1 Japan A. Takasuka KX062168 EJAP3 Japan A. Takasuka KX062169 EJAP5 Japan A. Takasuka KX062170 EANC Anchoita Argentine anchovy Engraulis anchoita EANCH1 Argentina Conxemar KX062155 EANCH10 Argentina Conxemar KX062156EANCH6 Argentina Conxemar KX062157 EANCH8 Argentina Conxemar KX062158 EANCH2 Argentina Conxemar KX062159 EANCH3 Argentina Conxemar KX062160 EANCH7 Argentina Conxemar KX062161EANCH4 Argentina Conxemar KX062162 EANCH9 Argentina Conxemar KX062163 EANCH5 Argentina Conxemar KX062164 EANCHOITA1 Argentina Conxemar KX062165 ERIN Anchoveta Peruvian anchovy Engraulis ringens ERIN2 Peru Conxemar KX062198 ERIN4 Peru Conxemar KX062199 (Continued ) Article No~e00124 4 http://dx.doi.org/10.1016/j.heliyon.2016.e00124 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/be/e8/main.PMC4946307.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/be/e8/main.PMC4946307.pdf
"(Continued ) Keys Common Name (Spanish) Common name Scientific name Specimens Origin Provided by Accession number ERIN3 Peru Conxemar KX062200 ERIN1 Peru Conxemar KX062201 ERIN5 Peru Conxemar KX062174 ANAS Anchovetas indias, anchoveta blanca Longnose anchovy Anchoa nasus ANAS1 Mexico IIM KX062149 ANAS4 Mexico IIM KX062150ANAS6 Mexico IIM KX062151 ANAS3 Mexico IIM KX062152 ANAS5 Mexico IIM KX062153 ANAS2 Mexico IIM KX062154 EMOR Anchoa de California Californian anchovy Engraulis mordax EMOR14GB GenBank JQ012350 EMOR15GB GenBank FJ264393 EMOR16GB GenBank FJ264392 EMOR17GB GenBank AY923783 EMOR18GB GenBank AY923782 SPIL Sardina European pilchard Sardina pilchardus SPIL10 Spain IIM KX062184 SPIL13 Spain IIM KX062185 SPIL12 Spain IIM KX062186 SPIL14 Spain IIM KX062187 SPIL11 Spain IIM KX062188 SAUR Sardinelas Round sardinella Sardinella aurita SAUR1 Senegal IIM KX062175 SAUR2 Senegal IIM KX062176 SAUR3 Spain IIM KX062177 SAUR4 Spain IIM KX062178 SAUR5 Spain IIM KX062179 (Continued ) Article No~e00124 5 http://dx.doi.org/10.1016/j.heliyon.2016.e00124 2405-8440/Â© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/be/e8/main.PMC4946307.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/be/e8/main.PMC4946307.pdf
(Continued ) Keys Common Name (Spanish) Common name Scientific name Specimens Origin Provided by Accession number SSAG Sardinopas Southamerican pilchard Sardinops sagax SSAG1 Peru/Chile IIM KX062189 SSAG4 Peru/Chile IIM KX062190 SSAG3 Peru/Chile IIM KX062191 SSAG2 Peru/Chile IIM KX062192 EMAC Machete Pacific Menhaden Ethmidium maculatum EMAC3 Peru/Chile BIP Vigo KX062171 EMAC2 Peru/Chile BIP Vigo KX062172 EMAC1 Peru/Chile BIP Vigo KX062173 SMAD Sardinelas Madeiran sardinella Sardinella maderiensis SMAD1 Senegal IIM KX062180 SMAD2 Senegal IIM KX062181 SMAD3 Senegal IIM KX062182 SMAD4 Senegal IIM KX062183 CHAR Arenque Atlantic herring Clupea harengus CLUPEAHARENGUSGB GenBank EU492008 Article No~e00124 6 http://dx.doi.org/10.1016/j.heliyon.2016.e00124 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/be/e8/main.PMC4946307.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/be/e8/main.PMC4946307.pdf
Article No~e00124 7 http://dx.doi.org/10.1016/j.heliyon.2016.e00124 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/be/e8/main.PMC4946307.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/be/e8/main.PMC4946307.pdf
Article No~e00124 8 http://dx.doi.org/10.1016/j.heliyon.2016.e00124 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/be/e8/main.PMC4946307.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/be/e8/main.PMC4946307.pdf
"This methodology is based on the analysis of DNA sequences, in this case a cytochrome b fragment of 464 bp Article No~e00124 9 http://dx.doi.org/10.1016/j.heliyon.2016.e00124 2405-8440/Â© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/be/e8/main.PMC4946307.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/be/e8/main.PMC4946307.pdf
Engraulis encrasicholus 02/06/ 2013Vigo Engraulis encrasicolus100 bp Engraulis encrasicolusEngraulis encrasicolus100% correct (Continued ) Article No~e00124 10 http://dx.doi.org/10.1016/j.heliyon.2016.e00124 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/be/e8/main.PMC4946307.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/be/e8/main.PMC4946307.pdf
"Engraulis encrasicholus, Mediterranean Sea (Morocco)02/08/ 2013Vigo Engraulis encrasicolus464 bp Engraulis encrasicolusEngraulis encrasicolus99% KJ563143 correct AS1 Anchovies in olive oil (40%) 06/12/ 2013Santiago de CompostelaAnchoas 464 bp Engraulis encrasicolusEngraulis encrasicolus99% KJ563162 correct AS2 Anchovies fillets in vegetable oil, Engraulis ringens 06/12/ 2013Santiago de CompostelaEngraulis ringens464 bp Engraulis encrasicolusEngraulis encrasicolus98% KJ563163 mislabelled AS3 Anchovies fillets in vegetable oil, Engraulis ringens 06/12/ 2013Santiago de CompostelaEngraulis ringens100 bp Engraulis ringensEngraulis ringens100% correct AS4 Anchovies fillets in sunflower oil 06/12/ 2013Santiago de CompostelaAnchoas 100 bp Engraulis ringensEngraulisringens100% correct AS5 Anchovies fillets in vegetable oil, Engraulis ringens 06/12/ 2013Santiago de CompostelaEngraulis ringens100 bp Engraulis ringensEngraulis ringens100% correct AS6 Anchovy fillets in virgin olive oil 06/12/ 2013Santiago de CompostelaAnchoa 464 bp Engraulis encrasicolusEngraulis encrasicolus99% KJ563164 correct AS7 Anchovies fillets in olive oil, from the Cantabrian Sea 06/12/ 2013Santiago de CompostelaAnchoas 464 bp Engraulis anchoitaEngraulis anchoita99% KJ563165 correct AS8 Anchovies fillets in sunflower oil, Engraulis ringens 06/12/ 2013Santiago de CompostelaEngraulis ringens100 bp Engraulis ringensEngraulis ringens100% correct (Continued ) Article No~e00124 11 http://dx.doi.org/10.1016/j.heliyon.2016.e00124 2405-8440/Â© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/be/e8/main.PMC4946307.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/be/e8/main.PMC4946307.pdf
"(Continued ) Saple codeLabel information Date of samplingCity Species de- claredFragment amplifiedFINS result BLAST re- sult%o f matchGenBank IDCorrect/ mislabelled AS9 Anchovies fillets in vegetable oil 06/12/ 2013Santiago de CompostelaAnchoas 464 bp Engraulis anchoitaEngraulis anchoita100% KJ563166 correct AS10 Anchovies fillets in vegetable oil 06/12/ 2013Santiago de CompostelaAnchoas Not ampli- fied AS11 Anchovies fillets in olive oil 06/12/ 2013Santiago de CompostelaAnchoas Not ampli- fied AS12 Anchovy fillets in olive oil, Engraulis encrasicolus 06/12/ 2013Santiago de CompostelaEngraulis encrasicolus464 bp Engraulis encrasicolusEngraulis encrasicolus99% KJ563167 correct AS13 Anchovy fillets in olive oil 06/12/ 2013Santiago de CompostelaAnchoa 464 bp Engraulis encrasicolusEngraulis encrasicolus99% KJ623921 correct AS14 Anchovy fillets in olive oil, Cantabrian Sea, Engraulis encrasicolus06/12/ 2013Santiago de CompostelaEngraulis encrasicolus464 bp Engraulis encrasicolusEngraulis encrasicolus100% KJ563168 correct AS15 Anchovies from the Cantabrian Sea in olive oil 06/12/ 2013Santiago de CompostelaAnchoas 464 bp Engraulis encrasicolusEngraulis encrasicolus99% KJ563169 correct AS16 Anchovy fillets in olive oil, Engraulis encrasicolus 06/12/ 2013Santiago de CompostelaEngraulis encrasicolus464 bp Engraulis encrasicolusEngraulis encrasicolus99% KJ563170 correct AS17 Anchovy fillets in olive oil, made in SantoÃ±a 06/12/ 2013Santiago de CompostelaAnchoa 464 bp Engraulis encrasicolusEngraulis encrasicolus99% KJ563171 correct AM1 Anchovies fillets in oilve oil 26/06/ 2013Madrid anchoas 464 bp Engraulis anchoitaEngraulis anchoita100% KJ563144 correct AM2 Anchovy fillets in vegetable oil, made in Cantabria 26/06/ 2013Madrid anchoa 464 bp Engraulis encrasicolusEngraulis encrasicolus99% KJ563145 correct AM3 Anchovy fillets from the Cantabrian in olive oil, Engraulis encrasicolus26/06/ 2013Madrid Engraulis encrasicolus464 bp Engraulis encrasicolusEngraulis encrasicolus99% KJ563146 correct AM4 Anchovies in vegetable oil, Engraulis spp, product from Peru 26/06/ 2013Madrid Engraulis spp Not ampli- fied AM5 Anchovies fillets in sunflower oil, Engraulis anchoita 26/06/ 2013Madrid Engraulis anchoita464 bp Engraulis anchoitaEngraulis anchoita99% KJ563147 correct (Continued ) Article No~e00124 12 http://dx.doi.org/10.1016/j.heliyon.2016.e00124 2405-8440/Â© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/be/e8/main.PMC4946307.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/be/e8/main.PMC4946307.pdf
"Anchoa (Engraulis spp) 26/06/ 2013Madrid anchoa (Engraulis spp)464 bp Engraulis anchoitaEngraulis anchoita100% KJ563152 mislabelled AM12 Anchovies fillets in vegetable oil 26/06/ 2013Madrid anchoas 464 bp Engraulis ringensEngraulis ringens98% KJ645862 correct AM13 Anchovies fillets in olive oil 26/06/ 2013Madrid anchoas 464 bp Engraulis japonicusEngraulis japonicus99% KJ563153 correct AB1 Anchovy fillets in sunflower oil 04/07/ 2013Bilbao anchoa 464 bp Engraulis anchoitaEngraulis anchoita98% KJ563173 mislabelled AB2 Anchovy fillets in olive oil 04/07/ 2013Bilbao anchoa 464 bp Engraulis encrasicolusEngraulis encrasicolus98% KJ563174 correct AB3 Filetes de anchoa del CantÃ¡brico 04/07/ 2013Bilbao anchoa 464 bp Engraulis encrasicolusEngraulis encrasicolus100% KJ563175 correct AB4 Anchovy fillets in olive oil 04/07/ 2013Bilbao anchoa 464 bp Engraulis anchoitaEngraulis anchoita99% KJ563176 mislabelled AB5 Anchovy fillets from the Cantabrian Sea, Engraulis encra- sicolus04/07/ 2013Bilbao Engraulis encrasicolus464 bp Engraulis encrasicolusEngraulis encrasicolus99% KJ563177 correct AB6 Anchovies 04/07/ 2013Bilbao Engraulis anchoita464 bp Engraulis anchoitaEngraulis anchoita99% KJ563178 correct AB7 Anchovies fillets in olive oil 04/07/ 2013Bilbao anchoas 100 bp Engraulis ringensEngraulis ringens98% correct (Continued ) Article No~e00124 13 http://dx.doi.org/10.1016/j.heliyon.2016.e00124 2405-8440/Â© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/be/e8/main.PMC4946307.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/be/e8/main.PMC4946307.pdf
"(Continued ) Saple codeLabel information Date of samplingCity Species de- claredFragment amplifiedFINS result BLAST re- sult%o f matchGenBank IDCorrect/ mislabelled AB8 Anchovy fillets in olive oil 04/07/ 2013Bilbao anchoa 464 bp Engraulis anchoitaEngraulis anchoita99% KJ563179 mislabelled AB9 Anchovy fillets in olive oil 04/07/ 2013Bilbao anchoa 464 bp Engraulis encrasicolusEngraulis encrasicolus99% KJ563180 correct AB10 Anchovy fillets in olive oil 04/07/ 2013Bilbao anchoa 464 bp Engraulis encrasicolusEngraulis encrasicolus99% KJ563181 correct AB11 Anchovy fillets in olive oil 04/07/ 2013Bilbao anchoa 464 bp Engraulis encrasicolusEngraulis encrasicolus95% KJ563182 correct AB12 Anchovies fillets in olive oil, Engraulis encrasicolus 04/07/ 2013Bilbao anchoas Not ampli- fied AB13 Anchovies fillets in olive oil 04/07/ 2013Bilbao anchoas 464 bp Engraulis encrasicolusEngraulis encrasicolus99% KJ645861 correct AB14 Anchovies fillets in vegetable oil 04/07/ 2013Bilbao anchoas Not ampli- fied Article No~e00124 14 http://dx.doi.org/10.1016/j.heliyon.2016.e00124 2405-8440/Â© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/be/e8/main.PMC4946307.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/be/e8/main.PMC4946307.pdf
Article No~e00124 15 http://dx.doi.org/10.1016/j.heliyon.2016.e00124 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/be/e8/main.PMC4946307.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/be/e8/main.PMC4946307.pdf
Number of samples % Total samples collected 63 Successfully identified samples 58 92.06Identified as Engraulis encrasicolus 32 50.79 Identified as other than Engraulis encrasicolus 26 41.27 Identified as Engraulis anchoita 17 26.98 Identified as Engraulis ringens 8 12.70 Identified as Engraulis japonicus 1 1.58 Correctly labelled 49 84.48 Mislabelled 9 15.52 Article No~e00124 16 http://dx.doi.org/10.1016/j.heliyon.2016.e00124 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/be/e8/main.PMC4946307.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/be/e8/main.PMC4946307.pdf
"The European Commission recognizes also the commercial designation â€œanchoa â€forEngraulis encrasicolus (http://mare.istc.cnr.it/site/engraulis_encrasi- colus_cd.htm ), but there is not such information for other Engraulis species.",Non-OADS,/arxiv_data1/oa_pdf/be/e8/main.PMC4946307.pdf
"It should be also adapted tothe current needs of the market, as the number of anchovy species captured and Article No~e00124 17 http://dx.doi.org/10.1016/j.heliyon.2016.e00124 2405-8440/Â© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/be/e8/main.PMC4946307.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/be/e8/main.PMC4946307.pdf
Brand code sample code declared FINS result 1 AV1 Anchoas Engraulis anchoita AV5 Engraulis encrasicolus Engraulis encrasicolus 2 AV2 Anchoas Engraulis anchoita 3 AV3 Anchoas Engraulis encrasicolus 4 AV4 Anchoas Engraulis encrasicolus 5 AV6 Anchoa Engraulis encrasicolus AS6 Anchoa Engraulis encrasicolus 6 AV7 Engraulis anchoita Engraulis anchoita AS8 Engraulis ringens Engraulis ringens AM5 Engraulis anchoita Engraulis anchoita 7 AV8 Anchoa Engraulis anchoita 8 AV9 Engraulis ringens Engraulis encrasicolus AM4 Engraulis spp failed 9 AV10 Engraulis ringens Engraulis ringens AS2 Engraulis ringens Engraulis encrasicolus AS5 Engraulis ringens Engraulis ringens 10 AV11 Engraulis ringens Engraulis ringens AS3 Engraulis ringens Engraulis ringens 11 AV12 Anchoa Engraulis anchoita AM8 Anchoas Engraulis anchoita AB8 Anchoa Engraulis anchoita 12 AV13 Engraulis encrasicolus Engraulis encrasicolus 13 AV14 Engraulis encrasicolus Engraulis encrasicolus 14 AV15 Anchoa Engraulis encrasicolus AS1 Anchoas Engraulis encrasicolus AS4 Anchoas Engraulis ringens 15 AV16 Anchoas Engraulis encrasicolus 16 AV17 Anchoas Engraulis encrasicolus 17 AV18 Anchoas Engraulis encrasicolus18 AV19 Anchoa Engraulis anchoita AS13 Anchoa Engraulis encrasicolus 19 AV20 Engraulis encrasicolus Engraulis encrasicolus 20 AS16 Engraulis encrasicolus Engraulis encrasicolus 21 AS7 Anchoas Engraulis anchoita AS9 Anchoas Engraulis anchoita AM1 Anchoas Engraulis anchoita 22 AS10 Anchoas failed (Continued ) Article No~e00124 18 http://dx.doi.org/10.1016/j.heliyon.2016.e00124 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/be/e8/main.PMC4946307.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/be/e8/main.PMC4946307.pdf
(Continued ) Brand code sample code declared FINS result AB7 Anchoas Engraulis ringens 23 AS11 Anchoas failed AM13 Anchoas Engraulis japonicus AB1 Anchoa Engraulis anchoita 24 AS12 Engraulis encrasicolus Engraulis encrasicolus 25 AS14 Engraulis encrasicolus Engraulis encrasicolus 26 AS15 Anchoas Engraulis encrasicolus 27 AS17 Anchoa Engraulis encrasicolus AM9 Anchoa Engraulis encrasicolus 28 AM2 Anchoa Engraulis encrasicolus 29 AM3 Engraulis encrasicolus Engraulis encrasicolus 30 AM6 Engraulis encrasicolus Engraulis encrasicolus 31 AM10 Anchoas Engraulis anchoita 32 AM11 Anchoa Engraulis anchoita33 AM12 Anchoas Engraulis ringens 34 AB2 Anchoa Engraulis encrasicolus 35 AB3 Anchoa Engraulis encrasicolus AB9 Anchoa Engraulis encrasicolus 36 AB4 Anchoa Engraulis anchoita37 AB5 Engraulis encrasicolus Engraulis encrasicolus 38 AB6 Anchoas Engraulis anchoita 39 AB10 Anchoa Engraulis encrasicolus AB11 Anchoa Engraulis encrasicolus 40 AB12 Anchoas failed 41 AB13 Anchoas Engraulis encrasicolus 42 AB14 Anchoas failed Article No~e00124 19 http://dx.doi.org/10.1016/j.heliyon.2016.e00124 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/be/e8/main.PMC4946307.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/be/e8/main.PMC4946307.pdf
Article No~e00124 20 http://dx.doi.org/10.1016/j.heliyon.2016.e00124 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/be/e8/main.PMC4946307.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/be/e8/main.PMC4946307.pdf
Article No~e00124 21 http://dx.doi.org/10.1016/j.heliyon.2016.e00124 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/be/e8/main.PMC4946307.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/be/e8/main.PMC4946307.pdf
Article No~e00124 22 http://dx.doi.org/10.1016/j.heliyon.2016.e00124 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/be/e8/main.PMC4946307.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/be/e8/main.PMC4946307.pdf
Article No~e00124 23 http://dx.doi.org/10.1016/j.heliyon.2016.e00124 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/be/e8/main.PMC4946307.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/be/e8/main.PMC4946307.pdf
Article No~e00124 24 http://dx.doi.org/10.1016/j.heliyon.2016.e00124 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/be/e8/main.PMC4946307.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/be/e8/main.PMC4946307.pdf
Article No~e00124 25 http://dx.doi.org/10.1016/j.heliyon.2016.e00124 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/be/e8/main.PMC4946307.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/be/e8/main.PMC4946307.pdf
Article No~e00124 26 http://dx.doi.org/10.1016/j.heliyon.2016.e00124 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/be/e8/main.PMC4946307.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/be/e8/main.PMC4946307.pdf
This is the first time that heavy metal pollution has been assessed in this water run-off canal system; information about Hg is of particularReceived: 13 February 2016 Revised: 6 May 2016 Accepted: 20 June 2016 Heliyon 2 (2016) e00128 http://dx.doi.org/10.1016/j.heliyon.2016.e00128 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/a0/6a/main.PMC4946308.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/a0/6a/main.PMC4946308.pdf
"A worldwide ban on the manufacture, export, and import ofproducts that contain mercury will be in place by 2020 ( Editor, 2013 ).Table 1 Article No~e00128 2 http://dx.doi.org/10.1016/j.heliyon.2016.e00128 2405-8440/Â© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/a0/6a/main.PMC4946308.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/a0/6a/main.PMC4946308.pdf
"Industries Amount of Hg emissionYear reportedMajor emitter Iron steel manufacturing 43 Mg/year 1990-2000 Asia (14.4 Mg yr â€“1), Europe and North America (12.5 Mg/year each) Primary & secondary non-ferrous metal Smelters 310 Mg/year 2008 Developing countries including China Caustic Soda production (Chlor-alkali plants)162.9 Mg/year 2008 Global production including China and India Cement production 232 Mg/year 2005 Global Waste derived from industrial processes 183 Mg/year 2000 GlobalLandfill process 0.29 â€“0.83 Mg/landfill - Finland Wastewater treatment process 0.6 â€“3 mg/Kg of sewage sludge1995/1998 7 EU countries Article No~e00128 3 http://dx.doi.org/10.1016/j.heliyon.2016.e00128 2405-8440/Â© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/a0/6a/main.PMC4946308.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/a0/6a/main.PMC4946308.pdf
Article No~e00128 4 http://dx.doi.org/10.1016/j.heliyon.2016.e00128 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/a0/6a/main.PMC4946308.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/a0/6a/main.PMC4946308.pdf
Article No~e00128 5 http://dx.doi.org/10.1016/j.heliyon.2016.e00128 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/a0/6a/main.PMC4946308.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/a0/6a/main.PMC4946308.pdf
The Article No~e00128 6 http://dx.doi.org/10.1016/j.heliyon.2016.e00128 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/a0/6a/main.PMC4946308.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/a0/6a/main.PMC4946308.pdf
Article No~e00128 7 http://dx.doi.org/10.1016/j.heliyon.2016.e00128 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/a0/6a/main.PMC4946308.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/a0/6a/main.PMC4946308.pdf
Article No~e00128 8 http://dx.doi.org/10.1016/j.heliyon.2016.e00128 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/a0/6a/main.PMC4946308.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/a0/6a/main.PMC4946308.pdf
Article No~e00128 9 http://dx.doi.org/10.1016/j.heliyon.2016.e00128 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/a0/6a/main.PMC4946308.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/a0/6a/main.PMC4946308.pdf
Article No~e00128 10 http://dx.doi.org/10.1016/j.heliyon.2016.e00128 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/a0/6a/main.PMC4946308.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/a0/6a/main.PMC4946308.pdf
Article No~e00128 11 http://dx.doi.org/10.1016/j.heliyon.2016.e00128 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/a0/6a/main.PMC4946308.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/a0/6a/main.PMC4946308.pdf
Article No~e00128 12 http://dx.doi.org/10.1016/j.heliyon.2016.e00128 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/a0/6a/main.PMC4946308.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/a0/6a/main.PMC4946308.pdf
"The highest concentrations of Hg (5.61 ppb) in sediment sampleswere almost 10 times higher than the lowest concentrations (0.52 ppb), which Article No~e00128 13 http://dx.doi.org/10.1016/j.heliyon.2016.e00128 2405-8440/Â© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/a0/6a/main.PMC4946308.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/a0/6a/main.PMC4946308.pdf
"Also, the concentrations of Hg in water, sediment, and fish tissues were not too high in Jubail Industrial City;however, the Hg contents were higher in fish tissues from Jubail than in fish tissues Article No~e00128 14 http://dx.doi.org/10.1016/j.heliyon.2016.e00128 2405-8440/Â© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/a0/6a/main.PMC4946308.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/a0/6a/main.PMC4946308.pdf
Article No~e00128 15 http://dx.doi.org/10.1016/j.heliyon.2016.e00128 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/a0/6a/main.PMC4946308.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/a0/6a/main.PMC4946308.pdf
Article No~e00128 16 http://dx.doi.org/10.1016/j.heliyon.2016.e00128 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/a0/6a/main.PMC4946308.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/a0/6a/main.PMC4946308.pdf
Accessed 20 June 2015 http://ens-newswire.com/2013/01/26/ governments-agree-first-global-mercury-control-treaty/ .,Non-OADS,/arxiv_data1/oa_pdf/a0/6a/main.PMC4946308.pdf
Article No~e00128 17 http://dx.doi.org/10.1016/j.heliyon.2016.e00128 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/a0/6a/main.PMC4946308.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/a0/6a/main.PMC4946308.pdf
"), Springer Science + Business Media, LLC doi:http://dx.doi.org/10.1007/ 978-0-387-93958-2-1 .",Non-OADS,/arxiv_data1/oa_pdf/a0/6a/main.PMC4946308.pdf
Article No~e00128 18 http://dx.doi.org/10.1016/j.heliyon.2016.e00128 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/a0/6a/main.PMC4946308.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/a0/6a/main.PMC4946308.pdf
Accessed 30 September2009 http://www.pme.gov.sa/en/env_law.asp .,Non-OADS,/arxiv_data1/oa_pdf/a0/6a/main.PMC4946308.pdf
Article No~e00128 19 http://dx.doi.org/10.1016/j.heliyon.2016.e00128 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/a0/6a/main.PMC4946308.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/a0/6a/main.PMC4946308.pdf
The relative amount of hypoxic cells was significantly low in the small pseudo-islets whereas a hypoxicReceived: 7 January 2016 Revised: 29 May 2016 Accepted: 23 June 2016 Heliyon 2 (2016) e00129 http://dx.doi.org/10.1016/j.heliyon.2016.e00129 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/2b/21/main.PMC4946309.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/2b/21/main.PMC4946309.pdf
"For instance, native smaller rat islets released a Article No~e00129 2 http://dx.doi.org/10.1016/j.heliyon.2016.e00129 2405-8440/Â© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/2b/21/main.PMC4946309.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/2b/21/main.PMC4946309.pdf
"Pancreatic islets were isolated from 9 â€“12 week-old male Lewis rats (Charles River Laboratories, Yokohama, Japan) via collagenase digestion and density-gradient centrifugation Article No~e00129 3 http://dx.doi.org/10.1016/j.heliyon.2016.e00129 2405-8440/Â© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/2b/21/main.PMC4946309.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/2b/21/main.PMC4946309.pdf
Article No~e00129 4 http://dx.doi.org/10.1016/j.heliyon.2016.e00129 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/2b/21/main.PMC4946309.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/2b/21/main.PMC4946309.pdf
"Assessment of cell viability in microengineered pseudo-islets The cell survival and death of pseudo-islets were assessed by the LIVE/DEAD Viability/Cytotoxicity Kit (Thermo Fisher Scientific) at 7 days after cultivation.The aggregates were incubated in a mixture of 4 Î¼M calcein AM (live cell, green ) Article No~e00129 5 http://dx.doi.org/10.1016/j.heliyon.2016.e00129 2405-8440/Â© 2016 The Authors.",OADS,/arxiv_data1/oa_pdf/2b/21/main.PMC4946309.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/2b/21/main.PMC4946309.pdf
"Subsequently, the cells were incubated with fresh medium containing 3.3 mmol/L glucose for 1 h. Then,the medium was replaced with medium containing 20 mmol/L glucose, and the Article No~e00129 6 http://dx.doi.org/10.1016/j.heliyon.2016.e00129 2405-8440/Â© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/2b/21/main.PMC4946309.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/2b/21/main.PMC4946309.pdf
"After 7 days of cultivation, the average diameters Â± SD of the pseudo-islets in 100, 300, and 500 Î¼m microwells were 49.5 Â± 4.9 Î¼m, 144.1 Â± 13.7 Î¼m, 222.8 Â± 16.6 Î¼m, respectively, while the intact control islets were 174.9 Â± 65.8 Î¼m Article No~e00129 7 http://dx.doi.org/10.1016/j.heliyon.2016.e00129 2405-8440/Â© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/2b/21/main.PMC4946309.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/2b/21/main.PMC4946309.pdf
Article No~e00129 8 http://dx.doi.org/10.1016/j.heliyon.2016.e00129 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/2b/21/main.PMC4946309.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/2b/21/main.PMC4946309.pdf
Article No~e00129 9 http://dx.doi.org/10.1016/j.heliyon.2016.e00129 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/2b/21/main.PMC4946309.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/2b/21/main.PMC4946309.pdf
Article No~e00129 10 http://dx.doi.org/10.1016/j.heliyon.2016.e00129 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/2b/21/main.PMC4946309.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/2b/21/main.PMC4946309.pdf
Further optimization of the cultured conditions Article No~e00129 11 http://dx.doi.org/10.1016/j.heliyon.2016.e00129 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/2b/21/main.PMC4946309.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/2b/21/main.PMC4946309.pdf
Article No~e00129 12 http://dx.doi.org/10.1016/j.heliyon.2016.e00129 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/2b/21/main.PMC4946309.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/2b/21/main.PMC4946309.pdf
This morphology was less reconstituted in the large-sized pseudo-islets prepared using 500 Î¼m Article No~e00129 13 http://dx.doi.org/10.1016/j.heliyon.2016.e00129 2405-8440/Â© 2016 The Authors.,OADS,/arxiv_data1/oa_pdf/2b/21/main.PMC4946309.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/2b/21/main.PMC4946309.pdf
Article No~e00129 14 http://dx.doi.org/10.1016/j.heliyon.2016.e00129 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/2b/21/main.PMC4946309.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/2b/21/main.PMC4946309.pdf
Article No~e00129 15 http://dx.doi.org/10.1016/j.heliyon.2016.e00129 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/2b/21/main.PMC4946309.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/2b/21/main.PMC4946309.pdf
Article No~e00129 16 http://dx.doi.org/10.1016/j.heliyon.2016.e00129 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/2b/21/main.PMC4946309.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/2b/21/main.PMC4946309.pdf
"Baba, A. Satake, M. Nozawa, Y. Tabata, K. Inoue, Evaluation of Article No~e00129 17 http://dx.doi.org/10.1016/j.heliyon.2016.e00129 2405-8440/Â© 2016 The Authors.",OADS,/arxiv_data1/oa_pdf/2b/21/main.PMC4946309.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/2b/21/main.PMC4946309.pdf
Article No~e00129 18 http://dx.doi.org/10.1016/j.heliyon.2016.e00129 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/2b/21/main.PMC4946309.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/2b/21/main.PMC4946309.pdf
Article No~e00129 19 http://dx.doi.org/10.1016/j.heliyon.2016.e00129 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/2b/21/main.PMC4946309.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/2b/21/main.PMC4946309.pdf
"As a kind of short-term implant biomaterial, the results of the hemolysis and platelet adhesive tests were recorded by spectrophotometer and scanning electronReceived: 21 January 2016 Revised: 25 April 2016 Accepted: 14 June 2016 Heliyon 2 (2016) e00125 http://dx.doi.org/10.1016/j.heliyon.2016.e00125 2405-8440/Â© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/ff/ed/main.PMC4946310.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ff/ed/main.PMC4946310.pdf
"A comparative analysis was made between the synthesized materials and available commercial medical polyurethane materials, Pellethane 2363-80A, indicating thepoly(carbonate-urethane) elastomers can achieve the same level or even better in Article No~e00125 2 http://dx.doi.org/10.1016/j.heliyon.2016.e00125 2405-8440/Â© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/ff/ed/main.PMC4946310.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ff/ed/main.PMC4946310.pdf
Article No~e00125 3 http://dx.doi.org/10.1016/j.heliyon.2016.e00125 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ff/ed/main.PMC4946310.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ff/ed/main.PMC4946310.pdf
Article No~e00125 4 http://dx.doi.org/10.1016/j.heliyon.2016.e00125 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ff/ed/main.PMC4946310.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ff/ed/main.PMC4946310.pdf
Article No~e00125 5 http://dx.doi.org/10.1016/j.heliyon.2016.e00125 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ff/ed/main.PMC4946310.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ff/ed/main.PMC4946310.pdf
The characteristic absorption peaks of 906 cmâˆ’1and 1039 cmâˆ’1were standard double loop structure supported Article No~e00125 6 http://dx.doi.org/10.1016/j.heliyon.2016.e00125 2405-8440/Â© 2016 The Authors.,OADS,/arxiv_data1/oa_pdf/ff/ed/main.PMC4946310.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ff/ed/main.PMC4946310.pdf
Article No~e00125 7 http://dx.doi.org/10.1016/j.heliyon.2016.e00125 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ff/ed/main.PMC4946310.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ff/ed/main.PMC4946310.pdf
Article No~e00125 8 http://dx.doi.org/10.1016/j.heliyon.2016.e00125 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ff/ed/main.PMC4946310.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ff/ed/main.PMC4946310.pdf
Article No~e00125 9 http://dx.doi.org/10.1016/j.heliyon.2016.e00125 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ff/ed/main.PMC4946310.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ff/ed/main.PMC4946310.pdf
Article No~e00125 10 http://dx.doi.org/10.1016/j.heliyon.2016.e00125 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ff/ed/main.PMC4946310.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ff/ed/main.PMC4946310.pdf
Red blood cells Article No~e00125 11 http://dx.doi.org/10.1016/j.heliyon.2016.e00125 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ff/ed/main.PMC4946310.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ff/ed/main.PMC4946310.pdf
Samples Average optical density Negative Positive Hemolysis ratio (100%) HDI 1.3-PU 0.4319 0.0401 0.3722 1.3004 HDI 1.4-PU 0.4079 0.0401 0.3722 1.1076 HDI 1.5-PU 0.3140 0.0401 0.3722 0.8250H 12MDI 1.3-PU 0.4064 0.0401 0.3722 1.1031 H12MDI 1.4-PU 0.3341 0.0401 0.3722 0.8854 H12MDI 1.5-PU 0.3049 0.0401 0.3722 0.7973 Article No~e00125 12 http://dx.doi.org/10.1016/j.heliyon.2016.e00125 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ff/ed/main.PMC4946310.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ff/ed/main.PMC4946310.pdf
Article No~e00125 13 http://dx.doi.org/10.1016/j.heliyon.2016.e00125 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ff/ed/main.PMC4946310.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ff/ed/main.PMC4946310.pdf
Article No~e00125 14 http://dx.doi.org/10.1016/j.heliyon.2016.e00125 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ff/ed/main.PMC4946310.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ff/ed/main.PMC4946310.pdf
Article No~e00125 15 http://dx.doi.org/10.1016/j.heliyon.2016.e00125 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ff/ed/main.PMC4946310.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ff/ed/main.PMC4946310.pdf
Article No~e00125 16 http://dx.doi.org/10.1016/j.heliyon.2016.e00125 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ff/ed/main.PMC4946310.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ff/ed/main.PMC4946310.pdf
Article No~e00125 17 http://dx.doi.org/10.1016/j.heliyon.2016.e00125 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ff/ed/main.PMC4946310.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/ff/ed/main.PMC4946310.pdf
Keywords: Economics http://dx.doi.org/10.1016/j.heliyon.2016.e00108 2405-8440/ Â©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/b1/f2/main.PMC4946311.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b1/f2/main.PMC4946311.pdf
LNG supplies  from th e  USA and  2 http://dx.doi.org/10.1016/j.heliyon.2016.e00108 2405-8440/ Â©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/b1/f2/main.PMC4946311.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b1/f2/main.PMC4946311.pdf
Section 4details   3 http://dx.doi.org/10.1016/j.heliyon.2016.e00108 2405-8440/ Â©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/b1/f2/main.PMC4946311.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b1/f2/main.PMC4946311.pdf
"The Bak er  Institute World  Gas Trade Model (BIWGTM) employs an inter- temporal  equilibrium model of the world  gas market for calculating a pattern of  production,  transportation  routes  and prices  to equate demands  and supplies  while  4 http://dx.doi.org/10.1016/j.heliyon.2016.e00108 2405-8440/ Â©2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/b1/f2/main.PMC4946311.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b1/f2/main.PMC4946311.pdf
"The model is based on a non-linear   stochastic optimization  programming approach,  which also allows  us to capture   5 http://dx.doi.org/10.1016/j.heliyon.2016.e00108 2405-8440/ Â©2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/b1/f2/main.PMC4946311.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b1/f2/main.PMC4946311.pdf
"In 2013,  the most important  LNG exporters were Qatar,   6 http://dx.doi.org/10.1016/j.heliyon.2016.e00108 2405-8440/ Â©2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/b1/f2/main.PMC4946311.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b1/f2/main.PMC4946311.pdf
"Over the last ten years, LNG  imports  in Japan,  Korea  and Taiwan  have increased signiï¬cantly by 5.1, 6.8 and  7 http://dx.doi.org/10.1016/j.heliyon.2016.e00108 2405-8440/ Â©2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/b1/f2/main.PMC4946311.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b1/f2/main.PMC4946311.pdf
LNG imports  have been expanding  signiï¬cantly  8 http://dx.doi.org/10.1016/j.heliyon.2016.e00108 2405-8440/ Â©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/b1/f2/main.PMC4946311.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b1/f2/main.PMC4946311.pdf
"Table 4 represents  current  LNG receiving  ter minals  by country in Asia-Paciï¬c,  of which Japan accounts   9 http://dx.doi.org/10.1016/j.heliyon.2016.e00108 2405-8440/ Â©2016 The Authors.",OADS,/arxiv_data1/oa_pdf/b1/f2/main.PMC4946311.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b1/f2/main.PMC4946311.pdf
"According  to BP (2014) , th e most promising country for shale gas production is China,  which  10 http://dx.doi.org/10.1016/j.heliyon.2016.e00108 2405-8440/ Â©2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/b1/f2/main.PMC4946311.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b1/f2/main.PMC4946311.pdf
Qatarâ€™s  e xports  increased  11 http://dx.doi.org/10.1016/j.heliyon.2016.e00108 2405-8440/ Â©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/b1/f2/main.PMC4946311.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b1/f2/main.PMC4946311.pdf
"With eastern  Australiaâ€™s integration into the Asia-Paciï¬c  market and substantial new LNG  projects, the country is expected to surpass  Qatar,  becoming the worldâ€™s  largest LNG  12 http://dx.doi.org/10.1016/j.heliyon.2016.e00108 2405-8440/ Â©2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/b1/f2/main.PMC4946311.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b1/f2/main.PMC4946311.pdf
LNG supplies   that are contracted  from North  America to the Asia-Paciï¬c  region have started  to  13 http://dx.doi.org/10.1016/j.heliyon.2016.e00108 2405-8440/ Â©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/b1/f2/main.PMC4946311.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b1/f2/main.PMC4946311.pdf
14 http://dx.doi.org/10.1016/j.heliyon.2016.e00108 2405-8440/ Â©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/b1/f2/main.PMC4946311.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b1/f2/main.PMC4946311.pdf
15 http://dx.doi.org/10.1016/j.heliyon.2016.e00108 2405-8440/ Â©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/b1/f2/main.PMC4946311.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b1/f2/main.PMC4946311.pdf
The cos t of node ğ‘–(ğ‘’ğ‘–ğ‘—(ğ‘¡)) to import ğ‘‹ğ‘–ğ‘—(ğ‘¡)) from node ğ‘—is given by 16 http://dx.doi.org/10.1016/j.heliyon.2016.e00108 2405-8440/ Â©2016 The Authors.,OADS,/arxiv_data1/oa_pdf/b1/f2/main.PMC4946311.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b1/f2/main.PMC4946311.pdf
"The sources  of uncertainty  in energy demand are exogenous  shocks  from geopolitical and economic events, and  17 http://dx.doi.org/10.1016/j.heliyon.2016.e00108 2405-8440/ Â©2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/b1/f2/main.PMC4946311.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b1/f2/main.PMC4946311.pdf
"The total LNG export of node  ğ‘—is constrained  to be less than the export capacity,  or ğ‘‹ğ‘—(ğ‘¡)â‰¤Ì„ ğ‘¥ğ‘—(ğ‘¡) (9) 18 http://dx.doi.org/10.1016/j.heliyon.2016.e00108 2405-8440/ Â©2016 The Authors.",OADS,/arxiv_data1/oa_pdf/b1/f2/main.PMC4946311.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b1/f2/main.PMC4946311.pdf
19 http://dx.doi.org/10.1016/j.heliyon.2016.e00108 2405-8440/ Â©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/b1/f2/main.PMC4946311.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b1/f2/main.PMC4946311.pdf
20 http://dx.doi.org/10.1016/j.heliyon.2016.e00108 2405-8440/ Â©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/b1/f2/main.PMC4946311.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b1/f2/main.PMC4946311.pdf
21 http://dx.doi.org/10.1016/j.heliyon.2016.e00108 2405-8440/ Â©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/b1/f2/main.PMC4946311.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b1/f2/main.PMC4946311.pdf
"The capital cost of an LNG project  ğ‘–for a unit of MBTU   at 2015 prices  is given by ğ‘(ğ‘˜)ğ‘–=(ğœ‡ğ‘–+ğ‘šğ‘–)ğ¾ğ‘– ğ‘‡(ğ‘Œğ‘–)(ğ‘£ğ‘€ğµğ‘¡ğ‘¢)ğ‘ğ‘ğ‘–ğ‘– (18) where  ğ‘(ğ‘˜)ğ‘–is capital cost per unit of MBTU; ğœ‡ğ‘–is the depreciation rate per year;  ğ‘šğ‘–is average maintenance  rate per year; ğ¾ğ‘–is the investment cost; ğ‘‡is the lifetime  of the project  (with an average of about 30 years); ğ‘Œğ‘–is the supply capacity of the  project,  including LNG export and other gas output  measured in terms  of million  tons of oil equivalent (Mt);  ğ‘£ğ‘€ğ‘€ğµğ‘¡ğ‘¢ is the conversion rate between Mt and MBtu  22 http://dx.doi.org/10.1016/j.heliyon.2016.e00108 2405-8440/ Â©2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/b1/f2/main.PMC4946311.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b1/f2/main.PMC4946311.pdf
"Given the uncertainties  over  LNG demand,  delivery costs and prices,  the projection of LNG trade over the study  23 http://dx.doi.org/10.1016/j.heliyon.2016.e00108 2405-8440/ Â©2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/b1/f2/main.PMC4946311.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b1/f2/main.PMC4946311.pdf
24 http://dx.doi.org/10.1016/j.heliyon.2016.e00108 2405-8440/ Â©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/b1/f2/main.PMC4946311.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b1/f2/main.PMC4946311.pdf
Japan is  25 http://dx.doi.org/10.1016/j.heliyon.2016.e00108 2405-8440/ Â©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/b1/f2/main.PMC4946311.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b1/f2/main.PMC4946311.pdf
"In 2030,   26 http://dx.doi.org/10.1016/j.heliyon.2016.e00108 2405-8440/ Â©2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/b1/f2/main.PMC4946311.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b1/f2/main.PMC4946311.pdf
27 http://dx.doi.org/10.1016/j.heliyon.2016.e00108 2405-8440/ Â©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/b1/f2/main.PMC4946311.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b1/f2/main.PMC4946311.pdf
28 http://dx.doi.org/10.1016/j.heliyon.2016.e00108 2405-8440/ Â©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/b1/f2/main.PMC4946311.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b1/f2/main.PMC4946311.pdf
Available from URL https://argusmedia.com/Natural-Gas-LNG/~/media/ [accessed 4 January 2015].,OADS,/arxiv_data1/oa_pdf/b1/f2/main.PMC4946311.pdf
Available from URL http://www.bp.com/en/global/corporate/about-bp/ energy-economics/ [accessed 16 June 2015].,Non-OADS,/arxiv_data1/oa_pdf/b1/f2/main.PMC4946311.pdf
Available  from URL http://www.bp.com/content/dam/bp/pdf/Energy-economics/Energy- Outlook/ [accessed 16 August 2014].,Non-OADS,/arxiv_data1/oa_pdf/b1/f2/main.PMC4946311.pdf
29 http://dx.doi.org/10.1016/j.heliyon.2016.e00108 2405-8440/ Â©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/b1/f2/main.PMC4946311.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b1/f2/main.PMC4946311.pdf
Available from URL http://www.bloomberg.com/ news/articles/2014-09-30/ [accessed 3 October  2014].,Non-OADS,/arxiv_data1/oa_pdf/b1/f2/main.PMC4946311.pdf
Available from URL http://www.eia.gov/forecasts/documentation/ workshops/pdf/ [accessed 2 January 2016].,OADS,/arxiv_data1/oa_pdf/b1/f2/main.PMC4946311.pdf
Available from URL http://forum.gasfund.com.au/site/ï¬les/LNG [accessed  on 2 August 2014].,OADS,/arxiv_data1/oa_pdf/b1/f2/main.PMC4946311.pdf
Available  from URL http://www.c2es.org/indc-comparison [accessed 27 August 2015].,OADS,/arxiv_data1/oa_pdf/b1/f2/main.PMC4946311.pdf
Available from URL http://www.ivt.ntnu.no/ept/ fag/tep4215/innhold/LNG%20Conferences/1998/Papers/7-3-Hill.PDF [accessed  4 February  2015].,Non-OADS,/arxiv_data1/oa_pdf/b1/f2/main.PMC4946311.pdf
Available from URL http://energy.gov/sites/prod/ ï¬les/2014 [accessed 6 January 2015].,OADS,/arxiv_data1/oa_pdf/b1/f2/main.PMC4946311.pdf
"Research  report DOE/EIA-0484  (2014)  by the U.S. Department of Energy,   30 http://dx.doi.org/10.1016/j.heliyon.2016.e00108 2405-8440/ Â©2016 The Authors.",OADS,/arxiv_data1/oa_pdf/b1/f2/main.PMC4946311.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b1/f2/main.PMC4946311.pdf
Available from URL http://www.eia.gov/forecasts/ieo/pdf/ [accessed 23 October  2014].,OADS,/arxiv_data1/oa_pdf/b1/f2/main.PMC4946311.pdf
Available from URL http://www.eia.gov/countries [accessed 23  August 2014].,Non-OADS,/arxiv_data1/oa_pdf/b1/f2/main.PMC4946311.pdf
Available from  URL http://www.eia.gov/countries [accessed 23 August 2014].,Non-OADS,/arxiv_data1/oa_pdf/b1/f2/main.PMC4946311.pdf
Available from URL  http://www.eia.gov/countries [accessed 30 August 2014].,Non-OADS,/arxiv_data1/oa_pdf/b1/f2/main.PMC4946311.pdf
Available from URL http://www.eia.gov/forecasts/ieo/pdf/0484(2013).pdf [accessed 30 September  2014].,OADS,/arxiv_data1/oa_pdf/b1/f2/main.PMC4946311.pdf
Available from URL http://www5.fepc.or.jp/tok-bin-eng/kensaku.cgi [accessed 6  September  2014].,OADS,/arxiv_data1/oa_pdf/b1/f2/main.PMC4946311.pdf
Available from URL http://www.giignl.org/ publication [accessed 14 September  2014].,Non-OADS,/arxiv_data1/oa_pdf/b1/f2/main.PMC4946311.pdf
Available from URL http://www.globallnginfo.com [accessed 6 January  2015].,OADS,/arxiv_data1/oa_pdf/b1/f2/main.PMC4946311.pdf
31 http://dx.doi.org/10.1016/j.heliyon.2016.e00108 2405-8440/ Â©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/b1/f2/main.PMC4946311.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b1/f2/main.PMC4946311.pdf
Available from URL http://bakerinstitute.org/media/ï¬les/Research/81966512/ the-baker-institute-world-gas-trade-model-biwgtm.pdf [accessed on 2 September   2015].,Non-OADS,/arxiv_data1/oa_pdf/b1/f2/main.PMC4946311.pdf
Available from  URL http://www.ihs.com/info/cera/ihsindexes/index.aspx [accessed on 2 August  2014].,OADS,/arxiv_data1/oa_pdf/b1/f2/main.PMC4946311.pdf
http://www.worldenergyoutlook.org/media/weowebsite/ [accessed 24 August 2014].,Non-OADS,/arxiv_data1/oa_pdf/b1/f2/main.PMC4946311.pdf
Available from URL https://eneken.ieej.or.jp/data/5331.pdf [accessed 16 August  2014].,OADS,/arxiv_data1/oa_pdf/b1/f2/main.PMC4946311.pdf
Available  from URL http://www.iesc.environment.gov.au/system [accessed on 20 August  2015].,OADS,/arxiv_data1/oa_pdf/b1/f2/main.PMC4946311.pdf
Available from URL http://www.igu.org/sites/ [accessed 10  February  2015].,Non-OADS,/arxiv_data1/oa_pdf/b1/f2/main.PMC4946311.pdf
Available from  URL http://www.imf.org [accessed 10 February  2015].,Non-OADS,/arxiv_data1/oa_pdf/b1/f2/main.PMC4946311.pdf
Available from  URL http://www.ipaenergy.co.uk/images/ [accessed 17 August 2014].,Non-OADS,/arxiv_data1/oa_pdf/b1/f2/main.PMC4946311.pdf
32 http://dx.doi.org/10.1016/j.heliyon.2016.e00108 2405-8440/ Â©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/b1/f2/main.PMC4946311.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b1/f2/main.PMC4946311.pdf
Available from URL http://www.petroleum-conomist.,OADS,/arxiv_data1/oa_pdf/b1/f2/main.PMC4946311.pdf
Available from URL http://www.kbr.com/newsroom/publications/ technical-papers/ [accessed on 7 November  2014].,Non-OADS,/arxiv_data1/oa_pdf/b1/f2/main.PMC4946311.pdf
Available from URL http://www.kpmg.com/Global/en/ IssuesAndInsights/ArticlesPublications/ï¬‚oating-lng/ [accessed on 7 November   2014].,Non-OADS,/arxiv_data1/oa_pdf/b1/f2/main.PMC4946311.pdf
Available from URL http://web.mit.edu/ceepr/www/publications/ Natural_Gas_Study.pdf [accessed 14 November  2014].,OADS,/arxiv_data1/oa_pdf/b1/f2/main.PMC4946311.pdf
Available from URL http://www.meti.go.jp/english/statistics/index.html [accessed 14 February  2015].,OADS,/arxiv_data1/oa_pdf/b1/f2/main.PMC4946311.pdf
33 http://dx.doi.org/10.1016/j.heliyon.2016.e00108 2405-8440/ Â©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/b1/f2/main.PMC4946311.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b1/f2/main.PMC4946311.pdf
Available from  URL http://thinking.nexant.com/program/world-gas-model [accessed 16 August  2014].,Non-OADS,/arxiv_data1/oa_pdf/b1/f2/main.PMC4946311.pdf
Available from URL https://www.usea.org/sites/default/ï¬les/event-/ North%20American%20LNG%20Exports%20-%20USEA%20Presentation.pdf [accessed 12 March  2015].,OADS,/arxiv_data1/oa_pdf/b1/f2/main.PMC4946311.pdf
Available from URL  http://www.platts.com/news-feature/2014/naturalgas/china-coal-to-gas-projects/ china-gas-forecasts [accessed 23 January 2015].,Non-OADS,/arxiv_data1/oa_pdf/b1/f2/main.PMC4946311.pdf
Available from  URL http://www.platts.com/latest-news/natural-gas/ [accessed 20 September   2015].,OADS,/arxiv_data1/oa_pdf/b1/f2/main.PMC4946311.pdf
Available from URL http://www.platts.com/IM.Platts.Content/ lngmethodology.pdf [accessed 23 January 2015].,Non-OADS,/arxiv_data1/oa_pdf/b1/f2/main.PMC4946311.pdf
Available from URL http://climatechange.mit.edu/ [accessed 20 February  2015].,OADS,/arxiv_data1/oa_pdf/b1/f2/main.PMC4946311.pdf
Available from URL http://stop-csg-illawarra.org/ [accessed 18 September  2015].,Non-OADS,/arxiv_data1/oa_pdf/b1/f2/main.PMC4946311.pdf
34 http://dx.doi.org/10.1016/j.heliyon.2016.e00108 2405-8440/ Â©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/b1/f2/main.PMC4946311.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b1/f2/main.PMC4946311.pdf
Available from URL  https://www.quandl.com/ [accessed 21 February  2015].,Non-OADS,/arxiv_data1/oa_pdf/b1/f2/main.PMC4946311.pdf
Available from  URL http://knoema.com/yxptpab/crude-oil-price-forecast/long-term-2015-to- 2025-data-and-charts [accessed 23 February  2015].,OADS,/arxiv_data1/oa_pdf/b1/f2/main.PMC4946311.pdf
Available from URL http://www.doi.gov/intl/itap/ upload/Session-01-01-Changing-Asian-gas-markets-Presentation.pdf [accessed  17 December  2014].,OADS,/arxiv_data1/oa_pdf/b1/f2/main.PMC4946311.pdf
35 http://dx.doi.org/10.1016/j.heliyon.2016.e00108 2405-8440/ Â©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/b1/f2/main.PMC4946311.pdf
This is an open access article under the CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b1/f2/main.PMC4946311.pdf
"A properly rebuilt dam would not have overtopped and would likely have survived the runoff event, thereby saving thousands of lives.Received: 9 September 2015 Revised: 1 April 2016 Accepted: 27 May 2016 Heliyon 2 (2016) e00120 http://dx.doi.org/10.1016/j.heliyon.2016.e00120 2405-8440/Â© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/d4/dc/main.PMC4946313.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d4/dc/main.PMC4946313.pdf
"It occurred a little earlier inthe day on account of the changes, but we think the result would have been Article No~e00120 2 http://dx.doi.org/10.1016/j.heliyon.2016.e00120 2405-8440/Â© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/d4/dc/main.PMC4946313.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d4/dc/main.PMC4946313.pdf
But the 1862 failure set the stage for the dam breach disaster in 1889 because when thedam was rebuilt by the SFFHC significant changes were made to the original Article No~e00120 3 http://dx.doi.org/10.1016/j.heliyon.2016.e00120 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d4/dc/main.PMC4946313.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d4/dc/main.PMC4946313.pdf
Article No~e00120 4 http://dx.doi.org/10.1016/j.heliyon.2016.e00120 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d4/dc/main.PMC4946313.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d4/dc/main.PMC4946313.pdf
Article No~e00120 5 http://dx.doi.org/10.1016/j.heliyon.2016.e00120 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d4/dc/main.PMC4946313.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d4/dc/main.PMC4946313.pdf
Article No~e00120 6 http://dx.doi.org/10.1016/j.heliyon.2016.e00120 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d4/dc/main.PMC4946313.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d4/dc/main.PMC4946313.pdf
Article No~e00120 7 http://dx.doi.org/10.1016/j.heliyon.2016.e00120 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d4/dc/main.PMC4946313.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d4/dc/main.PMC4946313.pdf
Article No~e00120 8 http://dx.doi.org/10.1016/j.heliyon.2016.e00120 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d4/dc/main.PMC4946313.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d4/dc/main.PMC4946313.pdf
Article No~e00120 9 http://dx.doi.org/10.1016/j.heliyon.2016.e00120 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d4/dc/main.PMC4946313.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d4/dc/main.PMC4946313.pdf
Article No~e00120 10 http://dx.doi.org/10.1016/j.heliyon.2016.e00120 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d4/dc/main.PMC4946313.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d4/dc/main.PMC4946313.pdf
"The locations and number of measurements averaged by the committee were not shown in theirreport, but they noted the range of elevations varied from 0.14 ft higher to 0.08 ft Article No~e00120 11 http://dx.doi.org/10.1016/j.heliyon.2016.e00120 2405-8440/Â© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/d4/dc/main.PMC4946313.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d4/dc/main.PMC4946313.pdf
8 for map area and scale) Article No~e00120 12 http://dx.doi.org/10.1016/j.heliyon.2016.e00120 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d4/dc/main.PMC4946313.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d4/dc/main.PMC4946313.pdf
Article No~e00120 13 http://dx.doi.org/10.1016/j.heliyon.2016.e00120 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d4/dc/main.PMC4946313.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d4/dc/main.PMC4946313.pdf
Wellington and Burt (1889) describe a preserved Article No~e00120 14 http://dx.doi.org/10.1016/j.heliyon.2016.e00120 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d4/dc/main.PMC4946313.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d4/dc/main.PMC4946313.pdf
"Even though observers like J. Parke reported there was no large amount of debris clogging the spillway mouth, additional differences between the lake level and flow level in the spillway would Article No~e00120 15 http://dx.doi.org/10.1016/j.heliyon.2016.e00120 2405-8440/Â© 2016 The Authors.",OADS,/arxiv_data1/oa_pdf/d4/dc/main.PMC4946313.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d4/dc/main.PMC4946313.pdf
Our analysis using the LiDAR DEM also shows that the dam as originally built with a higher crest would have impounded 1.627 Ã— 107m3(16 million tons) below a lake stage of 493.5 m. Article No~e00120 16 http://dx.doi.org/10.1016/j.heliyon.2016.e00120 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d4/dc/main.PMC4946313.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d4/dc/main.PMC4946313.pdf
Article No~e00120 17 http://dx.doi.org/10.1016/j.heliyon.2016.e00120 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d4/dc/main.PMC4946313.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d4/dc/main.PMC4946313.pdf
Article No~e00120 18 http://dx.doi.org/10.1016/j.heliyon.2016.e00120 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d4/dc/main.PMC4946313.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d4/dc/main.PMC4946313.pdf
They Article No~e00120 19 http://dx.doi.org/10.1016/j.heliyon.2016.e00120 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d4/dc/main.PMC4946313.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d4/dc/main.PMC4946313.pdf
The extra length of small-scale meanders was not Article No~e00120 20 http://dx.doi.org/10.1016/j.heliyon.2016.e00120 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d4/dc/main.PMC4946313.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d4/dc/main.PMC4946313.pdf
"In a 1040 km2area north and east of Johnstown, rainfall totals of 6 to 12 inches were measured in 6 to 8 h. Mapping of rainfall showed that the greatest amounts fell Article No~e00120 21 http://dx.doi.org/10.1016/j.heliyon.2016.e00120 2405-8440/Â© 2016 The Authors.",OADS,/arxiv_data1/oa_pdf/d4/dc/main.PMC4946313.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d4/dc/main.PMC4946313.pdf
"The basin of the Little Conemaugh River has several dams with limited regulation, and extensive underground mining activity that could affect base flow conditions Article No~e00120 22 http://dx.doi.org/10.1016/j.heliyon.2016.e00120 2405-8440/Â© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/d4/dc/main.PMC4946313.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d4/dc/main.PMC4946313.pdf
"Flood-flow estimates (cfs) [1 m3sâˆ’1= 35.3 cfs] USGS gaging station 03041000 Type 2 yr 5 yr 10 yr 50 yr 100 yr 500 yr Observed 10,400 16,800 22,100 36,800 44,500 66,500 Predicted 11,700 17,900 22,600 35,300 41,700 59,500 Weighted 10,400 16,900 22,100 36,600 44,100 65,700 Article No~e00120 23 http://dx.doi.org/10.1016/j.heliyon.2016.e00120 2405-8440/Â© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/d4/dc/main.PMC4946313.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d4/dc/main.PMC4946313.pdf
Thestatements of eyewitnesses can be found at: http://www.nps.gov/jofl/learn/ historyculture/stories.htm [Accessed 2/14/2016].,Non-OADS,/arxiv_data1/oa_pdf/d4/dc/main.PMC4946313.pdf
"Downstream on the Little Conemaugh River at Conemaugh borough the water level was observed to rise until about noon and then came to a standstill, or perhaps Article No~e00120 24 http://dx.doi.org/10.1016/j.heliyon.2016.e00120 2405-8440/Â© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/d4/dc/main.PMC4946313.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d4/dc/main.PMC4946313.pdf
"The observations summarized above show that, before dam failure, streams in the area reached their highest levels between 10:00 a.m. and 1:00 p.m., depending on Article No~e00120 25 http://dx.doi.org/10.1016/j.heliyon.2016.e00120 2405-8440/Â© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/d4/dc/main.PMC4946313.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d4/dc/main.PMC4946313.pdf
"â€ We apply an analytical equation for the inflow capacity of a pipe spillway at full flow ( Chow, 1964 ), where qÂ¼aï¬ƒï¬ƒï¬ƒï¬ƒï¬ƒï¬ƒï¬ƒï¬ƒï¬ƒï¬ƒï¬ƒï¬ƒï¬ƒï¬ƒï¬ƒï¬ƒï¬ƒï¬ƒï¬ƒï¬ƒï¬ƒï¬ƒï¬ƒï¬ƒï¬ƒï¬ƒï¬ƒï¬ƒï¬ƒï¬ƒï¬ƒï¬ƒï¬ƒï¬ƒï¬ƒï¬ƒï¬ƒï¬ƒï¬ƒ 2gH 1Ã¾KeÃ¾KbÃ¾KpLs (4) q= discharge rate (cfs) (1 m3sâˆ’1= 35.3 cfs) a= cross-sectional area of pipe (ft2) (3.14 ft2) g= surface gravity (32.2 ft sâˆ’2) Article No~e00120 26 http://dx.doi.org/10.1016/j.heliyon.2016.e00120 2405-8440/Â© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/d4/dc/main.PMC4946313.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d4/dc/main.PMC4946313.pdf
Another factor that could have partially filled the culvert would be the spawning of a standing wave where the flows discharged from the Article No~e00120 27 http://dx.doi.org/10.1016/j.heliyon.2016.e00120 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d4/dc/main.PMC4946313.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d4/dc/main.PMC4946313.pdf
"QÂ¼CLï¬ƒï¬ƒ ï¬ƒgpd 1:5(5) where Q= discharge [m3Â·sâˆ’1] C= dimensionless weir coefficient [ âˆ¼0.465 for long or normal weirs, where weir head divided by downstream length of weir crest <0.4] g= gravitational acceleration [9.8 mÂ·sâˆ’2] L= length of weir crest, perpendicular to flow [21 m] Article No~e00120 28 http://dx.doi.org/10.1016/j.heliyon.2016.e00120 2405-8440/Â© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/d4/dc/main.PMC4946313.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d4/dc/main.PMC4946313.pdf
Article No~e00120 29 http://dx.doi.org/10.1016/j.heliyon.2016.e00120 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d4/dc/main.PMC4946313.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d4/dc/main.PMC4946313.pdf
Auxiliary spillway âˆ¼26 m3sâˆ’1 Five discharge pipes âˆ¼20 m3sâˆ’1 Added discharge for main spillway âˆ¼65 m3sâˆ’1(151 minus 86 m3sâˆ’1) Total added discharge âˆ¼111 m3sâˆ’1(3918) cfs) Article No~e00120 30 http://dx.doi.org/10.1016/j.heliyon.2016.e00120 2405-8440/Â© 2016 The Authors.,OADS,/arxiv_data1/oa_pdf/d4/dc/main.PMC4946313.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d4/dc/main.PMC4946313.pdf
"As previously indicated, there is evidence from local observers that in fact the streams had ceased Article No~e00120 31 http://dx.doi.org/10.1016/j.heliyon.2016.e00120 2405-8440/Â© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/d4/dc/main.PMC4946313.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d4/dc/main.PMC4946313.pdf
Article No~e00120 32 http://dx.doi.org/10.1016/j.heliyon.2016.e00120 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d4/dc/main.PMC4946313.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d4/dc/main.PMC4946313.pdf
Article No~e00120 33 http://dx.doi.org/10.1016/j.heliyon.2016.e00120 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d4/dc/main.PMC4946313.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d4/dc/main.PMC4946313.pdf
"Dam comparisons Original dam Rebuilt dam Embankment height 72 ft (22 m) â‰¤70 ft ( âˆ¼68â€“69 ft in center) Overtopping elevation (NAVD 88) âˆ¼493.5 m âˆ¼492.5 m ( âˆ¼1616 ft); lake level at time of dam breach Discharge capacity ( Q) at overtopping Main spillway âˆ¼151 m3sâˆ’1âˆ¼86 m3sâˆ’1 Auxiliary spillway âˆ¼26 m3sâˆ’1ditchâˆ¼<10 m3sâˆ’1 Five discharge pipes âˆ¼20 m3sâˆ’10m3sâˆ’1 Total Q âˆ¼197 m3sâˆ’1(6954 cfs) âˆ¼96 m3sâˆ’1(3430 cfs) Estimated time of embankment overtopping Would not have overtopped âˆ¼11:30 a.m. (actual) Spillway floor elevation (NAVD 88) âˆ¼490.4 m (crest) âˆ¼490.4 m (crest) Hydraulic and basin data Basin drainage area above Lake Conemaugh âˆ¼53 mi2(137 km2)(Brua, 1978 ) Time of concentration ( tc), South Fork of the Little Conemaugh R. 3.6 to 7.3 h Time to peak inflow to lake after period of most intense rainfall 2.5 to 5.1 h ( â‰¤7.3 h in extreme events) Rate of lake rise âˆ¼10:30 â€“11:30 a.m. just before initial overtopping of dam âˆ¼9i nhâˆ’1(J. Parke; Francis et al., 1891, p. 449 ) [corresponds to lake inflow of 115 m3sâˆ’1beyond main spillway capacity of rebuilt dam] Estimated peak lake inflow before 11:30 a.m. 201 m3sâˆ’1[spillway (86) + excess inflow (115)] [inflow of 216 m3sâˆ’1used in our analysis to reduce chance of underestimating inflow] Volume of lake at time of 1889 dam breach 1.455 Ã— 107m3(below stage 492.56 m, NAVD 88) Time to drain lake to base of the upper breach â‰¥65 min Article No~e00120 34 http://dx.doi.org/10.1016/j.heliyon.2016.e00120 2405-8440/Â© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/d4/dc/main.PMC4946313.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d4/dc/main.PMC4946313.pdf
Article No~e00120 35 http://dx.doi.org/10.1016/j.heliyon.2016.e00120 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d4/dc/main.PMC4946313.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d4/dc/main.PMC4946313.pdf
"However, the committee did not Article No~e00120 36 http://dx.doi.org/10.1016/j.heliyon.2016.e00120 2405-8440/Â© 2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/d4/dc/main.PMC4946313.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d4/dc/main.PMC4946313.pdf
Article No~e00120 37 http://dx.doi.org/10.1016/j.heliyon.2016.e00120 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d4/dc/main.PMC4946313.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d4/dc/main.PMC4946313.pdf
Article No~e00120 38 http://dx.doi.org/10.1016/j.heliyon.2016.e00120 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d4/dc/main.PMC4946313.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d4/dc/main.PMC4946313.pdf
The breach geometry was greatly simplified at mid to late times when all flow was in the bottom of the inner breach with an initial depth of 7.9 m. Toanalyze this portion of the hydrographs we applied equations from Walder and Article No~e00120 39 http://dx.doi.org/10.1016/j.heliyon.2016.e00120 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d4/dc/main.PMC4946313.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d4/dc/main.PMC4946313.pdf
Article No~e00120 40 http://dx.doi.org/10.1016/j.heliyon.2016.e00120 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d4/dc/main.PMC4946313.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d4/dc/main.PMC4946313.pdf
Article No~e00120 41 http://dx.doi.org/10.1016/j.heliyon.2016.e00120 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d4/dc/main.PMC4946313.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d4/dc/main.PMC4946313.pdf
Article No~e00120 42 http://dx.doi.org/10.1016/j.heliyon.2016.e00120 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d4/dc/main.PMC4946313.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d4/dc/main.PMC4946313.pdf
cannot be deemed to be the cause of the late disaster as we find that the embankment would have been overflowed and the Article No~e00120 43 http://dx.doi.org/10.1016/j.heliyon.2016.e00120 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d4/dc/main.PMC4946313.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d4/dc/main.PMC4946313.pdf
18 also reveals that had the reconstructed dam been built only Article No~e00120 44 http://dx.doi.org/10.1016/j.heliyon.2016.e00120 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d4/dc/main.PMC4946313.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d4/dc/main.PMC4946313.pdf
Article No~e00120 45 http://dx.doi.org/10.1016/j.heliyon.2016.e00120 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d4/dc/main.PMC4946313.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d4/dc/main.PMC4946313.pdf
Article No~e00120 46 http://dx.doi.org/10.1016/j.heliyon.2016.e00120 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d4/dc/main.PMC4946313.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d4/dc/main.PMC4946313.pdf
This seems unusual given James Francis â€™expertise in flood Article No~e00120 47 http://dx.doi.org/10.1016/j.heliyon.2016.e00120 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d4/dc/main.PMC4946313.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d4/dc/main.PMC4946313.pdf
Article No~e00120 48 http://dx.doi.org/10.1016/j.heliyon.2016.e00120 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d4/dc/main.PMC4946313.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d4/dc/main.PMC4946313.pdf
We appreciate the field work assistance of Dr. Carrie Davis Article No~e00120 49 http://dx.doi.org/10.1016/j.heliyon.2016.e00120 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d4/dc/main.PMC4946313.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d4/dc/main.PMC4946313.pdf
[Accessed 6/5/2016] http://help.arcgis.com/en/arcgisdesktop/10.0/help/index.html#// 009z00000076000000.htm .,OADS,/arxiv_data1/oa_pdf/d4/dc/main.PMC4946313.pdf
[Accessed 3/17/2016]http://www.dcnr.state.pa.us/topogeo/pamap/documents/index.htm .,Non-OADS,/arxiv_data1/oa_pdf/d4/dc/main.PMC4946313.pdf
Article No~e00120 50 http://dx.doi.org/10.1016/j.heliyon.2016.e00120 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d4/dc/main.PMC4946313.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d4/dc/main.PMC4946313.pdf
[Accessed 2/13/ 2016] http://www.smoter.com/flooddam/johnstow.htm .,Non-OADS,/arxiv_data1/oa_pdf/d4/dc/main.PMC4946313.pdf
"C. P. Dougherty (railroad agent in South Fork), interviewed by John H. Hampton, Pittsburgh, July 1889; http://www.nps.gov/jofl/learn/history-culture/dougherty.htm [Accessed 2/13/2016].",Non-OADS,/arxiv_data1/oa_pdf/d4/dc/main.PMC4946313.pdf
Article No~e00120 51 http://dx.doi.org/10.1016/j.heliyon.2016.e00120 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d4/dc/main.PMC4946313.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d4/dc/main.PMC4946313.pdf
Download site for PAMAP LiDAR: http://www.pasda.psu.edu/uci/SearchResults.aspx?originator=%20&Key- word=pamap%20lidar&searchType=keyword&entry=PASDA&conditio-n=AND&sessionID=5775552642015710143015 [Accessed 1/27/2016].,OADS,/arxiv_data1/oa_pdf/d4/dc/main.PMC4946313.pdf
Available at: http://www.pasda.psu.edu/uci/MetadataDisplay.aspx?entry=- PASDA&file=PAMAP_DEM.xml&dataset=1247 [Accessed 3/8/2016].,OADS,/arxiv_data1/oa_pdf/d4/dc/main.PMC4946313.pdf
[Accessed 1/27/2016] http://www.lakepowell.org/page_two/ information/THE%20LESSON%20OF%20CONEMAUGH.pdf .,Non-OADS,/arxiv_data1/oa_pdf/d4/dc/main.PMC4946313.pdf
Article No~e00120 52 http://dx.doi.org/10.1016/j.heliyon.2016.e00120 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d4/dc/main.PMC4946313.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d4/dc/main.PMC4946313.pdf
"Research Project Number 0â€“4696, [Accessed 1/27/2016] http://cleveland2.ce.ttu.edu/teaching/ RTFM_courses/RTFM-WSM-HEC-SWMM/Lesson-6/Reading-6/4696-KerbyKir- pich/0-4696-2.pdf .",Non-OADS,/arxiv_data1/oa_pdf/d4/dc/main.PMC4946313.pdf
Article No~e00120 53 http://dx.doi.org/10.1016/j.heliyon.2016.e00120 2405-8440/Â© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d4/dc/main.PMC4946313.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/d4/dc/main.PMC4946313.pdf
"2016;48(3):907-916pISSN 1598-2998, eISSN 2005-9256 http://dx.doi.org/10.4143/crt.2015.359  Èˆhttp://www.e-crt.org Èˆ 907 Copyright Ë…2016    by  the Korean Cancer Association This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Open Access The Effect of Induction Chemotherapy Using Docetaxel, Cisplatin,  and Fluorouracil on Survival in Locally Advanced Head and  Neck Squamous Cell Carcinoma: A Meta-AnalysisOriginal Article Purpose The purpose of this study was to compare the survival of patients with locally advanced head and neck squamous cell carcinoma (LA-HNSCC) undergoing concurrent chemoradio- therapy (CRT) alone with that of patients undergoing induction chemotherapy (IC) using  docetaxel, cisplatin, and 5-fluorouracil (TPF) followed by CRT.",Non-OADS,/arxiv_data1/oa_pdf/16/ed/crt-2015-359.PMC4946346.pdf
The following trial databases were also searched for ongoing and unpub- lished trials: the MetaRegister of controlled clinical trials (http://www.controlled-trials.com/) and the National Insti- tutes of Health Clinical Trials Registry (http://clinicaltrials.,Non-OADS,/arxiv_data1/oa_pdf/16/ed/crt-2015-359.PMC4946346.pdf
Electronic Supplementary Material Supplementary materials are available at Cancer Research and Treatment website (http://www.e-crt.org).,Non-OADS,/arxiv_data1/oa_pdf/16/ed/crt-2015-359.PMC4946346.pdf
"2016;48(3):1056-1064pISSN 1598-2998, eISSN 2005-9256 http://dx.doi.org/10.4143/crt.2015.282 Open Access Serum Concentrations of Selenium and Copper in Patients Diagnosed with Pancreatic CancerOriginal Article Purpose Understanding of the etiology and pathogenesis of pancreatic cancer (PaCa) is still insuffi- cient.",Non-OADS,/arxiv_data1/oa_pdf/e3/49/crt-2015-282.PMC4946347.pdf
"Key words Selenium, Copper, Pancreatic neoplasms, Retrospective studies +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +Correspondence: Marcin R. Lener, PhD Department of Genetics and Pathology,  International Hereditary Cancer Center, Pomeranian Medical University, Po!abska 4,  70-115 Szczecin, Poland Tel: 48-91-466-1532 Fax: 48-91-466-1533 E-mail: marcinlener@poczta.onet.pl Received  July 27, 2015 Accepted  December 16, 2015 Published Online  December 28, 2015Marcin R. Lener, PhD1 Rodney J. Scott, PhD2 Anna Wiechowska-Koz!owska, MD, PhD3 Pablo Serrano-FernÃ¡ndez, PhD1 Piotr Baszuk, MSc1 Katarzyna Jaworska-Bieniek, PhD1 Grzegorz Sukiennicki, MSc1 Wojciech Marciniak, MSc4 Magdalena Muszy""ska, MSc4 JÃ³zef K!adny, MD, PhD5 Tomasz Gromowski, MSc1 Katarzyna Kaczmarek, MSc1 Anna Jakubowska, PhD1 Jan Lubi""ski, MD, PhD1,4 1Department of Genetics and Pathology,  International Hereditary Cancer Center, Pomeranian Medical University, Szczecin,  Poland, 2Discipline of Medical Genetics, School of Biomedical Sciences,  Faculty of Health, University of Newcastle and The Hunter Medical Research Institute, Newcastle, New South Wales, Australia,  3Laboratory of Endoscopy,  Division of Heath Care  Ministry of Internal A!airs and  Administration, Szczecin, 4Read-Gene S.A., Grzepnica, 5Department of General and  Oncological Surgery,  Pomeranian Medical University, Szczecin, Poland Èˆhttp://www.e-crt.org Èˆ 1056Copyright â¡‹2016 by  the Korean Cancer Association This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e3/49/crt-2015-282.PMC4946347.pdf
"2016;48(3):883-891pISSN 1598-2998, eISSN 2005-9256 http://dx.doi.org/10.4143/crt.2015.218 Èˆhttp://www.e-crt.org Èˆ 883 Copyright Ë…2016    by  the Korean Cancer Association This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Open Access Responses to Overdiagnosis in Thyroid Cancer Screening among  Korean WomenOriginal Article Purpose Communicating the harms and benefits of thyroid screening is necessary to help individuals decide on whether or not to undergo thyroid cancer screening.",Non-OADS,/arxiv_data1/oa_pdf/63/0e/crt-2015-218.PMC4946348.pdf
"2016;48(3):1130-1140pISSN 1598-2998, eISSN 2005-9256 http://dx.doi.org/10.4143/crt.2015.206 Open Access Isotype-Specific Inhibition of Histone Deacetylases: Identification of Optimal Targets for RadiosensitizationOriginal Article Purpose Histone deacetylase (HDAC) inhibitors radiosensitize tumor cells.",Non-OADS,/arxiv_data1/oa_pdf/91/7a/crt-2015-206.PMC4946349.pdf
"Thus, classical HDACs have been a new targetJin Ho Kim, MD, PhD1,2 Sung Ho Moon, MD, PhD1 Mina No, BS3 Jae Jin Kim, BS1,3 Eun Jung Choi, PhD3 Bong Jun Cho, PhD3 Jae Sung Kim, MD, PhD1,3 Il Han Kim, MD, PhD1,2,4 In Ah Kim, MD, PhD1,3,4 1Department of Radiation Oncology,  Seoul National University  College of Medicine, Seoul,  2Institute of Radiation Medicine,  Medical Research Center,  Seoul National University, Seoul,  3Medical Science Research Institute,  Seoul National University Bundang Hospital, Seongnam, 4Cancer Research Institute,  Seoul National University  College of Medicine, Seoul, Korea Èˆhttp://www.e-crt.org Èˆ 1130Copyright â¡‹2016 by  the Korean Cancer Association This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.+  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +Correspondence: In Ah Kim, MD, PhD  Department of Radiation Oncology,  Seoul National University Bundang Hospital,  82 Gumi-ro 173beon-gil, Bundang-gu,  Seongnam 13620, Korea Tel: 82-31-787-7651  Fax: 82-31-787-4019 E-mail: inah228@snu.ac.kr Received  June 10, 2015 Accepted  November 1, 2015 Published Online  November 17, 2015 *Jin Ho Kim and Sung Ho Moon contributed equally to this work.",Non-OADS,/arxiv_data1/oa_pdf/91/7a/crt-2015-206.PMC4946349.pdf
The current study pro- vides a rationale for the need of optimized approach for  future development of HDAC-mediated radiosensitization strategies as well as an insight into the differential role of HDAC isotypes in modulating cellular radiosensitivity.Electronic Supplementary Material Supplementary materials are available at Cancer Research and Treatment website (http://www.e-crt.org).,Non-OADS,/arxiv_data1/oa_pdf/91/7a/crt-2015-206.PMC4946349.pdf
"2016;48(3):917-927pISSN 1598-2998, eISSN 2005-9256 http://dx.doi.org/10.4143/crt.2015.265 Èˆhttp://www.e-crt.org Èˆ 917 Copyright Ë…2016    by  the Korean Cancer Association This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Open Access The Role of Neoadjuvant Chemotherapy in the Treatment of  Nasopharyngeal Carcinoma: A Multi-institutional Retrospective Study (KROG 11-06) Using Propensity Score Matching AnalysisOriginal Article Purpose We compared the treatment results and toxicity in nasopharyngeal carcinoma (NPC) patients treated with concurrent chemotherapy (CCRT) alone (the CRT arm) or neoadjuvant chemotherapy followed by CCRT (the NCT arm).",Non-OADS,/arxiv_data1/oa_pdf/d5/cf/crt-2015-265.PMC4946350.pdf
"2016;48(3):869-882pISSN 1598-2998, eISSN 2005-9256 http://dx.doi.org/10.4143/crt.2015.290  Èˆhttp://www.e-crt.org Èˆ 869 Copyright Ë…2016    by  the Korean Cancer Association This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Open Access Incidence and Survival of Childhood Cancer in KoreaOriginal Article Purpose An epidemiologic study of childhood cancer would provide useful information on cancer  etiology and development of management guidelines.",Non-OADS,/arxiv_data1/oa_pdf/ce/7a/crt-2015-290.PMC4946351.pdf
KCCR statistics from 1999-2002 and 2003-2007 have been published in Cancer Incidence in Five Continentsvolumes IX and X (http://ci5.iarc.,OADS,/arxiv_data1/oa_pdf/ce/7a/crt-2015-290.PMC4946351.pdf
"2016;48(3):1030-1036pISSN 1598-2998, eISSN 2005-9256 http://dx.doi.org/10.4143/crt.2015.398 Open Access Chronological Changes of Quality of Life in Long-Term Survivors after Gastrectomy for Gastric CancerOriginal Article Purpose A few studies have prospectively evaluated changes in quality of life (QoL) after surgery in short-term survivors; however, no prospective study has evaluated the longitudinal changes in QoL in long-terms survivors.",Non-OADS,/arxiv_data1/oa_pdf/bd/64/crt-2015-398.PMC4946352.pdf
"The European Organization for Research and Treatment+  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  Correspondence: Wansik Yu, MD, PhD Gastric Cancer Center,  Kyungpook National University Medical Center, 807 Hoguk-ro, Buk-gu, Daegu 41404, Korea Tel: 82-53-200-2700 Fax: 82-53-200-2027 E-mail: wyu@knu.ac.kr Received  October 19, 2015 Accepted  December 19, 2015 Published Online  January 6, 2016Wansik Yu, MD, PhD1,2 Ki Bum Park, MD2 Ho Young Chung, MD, PhD3 Oh Kyoung Kwon, MD2 Seung Soo Lee, MD3 1Department of Surgery,  Kyungpook National University  School of Medicine, Daegu,  2Gastric Cancer Center,  Kyungpook National University  Medical Center, Daegu,  3Department of Surgery,  Kyungpook National University Hospital, Daegu, Korea Èˆhttp://www.e-crt.org Èˆ 1030Copyright â¡‹2016 by  the Korean Cancer Association This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/bd/64/crt-2015-398.PMC4946352.pdf
"2016;48(3):978-989pISSN 1598-2998, eISSN 2005-9256 http://dx.doi.org/10.4143/crt.2015.311 Open Access Prospective Study on the Incidence of Postoperative Venous  Thromboembolism in Korean Patients with Colorectal CancerOriginal Article Purpose Pharmacologic thromboprophylaxis is routinely recommended for Western cancer patients undergoing major surgery for prevention of venous thromboembolism (VTE).",Non-OADS,/arxiv_data1/oa_pdf/20/c6/crt-2015-311.PMC4946353.pdf
"*This paper was presented at the 25th Congress of the International Society of Thrombosis and Haemostasis in Toronto, Canada, June 20-25, 2015.Eunyoung Lee, MD1,2 Sung-Bum Kang, MD, PhD3 Sang Il Choi, MD, PhD4 Eun Ju Chun, MD4 Min Jeong Kim, RN1 Duck-Woo Kim, MD, PhD3 Heung-Kwon Oh, MD3 Myong Hoon Ihn, MD3 Jin Won Kim, MD1 Soo-Mee Bang, MD, PhD1 Jeong-Ok Lee, MD1 Yu Jung Kim, MD, PhD1 Jee Hyun Kim, MD, PhD1 Jong Seok Lee, MD, PhD1 Keun-Wook Lee, MD, PhD1 1Department of Internal Medicine,  Seoul National University Bundang Hospital,  Seoul National University  College of Medicine, Seongnam,  2Hematologic Oncology Clinics,  Center for Speciï¬c Organs Cancer,  National Cancer Center, Goyang,  Departments of 3Surgery and 4Radiology, Seoul National University Bundang Hospital, Seoul National University  College of Medicine, Seongnam, Korea Èˆhttp://www.e-crt.org Èˆ 978Copyright â¡‹2016 by  the Korean Cancer Association This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/20/c6/crt-2015-311.PMC4946353.pdf
"2016;48(3):1010-1019pISSN 1598-2998, eISSN 2005-9256 http://dx.doi.org/10.4143/crt.2015.279 Open Access Cost Effectiveness of Colorectal Cancer Screening Interventions with Their Effects on Health Disparity Being ConsideredOriginal Article Purpose The purpose of this study was to evaluate the cost effectiveness of colorectal cancer screen- ing interventions with their effects on health disparity being considered.",Non-OADS,/arxiv_data1/oa_pdf/b4/da/crt-2015-279.PMC4946354.pdf
"However, participation in colorectal cancer screening shows a wide variation across different socioeconomic or regional condi- tions, e.g., from 53% in Oklahoma to 72% in Delaware in the United States during 2006-2010 [2], from 33% in the most  deprived area to 67% in the least deprived area in England for the year 2008 (organized screening) [3], and from 22% in+  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +Correspondence: Eun-Cheol Park, MD, PhD  Department of Preventive Medicine and  Institute of Health Services Research,  Yonsei University, 50-1 Yonsei-ro,  Seodaemun-gu, Seoul 03722, Korea  Tel: 82-2-2228-1862   Fax: 82-2-392- 8133 E-mail: ecpark@yuhs.ac Received  July 26, 2015 Accepted  December 16, 2015 Published Online  December 28, 2015Kwang-Sig Lee, PhD1 Eun-Cheol Park, MD, PhD2 1Health Insurance Policy Research Institute, Korea National Health Insurance Service, Wonju, 2Department of Preventive Medicine and Institute of Health Services Research, Yonsei University, Seoul, Korea Èˆhttp://www.e-crt.org Èˆ 1010Copyright â¡‹2016 by  the Korean Cancer Association This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b4/da/crt-2015-279.PMC4946354.pdf
Available from: http://globocan.iarc.fr/Default.aspx.,Non-OADS,/arxiv_data1/oa_pdf/b4/da/crt-2015-279.PMC4946354.pdf
Available from: http://kosis.kr/.,Non-OADS,/arxiv_data1/oa_pdf/b4/da/crt-2015-279.PMC4946354.pdf
Electronic Supplementary Material Supplementary materials are available at Cancer Research and Treatment website (http://www.e-crt.org).,Non-OADS,/arxiv_data1/oa_pdf/b4/da/crt-2015-279.PMC4946354.pdf
Available from: http://data.worldbank.org/data-catalog/world-devel- opment-indicators.,OADS,/arxiv_data1/oa_pdf/b4/da/crt-2015-279.PMC4946354.pdf
"2016;48(3):928-941pISSN 1598-2998, eISSN 2005-9256 http://dx.doi.org/10.4143/crt.2015.275 Open Access The Clinical Usefulness of 18F-Fluorodeoxyglucose Positron Emission Tomography (PET)  to Predict Oncologic Outcomes and PET-Based Radiotherapeutic  Considerations in Locally Advanced Nasopharyngeal CarcinomaOriginal Article Purpose We investigated 18F-fluorodeoxyglucose positron emission tomography (PET)-derived  parameters as prognostic indices for disease progression and survival in locally advanced nasopharyngeal carcinoma (NPC) and the effect of high-dose radiotherapy for a subpopu- lation with PET-based poor prognoses.",Non-OADS,/arxiv_data1/oa_pdf/b2/d5/crt-2015-275.PMC4946355.pdf
"This was the impetus to investigate a predictive index for disease progression through the recent development of an RT modality and improved imaging tech-+  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +Correspondence: Ki Chang Keum, MD, PhD Department of Radiation Oncology,  Yonsei Cancer Center, Yonsei University  College of Medicine, 50-1 Yonsei-ro,  Seodaemun-gu, Seoul 03722, Korea  Tel: 82-2-2228-8112  Fax: 82-2-2227-7823  E-mail: kckeum@yuhs.ac Received  July 24, 2015 Accepted  November 30, 2015 Published Online  December 11, 2015Hong In Yoon, MD1 Kyung Hwan Kim, MD1 Jeongshim Lee, MD1 Yun Ho Roh, MS2 Mijin Yun, MD, PhD3 Byoung Chul Cho, MD, PhD4 Chang Geol Lee, MD, PhD1 Ki Chang Keum, MD, PhD1 1Department of Radiation Oncology,  Yonsei Cancer Center, Yonsei University  College of Medicine, Seoul,  2Biostatistics Collaboration Unit,  Yonsei University College of Medicine, Seoul,  3Department of Nuclear Medicine,  Yonsei University College of Medicine, Seoul,  4Department of Internal Medicine,  Yonsei Cancer Center, Yonsei University  College of Medicine, Seoul, Korea Èˆhttp://www.e-crt.org Èˆ 928Copyright â¡‹2016 by  the Korean Cancer Association This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b2/d5/crt-2015-275.PMC4946355.pdf
A well-designed prospective study to compare the effect of TLG-based high-dose RT to conventional RT in  locally advanced NPC is needed to examine the survival ben- efit of high-dose RT in high TLG patients.Electronic Supplementary Material Supplementary materials are available at Cancer Research and Treatment website (http://www.e-crt.org).,Non-OADS,/arxiv_data1/oa_pdf/b2/d5/crt-2015-275.PMC4946355.pdf
Available from: http://www.nccn.org/professionals/physician_gls/pdf/head -and-neck.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b2/d5/crt-2015-275.PMC4946355.pdf
"2016;48(3):892-898pISSN 1598-2998, eISSN 2005-9256 http://dx.doi.org/10.4143/crt.2015.370   Open Access The Clinical Status of Radiation Therapy in Korea in 2009 and 2013Original Article Purpose The purpose of this study is to estimate the clinical status of radiation therapy (RT) in Korea.",Non-OADS,/arxiv_data1/oa_pdf/4f/82/crt-2015-370.PMC4946356.pdf
"As the market and clinical demand for RT grow in importance, providing accurate, nationally based+  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +Correspondence: Mi-Sook Kim, MD, PhD Department of Radiation Oncology,  Korea Institute of Radiological and  Medical Sciences, 75 Nowon-ro, Nowon-gu, Seoul 01812, Korea Tel: 82-2-970-2484 Fax: 82-2-970-2412 E-mail: mskim@kirams.re.kr Received  October 1, 2015 Accepted  November 24, 2015 Published Online  December 14, 2015Jin-Kyu Kang, MD1 Mi-Sook Kim, MD, PhD1,2 Won-Il Jang, MD1 Hee Jin Kim2 Chul Koo Cho, MD, PhD1 Hyung Jun Yoo, MD1 Young Seok Seo, MD1 Eun Kyung Paik, MD1 Yu Jin Cha, MD1 1Department of Radiation Oncology,  2Radiation Medicine Policy Development  Center, Korea Institute of Radiological and Medical Sciences, Seoul, Korea Èˆhttp://www.e-crt.org Èˆ 892Copyright â¡‹2016 by  the Korean Cancer Association This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4f/82/crt-2015-370.PMC4946356.pdf
"2016;48(3):1020-1029pISSN 1598-2998, eISSN 2005-9256 http://dx.doi.org/10.4143/crt.2015.264   Open Access Effect of Helicobacter pyloriEradication on Long-Term Survival after Distal Gastrectomy for Gastric CancerOriginal Article Purpose Negative Helicobacter pyloristatus has been identified as a poor prognostic factor for sur- vival in gastric cancer (GC) patients who underwent surgery.",Non-OADS,/arxiv_data1/oa_pdf/c3/cc/crt-2015-264.PMC4946357.pdf
"In addition, H. pylori+  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  Correspondence: Il Ju Choi, MD, PhD Center for Gastric Cancer,  National Cancer Center, 323 Ilsan-ro,  Ilsandong-gu, Goyang 10408, Korea Tel: 82-31-920-1629 Fax: 82-31-920-0069 E-mail: cij1224@hanmail.net Received  July 19, 2015 Accepted  October 27, 2015 Published Online  November 17, 2015Young-Il Kim, MD Soo-Jeong Cho, MD, PhD Jong Yeul Lee, MD Chan Gyoo Kim, MD, PhD Myeong-Cherl Kook, MD, PhD Keun Won Ryu, MD, PhD Young-Woo Kim, MD, PhD Il Ju Choi, MD, PhD Center for Gastric Cancer,  National Cancer Center, Korea Èˆhttp://www.e-crt.org Èˆ 1020Copyright â¡‹2016 by  the Korean Cancer Association This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c3/cc/crt-2015-264.PMC4946357.pdf
"2016;48(3):1045-1055pISSN 1598-2998, eISSN 2005-9256 http://dx.doi.org/10.4143/crt.2015.226  1045Open Access Concurrent Chemoradiotherapy Versus Chemotherapy Alone for  Unresectable Locally Advanced Pancreatic Cancer: A Retrospective Cohort StudyOriginal Article Purpose The optimal treatment strategy for locally advanced pancreatic cancer (LAPC), particularly the role of concurrent chemoradiotherapy (CCRT), remains debatable.",Non-OADS,/arxiv_data1/oa_pdf/8c/dd/crt-2015-226.PMC4946358.pdf
"The optimal treatment strategy for locally advanced pan-+  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +Correspondence: Do-Youn Oh, MD, PhD Department of Internal Medicine,  Seoul National University Hospital,  101 Daehak-ro, Jongno-gu, Seoul 03080, Korea Tel: 82-2-2072-0701 Fax: 82-2-762-9662 E-mail: ohdoyoun@snu.ac.kr Received  June 24, 2015 Accepted  September 30, 2015 Published Online  October 16, 2015 aPresent address: Department of Internal  Medicine, Dongguk University Gyeongju  Hospital, Gyeongju, KoreaYounak Choi, MD1,a Do-Youn Oh, MD, PhD1,2 Kyubo Kim, MD, PhD3 Eui Kyu Chie, MD, PhD3 Tae-Yong Kim, MD, PhD1,2 Kyung-Hun Lee, MD, PhD1,2 Sae-Won Han, MD, PhD1,2 Seock-Ah Im, MD, PhD1,2 Tae-You Kim, MD, PhD1,2 Sung Whan Ha, MD, PhD3 Yung-Jue Bang, MD, PhD1,2 1Department of Internal Medicine,  Seoul National University Hospital, Seoul,  2Cancer Research Institute,  Seoul National University  College of Medicine, Seoul,  3Department of Radiation Oncology,  Seoul National University Hospital, Seoul, Korea Èˆhttp://www.e-crt.org Èˆ Copyright Ë…2016    by  the Korean Cancer Association This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8c/dd/crt-2015-226.PMC4946358.pdf
"2016;48(3):1065-1073pISSN 1598-2998, eISSN 2005-9256 http://dx.doi.org/10.4143/crt.2015.302 Open Access The Overexpression of CCAR1 in Hepatocellular Carcinoma Associates with Poor PrognosisOriginal Article Purpose Cell division cycle and apoptosis regulator 1 (CCAR1) plays a dynamic role in regulation of cell growth and apoptosis by serving as a cofactor of steroid/thyroid nuclear receptors, !- catenin, and p53 in a variety of cell types including different cancer cells.",Non-OADS,/arxiv_data1/oa_pdf/c0/21/crt-2015-302.PMC4946359.pdf
"Cell division cycle and apoptosis regulator 1 (CCAR1) was originally identified as a peri-nuclear phospho-protein+  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +Correspondence: Cheol-Keun Park, MD, PhD Department of Pathology,  Samsung Medical Center,  Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul 06351, Korea Tel: 82-2-3410-2766 Fax: 82-2-3410-0025 E-mail: ckpark@skku.edu Received  August 11, 2015 Accepted  October 6, 2015 Published Online  October 16, 2015Sang Yun Ha, MD, PhD1 Jeong Hoon Kim, PhD2 Jung Wook Yang, MD1 Jimin Kim, MD1 Binnari Kim, MD1 Cheol-Keun Park, MD, PhD1 1Department of Pathology,  Samsung Medical Center,  Sungkyunkwan University  School of Medicine, Seoul,  2Department of Molecular Biology,  Samsung Advanced Institute for  Health Science and Technology, Sungkyunkwan University  School of Medicine, Seoul, Korea 1065 Èˆhttp://www.e-crt.org Èˆ Copyright Ë…2016    by  the Korean Cancer Association This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c0/21/crt-2015-302.PMC4946359.pdf
"2016;48(3):1102-1109pISSN 1598-2998, eISSN 2005-9256 http://dx.doi.org/10.4143/crt.2015.207  Open Access Variation in Practice Patterns of Korean Radiation Oncologists for Spine Metastasis between 2009 and 2014Original Article Purpose The Korean Society of Radiation Oncologists (KOSRO) conducted the Patterns of Care Study (PCS) of radiotherapy (RT) for spine metastases in 2009.",Non-OADS,/arxiv_data1/oa_pdf/0b/4e/crt-2015-207.PMC4946360.pdf
"Furthermore, survival duration of patients with distant metastasis has been continuously extended due to recent developments in sys-+  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +Correspondence: Hee Chul Park, MD, PhD Department of Radiation Oncology,  Samsung Medical Center,  Sungkyunkwan University School of Medicine,  81 Irwon-ro, Gangnam-gu, Seoul 06351, Korea Tel: 82-2-3410-2605 Fax: 82-2-3410-2619 E-mail: hee.ro.park@samsung.com Received  June 11, 2015 Accepted  November 7, 2015 Published Online  December 2, 2015Jeong Il Yu, MD1 Hee Chul Park, MD, PhD1,2 Yong Chan Ahn, MD, PhD1,2 Yoonsun Chung, PhD1 Woong Sub Koom, MD, PhD3 Si Yeol Song, MD, PhD4 1Department of Radiation Oncology,  Samsung Medical Center,  Sungkyunkwan University  School of Medicine, Seoul,  2Department of Medical Device  Management and Research, SAIHST, Sungkyunkwan University, Seoul,  3Department of Radiation Oncology,  Yonsei Institute for Cancer Research,  Yonsei University College of Medicine, Seoul,  4Department of Radiation Oncology,  Asan Medical Center, University of Ulsan  College of Medicine, Seoul, Korea Èˆhttp://www.e-crt.org Èˆ 1102Copyright â¡‹2016 by  the Korean Cancer Association This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0b/4e/crt-2015-207.PMC4946360.pdf
Electronic Supplementary Material Supplementary materials are available at Cancer Research and Treatment website (http://www.e-crt.org).,Non-OADS,/arxiv_data1/oa_pdf/0b/4e/crt-2015-207.PMC4946360.pdf
"2016;48(3):1092-1101pISSN 1598-2998, eISSN 2005-9256 http://dx.doi.org/10.4143/crt.2015.316 Open Access Systemic Treatments for Metastatic Renal Cell Carcinoma: 10-Year  Experience of Immunotherapy and Targeted TherapyOriginal Article Purpose The purpose of this study is to compare the outcomes of first-line systemic targeted therapy (TT) and immunotherapy (IT) in patients with metastatic renal cell carcinoma (mRCC).",Non-OADS,/arxiv_data1/oa_pdf/21/ac/crt-2015-316.PMC4946361.pdf
"Further attempts to augment cytokine-based IT activity (e.g., inclu- sion of vinblastine and 5-fluorouracil [5-FU] chemotherapy) led to slightly improved objective response rate (ORR) [3,4].+  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +Correspondence: Jinsoo Chung, MD, PhD Department of Urology,  Center for Prostate Cancer,  Research Institute and  Hospital of National Cancer Center,  323 Ilsan-ro, Ilsandong-gu, Goyang 10408, Korea Tel: 82-31-920-2456 Fax: 82-31-920-2474 E-mail: cjs5225@ncc.re.kr Received  August 19, 2015 Accepted  January 11, 2016 Published Online  January 28, 2016Sung Han Kim, MD, PhD1 Weon Seo Park, MD, PhD1,2 Sun Ho Kim, MD, PhD3 Jae Young Joung, MD, PhD1 Ho Kyung Seo, MD, PhD1 Kang Hyun Lee, MD, PhD1 Jinsoo Chung, MD, PhD1 Departments of 1Urology, 2Pathology,  and 3Radiology, Center for Prostate Cancer, Research Institute and Hospital of National Cancer Center, Goyang, Korea Èˆhttp://www.e-crt.org Èˆ 1092Copyright â¡‹2016 by  the Korean Cancer Association This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/21/ac/crt-2015-316.PMC4946361.pdf
http://dx.doi.org/10.1111/bju.13374.,Non-OADS,/arxiv_data1/oa_pdf/21/ac/crt-2015-316.PMC4946361.pdf
"2016;48(3):942-947pISSN 1598-2998, eISSN 2005-9256 http://dx.doi.org/10.4143/crt.2015.362  Open Access TERTPromoter Mutations and Tumor Persistence/Recurrence in  Papillary Thyroid CancerOriginal Article Purpose A telomerase reverse transcriptase (TERT) promoter mutation was identified in thyroid can- cer.",Non-OADS,/arxiv_data1/oa_pdf/39/47/crt-2015-362.PMC4946362.pdf
"Two hot spots of TERTpromoter mutation in thyroid cancer cells have recently been reported [124G>A+  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  Correspondence: Min Joo Kim, MD, PhD Department of Internal Medicine,  Korea Cancer Center Hospital, 75, Nowon-ro, Nowon-gu, Seoul 01812, Korea Tel: 82-2-970-1215 Fax: 82-2-970-2438 E-mail: chorong24@gmail.com Received  September 24, 2015 Accepted  December 17, 2015 Published Online  December 28, 2015Jae Kyung Myung, MD1 Byung Kuk Kwak, MS2 Jung Ah Lim, MD, PhD3 Myung-Chul Lee, MD, PhD4 Min Joo Kim, MD, PhD2 Departments of 1Pathology and  2Internal Medicine,  Korea Cancer Center Hospital, Seoul,  3Department of Internal Medicine,  National Medical Center, Seoul,  4Department of Otorhinolaryngology,  Korea Cancer Center Hospital, Seoul, Korea Èˆhttp://www.e-crt.org Èˆ 942Copyright â¡‹2016 by  the Korean Cancer Association This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/39/47/crt-2015-362.PMC4946362.pdf
"2016;48(3):1120-1129pISSN 1598-2998, eISSN 2005-9256 http://dx.doi.org/10.4143/crt.2015.436 Open Access A Multi-centric Bioequivalence Trial in Ph+ Chronic Myeloid Leukemia Patients to Assess Bioequivalence and Safety Evaluation of Generic Imatinib Mesylate 400 mg TabletsOriginal Article Purpose This study was designed to characterize the pharmacokinetic profile and to assess bioe- quivalence of the sponsorâ€™s test formulation (imatinib mesylate 400 mg tablets) with an  innovator product (Gleevec 400 mg tablets, Novartis Pharmaceuticals) under fed conditions, in adult patients of Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML) stabilized on imatinib mesylate 400 mg.",Non-OADS,/arxiv_data1/oa_pdf/5f/9b/crt-2015-436.PMC4946363.pdf
"GP-5, Sector 18,  Udyog Vihar Industrial Area,  Gurgaon 122015, Haryana, India Tel: 91-9818001209 Fax: 91-1244231002 E-mail: rachna.arora@sunpharma.com Received  November 13, 2015 Accepted  December 25, 2015 Published Online  February 12, 2016Rachna Arora, MBBS, DGO1,2 Manju Sharma, PhD1 Tausif Monif, PhD2 Sunil Iyer, PhD2 1Faculty of Pharmacy, Jamia Hamdard,  Hamdard University, New Delhi,  2Clinical Pharmacology and Pharmacokinetics,  Sun Pharmaceutical Industries Limited,  Gurgaon, Haryana, India Èˆhttp://www.e-crt.org Èˆ 1120Copyright â¡‹2016 by  the Korean Cancer Association This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5f/9b/crt-2015-436.PMC4946363.pdf
"2016;48(3):970-977pISSN 1598-2998, eISSN 2005-9256 http://dx.doi.org/10.4143/crt.2015.140   Open Access In VitroAdenosine Triphosphate-Based Chemotherapy Response Assay as a Predictor of Clinical Response to Fluorouracil-Based Adjuvant Chemotherapy in Stage II Colorectal Cancer Original Article Purpose We evaluated the usefulness of the in vitro adenosine triphosphate-based chemotherapy response assay (ATP-CRA) for prediction of clinical response to fluorouracil-based adjuvant chemotherapy in stage II colorectal cancer.",Non-OADS,/arxiv_data1/oa_pdf/41/f4/crt-2015-140.PMC4946364.pdf
"+  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +Correspondence: Kang Young Lee, MD, PhD Department of Surgery, Severance Hospital, Yonsei University College of Medicine,  50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea Tel: 82-2-2228-2096 Fax: 82-2-313-8289 E-mail: kylee117@yuhs.ac Received  April 19, 2015 Accepted  September 30, 2015 Published Online  October 22, 2015Hye Youn Kwon, MD1 Im-kyung Kim, MD2 Jeonghyun Kang, MD2 Seung-Kook Sohn, MD, PhD2 Kang Young Lee, MD, PhD3 1Department of Surgery,  Sahmyook Medical Center, Seoul,  2Department of Surgery,  Gangnam Severance Hospital,  Yonsei University College of Medicine, Seoul,  3Department of Surgery, Severance Hospital,  Yonsei University College of Medicine, Seoul,  Korea Èˆhttp://www.e-crt.org Èˆ 970Copyright â¡‹2016 by  the Korean Cancer Association This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/41/f4/crt-2015-140.PMC4946364.pdf
"2016;48(3):1037-1044pISSN 1598-2998, eISSN 2005-9256 http://dx.doi.org/10.4143/crt.2015.333 Èˆhttp://www.e-crt.org Èˆ Copyright Ë…2016    by  the Korean Cancer Association This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Open Access Relationship between Salt Preference and Gastric Cancer Screening: An Analysis of a Nationwide Survey in KoreaOriginal Article Purpose Epidemiological studies have demonstrated an association between excessive salt intake and gastric cancer risk, and this potential risk increases the need for adequate gastric can- cer screening in individuals with high salt intake.",Non-OADS,/arxiv_data1/oa_pdf/dc/d8/crt-2015-333.PMC4946365.pdf
Available from: http://globocan.iarc.fr/Pages/fact_sheets_ cancer.aspx.,Non-OADS,/arxiv_data1/oa_pdf/dc/d8/crt-2015-333.PMC4946365.pdf
"2016;48(3):955-961pISSN 1598-2998, eISSN 2005-9256 http://dx.doi.org/10.4143/crt.2015.191 Èˆhttp://www.e-crt.org Èˆ 955 Copyright Ë…2016    by  the Korean Cancer Association This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Open Access Analysis of BRIP1Variants among Korean Patients with BRCA1/2  Mutation-Negative High-Risk Breast CancerOriginal Article Purpose The aim of the current study is to assess the spectrum of genetic variation in the BRIP1 gene among Korean high-risk breast cancer patients who tested negative for the BRCA1/2 mutation.",Non-OADS,/arxiv_data1/oa_pdf/9f/2e/crt-2015-191.PMC4946366.pdf
"In the current study, variations are categorized as novel sequence variations when they can- not be found in publically available sequence variation data- bases including dbSNP (http://www.ncbi.nlm.nih.gov/snp/), Exome Aggregation Consortium (EXAC; http://exac.broad- institute.org/), Leiden Open Variation Database (LOVD; http://www.lovd.nl/3.0/), Human Genome Mutation Data- base (HGMD; http://www.hgmd.cf.ac.uk/ac/), ClinVar (http:// www.ncbi.nlm.nih.gov/clinvar/), 1000 Genomes (http://www.",OADS,/arxiv_data1/oa_pdf/9f/2e/crt-2015-191.PMC4946366.pdf
2 (PolyPhen-2; http://genetics.bwh.harvard.edu/pph2) and Sorting Intol- erant From Tolerant (SIFT; http://sift.jcvi.org/index.html) to predict the impact on the function of a protein.,OADS,/arxiv_data1/oa_pdf/9f/2e/crt-2015-191.PMC4946366.pdf
"2; L, Leiden Open Variation Database (LOVD; http://www.lovd.nl/3.0/); C, ClinVar (http://www.ncbi.nlm.nih.gov/clinvar/); T, 1000Genome (http://www.1000genomes.org/); V, Exome Variant Server (http://evs.gs.washington.edu/EVS/); E, Exome Aggregation Consortium (EXAC; http://exac.broadinstitute.org/); D, dbSNP (http://www.ncbi.nlm.nih.gov/SNP/); H, Human Genome Mutation Data- base (HGMD; http://www.hgmd.cf.ac.uk/ac/).",OADS,/arxiv_data1/oa_pdf/9f/2e/crt-2015-191.PMC4946366.pdf
"Èˆhttp://www.e-crt.org Èˆ 948Copyright â¡‹2016 by  the Korean Cancer Association This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Cancer Res Treat.",Non-OADS,/arxiv_data1/oa_pdf/d3/b1/crt-2015-360.PMC4946367.pdf
"2016;48(3):948-954pISSN 1598-2998, eISSN 2005-9256 http://dx.doi.org/10.4143/crt.2015.360 Open Access Polymorphic Variants in Oxidative Stress Genes and Acute Toxicity in Breast Cancer Patients Receiving RadiotherapyOriginal Article Purpose Reactive oxygen species (ROS) are generated as an indirect product of radiation therapy (RT).",Non-OADS,/arxiv_data1/oa_pdf/d3/b1/crt-2015-360.PMC4946367.pdf
"2016;48(3):899-906 pISSN 1598-2998, eISSN 2005-9256  http://dx.doi.org/10.4143/crt.2015.212  Open Access  Changing Patterns of Primary Treatment in Korean Men with Prostate  Cancer Over 10 Years: A Nationwide Population Based Study Original Article  Purpose We investigated changing patterns of primary treatment in Korean men with prostate cancer  (PC) and impact of sociodemographic factors on treatment choice from a nationwide cohort  over 10 years.",Non-OADS,/arxiv_data1/oa_pdf/14/5d/crt-2015-212.PMC4946368.pdf
"Multiple reasons including population  aging, westernization of diet and increase of prostate-specific +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + Correspondence: Hanjong Ahn, MD, PhD  Department of Urology, Asan Medical Center,  University of Ulsan College of Medicine,  88 Olympic-ro 43-gil, Songpa-gu, Seoul 05505,  Korea  Tel: 82-2-3010-3733  Fax: 82-2-477-8928  E-mail: hjahn@amc.seoul.kr  Received  June 15, 2015  Accepted  September 30, 2015  Published Online  October 20, 2015 Jinsung Park, MD, PhD 1 Beomseok Suh, MD, MPH 2 Dong Wook Shin, MD, DrPH, MBA 2 Jun Hyuk Hong, MD, PhD 3 Hanjong Ahn, MD, PhD 3 1Department of Urology,  Eulji University Hospital, Daejeon,  2Department of Family Medicine,  Seoul National University Hospital, Seoul,  3Department of Urology,  Asan Medical Center,  University of Ulsan College of Medicine,  Seoul, Korea  â”‚http://www.e-crt.org â”‚ 899 Copyright â“’2016    by  the Korean Cancer Association  This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/14/5d/crt-2015-212.PMC4946368.pdf
"2016;48(3):990-997pISSN 1598-2998, eISSN 2005-9256 http://dx.doi.org/10.4143/crt.2015.296 Open Access Splenomegaly and Its Associations with Genetic Polymorphisms and Treatment Outcome in Colorectal Cancer Patients Treated with  Adjuvant FOLFOXOriginal Article Purpose Splenomegaly is a clinical surrogate of oxaliplatin-induced sinusoidal obstruction syndrome (SOS).",Non-OADS,/arxiv_data1/oa_pdf/12/07/crt-2015-296.PMC4946369.pdf
"Key words Colorectal neoplasms, Oxaliplatin,  Sinusoidal obstruction syndrome, Splenomegaly,  Genetic polymorphism+  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  Correspondence: Sae-Won Han, MD, PhD Department of Internal Medicine,  Seoul National University Hospital,  101 Daehak-ro, Jongno-gu, Seoul 03080, Korea Tel: 82-2-2072-0242  Fax: 82-2-762-9662 E-mail: saewon1@snu.ac.kr Received  August 6, 2015 Accepted  December 19, 2015 Published Online  January 14, 2016Mi-Jung Kim, MD1,2,3 Sae-Won Han, MD, PhD1,2 Dae-Won Lee, MD1 Yongjun Cha, MD1 Kyung-Hun Lee, MD1,2 Tae-Yong Kim, MD1,2 Do-Youn Oh, MD,PhD1,2 Se Hyung Kim, MD, PhD4 Seock-Ah Im, MD, PhD1,2 Yung-Jue Bang, MD, PhD1,2 Tae-You Kim, MD, PhD1,2 1Department of Internal Medicine,  Seoul National University Hospital, Seoul,  2Cancer Research Institute,  Seoul National University  College of Medicine, Seoul,  3Center for Gastric Cancer,  National Cancer Center, Goyang,  4Department of Radiology and  Institute of Radiation Medicine,  Seoul National University Hospital,  Seoul National University  College of Medicine, Seoul, Korea Èˆhttp://www.e-crt.org Èˆ 990Copyright â¡‹2016 by  the Korean Cancer Association This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/12/07/crt-2015-296.PMC4946369.pdf
"As we found no association between the genetic polymorphisms analyzed herein and development of sple- nomegaly, future studies investigating other biomarker can- didates are warranted for prediction of SOS.Electronic Supplementary Material Supplementary materials are available at Cancer Research and Treatment website (http://www.e-crt.otg).",Non-OADS,/arxiv_data1/oa_pdf/12/07/crt-2015-296.PMC4946369.pdf
"2016;48(3):1074-1083pISSN 1598-2998, eISSN 2005-9256 http://dx.doi.org/10.4143/crt.2015.356  Open Access Adjuvant Treatment after Surgery in Stage IIIA Endometrial  AdenocarcinomaOriginal Article Purpose We evaluated the role of adjuvant therapy in stage IIIA endometrioid adenocarcinoma  patients who underwent surgery followed by radiotherapy (RT) alone or chemoradiotherapy (CTRT) according to risk group.",Non-OADS,/arxiv_data1/oa_pdf/2e/2c/crt-2015-356.PMC4946370.pdf
"Èˆhttp://www.e-crt.org Èˆ 1074Copyright â¡‹2016 by  the Korean Cancer Association This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2e/2c/crt-2015-356.PMC4946370.pdf
"2016;48(3):1110-1119pISSN 1598-2998, eISSN 2005-9256 http://dx.doi.org/10.4143/crt.2015.289 Open Access Clinical Characteristics and Continued Epidermal Growth Factor  Receptor (EGFR) Tyrosine Kinase Inhibitor Administration in  EGFR-Mutated Non-small Cell Lung Cancer with Skeletal MetastasisOriginal Article Purpose The aim of this study was to analyze clinical characteristics of skeletal metastasis in epi- dermal growth factor receptor (EGFR) mutant non-small cell lung cancer (NSCLC) and treat- ment outcomes of continued EGFR tyrosine kinase inhibitor (TKI) therapy in patients presenting with skeletal metastasis progression.",Non-OADS,/arxiv_data1/oa_pdf/18/80/crt-2015-289.PMC4946371.pdf
"Key words EGFR, Non-small cell lung carcinoma,  EGFR tyrosine kinase inhibitor, Bone metastasis,  Response Evaluation Criteria in Solid Tumors+  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +Correspondence: Jin-Hyoung Kang, MD, PhD Division of Medical Oncology,  Department of Internal Medicine,  College of Medicine,  The Catholic University of Korea,  222 Banpo-daero, Seocho-gu, Seoul 06591, Korea Tel: 82-2-2258-6043 Fax: 82-2-594-6043 E-mail: jinkang@catholic.ac.kr Received  July 31, 2015 Accepted  December 10, 2015 Published Online  January 6, 2016Sook-Hee Hong, MD, PhD1,2 Yeon-Sil Kim, MD, PhD3 Ji Eun Lee, MD1 In-Ho Kim, MD1 Seung Joon Kim, MD, PhD4 Daehee Han, MD, PhD5 Ie Ryung Yoo, MD, PhD6 Yang-Guk Chung, MD, PhD7 Young-Hoon Kim, MD, PhD7 Kyo-Young Lee, MD, PhD8 Jin-Hyoung Kang, MD, PhD1 1Division of Medical Oncology,  Department of Internal Medicine,  College of Medicine, The Catholic University of Korea, Seoul, 2Cancer Research Institute, The Catholic University of Korea, Seoul,  3Department of Radiation Oncology,  4Division of Respiratory and  Critical Care Medicine,  Department of Internal Medicine,  Departments of 5Radiology,  6Nuclear Medicine, 7Orthopedics,  and 8Hospital Pathology,  College of Medicine,  The Catholic University of Korea, Seoul, Korea Èˆhttp://www.e-crt.org Èˆ 1110Copyright â¡‹2016 by  the Korean Cancer Association This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/18/80/crt-2015-289.PMC4946371.pdf
"2016;48(3):1141-1153pISSN 1598-2998, eISSN 2005-9256 http://dx.doi.org/10.4143/crt.2015.209 Open Access Dexamethasone Inhibits TGF-!1â€“Induced Cell Migration by Regulating the ERK and AKT Pathways in Human Colon Cancer Cells Via CYR61Original Article Purpose One of the features in cancer development is the migration of cancer cells to form metastatic lesions.",Non-OADS,/arxiv_data1/oa_pdf/2c/fd/crt-2015-209.PMC4946372.pdf
"The EMT playsSanghoon Han, MD1 Ngoc Thuy Bui, MS2 Manh Tin Ho, MS2 Young Mee Kim, PhD2 Moonjae Cho, PhD2 Dong Bok Shin, MD, PhD3 Departments of 1Internal Medicine and  2Biochemistry, Jeju National University School of Medicine, Jeju,  3Department of Internal Medicine,  Gachon University Gil Medical Center,  Incheon, Korea +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +Correspondence: Moonjae Cho, PhD  Department of Biochemistry,  Jeju National University School of Medicine,  15 Aran 13-gil, Jeju 63241, Korea Tel: 82-64-754-3837 Fax: 82-64-725-2593 E-mail: moonjcho@jejunu.ac.kr Co-Correspondence: Dong Bok Shin, MD, PhD Department of Internal Medicine,  Gachon University Gil Medical Center,  21 Namdong-daero 774beon-gil, Namdong-gu, Incheon 21565, Korea  Tel: 82-32-460-8371 Fax: 82-32-460-3233  E-mail: dbs@gilhospital.com Received  June 12, 2015 Accepted  November 14, 2015 Published Online  December 15, 2015 1141 Èˆhttp://www.e-crt.org Èˆ Copyright Ë…2016    by  the Korean Cancer Association This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2c/fd/crt-2015-209.PMC4946372.pdf
"Èˆhttp://www.e-crt.org Èˆ 998Copyright â¡‹2016 by  the Korean Cancer Association This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Cancer Res Treat.",Non-OADS,/arxiv_data1/oa_pdf/4d/10/crt-2015-254.PMC4946373.pdf
"2016;48(3):998-1009pISSN 1598-2998, eISSN 2005-9256 http://dx.doi.org/10.4143/crt.2015.254  Open Access What Is the Ideal Tumor Regression Grading System in Rectal Cancer Patients after Preoperative Chemoradiotherapy?Original Article Purpose Tumor regression grade (TRG) is predictive of therapeutic response in rectal cancer patients after chemoradiotherapy (CRT) followed by curative resection.",Non-OADS,/arxiv_data1/oa_pdf/4d/10/crt-2015-254.PMC4946373.pdf
"2016;48(3):1084-1091pISSN 1598-2998, eISSN 2005-9256 http://dx.doi.org/10.4143/crt.2015.405 Open Access Cisplatin, Gemcitabine, and Lapatinib as Neoadjuvant Therapy for Muscle-Invasive Bladder CancerOriginal Article Purpose We sought to investigate the safety and efficacy of gemcitabine, cisplatin, and lapatinib (GCL) as neoadjuvant therapy in patients with muscle-invasive bladder cancer (MIBC) planned for radical cystectomy.",Non-OADS,/arxiv_data1/oa_pdf/d0/4e/crt-2015-405.PMC4946374.pdf
"Therefore, the+  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +Correspondence: David J. Vaughn, MD Department of Medicine,  Division of Hematology/Medical Oncology, Hospital of the University of Pennsylvania,  7th Floor PCAM South Pavilion, Philadelphia, PA 19104, USA Tel: 1-215-349-8140 Fax: 1-215-662-7804  E-mail: david.vaughn@uphs.upenn.edu Received  October 22, 2015 Accepted  November 9, 2015 Published Online  December 2, 2015Vivek Narayan, MD1 Ronac Mamtani, MD1 Stephen Keefe, MD1 Thomas Guzzo, MD2 S. Bruce Malkowicz, MD2 David J. Vaughn, MD1 1Division of Medical Oncology,  Hospital of the University of Pennsylvania, Abramson Cancer Center, Philadelphia, PA, 2Department of Urology,  Hospital of the University of Pennsylvania, Philadelphia, PA, USA Èˆhttp://www.e-crt.org Èˆ 1084Copyright â¡‹2016 by  the Korean Cancer Association This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d0/4e/crt-2015-405.PMC4946374.pdf
Available from: http://www.nccn.org/professionals/physi- cian_gls/f_guidelines.asp#bladder.,Non-OADS,/arxiv_data1/oa_pdf/d0/4e/crt-2015-405.PMC4946374.pdf
"2016;48(3):962-969pISSN 1598-2998, eISSN 2005-9256 http://dx.doi.org/10.4143/crt.2015.173  Open Access Delay of Treatment Initiation Does Not Adversely Affect Survival  Outcome in Breast Cancer Original Article Purpose Previous studies examining the relationship between time to treatment and survival out- come in breast cancer have shown inconsistent results.",Non-OADS,/arxiv_data1/oa_pdf/0b/29/crt-2015-173.PMC4946375.pdf
"Key words Breast neoplasms, Time-to-treatment, Survival rate+  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +Correspondence: Wonshik Han, MD, PhD Department of Surgery,  Seoul National University Hospital,  101 Daehak-ro, Jongno-gu, Seoul, 03080, Korea Tel: 82-2-2072-1958 Fax: 82-2-766-3975 E-mail: hanw@snu.ac.kr Received  May 19, 2015 Accepted  September 30, 2015 Published Online  October 22, 2015 Present address: aDepartment of Surgery,  University of Ulsan College of Medicine,  Asan Medical Center, Seoul, Korea,  bDepartment of Surgery,  Ewha Womans University School of Medicine,  Seoul, Korea, cDepartment of Surgery,  Kangwon National University, Chuncheon,  Korea, dDepartment of Surgery,  Bundang Jesaeng Hospital, Seongnam, Korea,  eDepartment of Surgery,  SMG-SNU Boramae Medical Center, Seoul, KoreaTae-Kyung Yoo, MD1 Wonshik Han, MD, PhD1,2 Hyeong-Gon Moon, MD, PhD1,2 Jisun Kim, MD, PhD1,a Jun Woo Lee, MD1,b Min Kyoon Kim, MD, PhD1,c Eunshin Lee, MD1,d Jongjin Kim, MD1,e Dong-Young Noh, MD, PhD1,2 1Department of Surgery,  Seoul National University  College of Medicine, Seoul,  2Laboratory of Breast Cancer Biology,  Cancer Research Institute,  Seoul National University  College of Medicine, Seoul, Korea Èˆhttp://www.e-crt.org Èˆ 962Copyright â¡‹2016 by  the Korean Cancer Association This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0b/29/crt-2015-173.PMC4946375.pdf
Available at: http://www.framing - hamheartstudy.org/risk/coronary.html.,Non-OADS,/arxiv_data1/oa_pdf/81/20/HI-10-1-12.PMC4946384.pdf
"pISSN 2287-2728       eISSN 2287-285X http://dx.doi.org/10.3350/cmh .2015.0021 Clinical and Molecular Hepatology 2016;22:276-280 Case Report Corresponding author :  Sun Hong Yoo Hepatology Center, Bundang Jesaeng General Hospital, 20 Seohyeon-ro  180beon-gil, Bundang-gu, Seongnam 13590, Korea Tel: +82-31-779-5065, Fax: +82-31-779-0164 E-mail: hepayoo@dmc.or.krAbbreviations:   MPNST, malignant peripheral nerve sheath tumor; NF1, neurofibromatosis type 1;  PNF, plexiform neurofibroma Received :  Apr.",Non-OADS,/arxiv_data1/oa_pdf/f8/c5/cmh-2015-0021.PMC4946396.pdf
"(Clin Mol Hepatol 2016;22:276-280) Keywords:  Plexiform neurofibroma; Portal hypertension; Esophageal varix Copyright Â© 2016 by The Korean Associa tion for the Study of the Liver This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f8/c5/cmh-2015-0021.PMC4946396.pdf
Plexiform neurofibroma induced portal hypertension http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.0021CASE REPORT A 49-year-old man without any personal or familial history of  relevant diseases except NF1 underwent esophagogastroduode - noscopy and abdominal ultrasonography for screening purposes.,Non-OADS,/arxiv_data1/oa_pdf/f8/c5/cmh-2015-0021.PMC4946396.pdf
278 http://www.e-cmh.orgClin Mol Hepatol Volume _22  Number _2  June 2016 http://dx.doi.org/10.3350/cmh.2015.0021portal vein in the hepatoduodenal ligament.,Non-OADS,/arxiv_data1/oa_pdf/f8/c5/cmh-2015-0021.PMC4946396.pdf
Plexiform neurofibroma induced portal hypertension http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.0021it was determined that removing the tumor entirely would not be  feasible due to its extension into the lesser sac and hepatic hilum.,Non-OADS,/arxiv_data1/oa_pdf/f8/c5/cmh-2015-0021.PMC4946396.pdf
280 http://www.e-cmh.orgClin Mol Hepatol Volume _22  Number _2  June 2016 http://dx.doi.org/10.3350/cmh.2015.0021tal vein and causing portal hypertension with its corresponding  complications.,Non-OADS,/arxiv_data1/oa_pdf/f8/c5/cmh-2015-0021.PMC4946396.pdf
"pISSN 2287-2728       eISSN 2287-285X http://dx.doi.org/10.3350/cmh .2015.0102 Clinical and Molecular Hepatology 2016;22:292-295 Liver Pathology Corresponding author :  Kyoung-Bun Lee Department of Pathology, Seoul National University Hospital,  101 Daehak-ro, Jongno-gu, Seoul 03080, Korea Tel: +82-2-2072-2968, Fax: +82-2-743-5530  E-mail: kblee@snuh.orgAbbreviations:   anti-HCV, anti-hepatitis C viral antibody; HBsAg, hepatitis B surface antigen;   MRI, magnetic resonance Imaging; UESL, undifferentiated embryonal sarcoma  of the liverINTRODUCTION  Undifferentiated embryonal sarcoma of the liver (UESL) has also  been called undifferentiated sarcoma of the liver or malignant  mesenchymoma of the liver.",Non-OADS,/arxiv_data1/oa_pdf/93/ad/cmh-2015-0102.PMC4946397.pdf
"(Clin Mol Hepatol 2016;22:292-295) Keywords:  Undifferentiated embryonal sarcoma of the liver; Hepatic sarcoma Copyright Â© 2016 by The Korean Associa tion for the Study of the Liver This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/93/ad/cmh-2015-0102.PMC4946397.pdf
Undifferentiated embryonal sarcoma of the liver http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.0102(HBsAg and anti-HCV).,Non-OADS,/arxiv_data1/oa_pdf/93/ad/cmh-2015-0102.PMC4946397.pdf
"294 http://www.e-cmh.orgClin Mol Hepatol Volume _22  Number _2  June 2016 http://dx.doi.org/10.3350/cmh.2015.0102DISCUSSION UESL is a rare primary mesenchymal tumor that usually occurs  in older children, but some cases have been reported in adults.",Non-OADS,/arxiv_data1/oa_pdf/93/ad/cmh-2015-0102.PMC4946397.pdf
Undifferentiated embryonal sarcoma of the liver http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.0102liver: report of 31 cases.,Non-OADS,/arxiv_data1/oa_pdf/93/ad/cmh-2015-0102.PMC4946397.pdf
"pISSN 2287-2728   eISSN 2287-285X http://dx.doi.org/10.3350/cmh .2016.0024 Clinical and Molecular Hepatology 2016;22:219-237 Review Corresponding author :  Dr Venessa Pattullo Department of Gastroenterology, Royal North Shore Hospital, 4B Acute  Services Building, St Leonards NSW, 2065, Australia Tel: +61-2-94632450, Fax: +61-2-94632041 Email: venessa.pattullo@sydney.edu.auAbbreviations:   AGA, American gastroenterological association; ALT, alanine aminotransferase;  Anti-HBc, hepatitis B core antibody; Anti-HBs, hepatitis B surface antibody;  BMT, bone marrow transplant; CHB, chronic hepatitis B; DNA, deoxyribonucleic  acid; EASL, European association for the study of the liver; HBeAg, hepatitis  B e-antigen; HBsAg, hepatitis B surface antigen; HBV, hepatitis B virus; HBV  reactivation, hepatitis B virus reactivation; HDV, hepatitis D virus; HSCT,  haematopoetic stem cell transplant; IL, interleukin; LPAM, lymphocyte Peyer's  patch adhesion molecule; OR, odds ratio; R-CHOP , rituximab-cyclophosphamide,  hydroxydaunorubicin (doxorubicin or adriamycin), oncovin (vincristine) and  prednisolone; R-CHEOP , rituximab-cyclophosphamide, hydroxydaunorubicin  (doxorubicin or adriamycin), etoposide, oncovin (vincristine) and prednisolone;  RR, risk ratio; RNA, ribonucleic acid; SLE, systemic lupus erythematosus; TNF,  tumour necrosis factor Received :  Apr.",Non-OADS,/arxiv_data1/oa_pdf/9c/21/cmh-2016-0024.PMC4946398.pdf
"(Clin Mol Hepatol 2016;22:219-237) Keywords:  Hepatitis B reactivation; Prophylaxis; Chemotherapy; Immunosuppression; Guidelines Copyright Â© 2016 by The Korean Associa tion for the Study of the Liver This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9c/21/cmh-2016-0024.PMC4946398.pdf
220 http://www.e-cmh.orgClin Mol Hepatol Volume _22  Number _2  June 2016 http://dx.doi.org/10.3350/cmh.2016.0024HOW AND WHY DOES HBV REACTIVATION  OCCUR WITH IMMUNOSUPPRESSION?,Non-OADS,/arxiv_data1/oa_pdf/9c/21/cmh-2016-0024.PMC4946398.pdf
HBV reactivation with immunosuppression http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2016.0024who experienced HBV reactivation in comparison with only 33%  of patients in whom HBV reactivation did not occur ( P=0.019).14  The potential outcome of any treatment interruption is a higher  morbidity or mortality associated with the primary diseases pro - cess.,Non-OADS,/arxiv_data1/oa_pdf/9c/21/cmh-2016-0024.PMC4946398.pdf
222 http://www.e-cmh.orgClin Mol Hepatol Volume _22  Number _2  June 2016 http://dx.doi.org/10.3350/cmh.2016.0024death may be considered clinical endpoints resulting  from HBV reactivation.,Non-OADS,/arxiv_data1/oa_pdf/9c/21/cmh-2016-0024.PMC4946398.pdf
"HBV reactivation with immunosuppression http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2016.0024geal carcinoma, some being fatal.65-67 In one cohort of 1301 pa - tients with nasopharyngeal carcinoma, the prevalence of CHB was  10.9%.67 Just over half the patients who were HBsAg positive re - ceived systemic chemotherapy (as opposed to locoregional radio - therapy alone) and of these, 44.2% had a hepatic adverse event,  3.5% classified as a severe hepatic event.",Non-OADS,/arxiv_data1/oa_pdf/9c/21/cmh-2016-0024.PMC4946398.pdf
"224 http://www.e-cmh.orgClin Mol Hepatol Volume _22  Number _2  June 2016 http://dx.doi.org/10.3350/cmh.2016.0024range of autoimmune conditions however due to low numbers of  cases, the true incidence of HBV reactivation is not clear.",Non-OADS,/arxiv_data1/oa_pdf/9c/21/cmh-2016-0024.PMC4946398.pdf
HBV reactivation with immunosuppression http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2016.0024developed for a range of disease states.,Non-OADS,/arxiv_data1/oa_pdf/9c/21/cmh-2016-0024.PMC4946398.pdf
"226 http://www.e-cmh.orgClin Mol Hepatol Volume _22  Number _2  June 2016 http://dx.doi.org/10.3350/cmh.2016.0024vation exist largely as case reports however the risk of HBV reac - tivation associated with these agents may be attributed to their  known relative potency of immunosuppression according to the   agentsâ€™ mechanism of action .115,116  Tyrosine kinase inhibitors including imantinib and nilotinib are  considered moderately immunosuppressive and have been associ - ated with HBV reactivation in the setting of chronic myeloid leu - kaemia and gastrointestinal stromal tumours amongst other dis - eases.37-40,54,55,117 Corticosteroids are very commonly used immunosuppessive  drugs across many disease processes.",Non-OADS,/arxiv_data1/oa_pdf/9c/21/cmh-2016-0024.PMC4946398.pdf
HBV reactivation with immunosuppression http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2016.0024susceptible patients who will receive immunosuppressive therapy.,Non-OADS,/arxiv_data1/oa_pdf/9c/21/cmh-2016-0024.PMC4946398.pdf
228 http://www.e-cmh.orgClin Mol Hepatol Volume _22  Number _2  June 2016 http://dx.doi.org/10.3350/cmh.2016.0024Which antiviral drug should be used for prophylaxis  of hepatitis B Reactivation?,Non-OADS,/arxiv_data1/oa_pdf/9c/21/cmh-2016-0024.PMC4946398.pdf
HBV reactivation with immunosuppression http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2016.0024of tenofovir in prevention of HBV reactivation.,Non-OADS,/arxiv_data1/oa_pdf/9c/21/cmh-2016-0024.PMC4946398.pdf
230 http://www.e-cmh.orgClin Mol Hepatol Volume _22  Number _2  June 2016 http://dx.doi.org/10.3350/cmh.2016.0024There is a paucity of data on the best and most cost-effective  approach to screening for HBV in patients at risk of HBV reactiva - tion.,Non-OADS,/arxiv_data1/oa_pdf/9c/21/cmh-2016-0024.PMC4946398.pdf
HBV reactivation with immunosuppression http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2016.0024virus reactivation after cessation of preemptive lamivudine in lym - phoma patients treated with rituximab plus CHOP.,Non-OADS,/arxiv_data1/oa_pdf/9c/21/cmh-2016-0024.PMC4946398.pdf
232 http://www.e-cmh.orgClin Mol Hepatol Volume _22  Number _2  June 2016 http://dx.doi.org/10.3350/cmh.2016.002429.,Non-OADS,/arxiv_data1/oa_pdf/9c/21/cmh-2016-0024.PMC4946398.pdf
HBV reactivation with immunosuppression http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2016.002455.,Non-OADS,/arxiv_data1/oa_pdf/9c/21/cmh-2016-0024.PMC4946398.pdf
234 http://www.e-cmh.orgClin Mol Hepatol Volume _22  Number _2  June 2016 http://dx.doi.org/10.3350/cmh.2016.0024Gut 2010;59:1340-1346.,Non-OADS,/arxiv_data1/oa_pdf/9c/21/cmh-2016-0024.PMC4946398.pdf
HBV reactivation with immunosuppression http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2016.0024therapy.,Non-OADS,/arxiv_data1/oa_pdf/9c/21/cmh-2016-0024.PMC4946398.pdf
236 http://www.e-cmh.orgClin Mol Hepatol Volume _22  Number _2  June 2016 http://dx.doi.org/10.3350/cmh.2016.0024spective and randomized controlled study: Can the prophylactic  use of lamivudine prevent hepatitis B virus reactivation in hepatitis  B s-antigen seropositive breast cancer patients during chemothera - py?,Non-OADS,/arxiv_data1/oa_pdf/9c/21/cmh-2016-0024.PMC4946398.pdf
HBV reactivation with immunosuppression http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2016.0024patients with breast cancer: a single institutionâ€™s experience.,Non-OADS,/arxiv_data1/oa_pdf/9c/21/cmh-2016-0024.PMC4946398.pdf
"pISSN 2287-2728       eISSN 2287-285X http://dx.doi.org/10.3350/cmh .2015.0040 Clinical and Molecular Hepatology 2016;22:281-285 Case Report Corresponding author :  Soon Ho Um Department of Internal Medicine, Korea University College of Medicine,  73 Inchon-ro, Seongbuk-gu, Seoul 02841, Korea Tel: +82-2-920-6555, Fax: +82-2-953-1943 E-mail: umsh@korea.ac.krAbbreviations:   AIH, autoimmune hepatitis; ALP , alkaline phosphatase; ALT, alanine aminotransferase;  ANA, antinuclear antibody; Anti-LKM, antibody anti-Liver Kidney Microsomal  antibody; AST, aspartate aminotransferase; AZA, azathioprine; HAV Ab IgM,  hepatitis A antibody immunoglobulin M; HBsAg, hepatitis B surface antigen; HCV  Ab, hepatitis C antibody; IgG, Immunoglobulin G; MMF, mycophenolate mofetil;  PT INR, prothrombin time internal normalisation ratio; SMA, anti-smooth muscle  antibody; TPMT, Thiopurine S-methyltransferase; 6-MP , 6-mercaptopurine; 6-TG,  6-thioguanine Received :  Jul.",Non-OADS,/arxiv_data1/oa_pdf/e8/fc/cmh-2015-0040.PMC4946399.pdf
"(Clin Mol Hepatol 2016;22:281-285) Keywords:  Mycophenolate mofetil; Autoimmune hepatitis; Azathioprine Copyright Â© 2016 by The Korean Associa tion for the Study of the Liver This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e8/fc/cmh-2015-0040.PMC4946399.pdf
282 http://www.e-cmh.orgClin Mol Hepatol Volume _22  Number _2  June 2016 http://dx.doi.org/10.3350/cmh.2015.0040pancytopenia and skin rash.,Non-OADS,/arxiv_data1/oa_pdf/e8/fc/cmh-2015-0040.PMC4946399.pdf
"MMF for AIH  http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.0040DISCUSSION  Autoimmune hepatitis (AIH) was first reported in 1951 as a  fluctuating persistent hepatitis of young woman with marked ele - vations of serum immunoglobulins.5,6 The median and mean age  of initial disease presentation are in the forties and the etiology of  AIH is unknown, but it carries all features of an autoimmune dis - ease: genetic predisposition, spontaneous disease fluctuations,  circulating autoantibodies, auto-reactive T cells, inflammatory in - filtrations in liver, and a good response to immunosuppressive agents.1,5,7-9 AIH can be diagnosed when compatible clinical signs  and symptoms, laboratory abnormalities (increased serum AST or  ALT, and total IgG), serological (autoantibodies), and histological  (interface hepatitis, lymphocytic and lymphoplasmacytic infiltrates  in portal tracts and extending in the lobule, hepatic rosette for - mation, or chronic hepatitis with lymphocytic infiltration) findings  are present; and other conditions that can cause chronic hepatitis,  including viral, metabolic, cholestatic, hereditary, and drug-in - duced diseases, have been excluded.1  Studies reported that when AIH is left untreated, as many as 050010001500200025003000 0 3 6 9 12 15 18 21 24 27 30 33 36 39 42 45 48 51IgG (mg/dL) Follow up duration (months)Addition of AZA MMF as an alternativePD, AZA start Discontinuation of AZA Discontinuation of AZA 0.000.501.001.502.002.503.003.504.004.50 020040060080010001200 0 3 6 9 12 15 18 21 24 27 30 33 36 39 42 45 48 51 Total bilirubin (mg/dL)AST (IU/L), ALT (IU/L) Follow up duration (Months) AST (IU/L) ALT (IU/L) Bilirubin, total (mg/dL)PD, AZA start Discontinuation of AZAAddition of AZA MMF as an alternativeDiscontinuation of AZA 050100150200250300350400450 020004000600080001000012000 0 3 6 9 12 15 18 21 24 27 30 33 36 39 42 45 48 51 PLT (103/Î¼L)WBC (/Î¼L), ANC (/Î¼L) Follow up duration (months) WBC (/uL) ANC (/uL) PLT (103/uL)Addition of AZA PD, AZA start Discontinuation of AZA MMF as an alternativeDiscontinuation of AZAFigure 2.",Non-OADS,/arxiv_data1/oa_pdf/e8/fc/cmh-2015-0040.PMC4946399.pdf
"284 http://www.e-cmh.orgClin Mol Hepatol Volume _22  Number _2  June 2016 http://dx.doi.org/10.3350/cmh.2015.004040% of the patients with severe disease die within 6 months and  of the remaining 40% develop cirrhosis.9,10 Therefore, when clini - cal, laboratory or histologic features of active liver inflammation is  present, immunosuppressive treatment should be initiated.",Non-OADS,/arxiv_data1/oa_pdf/e8/fc/cmh-2015-0040.PMC4946399.pdf
"MMF for AIH  http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.0040gani D, et al.",OADS,/arxiv_data1/oa_pdf/e8/fc/cmh-2015-0040.PMC4946399.pdf
"pISSN 2287-2728        eISSN 2287-285X http://dx.doi.org/10.3350/cmh .2016.0103 Clinical and Molecular Hepatology 2016;22:238-240 Editorial During the past decade, management of drug resistant chronic  hepatitis B (CHB) has been a major issue.1,2 A series of new antivi - ral agents has been developed, which provided new treatment op - tions as well as new resistance issues.",Non-OADS,/arxiv_data1/oa_pdf/cc/fc/cmh-2016-0103.PMC4946400.pdf
"10, 2016  Copyright Â© 2016 by The Korean Associa tion for the Study of the Liver This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/cc/fc/cmh-2016-0103.PMC4946400.pdf
239 Hyung Joon Yim Tenofovir for treatment failure in CHB http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2016.0103obtained from 4 patients.,Non-OADS,/arxiv_data1/oa_pdf/cc/fc/cmh-2016-0103.PMC4946400.pdf
240 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2016.0103Clin Mol Hepatol Volume _22  Number _2  June 2016not be able to be reached in CHB patients who have experienced  multiple drug resistance.,Non-OADS,/arxiv_data1/oa_pdf/cc/fc/cmh-2016-0103.PMC4946400.pdf
"pISSN 2287-2728       eISSN 2287-285X http://dx.doi.org/10.3350/cmh .2015.0066 Clinical and Molecular Hepatology 2016;22:286-291 Case Report Corresponding author :  Yoon Jun Kim Department of Internal Medicine, Seoul National University Hospital, 101  Daehak-ro, Chongno-gu, Seoul 03080, Korea Tel: +82-2-2072-3081, Fax: +82-2-743-6701 E-mail: yoonjun@snu.ac.krAbbreviations:   AKI, acute kidney injury; ALT, alanine aminotransferase; AST, aspartate  aminotransferase; CHB, chronic hepatitis B; EASL, European Association for the  Study of the Liver; eGFR, estimated glomerular filtration rate; ETV, entecavir; HBV,  hepatitis B virus; HCC, hepatocellular carcinoma; HIV, human immunodeficiency  virus; IDSA, Infectious Diseases Society of America; INR, international normalized  ratio; MDRD, Modification of Diet in Renal Disease; MPGN, membranoproliferative  glomerulonephritis; NSAID, non-steroidal anti-inflammatory drugs; OTC, over-the- counter; PEI, percutaneous ethanol injection; RFA, radiofrequency ablation; TACE,  transcatheter arterial chemoembolization; TDF, tenofovir disoproxil fumarate Received :  Oct. 4, 2015 /  Revised :  Nov. 3, 2015 /  Accepted :  Nov. 4, 2015INTRODUCTION  Tenofovir disoproxil fumarate (TDF) is an orally bioavailable pro - drug of tenofovir.1 Tenofovir is a nucleotide analogue reverse tran - scriptase inhibitor that has potent efficacy against retroviruses  and hepadnaviruses.2 TDF was approved by the US Food and  Drug Administration for the treatment of human immunodeficien - cy virus (HIV) infection in 2001, and for the treatment of chronic  hepatitis B (CHB) infection in 2008.",Non-OADS,/arxiv_data1/oa_pdf/b5/07/cmh-2015-0066.PMC4946401.pdf
"(Clin Mol Hepatol 2016;22:286-291) Keywords:  Tenofovir; Acute Kidney Injury; Drug-Related Side Effects and Adverse Reactions; Chronic Hepatitis B; Kidney Tubules Copyright Â© 2016 by The Korean Associa tion for the Study of the Liver This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b5/07/cmh-2015-0066.PMC4946401.pdf
Tenofovir-associated nephrotoxicity http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.0066phate levels occurring 4-12 months after starting the agent.,Non-OADS,/arxiv_data1/oa_pdf/b5/07/cmh-2015-0066.PMC4946401.pdf
288 http://www.e-cmh.orgClin Mol Hepatol Volume _22  Number _2  June 2016 http://dx.doi.org/10.3350/cmh.2015.0066prothrombin time was 1.05 (INR).,OADS,/arxiv_data1/oa_pdf/b5/07/cmh-2015-0066.PMC4946401.pdf
Tenofovir-associated nephrotoxicity http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.0066the serum creatinine had fallen to 1.46 mg/dL and the eGFR had  increased to 46.9 mL/min/1.73m2 (Fig.,Non-OADS,/arxiv_data1/oa_pdf/b5/07/cmh-2015-0066.PMC4946401.pdf
"290 http://www.e-cmh.orgClin Mol Hepatol Volume _22  Number _2  June 2016 http://dx.doi.org/10.3350/cmh.2015.0066es with TDF-associated Fanconi syndrome.9,10 However, renal  function in our cases was not fully recovered to pretreatment lev - el.",Non-OADS,/arxiv_data1/oa_pdf/b5/07/cmh-2015-0066.PMC4946401.pdf
Tenofovir-associated nephrotoxicity http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.0066Agents Chemother 2008;52:3144-3160.,Non-OADS,/arxiv_data1/oa_pdf/b5/07/cmh-2015-0066.PMC4946401.pdf
"pISSN 2287-2728       eISSN 2287-285X http://dx.doi.org/10.3350/cmh .2015.0037 Clinical and Molecular Hepatology 2016;22:272-275 Case Report Corresponding author :  Jin Woo Lee Department of Internal Medicine, Inha University School of Medicine, 27  Inhang-ro, Jung-gu, Incheon 22332, Korea Tel: +82-32-890-2548, Fax: +82-32-890-2549 E-mail: jin@inha.ac.krAbbreviations:   DTC, differentiated thyroid cancer; DILI, drug-induced liver injury;   AIH, autoimmune hepatitis Received :  Jun.",Non-OADS,/arxiv_data1/oa_pdf/05/f5/cmh-2015-0037.PMC4946402.pdf
"(Clin Mol Hepatol 2016;22:272-275) Keywords:  Iodine-131; Drug-induced liver injury (DILI); Corticosteroid Copyright Â© 2016 by The Korean Associa tion for the Study of the Liver This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/05/f5/cmh-2015-0037.PMC4946402.pdf
"Drug-induced hepatitis by Iodine http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.0037The patient was taking only prescribed medications, including  levothyroxine 150 Âµg, calcitriol 0.25 Âµg, and calcium carbonate  500 mg daily  for 2 months after the total thyroidectomy.",Non-OADS,/arxiv_data1/oa_pdf/05/f5/cmh-2015-0037.PMC4946402.pdf
"274 http://www.e-cmh.orgClin Mol Hepatol Volume _22  Number _2  June 2016 http://dx.doi.org/10.3350/cmh.2015.0037A blood test conducted on the third day of hospitalization  showed that AST/ALT was 1,308/1,920 IU/L, total bilirubin was 2.9  mg/dL, and ALP was 675 IU/L, indicating the aggravation of jaun - dice.",Non-OADS,/arxiv_data1/oa_pdf/05/f5/cmh-2015-0037.PMC4946402.pdf
Drug-induced hepatitis by Iodine http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.0037pected therapeutic effect.,Non-OADS,/arxiv_data1/oa_pdf/05/f5/cmh-2015-0037.PMC4946402.pdf
"pISSN 2287-2728       eISSN 2287-285X http://dx.doi.org/10.3350/cmh .2016.0020 Clinical and Molecular Hepatology 2016;22:259-266 Original Article Corresponding author :  Myeong Jun Song Division of Hepatology, Department of Internal Medicine, Daejeon St.  Maryâ€™s Hospital, College of Medicine, The Catholic University of Korea,  Daeheung-ro 64, Jung-gu, Daejeon 34943, Korea Tel: +82-42-220-9291, Fax: +82-42-252-6807 Email: mjsong95@gmail.comAbbreviations:   HCV, hepatitis c virus; GTs, genotypes; DCV, daclatasvir; ASV, asunaprevir;  PegIFN, pegylated interferon; RBV, ribavirin; SVR, sustained virological response;  NS5A, nonstructural protein 5A; AST, aspartate aminotransferase; ALT, alanine  aminotransferase; APRI, AST to platelet ratio index; RAV, resistance-associated  variants Received :  Apr.",Non-OADS,/arxiv_data1/oa_pdf/2c/c4/cmh-2016-0020.PMC4946403.pdf
"(Clin Mol Hepatol 2016;22:259-266) Keywords:  Hepatitis C virus; Liver cirrhosis; Direct-acting antivirals; Daclatasvir; Asunaprevir Copyright Â© 2016 by The Korean Associa tion for the Study of the Liver This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2c/c4/cmh-2016-0020.PMC4946403.pdf
"260 http://www.e-cmh.orgClin Mol Hepatol Volume _22  Number _2  June 2016 http://dx.doi.org/10.3350/cmh.2016.0020Until 2011, the combination of pegylated interferon (PegIFN)  and ribavirin (RBV) was the only approved treatment for chronic  hepatitis C. With this regimen, patients infected with HCV GT 1  had sustained virological response (SVR) rates of approximately  40% to 50%.5 Because of the low efficacy and treatment-limiting  adverse events associated with PegIFN/RBV regimen, many pa - tients cannot tolerate or are ineligible for this treatment.6 Twenty  to fifty percent of patients treated with PegIFN and RBV did not  achieve an SVR and those patients had been the major challenge  to treatment of HCV.3 And an estimated 20% of patients with  chronic HCV infection will develop cirrhosis.",Non-OADS,/arxiv_data1/oa_pdf/2c/c4/cmh-2016-0020.PMC4946403.pdf
Early experience in compensated cirrhosis patients http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2016.0020RESULTS  Baseline characteristics Eight patients were treated with DCV and ASV.,Non-OADS,/arxiv_data1/oa_pdf/2c/c4/cmh-2016-0020.PMC4946403.pdf
262 http://www.e-cmh.orgClin Mol Hepatol Volume _22  Number _2  June 2016 http://dx.doi.org/10.3350/cmh.2016.0020(Fig.,Non-OADS,/arxiv_data1/oa_pdf/2c/c4/cmh-2016-0020.PMC4946403.pdf
Early experience in compensated cirrhosis patients http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2016.0020(<15 IU/ml) at week 4 till 12 and she complained of generalized  weakness during the DCV/ASV therapy.,Non-OADS,/arxiv_data1/oa_pdf/2c/c4/cmh-2016-0020.PMC4946403.pdf
"264 http://www.e-cmh.orgClin Mol Hepatol Volume _22  Number _2  June 2016 http://dx.doi.org/10.3350/cmh.2016.0020GT 1b is the most prevalent subtype in Korea that proportion of  the GT 1b is up to 45.4%.4,20 Korea shares the similar trend with  Japan toward GT1b being the predominant HCV genotype and  DCV with ASV combination therapy is widely used in real-life  practice in Japan.",Non-OADS,/arxiv_data1/oa_pdf/2c/c4/cmh-2016-0020.PMC4946403.pdf
Early experience in compensated cirrhosis patients http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2016.0020Acknowledgements Daclatasvir and Asunaprevir were supported by Bristol-Myers  Squibb expanded access program.,Non-OADS,/arxiv_data1/oa_pdf/2c/c4/cmh-2016-0020.PMC4946403.pdf
266 http://www.e-cmh.orgClin Mol Hepatol Volume _22  Number _2  June 2016 http://dx.doi.org/10.3350/cmh.2016.002028.,Non-OADS,/arxiv_data1/oa_pdf/2c/c4/cmh-2016-0020.PMC4946403.pdf
"pISSN 2287-2728       eISSN 2287-285X http://dx.doi.org/10.3350/cmh .2016.0101 Clinical and Molecular Hepatology 2016;22:199-211 Review Corresponding author :  Massimo Roncalli Pathology, Humanitas Clinical and Research Center, Via Manzoni 56,  20089 Rozzano (MI), Italy.",Non-OADS,/arxiv_data1/oa_pdf/41/f7/cmh-2016-0101.PMC4946404.pdf
"(Clin Mol Hepatol 2016;22:199-211) Keywords:   Hepatocellular adenoma; Focal nodular hyperplasia; Hepatocellular carcinoma; Differential diagnosis; Liver  biopsy Copyright Â© 2016 by The Korean Associa tion for the Study of the Liver This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/41/f7/cmh-2016-0101.PMC4946404.pdf
200 http://www.e-cmh.orgClin Mol Hepatol Volume _22  Number _2  June 2016 http://dx.doi.org/10.3350/cmh.2016.0101mography (CT) in the clinical practice has increased the detection  rate of FNH.,Non-OADS,/arxiv_data1/oa_pdf/41/f7/cmh-2016-0101.PMC4946404.pdf
"A review http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2016.0101thologists should be aware that atypical patterns of staining ex - ist.20 Notably, FNH-like lesions arising in cirrhosis do not usually  display this pattern of staining.",Non-OADS,/arxiv_data1/oa_pdf/41/f7/cmh-2016-0101.PMC4946404.pdf
"202 http://www.e-cmh.orgClin Mol Hepatol Volume _22  Number _2  June 2016 http://dx.doi.org/10.3350/cmh.2016.0101er.20 Tumor hepatocytes have cytoplasms that may be normal,  clear (glycogen-rich), steatotic, or contain pigment in lysosomes.",Non-OADS,/arxiv_data1/oa_pdf/41/f7/cmh-2016-0101.PMC4946404.pdf
A review http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2016.010180% of the overall I-HCAs.,Non-OADS,/arxiv_data1/oa_pdf/41/f7/cmh-2016-0101.PMC4946404.pdf
"204 http://www.e-cmh.orgClin Mol Hepatol Volume _22  Number _2  June 2016 http://dx.doi.org/10.3350/cmh.2016.0101plasmic expression of GS and, at the best, a nuclear and cytoplas - mic immunohistochemical staining of Î²-catenin (Fig.",Non-OADS,/arxiv_data1/oa_pdf/41/f7/cmh-2016-0101.PMC4946404.pdf
"A review http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2016.0101HCA molecular classification (GS, Î²-catenin, LFABP, PCR, and  SAA).20,34,46 Intralesional morphology supplemented by special  stains (reticulin, vascular profile, immunomarkers panel) can help  to distinguish HCA from HCC in the majority of cases, as it will be  discussed later.",Non-OADS,/arxiv_data1/oa_pdf/41/f7/cmh-2016-0101.PMC4946404.pdf
"206 http://www.e-cmh.orgClin Mol Hepatol Volume _22  Number _2  June 2016 http://dx.doi.org/10.3350/cmh.2016.0101series.31,54,56 However, most of the series that report malignant  transformation focused on HCA-treated resection.54 This could  lead to an overestimation of the risk of malignant transforma - tion.55 In all cases, oral contraception or intake of androgen  should be discontinued at diagnosis of HCA because regression of  HCA has been described particularly after withdrawal of hor - mones.",Non-OADS,/arxiv_data1/oa_pdf/41/f7/cmh-2016-0101.PMC4946404.pdf
"A review http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2016.0101radic HCAs should be applied considering for resections larger  and Î²-catenin mutated lesions.38,66 Even if bleeding from HCAs  were sometimes observed during pregnancy, larger series have  shown that pregnancy in patients with residuals, not at risk  HCAs, is usually safe.38,67,68 Thus, pregnancy should not be con - traindicated but closely follow-up by imaging.",Non-OADS,/arxiv_data1/oa_pdf/41/f7/cmh-2016-0101.PMC4946404.pdf
"208 http://www.e-cmh.orgClin Mol Hepatol Volume _22  Number _2  June 2016 http://dx.doi.org/10.3350/cmh.2016.0101with true portal tracts (containing normal branch of hepatic ar - tery, portal vein and interlobular bile ducts, without a ductular  reaction) which may be trapped within the lesion at the borders.",Non-OADS,/arxiv_data1/oa_pdf/41/f7/cmh-2016-0101.PMC4946404.pdf
A review http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2016.0101liver.,Non-OADS,/arxiv_data1/oa_pdf/41/f7/cmh-2016-0101.PMC4946404.pdf
210 http://www.e-cmh.orgClin Mol Hepatol Volume _22  Number _2  June 2016 http://dx.doi.org/10.3350/cmh.2016.0101FRK-activating mutations and the mechanisms of malignant trans - formation.,Non-OADS,/arxiv_data1/oa_pdf/41/f7/cmh-2016-0101.PMC4946404.pdf
A review http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2016.01012000;231:74-81.,Non-OADS,/arxiv_data1/oa_pdf/41/f7/cmh-2016-0101.PMC4946404.pdf
"pISSN 2287-2728       eISSN 2287-285X http://dx.doi.org/10.3350/cmh .2015.0053 Clinical and Molecular Hepatology 2016;22:241-249 Original Article Corresponding author :  Jeong Han Kim Department of Internal Medicine, Konkuk University School of Medicine,  Konkuk University Medical Center, 120-1 Neungdong-ro, Hwayang-dong,  Gwangjin-gu, Seoul 05030, Korea Tel: +82-2-2030-7764, Fax: +82-2-2030-5029 E-mail: 93haan@hanmail.netAbbreviations:   ADV, adefovir; ALT, alanine amino transferase; BR, biochemical response; CHB,  chronic hepatitis B; CLV, clevudine; DMEM, Dulbeccoâ€™s modified Eagleâ€™s medium;  ETV, entecavir; HBeAg, hepatitis B envelope antigen; HBV, hepatitis B virus; HCC,  hepatocellular carcinoma; HEPES, 4-(2-hydroxyethyl)-1-piperazineethanesulfonic  acid; LMV, lamivudine; PCR, polymerase chain reaction; PEG, polyethylene glycol;  RFMP , restriction fragment mass polymorphism; RT, reverse transcriptase; TDF,  tenofovir; VR, virological response Received :  Aug. 10, 2015 /  Revised :  Mar.",Non-OADS,/arxiv_data1/oa_pdf/fe/2f/cmh-2015-0053.PMC4946405.pdf
"(Clin Mol Hepatol 2016;22:241-249) Keywords:  Chronic Hepatitis B; Entecavir; Adefovir; Lamivudine; Tenofovir; Resistance Copyright Â© 2016 by The Korean Associa tion for the Study of the Liver This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fe/2f/cmh-2015-0053.PMC4946405.pdf
"242 http://www.e-cmh.orgClin Mol Hepatol Volume _22  Number _2  June 2016 http://dx.doi.org/10.3350/cmh.2015.0053treatment guidelines suggest entecavir (ETV) or tenofovir (TDF) as  first-line antiviral agent for CHB treatment.6-9 However, ETV and  TDF have been made available in South Korea only since 2007  and 2011, respectively.",Non-OADS,/arxiv_data1/oa_pdf/fe/2f/cmh-2015-0053.PMC4946405.pdf
Tenofovir for suboptimal response to entecavir-adefovir combination http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.0053Table 1.,Non-OADS,/arxiv_data1/oa_pdf/fe/2f/cmh-2015-0053.PMC4946405.pdf
"244 http://www.e-cmh.orgClin Mol Hepatol Volume _22  Number _2  June 2016 http://dx.doi.org/10.3350/cmh.2015.0053Antiviral drugs and treatment condition ETV was purchased from Moravek (Brea, CA, USA), and ADV and  TDF were obtained from Gilead Science (Foster City, CA, USA).",OADS,/arxiv_data1/oa_pdf/fe/2f/cmh-2015-0053.PMC4946405.pdf
"Tenofovir for suboptimal response to entecavir-adefovir combination http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.0053Treatment response to ETV-ADV combination  therapy within 3 years Twelve patients achieved VR, and no difference in baseline  characteristics were observed between the groups with or with - out VR (Table 1).",Non-OADS,/arxiv_data1/oa_pdf/fe/2f/cmh-2015-0053.PMC4946405.pdf
246 http://www.e-cmh.orgClin Mol Hepatol Volume _22  Number _2  June 2016 http://dx.doi.org/10.3350/cmh.2015.0053clones were selected from the four patients and generated to 1.2  mer replicon by swapping the RT region of the WT 1.2 mer clone.,Non-OADS,/arxiv_data1/oa_pdf/fe/2f/cmh-2015-0053.PMC4946405.pdf
Tenofovir for suboptimal response to entecavir-adefovir combination http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.0053without prior ADV resistance.,Non-OADS,/arxiv_data1/oa_pdf/fe/2f/cmh-2015-0053.PMC4946405.pdf
248 http://www.e-cmh.orgClin Mol Hepatol Volume _22  Number _2  June 2016 http://dx.doi.org/10.3350/cmh.2015.0053in vitro drug susceptibility tests in the present study showed in - complete viral suppression with TDF monotherapy and complete  viral suppression with ETV-TDF combination therapy.,Non-OADS,/arxiv_data1/oa_pdf/fe/2f/cmh-2015-0053.PMC4946405.pdf
Tenofovir for suboptimal response to entecavir-adefovir combination http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.0053dine-resistant hepatitis B virus with or without adefovir resistance.,Non-OADS,/arxiv_data1/oa_pdf/fe/2f/cmh-2015-0053.PMC4946405.pdf
"pISSN 2287-2728       eISSN 2287-285X http://dx.doi.org/10.3350/cmh .2015.0017 Clinical and Molecular Hepatology 2016;22:267-271 Case Report Corresponding author :  Ki Tae Yoon Department of Internal Medicine, Pusan National University Yangsan  Hospital, 20 Geumo-ro, Mulgeum-eup, Yangsan 50612, Korea Tel: +82-55-360-2362, Fax: +82-55-360-1737 E-mail: ktyoon@pusan.ac.krAbbreviations:   CT, computed tomography; DCBM, disseminated carcinomatosis of the bone  marrow; DIC, disseminated intravascular coagulation; Hb, hemoglobin; HCC,  hepatocellular carcinoma; LN, lymph node; MRI, magnetic resonance imaging;  PET, positron emission tomography Received :  Apr.",Non-OADS,/arxiv_data1/oa_pdf/7a/d9/cmh-2015-0017.PMC4946406.pdf
"(Clin Mol Hepatol 2016;22:267-271) Keywords:  Carcinoma; Hepatocellular; Bone marrow; Metastasis Copyright Â© 2016 by The Korean Associa tion for the Study of the Liver This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7a/d9/cmh-2015-0017.PMC4946406.pdf
"268 http://www.e-cmh.orgClin Mol Hepatol Volume _22  Number _2  June 2016 http://dx.doi.org/10.3350/cmh.2015.0017sis of the bone originating from HCC, bone marrow metastasis  presented as bicytopenia has not been reported in the past litera - ture.13 Herein, we present a rare case of bone marrow metastasis  from HCC presented as bicytopenia.",Non-OADS,/arxiv_data1/oa_pdf/7a/d9/cmh-2015-0017.PMC4946406.pdf
"Bone marrow metastasis originating from HCC  http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.0017DISCUSSION The bone is one of the common sites for metastasis in HCC, al - though bone marrow metastasis from HCC is rarely reported and  its frequency is not well known.",Non-OADS,/arxiv_data1/oa_pdf/7a/d9/cmh-2015-0017.PMC4946406.pdf
"270 http://www.e-cmh.orgClin Mol Hepatol Volume _22  Number _2  June 2016 http://dx.doi.org/10.3350/cmh.2015.0017bone marrow.16-18 Lung, breast, and prostate malignancies in  adults, and neuroblastoma and rhabdomyosarcoma in children  are the most common nonhematological malignancies frequently  metastasize to the bone marrow.16 The detection depends on the  stage of the malignancy and the other sites of the metastases.",Non-OADS,/arxiv_data1/oa_pdf/7a/d9/cmh-2015-0017.PMC4946406.pdf
"Bone marrow metastasis originating from HCC  http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2015.0017alkalinephosphatasia, manifested 10 years after resection of early  gastric cancer.",Non-OADS,/arxiv_data1/oa_pdf/7a/d9/cmh-2015-0017.PMC4946406.pdf
"pISSN 2287-2728       eISSN 2287-285X http://dx.doi.org/10.3350/cmh .2016.0026 Clinical and Molecular Hepatology 2016;22:212-218 Review Corresponding author :  Jai Young Cho Department of Surgery, Seoul National University Bundang Hospital,   82 Gumi-ro 173beon-gil, Bundang-gu, Seongnam 13620, Korea Tel: +82-31-787-7098, Fax: +82-31-787-4078 E-mail: jychogs@gmail.comAbbreviations:   HCC, hepatocellular carcinoma; LLR, laparoscopic liver resection; OLR, open liver  resection; RCT, randomized controlled trial Received :  Apr.",Non-OADS,/arxiv_data1/oa_pdf/46/86/cmh-2016-0026.PMC4946407.pdf
"(Clin Mol Hepatol 2016;22:212-218) Keywords:  Laparoscopy; Hepatectomy; Outcome; Prognosis; Recurrence Copyright Â© 2016 by The Korean Associa tion for the Study of the Liver This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/46/86/cmh-2016-0026.PMC4946407.pdf
Laparoscopic hepatectomy for HCC http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2016.0026patients with HCC and chronic liver disease.,Non-OADS,/arxiv_data1/oa_pdf/46/86/cmh-2016-0026.PMC4946407.pdf
"214 http://www.e-cmh.orgClin Mol Hepatol Volume _22  Number _2  June 2016 http://dx.doi.org/10.3350/cmh.2016.0026tages are related to less postoperative pain, early ambulation,  early return of oral feeding, and lower incidence of postopera - tive complications after LLR.",Non-OADS,/arxiv_data1/oa_pdf/46/86/cmh-2016-0026.PMC4946407.pdf
Laparoscopic hepatectomy for HCC http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2016.0026and shorter hospital stay compared with OLR.,Non-OADS,/arxiv_data1/oa_pdf/46/86/cmh-2016-0026.PMC4946407.pdf
"216 http://www.e-cmh.orgClin Mol Hepatol Volume _22  Number _2  June 2016 http://dx.doi.org/10.3350/cmh.2016.0026In the last 5 years, several meta-analyses of studies compar - ing LLR and OLR for malignant lesions have been published  (Table 1).",Non-OADS,/arxiv_data1/oa_pdf/46/86/cmh-2016-0026.PMC4946407.pdf
Laparoscopic hepatectomy for HCC http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2016.002611.,Non-OADS,/arxiv_data1/oa_pdf/46/86/cmh-2016-0026.PMC4946407.pdf
218 http://www.e-cmh.orgClin Mol Hepatol Volume _22  Number _2  June 2016 http://dx.doi.org/10.3350/cmh.2016.002641.,Non-OADS,/arxiv_data1/oa_pdf/46/86/cmh-2016-0026.PMC4946407.pdf
"pISSN 2287-2728       eISSN 2287-285X http://dx.doi.org/10.3350/cmh .2016.0015 Clinical and Molecular Hepatology 2016;22:250-258 Original Article Corresponding author :  Dong Hyun Sinn Department of Medicine, Samsung Medical Center, Sungkyunkwan  University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul 135-710,  Korea  Tel: +82-2-3410-3409, Fax: +82-2-3410-6983 E-mail: dh.sinn@samsung.com Abbreviations:   HCC, hepatocellular carcinoma; TACE, transarterial chemoembolization;   BCLC, the barcelona clinic liver cancer; AFP , alphafetoprotein; EASL, European  association for the study of the liver; AASLD, American association for the study  of the liver disease; SR, surgical resection; HKLC, Hong Kong liver cancer Received :  Mar.",Non-OADS,/arxiv_data1/oa_pdf/3f/1b/cmh-2016-0015.PMC4946408.pdf
"(Clin Mol Hepatol 2016;22:250-258) Keywords:  Hepatocellular carcinoma; Intermediate stage; Transarterial chemoembolization; Resection; Survival Copyright Â© 2016 by The Korean Associa tion for the Study of the Liver This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3f/1b/cmh-2016-0015.PMC4946408.pdf
"TACE or SR in HCC http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2016.0015tem for HCC that is endorsed by the European Association for the  Study of the Liver (EASL) and the American Association for the  Study of the Liver Disease (AASLD).2,3 BCLC staging system divides  HCC patients into 5 stages (0, A, B, C and D), and allocates treat - ment strategy accordingly.2,3   In BCLC staging system, intermediate stage (B) is defined as as - ymptomatic, multinodular tumors without an invasive pattern  (multinodular tumor, Child-Pugh A-B and performance status 0),  and transarterial chemoembolization (TACE) is recommended as a  first-line treatment.2,3 TACE has been reported to extend the surviv - al of these patients,4 nonetheless, outcome prediction has been  heterogeneous for BCLC B, and sub-staging of BCLC stage B is be - ing suggested to further refine BCLC stage B.5 Furthermore, surgi - cal resection (SR) was applied to certain groups of patients with in - termediate HCC, with an improved survival by SR over TACE.6-8  However, TACE was proven to be as effective as SR among opera - ble HCC,9 indicating that recommending resection for all operable HCC is not a good approach for intermediate stage HCC.",Non-OADS,/arxiv_data1/oa_pdf/3f/1b/cmh-2016-0015.PMC4946408.pdf
"252 http://www.e-cmh.orgClin Mol Hepatol Volume _22  Number _2  June 2016 http://dx.doi.org/10.3350/cmh.2016.0015Ã¯ve, newly-diagnosed HCC patients who received care at Samsung  Medical Center, Seoul, Korea since January 2005.",Non-OADS,/arxiv_data1/oa_pdf/3f/1b/cmh-2016-0015.PMC4946408.pdf
"TACE or SR in HCC http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2016.0015summarized as the number of events for each category and percent - age, and compared using the Ï‡2 or Fisher exact test, as appropriate.",OADS,/arxiv_data1/oa_pdf/3f/1b/cmh-2016-0015.PMC4946408.pdf
"254 http://www.e-cmh.orgClin Mol Hepatol Volume _22  Number _2  June 2016 http://dx.doi.org/10.3350/cmh.2016.0015than in the TACE group (78.8% vs. 35.6%, P<0.001).",Non-OADS,/arxiv_data1/oa_pdf/3f/1b/cmh-2016-0015.PMC4946408.pdf
"TACE or SR in HCC http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2016.0015Identifying survival nodes with similar survival  expectancy In decision tree analysis, patients were first divided by tumor  size followed by tumor number.",OADS,/arxiv_data1/oa_pdf/3f/1b/cmh-2016-0015.PMC4946408.pdf
"256 http://www.e-cmh.orgClin Mol Hepatol Volume _22  Number _2  June 2016 http://dx.doi.org/10.3350/cmh.2016.0015stage HCC in BCLC staging system.2,3 Current guidelines recom - mend SR only for single nodules of any size in patients without  tumor-related symptoms and clinically significant portal hyperten - sion and with normal bilirubin.2,3 However, in this study, the over - all survival was significantly better in the SR group than TACE  group (median 61 vs. 30 months), indicating that SR can be a bet - ter treatment modality than TACE in intermediate stage HCC.",Non-OADS,/arxiv_data1/oa_pdf/3f/1b/cmh-2016-0015.PMC4946408.pdf
TACE or SR in HCC http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2016.0015showed survival benefit over TACE.,Non-OADS,/arxiv_data1/oa_pdf/3f/1b/cmh-2016-0015.PMC4946408.pdf
258 http://www.e-cmh.orgClin Mol Hepatol Volume _22  Number _2  June 2016 http://dx.doi.org/10.3350/cmh.2016.0015Clin Oncol 2011;8:378-382.,Non-OADS,/arxiv_data1/oa_pdf/3f/1b/cmh-2016-0015.PMC4946408.pdf
"pISSN 2287-2728       eISSN 2287-285X http://dx.doi.org/10.3350/cmh .2016.0028 Clinical and Molecular Hepatology 2016;22:296-307 Liver Imaging Corresponding author :  Chansik An Department of Radiology, Research Institute of Radiological Science,  Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu,  Seoul 03722, Korea Tel: +82-2-2228-7400, Fax: +82-2-393-3035 E-mail: chansikan@gmail.comAbbreviations:   AASLD, the American association for the study of liver diseases; ACR, American  College of Radiology; CT, computed tomography; HCC, hepatocellular  carcinoma; ICC, intrahepatic cholangiocarcinoma; LI-RADS, liver imaging  reporting and data system; MRI, magnetic resonance imaging; OPTN-UNOS,  organ procurement and transplantation network-united network for organ  sharingINTRODUCTION  Liver Imaging Reporting and Data System (LI-RADS) is a system  for interpreting and reporting of computed tomography (CT) and  magnetic resonance imaging (MRI) examinations of the liver in  patients at risk for hepatocellular carcinoma (HCC).",Non-OADS,/arxiv_data1/oa_pdf/cb/4c/cmh-2016-0028.PMC4946409.pdf
"(Clin Mol Hepatol 2016;22:296-307) Keywords:  Hepatocellular; Carcinoma; Guideline; Diagnosis; Algorithms  Copyright Â© 2016 by The Korean Associa tion for the Study of the Liver This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/cb/4c/cmh-2016-0028.PMC4946409.pdf
"Liver Imaging Reporting and Data System (LI-RADS) http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2016.0028LI-RADS provides the detailed descriptions and supporting illus - trations of all imaging features defined.8 Prior systems generally categorize hepatic lesions as positive,  negative, or indeterminate for HCC; for the latter biopsy is sug - gested.",Non-OADS,/arxiv_data1/oa_pdf/cb/4c/cmh-2016-0028.PMC4946409.pdf
2014) of LI-RADS is available online with extensive sup - porting information (http://www.acr.org/Quality-Safety/Resourc - es/ LIRADS).,Non-OADS,/arxiv_data1/oa_pdf/cb/4c/cmh-2016-0028.PMC4946409.pdf
298 http://www.e-cmh.orgClin Mol Hepatol Volume _22  Number _2  June 2016 http://dx.doi.org/10.3350/cmh.2016.0028LI-RADS DIAGNOSTIC ALGORITHM How to use the diagnostic algorithm The LI-RADS diagnostic algorithm is intended to mimic the nat - ural thought process of a radiologist who evaluates a hepatic ob - servation found in patients at risk for HCC.,Non-OADS,/arxiv_data1/oa_pdf/cb/4c/cmh-2016-0028.PMC4946409.pdf
Summary schematic of LI-RADS 2014 diagnostic algorithm (adapted and modified from ACR LI-RADS content at: http://www.acr.org/Quali - ty-Safety/Resources/LIRADS).,OADS,/arxiv_data1/oa_pdf/cb/4c/cmh-2016-0028.PMC4946409.pdf
Liver Imaging Reporting and Data System (LI-RADS) http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2016.0028ence of macrovascular invasive tumor (LR-5V).,Non-OADS,/arxiv_data1/oa_pdf/cb/4c/cmh-2016-0028.PMC4946409.pdf
A full description can be found at  the official website of ACR (http://www.acr.org/Quality-Safety/Re - sources/ LIRADS).,Non-OADS,/arxiv_data1/oa_pdf/cb/4c/cmh-2016-0028.PMC4946409.pdf
"300 http://www.e-cmh.orgClin Mol Hepatol Volume _22  Number _2  June 2016 http://dx.doi.org/10.3350/cmh.2016.0028and, depending on their size and number, could be used to assign  priority for liver transplantation in eligible patients.10 As a conse - quence, some small or early HCCs may be categorized as LR-4 or  lower.",Non-OADS,/arxiv_data1/oa_pdf/cb/4c/cmh-2016-0028.PMC4946409.pdf
"Liver Imaging Reporting and Data System (LI-RADS) http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2016.0028phase hyperenhancement and washout appearance, and were  visible as discrete nodules at antecedent surveillance US.2 LR-5g  refers to observations that meet the criteria for OPTN Class 5A-g,  that is, those that present â‰¥50% diameter increase in â‰¤6  months.4  LR-5V category is assigned when there is definite enhancing  soft tissue in a vein irrespective of the presence or absence of visi - ble intraparenchymal HCC (Fig.",Non-OADS,/arxiv_data1/oa_pdf/cb/4c/cmh-2016-0028.PMC4946409.pdf
"302 http://www.e-cmh.orgClin Mol Hepatol Volume _22  Number _2  June 2016 http://dx.doi.org/10.3350/cmh.2016.0028hancement, tumor diameter, washout appearance, capsule ap - pearance, and threshold growth.",Non-OADS,/arxiv_data1/oa_pdf/cb/4c/cmh-2016-0028.PMC4946409.pdf
Liver Imaging Reporting and Data System (LI-RADS) http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2016.0028er major features discussed below.,Non-OADS,/arxiv_data1/oa_pdf/cb/4c/cmh-2016-0028.PMC4946409.pdf
304 http://www.e-cmh.orgClin Mol Hepatol Volume _22  Number _2  June 2016 http://dx.doi.org/10.3350/cmh.2016.0028 A B Figure 7 .,Non-OADS,/arxiv_data1/oa_pdf/cb/4c/cmh-2016-0028.PMC4946409.pdf
Liver Imaging Reporting and Data System (LI-RADS) http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2016.0028in the LI-RADS table embedded in Figure 1.,OADS,/arxiv_data1/oa_pdf/cb/4c/cmh-2016-0028.PMC4946409.pdf
"In  contrast, ancillary features favoring benignity (including homoge - nous marked T2 hyperintensity or hypointensity, and diameter re - duction or stability) can be used to decrease category down to  LR-1 as appropriate.A complete description of the major and ancillary imaging fea - tures is beyond the scope of this article, but detailed descriptions  and supporting illustrations are available online (http://www.acr.",Non-OADS,/arxiv_data1/oa_pdf/cb/4c/cmh-2016-0028.PMC4946409.pdf
"306 http://www.e-cmh.orgClin Mol Hepatol Volume _22  Number _2  June 2016 http://dx.doi.org/10.3350/cmh.2016.0028factors other than the likelihood of HCC, such as comorbidities,  patient preference, or technical difficulty of biopsy.",Non-OADS,/arxiv_data1/oa_pdf/cb/4c/cmh-2016-0028.PMC4946409.pdf
ACR Web site < http://www.acr.org/Quality- Safety/Resources/LIRADS > Accessed 2016.04.15.,Non-OADS,/arxiv_data1/oa_pdf/cb/4c/cmh-2016-0028.PMC4946409.pdf
Liver Imaging Reporting and Data System (LI-RADS) http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2016.0028Hepatobiliary agents and their role in LI-RADS.,OADS,/arxiv_data1/oa_pdf/cb/4c/cmh-2016-0028.PMC4946409.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License(http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium,provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2e/03/ckw057.PMC4946411.pdf
"207-213 (2016) http://dx.doi.org/10.5487/TR.2016.32.3.207 plSSN: 1976-8257 eISSN: 2234-2753 Original ArticleOpen Access Inhibition of Cytochrome P450 by Propolis in Human Liver Microsomes Chang Seon Ryu1,â€ , Soo Jin Oh2,â€ , Jung Min Oh1, Ji-Y oon Lee1, Sang Y oon Lee1, Jung-woo Chae1, Kwang-il Kwon1 and Sang Kyum Kim1 1College of Pharmacy, Chungnam National University, Daejeon, Korea 2Bio-Evaluation Center, Korea Research Institute of Bioscience and Biotechnology, Ochang, Korea (Received April 15, 2016; Revised May 20, 2016; Accepted May 23, 2016) Although propolis is one of the most popular functional foods for human health, there have been no com- prehensive studies of herb-drug interactions through cytochrome P450 (CYP) inhibition.",Non-OADS,/arxiv_data1/oa_pdf/fe/3d/tr-32-207.PMC4946414.pdf
"195-205 (2016) http://dx.doi.org/10.5487/TR.2016.32.3.195 plSSN: 1976-8257 eISSN: 2234-2753 Original ArticleOpen Access Allele Frequencies of the Single Nucleotide Polymorphisms Related to the Body Burden of Heavy Metals in the Korean Population and Their Ethnic Differences Sang-Y ong Eom1, Ji-Ae Lim2, Y ong-Dae Kim1, Byung-Sun Choi3, Myung Sil Hwang4, Jung-Duck Park3, Heon Kim1 and Ho-Jang Kwon2 1Department of Preventive Medicine , College of Medicine, Chungbuk National University, Cheongju, Korea 2Department of Preventive Medicine, Dankook University College of Medicine, Cheonan, Korea 3Department of Preventive Medicine, Chung-Ang University College of Medicine, Seoul, Korea 4Food Risk Analysis Division, National Institute of  Food and Drug Safety Evaluation, Cheongju, Korea (Received February 11, 2016; Revised March 13, 2016; Accepted May 19, 2016) This study was performed to select single nucleotide polymorphisms (SNPs) related to the body burden of heavy metals in Koreans, to provide Korean allele frequencies of selected SNPs, and to assess the differ- ence in allele frequencies with other ethnicities.",Non-OADS,/arxiv_data1/oa_pdf/bf/af/tr-32-195.PMC4946415.pdf
"177-193 (2016) http://dx.doi.org/10.5487/TR.2016.32.3.177 plSSN: 1976-8257 eISSN: 2234-2753 Review ArticleOpen Access Targeting Cancer Metabolism - Revisiting the Warburg Effects Quangdon Tran1, Hyunji Lee1, Jisoo Park1, Seon-Hwan Kim2 and Jongsun Park1 1Department of Pharmacology and Medical Science, Metabolic Diseases and Cell Signaling Laboratory, Research Institute for Medical Scienc es, College of Medicine, Chungnam National University, Daejeon, Korea 2Department of Neurosurgery, Institute fo r Cancer Research, College of Medicine, Chungnam National University, Daejeon, Korea (Received March 15, 2016; Revised April 21, 2016; Accepted May 20, 2016) After more than half of century since the Warburg effect was described, this atypical metabolism has been standing true for almost every type of cancer, exhibiting higher glycolysis and lactate metabolism anddefective mitochondrial ATP production.",Non-OADS,/arxiv_data1/oa_pdf/64/86/tr-32-177.PMC4946416.pdf
"245-250 (2016) http://dx.doi.org/10.5487/TR.2016.32.3.245 plSSN: 1976-8257 eISSN: 2234-2753 Original ArticleOpen Access Subacute Inhalation Toxicity of 3-Methylpentane Y ong Hyun Chung, Seo-Ho Shin, Jeong Hee Han and Y ong-Hoon Lee Pathology Department, Chronic Inhala tion Toxicity Research  Center, Chemicals Toxicity Research Bureau, Occupational Safety and Health Research Institute, Korea Occupational Safety and Health Agency, Daejeon, Korea (Received April 7, 2016; Revised May 18, 2016; Accepted June 1, 2016) 3-Methylpentane (C6H14, CAS No.",Non-OADS,/arxiv_data1/oa_pdf/6e/41/tr-32-245.PMC4946417.pdf
Available from: https://www.mathesongas.com/pdfs/msds/MAT29460.pdf.3.,Non-OADS,/arxiv_data1/oa_pdf/6e/41/tr-32-245.PMC4946417.pdf
(Substance name: 3-methylpentane) Available from: http://toxnet.nlm.nih.gov/cgi-bin/sis/search2/f?./temp/~rVVliU:1.,Non-OADS,/arxiv_data1/oa_pdf/6e/41/tr-32-245.PMC4946417.pdf
"215-223 (2016) http://dx.doi.org/10.5487/TR.2016.32.3.215 plSSN: 1976-8257 eISSN: 2234-2753 Original ArticleOpen Access Isolation and Identification of Cytotoxic and Biological Active Toxin from the Puffer Fish Arothron stellatus Anguchamy Veeruraj1,4, Sampath Renuga Pugazhvendan2, Thipramalai Thankappan Ajithkumar3 and Muthuvel Arumugam1 1Centre of Advanced Study in Marine Biology, Faculty of  Marine Sciences, Annamalai University, Tamilnadu, India 2Department of Zoology, DDE-Wing, Annamalai University, Tamilnadu, India 3National Bureau of Fish Genetic Resources, Indian Council of Agricultural Research, Uttar Pradesh, India 4Centre for Ocean Research, SU-NIOT Joint Init iative Research Centre, Rajiv Gandhi Sala i, Sathyabama University, Tamilnadu, Indi a (Received November 12, 2015; Revised April 19, 2016; Accepted May 20, 2016) This study is to investigate the biological, biochemical and cytotoxic effects of puffer fish ( Arothron stella- tus) toxin extracts under in-vitro  condition.",Non-OADS,/arxiv_data1/oa_pdf/a4/77/tr-32-215.PMC4946418.pdf
"259-267 (2016) http://dx.doi.org/10.5487/TR.2016.32.3.259 plSSN: 1976-8257 eISSN: 2234-2753 Original ArticleOpen Access A Web-based Alternative Non-animal Method Database for Safety Cosmetic Evaluations Seung Won Kim and Bae-Hwan Kim Major in Public Health, Faculty of Food and Health Sciences, Keimyung University, Daegu, Korea (Received March 15, 2016; Revised April 5, 2016; Accepted April 11, 2016) Animal testing was used traditionally in the cosmetics industry to confirm product safety, but has begun to be banned; alternative methods to replace animal experiments are either in development, or are being vali- dated, worldwide.",Non-OADS,/arxiv_data1/oa_pdf/5f/15/tr-32-259.PMC4946419.pdf
"We have built a database of alternative methods for cos- metics safety evaluations, the integrated CAMSEC data-base, available at http://camsec.kr/.",OADS,/arxiv_data1/oa_pdf/5f/15/tr-32-259.PMC4946419.pdf
"The content of the CAMSEC database can be classified into four categories: chemical information (Table 2), alter-native methods information (Table 3), animal toxicologyinformation, and chemical efficacy information (Table 4).This information is available in English and Korean at http://camsec.kr/dbsearch/page1.htm.",OADS,/arxiv_data1/oa_pdf/5f/15/tr-32-259.PMC4946419.pdf
This information is available at http://camsec.kr/dbsearch/qsar.htm.,OADS,/arxiv_data1/oa_pdf/5f/15/tr-32-259.PMC4946419.pdf
Available from: http://www.cosmeticsdesign-asia.com/Regu-lation-Safety/South-Korea-proposes-to-recognize-animal-test- ing-alternatives.,Non-OADS,/arxiv_data1/oa_pdf/5f/15/tr-32-259.PMC4946419.pdf
Availablefrom: http://ecvam-dbalm.jrc.ec.europa.eu/beta.,Non-OADS,/arxiv_data1/oa_pdf/5f/15/tr-32-259.PMC4946419.pdf
Available from: http://www.cosmeticsdesign-asia.com/Business-Financial/,Non-OADS,/arxiv_data1/oa_pdf/5f/15/tr-32-259.PMC4946419.pdf
"225-230 (2016) http://dx.doi.org/10.5487/TR.2016.32.3.225 plSSN: 1976-8257 eISSN: 2234-2753 Original ArticleOpen Access Cytotoxicity Evaluation of Essential Oil and its Component from Zingiber officinale Roscoe Yo n g k y u  Le e Department of Energy and Bio Engineering, Dongseo University, Busan, Korea (Received April 11, 2016; Revised June 1, 2016; Accepted June 7, 2016) Zingiber officinale Roscoe  has been widely used as a folk medicine to treat various diseases, including cancer.",Non-OADS,/arxiv_data1/oa_pdf/0a/ec/tr-32-225.PMC4946420.pdf
231-237 (2016) http://dx.doi.org/10.5487/TR.2016.32.3.231 plSSN: 1976-8257 eISSN: 2234-2753 Original ArticleOpen Access A 24-Weeks Toxicity Study of Eryngium foetidum  Linn.,Non-OADS,/arxiv_data1/oa_pdf/03/e5/tr-32-231.PMC4946421.pdf
"251-258 (2016) http://dx.doi.org/10.5487/TR.2016.32.3.251 plSSN: 1976-8257 eISSN: 2234-2753 Original ArticleOpen Access Tumorigenicity Evaluation of Umbilical Cord Blood-derived Mesenchymal Stem Cells Sang-Jin Park1,â€ , Hyun-Jung Kim1,â€ , Woojin Kim1, Ok-Sun Kim1, Sunyeong Lee1, Su-Y eon Han1, Eun Ju Jeong1, Hyun-shin Park2, Hea-Won Kim2 and Kyoung-Sik Moon1 1Department of Toxicological Evaluation and Research, Korea Institute of Toxicology, Daejeon, Korea 2Research Institute, Genexi ne Co., Seongnam, Korea (Received November 24, 2015; Revised February 18, 2016; Accepted June 1, 2016) Mesenchymal stem cells (MSCs) have been identified in multiple types of tissue and exhibit characteristic self-renewal and multi-lineage differentiation abilities.",Non-OADS,/arxiv_data1/oa_pdf/38/0f/tr-32-251.PMC4946422.pdf
239-243 (2016) http://dx.doi.org/10.5487/TR.2016.32.3.239 plSSN: 1976-8257 eISSN: 2234-2753 Original ArticleOpen Access Propolis Inhibits Neurite Outgrowth in Differentiating SH-SY5Y Human Neuroblastoma Cells Han Bit Kim and Byung Sun Y oo Dept.,Non-OADS,/arxiv_data1/oa_pdf/6f/f4/tr-32-239.PMC4946423.pdf
"265 e-ultrasonography.org Ultrasonography 35(3), July 2016Macrocalcifications in a thyroid  microcarcinoma http://dx.doi.org/10.14366/usg.16011 pISSN: 2288-5919 â€¢ eISSN: 2288-5943 Ultrasonography 2016;35:265-266 Received: February 24, 2016 Revised: March 3, 2016Accepted: March 4, 2016 Correspondence to: Adriana Handra-Luca, MD, PhD, Service d'Anatomie Pathologique, APHP GHU Avicenne, Universite Paris Nord Sorbonne Cite, 125 rue Stalingrad, 93009 Bobigny, France Tel.",Non-OADS,/arxiv_data1/oa_pdf/09/5f/usg-16011.PMC4946440.pdf
"+33-14895555602/5480 E-mail: adriana.handra-luca@aphp.frLETTER This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly  cited.",Non-OADS,/arxiv_data1/oa_pdf/09/5f/usg-16011.PMC4946440.pdf
"Adriana Handra-Luca, et al.266  Ultrasonography 35(3), July 2016 e-ultrasonography.orgORCID: Adriana Handra-Luca: http://orcid.org/0000-0003-3816-058X Conflict of Interest No potential conflict of interest relevant to this article was reported.",Non-OADS,/arxiv_data1/oa_pdf/09/5f/usg-16011.PMC4946440.pdf
Microscopic features of the thyroid microcarcinoma with extensive dystrophic calcification in a 50-year- old man (http://dx.doi.org/10.14366/usg.16011).References  1.,Non-OADS,/arxiv_data1/oa_pdf/09/5f/usg-16011.PMC4946440.pdf
http://creativecommons.org/ licenses/by-nc-nd/3.0.,Non-OADS,/arxiv_data1/oa_pdf/0b/f3/txd-1-e45.PMC4946449.pdf
http://www.statistics.gov.my/portal/download_Economics/download.,Non-OADS,/arxiv_data1/oa_pdf/0b/f3/txd-1-e45.PMC4946449.pdf
Available at http://napic.jpph.gov.my/epsKeyStatistics/keyst/streamFile.dl?itemId= 1542&org.jboss.portle tbridge.NAMESPACE=jb pns_2feps_2fdefault_ 2fEpsKeyStatisticsPortletWindowsnpbj.,OADS,/arxiv_data1/oa_pdf/0b/f3/txd-1-e45.PMC4946449.pdf
"We composed a panel of 16 different HLA-typed stimulator PBMCs, which covered the most common HLA class I mole-cules in the Western European population (>5%) ( Table S1, SDC, http://links.lww.com/TXD/A15).",OADS,/arxiv_data1/oa_pdf/d7/06/txd-1-e40.PMC4946452.pdf
"In both individuals, CD8 +Tcells directed against different viral epitopes proliferated upon encounter with 1 or more stimu- lator targets ( Table S2, SDC, http://links.lww.com/TXD/A15).",Non-OADS,/arxiv_data1/oa_pdf/d7/06/txd-1-e40.PMC4946452.pdf
"Homogeneity of the lines and clones was confirmed by TCR usage ( Table S3, SDC, http://links.lww.com/TXD/A15).",OADS,/arxiv_data1/oa_pdf/d7/06/txd-1-e40.PMC4946452.pdf
"the detection of virus-specific CD8+T cells with cross- reactivity to allogeneic HLA antigen (see overview in Table S4, SDC, http://links.lww.com/TXD/A15).",Non-OADS,/arxiv_data1/oa_pdf/d7/06/txd-1-e40.PMC4946452.pdf
http://creativecommons.org/licenses/by-nc-nd/3.0.,Non-OADS,/arxiv_data1/oa_pdf/8c/4b/txd-1-0e9.PMC4946455.pdf
http://creativecommons.org/ licenses/by-nc-nd/3.0.,Non-OADS,/arxiv_data1/oa_pdf/e2/bf/txd-1-0e8.PMC4946459.pdf
"Current use and outcome of hematopoietic stem cell transplantation: CIBMTR Summary Slides, 2012: http://www.cibmtr.org.",Non-OADS,/arxiv_data1/oa_pdf/e2/bf/txd-1-0e8.PMC4946459.pdf
"Annual report of nationwide survey 2012: JSHCT Data Center, Nagoya,Japan, 2013. http://www.jshct.com/report_recent/.",OADS,/arxiv_data1/oa_pdf/e2/bf/txd-1-0e8.PMC4946459.pdf
http://creativecommons.org/licenses/by-nc-nd/3.0.,Non-OADS,/arxiv_data1/oa_pdf/02/07/txd-1-e17.PMC4946466.pdf
"transplantation ( Figure S1, SDC , http://links.lww.com/TXD/ A2).",Non-OADS,/arxiv_data1/oa_pdf/02/07/txd-1-e17.PMC4946466.pdf
"The kinetics of anti-A Ab titers are shown in Figure S2 , http://links.lww.com/ TXD/A2.",Non-OADS,/arxiv_data1/oa_pdf/02/07/txd-1-e17.PMC4946466.pdf
"The Ab titers specific for cyto-megalovirus and varicella zoster virus remained above the levelof protection during the observation period ( Figure S3, SDC , http://links.lww.com/TXD/A2), whereas both DSA and non-DSA were undetectable even at the latest follow-up (Table 1B andFigure S4, SDC , http://links.lww.com/TXD/A2).",Non-OADS,/arxiv_data1/oa_pdf/02/07/txd-1-e17.PMC4946466.pdf
"Consistent with the previous observation, 6IgM+CD27+memory B cells remained undetectable in the peripheral blood during observation even after the reappearance of IgM+CD19+ B cells ( Figure S1, SDC , http://links.lww.com/TXD/A2).",Non-OADS,/arxiv_data1/oa_pdf/02/07/txd-1-e17.PMC4946466.pdf
"Owing tothe continuous administration of CNI and MMF during desensi-tization, the antidonor T-cell responses in all the 3 patients were d e c r e a s e di nt h eC F S E - M L Ra s s a yc o m p a r e dw i t ht h o s eb e f o r e desensitization ( Figure S5, SDC , http://links.lww.com/TXD/A2).",Non-OADS,/arxiv_data1/oa_pdf/02/07/txd-1-e17.PMC4946466.pdf
"One of the striking findings in this series might be the min- imal impact of the phased desensitization protocol on Abs spe- cific for varicella zoster virus and cytomegalovirus ( Figure S3, SDC, http://links.lww.com/TXD/A2) despite its remarkable depleting effects on both DSA and non-DSA.",Non-OADS,/arxiv_data1/oa_pdf/02/07/txd-1-e17.PMC4946466.pdf
Normali zation factors were calculated with the Excel based software geN orm (http://medgen.ugent.be/ ~jvdesomp/genorm/).,OADS,/arxiv_data1/oa_pdf/99/75/txd-1-e23.PMC4946468.pdf
"These difficulties were encountered already in the anal- ysis of the previous hHO-1 transgenic pig line.6Western blot analysis for hA20 expression in tr iple transgenic pigs revealed nonspecific protein bands caused by the cross-reactivity of theantibody (polyclonal rabbit antihuman-A20 antibody, A302- 633A, Bethyl Laboratories) with porcine hA20 ( Figure S1, SDC, http://links.lww.com/TXD/A6).",Non-OADS,/arxiv_data1/oa_pdf/99/75/txd-1-e23.PMC4946468.pdf
Available at: http://srtr.transplant.hrsa.gov/annual_re- ports/2012/pdf/03_liver_13.pdf.,OADS,/arxiv_data1/oa_pdf/02/0c/txd-1-e21.PMC4946469.pdf
Available at: http://mb.cision.com/Main/ 652/9675365/308904.pdf.17.,Non-OADS,/arxiv_data1/oa_pdf/02/0c/txd-1-e21.PMC4946469.pdf
"On average, the extent and types of minor H antigen differences between MHC-identical and MHC-1haploMM siblings ought to be similar â€”yet the man- ifestation of regulatory activity was consistently lower in the latter group ( Figures 1 and 2, and Tables S1 and S2, SDC, http://links.lww.com/TXD/A4 and http://links.lww.com/TXD/A5).",OADS,/arxiv_data1/oa_pdf/79/52/txd-1-e20.PMC4946471.pdf
"It was possible to determine thekiller immunoglobulin-like receptor ligand HLA-Bw4 and HLA-Bw6 status in 3962 and in 3973 patients, respectively, based on http://hla.alleles.org/antigens/bw46.html.",Non-OADS,/arxiv_data1/oa_pdf/3b/4a/txd-1-e25.PMC4946472.pdf
"The relevant ORs are presented in Figure 1, and the sex- specific ORs in Figure S1 (SDC, http://links.lww.com/TXD/A7).",Non-OADS,/arxiv_data1/oa_pdf/3b/4a/txd-1-e25.PMC4946472.pdf
"The risk of PTLD, as illustrated by the incidence rate, differed according to time after transplantation and to the EBV status of the tumor ( Table S2, SDC, http://links.lww.com/TXD/A7).",Non-OADS,/arxiv_data1/oa_pdf/3b/4a/txd-1-e25.PMC4946472.pdf
"â€Baseline and follow-up data at 6 months of patients with low and high6-month urinary CXCL10 levels, as well as low and high uri-nary CXCL10-burden are summarized in Tables S1 and S2 (SDC, http://links.lww.com/TXD/A11), respectively.",Non-OADS,/arxiv_data1/oa_pdf/f2/07/txd-1-e31.PMC4946476.pdf
"Patients with high urinary 6-month CXCL10 levels had a higher fre-quency of second and deceased donor transplantations (bothP= 0.01), a higher rate of BKV viremia ( P= 0.0001) and higher proteinuria ( P= 0.04) compared to patients with low 6-month urinary CXCL10 levels ( Table S1, SDC , http://links.lww.com/TXD/A11).",Non-OADS,/arxiv_data1/oa_pdf/f2/07/txd-1-e31.PMC4946476.pdf
"Patients with high urinary CXCL10-burden had more rejection episodes ( P= 0.02; driven by more subclinical rejections), a higher rate of BKV viremia (P< 0.0001), and higher proteinuria ( P= 0.005) compared to patients with low urinary CXCL10-burden ( Table S2, SDC , http://links.lww.com/TXD/A11).",Non-OADS,/arxiv_data1/oa_pdf/f2/07/txd-1-e31.PMC4946476.pdf
http://creativecommons.org/licenses/by-nc-nd/3.0.,Non-OADS,/arxiv_data1/oa_pdf/c0/46/txd-1-e30.PMC4946477.pdf
The work cannot be changed in any way or used commercially http://creativecommons.org/licenses/by-nc-nd/3.0.,Non-OADS,/arxiv_data1/oa_pdf/c2/cd/txd-1-e32.PMC4946479.pdf
"Preparation of PBMC for LA-ICP-MS Cell-surface staining was performed at 4Â°C in DPBS/1% BSA/0.02% NaN 3/10% FcR-block (Miltenyi) using primary metal-tagged MaxParÂ® antibodies (Fluidigm Sciences Inc., Sunnyvale, CA) at the recommended concentrations for mass spectrometry ( Table S1, SDC , http://links.lww.com/TXD/A12).",Non-OADS,/arxiv_data1/oa_pdf/c2/cd/txd-1-e32.PMC4946479.pdf
"Accordingly, we can be confident that values above 200 c/s are true- positive signals, but signals below this limit may be true orfalse negatives ( Figure S1, SDC , http://links.lww.com/TXD/A12).",Non-OADS,/arxiv_data1/oa_pdf/c2/cd/txd-1-e32.PMC4946479.pdf
"Sections from the allografts were harvested 10 days after transplantation and assessed by hematoxylin-eosin (Figure 1) or Elastica-Masson staining ( Figure S1, SDC, http://links.lww.com/TXD/A10).",Non-OADS,/arxiv_data1/oa_pdf/f7/11/txd-1-e35.PMC4946481.pdf
"The Inhibition of Epithelial Cell Loss in the Heterotopically Transplanted Tracheal Allograft by an LPA 1- and LPA 3-Specific Antagonist Is not Continued to the Later Phase To examine whether LPA signaling via LPA 1and/or LPA 3 involved in the onset of obliteration, the allografts harvested at 28 days after transplantation were also assessed (Figure 8) (Figure S2, SDC, http://links.lww.com/TXD/A10).",Non-OADS,/arxiv_data1/oa_pdf/f7/11/txd-1-e35.PMC4946481.pdf
"A complete list of data collectives, participatinginstitutions, and ISHLT registration data elements are avail- able at http://www.ishlt.org/registries/.",OADS,/arxiv_data1/oa_pdf/9c/4f/txd-1-e38.PMC4946482.pdf
http://creativecommons.org/ licenses/by-nc-nd/3.0.,Non-OADS,/arxiv_data1/oa_pdf/49/8d/txd-1-e37.PMC4946484.pdf
"8 RESULTS One hundred thirty-eight PSC patients who received a liver allograft in Norway between 1984 and 2009 were included in the final analysis, together with a comparison group of 84 consecutive patients transplanted at our center for PBC(n = 59) or AIH (n = 25) during the same period ( Table S1, SDC, http://links.lww.com/TXD/A14).",OADS,/arxiv_data1/oa_pdf/87/68/txd-1-e39.PMC4946487.pdf
"Median age at the time of listingfor PSC patients was 43.0 years (range, 17-71) for PBC patients 55.2 (range, 24-69) and for AIH 42.6 years (range, 19-69), respectively ( Table S1, SDC , http://links.lww.com/TXD/A14).",Non-OADS,/arxiv_data1/oa_pdf/87/68/txd-1-e39.PMC4946487.pdf
"All pa- tients with AIH (n = 25) were transplanted due to end-stage liver disease ( Table S2, SDC , http://links.lww.com/TXD/A14).",Non-OADS,/arxiv_data1/oa_pdf/87/68/txd-1-e39.PMC4946487.pdf
"Encephalopathy was overall rare in the PSC group, and only 8.1% of the patients had encephalopathy grade 2 orhigher at the time of acceptance for LTX (Table 2), whereas the corresponding figures for PBC and AIH pa- tients were 25.0% and 47.6%, respectively ( Table S3, SDC, http://links.lww.com/TXD/A14).",Non-OADS,/arxiv_data1/oa_pdf/87/68/txd-1-e39.PMC4946487.pdf
"In the AIH group, the tendency was similar, whereas, for PBC patients, there was a little difference between the periods ( Table S3, SDC , http://links.lww.com/TXD/A14).",Non-OADS,/arxiv_data1/oa_pdf/87/68/txd-1-e39.PMC4946487.pdf
"Patient Outcomes After LTX During 2001 to 2009 Figure S1, SDC , http://links.lww.com/TXD/A14 shows the Kaplan-Meier plots for all 3 groups of PSC patients accord- ing to patient survival.",OADS,/arxiv_data1/oa_pdf/87/68/txd-1-e39.PMC4946487.pdf
"One- and 5-year patient survival rates for the 24 PSC patientswith pre-LTX suspicion of neoplasia transplanted between 2001 and 2009 were 95.8% and 83.3%, respectively ( Figure S2, SDC , http://links.lww.com/TXD/A14).",Non-OADS,/arxiv_data1/oa_pdf/87/68/txd-1-e39.PMC4946487.pdf
"One- and 5-year patient survival rates for patients transplanted on the basis of AIH (n = 17) were 88.2% and 88.2% at both timepoints ( Figure S3, SDC , http://links.lww.com/TXD/A14).",Non-OADS,/arxiv_data1/oa_pdf/87/68/txd-1-e39.PMC4946487.pdf
Santiago de Compos tela 2015. https://wcd.coe.int/ ViewDoc.jsp?Ref=CM/Del/Dec% 282014%291205/10.3&Language= lanEnglish&Ver=app10&Site=COE &BackColorInternet=DBDCF2& BackColorIntranet=FDC864&Back ColorLogged=FDC864.,Non-OADS,/arxiv_data1/oa_pdf/2f/c1/txd-2-e61.PMC4946490.pdf
http://www.ncbi.nlm.nih.gov/pubmed/4886455.,Non-OADS,/arxiv_data1/oa_pdf/38/08/txd-2-e62.PMC4946491.pdf
Baseline donor-specific antibody levels and outcomes in positive crossmatch kidney transplantation.http://www.ncbi.nlm.nih.gov/pubmed/20121740.,Non-OADS,/arxiv_data1/oa_pdf/38/08/txd-2-e62.PMC4946491.pdf
http://www.ncbi.nlm.nih.gov/ pubmed/20634297.,Non-OADS,/arxiv_data1/oa_pdf/38/08/txd-2-e62.PMC4946491.pdf
http://www.ncbi.nlm.nih.gov/pubmed/23160511.,Non-OADS,/arxiv_data1/oa_pdf/38/08/txd-2-e62.PMC4946491.pdf
5. http://srtr.transplant .hrsa.gov/annual_reports/ 2012/pdf/01_kidney_13.pdf.,OADS,/arxiv_data1/oa_pdf/38/08/txd-2-e62.PMC4946491.pdf
http://www.ncbi.nlm.nih.gov/pubmed/12973100.,Non-OADS,/arxiv_data1/oa_pdf/38/08/txd-2-e62.PMC4946491.pdf
http://www.ncbi.nlm.nih.gov/pubmed/18635429.,Non-OADS,/arxiv_data1/oa_pdf/38/08/txd-2-e62.PMC4946491.pdf
http://www.ncbi.nlm.nih.gov/ pubmed/21793744.,Non-OADS,/arxiv_data1/oa_pdf/38/08/txd-2-e62.PMC4946491.pdf
http://www.ncbi.nlm.nih.gov/pubmed/23511212.,Non-OADS,/arxiv_data1/oa_pdf/38/08/txd-2-e62.PMC4946491.pdf
http://www.ncbi.,Non-OADS,/arxiv_data1/oa_pdf/38/08/txd-2-e62.PMC4946491.pdf
http://www.ncbi.nl m.nih.gov/pubmed/9402096.,Non-OADS,/arxiv_data1/oa_pdf/38/08/txd-2-e62.PMC4946491.pdf
Benefits of rituximab combined with intra- venous immunoglobulin for desensitization in kidney transplant recipients.http://www.ncbi.nlm.nih.gov/pubmed/24770617.,Non-OADS,/arxiv_data1/oa_pdf/38/08/txd-2-e62.PMC4946491.pdf
http://www.ncbi.nlm.ni h.gov/pubmed/19502960.,Non-OADS,/arxiv_data1/oa_pdf/38/08/txd-2-e62.PMC4946491.pdf
http://www.ncbi.nlm.nih.gov/pubmed/18337549.,Non-OADS,/arxiv_data1/oa_pdf/38/08/txd-2-e62.PMC4946491.pdf
http://www.ncbi.nlm.nih.gov/pubmed/ 18813107.,Non-OADS,/arxiv_data1/oa_pdf/38/08/txd-2-e62.PMC4946491.pdf
Characteristics of circulating do- nor human leukocyte antigen-specific immunoglobulin G antibodies pred-icative of acute antibody-mediated rejection and kidney allograft failure.http://www.ncbi.nlm.nih.gov/pubmed/25629531.,Non-OADS,/arxiv_data1/oa_pdf/38/08/txd-2-e62.PMC4946491.pdf
http://www.ncbi.nlm.nih.gov/pubmed/23726814.,Non-OADS,/arxiv_data1/oa_pdf/38/08/txd-2-e62.PMC4946491.pdf
http://www.ncbi.nlm.nih.gov/ pubmed/25054778.,Non-OADS,/arxiv_data1/oa_pdf/38/08/txd-2-e62.PMC4946491.pdf
http://www.ncbi.nlm.nih.gov/pubmed/23778648.,Non-OADS,/arxiv_data1/oa_pdf/38/08/txd-2-e62.PMC4946491.pdf
http://www.ncbi.nlm.nih.gov/pubmed/22326708.,Non-OADS,/arxiv_data1/oa_pdf/38/08/txd-2-e62.PMC4946491.pdf
http://www.ncbi.nlm.nih.gov/pubmed/22262128.,Non-OADS,/arxiv_data1/oa_pdf/38/08/txd-2-e62.PMC4946491.pdf
http://www.ncbi.nlm.nih.gov/pubmed/25524446.,Non-OADS,/arxiv_data1/oa_pdf/38/08/txd-2-e62.PMC4946491.pdf
http://www.ncbi.nlm.nih.gov/pubmed/25321163.,Non-OADS,/arxiv_data1/oa_pdf/38/08/txd-2-e62.PMC4946491.pdf
http://www.ncbi.nlm.nih.gov/pubmed/22755431.,Non-OADS,/arxiv_data1/oa_pdf/38/08/txd-2-e62.PMC4946491.pdf
http://www.ncbi.nlm.nih.gov/pubmed/25839705.Transplantation .,Non-OADS,/arxiv_data1/oa_pdf/38/08/txd-2-e62.PMC4946491.pdf
http://www.ncbi.nlm.nih.gov/pubmed/18853952.Am J Transplant .,Non-OADS,/arxiv_data1/oa_pdf/38/08/txd-2-e62.PMC4946491.pdf
http://www.ncbi.nlm.nih.,Non-OADS,/arxiv_data1/oa_pdf/38/08/txd-2-e62.PMC4946491.pdf
http://www.ncbi.nlm.nih.gov/pubmed/24918614.Transplantation .,Non-OADS,/arxiv_data1/oa_pdf/38/08/txd-2-e62.PMC4946491.pdf
"Insulin genes 1 and 2 were analyzed using our primers and probes (Table S1, SDC, http://links.lww.com/TXD/A22),whereas all genes were analyzed using TaqMan Gene Expres- sion Assays (Table S2, SDC, http://links.lww.com/TXD/A22).",OADS,/arxiv_data1/oa_pdf/13/bf/txd-2-e65.PMC4946492.pdf
"At the same sirolimus dose,obese rats had higher sirolimus blood levels than lean rats (20.3 Â± 3.1 and 12.1 Â± 1.8 ng/mL, respectively) (Figure S1,SDC, http://links.lww.com/TXD/A22).",Non-OADS,/arxiv_data1/oa_pdf/13/bf/txd-2-e65.PMC4946492.pdf
"The OZR (54.5%) af-ter SRL (1.0) treatment were considered diabetic rats, be-cause 120-minute glucose in the IPGTT was higher than 200 mg/dL (Table S3, SDC, http://links.lww.com/TXD/A22).",Non-OADS,/arxiv_data1/oa_pdf/13/bf/txd-2-e65.PMC4946492.pdf
"Addition- ally, these rats did not respond to IPGTT, having equal insu- lin blood levels after 30 minutes of glucose administration (Figure S2A, SDC, http://links.lww.com/TXD/A22).",Non-OADS,/arxiv_data1/oa_pdf/13/bf/txd-2-e65.PMC4946492.pdf
"The SRL treatment induced dia- betes in a dose-dependent manner only in obese Zucker rats after 28 days, whereas the SRL withdrawal reverses all diabetic conditions (Table S4, SDC, http://links.lww.com/TXD/A22).",Non-OADS,/arxiv_data1/oa_pdf/13/bf/txd-2-e65.PMC4946492.pdf
Available from: http://tlhrc.house.gov/docs/transcripts/2012_1_23_Organ_Trafficking_Briefing/Bu diani_testimony.pdf:11.,Non-OADS,/arxiv_data1/oa_pdf/e5/c8/txd-2-e59.PMC4946495.pdf
CMA Code of Ethics 2004: Available from: http://policybase.cma.ca/dbtw-wpd/PolicyPDF/PD04-06.pdf.,Non-OADS,/arxiv_data1/oa_pdf/89/08/txd-2-e60.PMC4946496.pdf
2012: Avail-able from: https://www.cmpa-acpm.ca/duties-and-responsibilities/-/asset_publisher/bFaUiyQG069N/content/releasing-a-patient-s-personal- health-information-what-are-the-obligations-of-the-physician-;jsessionid=B65C4670035A2DA471BBC6938C53B0CD.,Non-OADS,/arxiv_data1/oa_pdf/89/08/txd-2-e60.PMC4946496.pdf
"Analysis performed per severity subgroup (MELD score â‰¤ or > 21) showed that this trend can be found in equal mea- sure in sicker patients and those in less serious conditions (Tables S1 and S2, SDC, http://links.lww.com/TXD/A19).",Non-OADS,/arxiv_data1/oa_pdf/45/c8/txd-2-e49.PMC4946500.pdf
"The results of resource consumptions related to liver trans- plantations alone are perfectly in line with the overall analy- sis, because the impact of interventions other than the liver transplantations alone is imperceptible because of the small number of interventions (23 of 256 before 2012 and 7 of 117 after 2012) (Table S3, SDC, http://links.lww.com/TXD/A19).",Non-OADS,/arxiv_data1/oa_pdf/45/c8/txd-2-e49.PMC4946500.pdf
"We performed univariate and multivariate linear re- gression analyses for the consumption of homologous and autologous blood, FFP, platelets, albumin, and fibrinogen (detailed results in Tables S4, S5, S6, S7, S8, and S9, SDC, http://links.lww.com/TXD/A19).",OADS,/arxiv_data1/oa_pdf/45/c8/txd-2-e49.PMC4946500.pdf
"In both cases, the results are not statistically differ-ent (Table S10, SDC, http://links.lww.com/TXD/A19).",Non-OADS,/arxiv_data1/oa_pdf/45/c8/txd-2-e49.PMC4946500.pdf
"A series of univariate logistic regressions has shown that the only factor statistically associated with mortal- ity is patients' MELD score (Tables S11 and S12, SDC, http://links.lww.com/TXD/A19).",Non-OADS,/arxiv_data1/oa_pdf/45/c8/txd-2-e49.PMC4946500.pdf
URL http://www.R-project.org/.,Non-OADS,/arxiv_data1/oa_pdf/45/c8/txd-2-e49.PMC4946500.pdf
"The ICD-9-CM diagnosis and procedure codes used in this study are listed in Table S1 (SDC , http://links.lww.com/TXD/A21).",Non-OADS,/arxiv_data1/oa_pdf/44/19/txd-2-e67.PMC4946508.pdf
"newly coded transplant failure or rejection, posttransplant laparotomy, hemodialysis, and repeat solid-organ transplantduring readmission ( Table S1, SDC , http://links.lww.com/ TXD/A21).",Non-OADS,/arxiv_data1/oa_pdf/44/19/txd-2-e67.PMC4946508.pdf
16. http://www.hcup-us.ahrq.gov/db/state/costtocharge.jsp.,OADS,/arxiv_data1/oa_pdf/44/19/txd-2-e67.PMC4946508.pdf
17. http://www.bls.gov/cpi/cpi_dr.htm.,Non-OADS,/arxiv_data1/oa_pdf/44/19/txd-2-e67.PMC4946508.pdf
https://cme.utsouthwestern.edu/sites/cme.utsouthwestern.edu/files/em1508d_082115_protocol_domingu ez.pdf.,Non-OADS,/arxiv_data1/oa_pdf/fc/82/txd-2-e70.PMC4946510.pdf
https://www.nice.org.uk/guidance/ipg257.,Non-OADS,/arxiv_data1/oa_pdf/51/b4/txd-2-e72.PMC4946514.pdf
http://www.diabetes.org.uk/Documents/Guide to diabetes/ Treatments/islet-cell-transplant-what-you-need-to-know-0513.pdf.London: Diabetes UK; 2012.,Non-OADS,/arxiv_data1/oa_pdf/51/b4/txd-2-e72.PMC4946514.pdf
"Preliminaryanalysis demonstrated that only acylcarnitines and hexosewere discriminatory (Table S1, SDC, http://links.lww.",Non-OADS,/arxiv_data1/oa_pdf/06/8a/txd-2-e78.PMC4946516.pdf
"Extracellular flux analysis was per- formed as per Wikstrom et al43(Supplementary methods and Table S1, SDC , http://links.lww.com/TXD/A25).",OADS,/arxiv_data1/oa_pdf/7e/13/txd-2-e77.PMC4946518.pdf
https://assets.digital.cabinet-office.gov.uk/media/5473080eed915d138000004b/con464230.pdf.,Non-OADS,/arxiv_data1/oa_pdf/8f/21/txd-2-e81.PMC4946520.pdf
"The kinetics of the different memory subsets followed the same pattern ( Figure S1, SDC, http://links.lww.com/TXD/A26).",OADS,/arxiv_data1/oa_pdf/74/1a/txd-2-e83.PMC4946521.pdf
"Memory CD8+ T cells were af-fected in functionality because 12 months after antirejection therapy, their STAT5 phosphorylation capacity was still di- minished ( Figure 3G and Figure S1, SDC, http://links.lww.",Non-OADS,/arxiv_data1/oa_pdf/74/1a/txd-2-e83.PMC4946521.pdf
Meeting Agenda available at http://www.fda.gov/downloads/ Drugs/NewsEvents/UCM459437.pdf.,Non-OADS,/arxiv_data1/oa_pdf/86/07/txd-2-e79.PMC4946524.pdf
"The correlation coefficients for the DOI: 10.6061/clinics/2016(07)03Copyright &2016 CLINICS â€“This is an Open Access article distributed under the terms of the Creative Commons License (http://creativecommons.org/licenses/by/ 4.0/) which permits unrestricted use, distribution, and reproduction in any medium or format, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e5/cd/cln-71-07-370.PMC4946526.pdf
"2002;21(5):221-5, http://dx.doi.org/10.1159/000065639.",Non-OADS,/arxiv_data1/oa_pdf/e5/cd/cln-71-07-370.PMC4946526.pdf
"2009;72(18):1548-54, http://dx.doi.org/10.1212/WNL.",Non-OADS,/arxiv_data1/oa_pdf/e5/cd/cln-71-07-370.PMC4946526.pdf
"2010;18 10:46, http://dx.doi.org/10.1186/1471-2377-10-46.",Non-OADS,/arxiv_data1/oa_pdf/e5/cd/cln-71-07-370.PMC4946526.pdf
"2012;45(6):909-17,http://dx.doi.org/10.1002/mus.23330.",Non-OADS,/arxiv_data1/oa_pdf/e5/cd/cln-71-07-370.PMC4946526.pdf
"2012;46(1):9-25, http://dx.doi.org/10.1002/mus.23245.",Non-OADS,/arxiv_data1/oa_pdf/e5/cd/cln-71-07-370.PMC4946526.pdf
"2012; 33(6):1375-81, http://dx.doi.org/10.1007/s10072-012-1170-2.",Non-OADS,/arxiv_data1/oa_pdf/e5/cd/cln-71-07-370.PMC4946526.pdf
"2010;42(1):5-13, http://dx.doi.org/10.1002/mus.21713.",Non-OADS,/arxiv_data1/oa_pdf/e5/cd/cln-71-07-370.PMC4946526.pdf
"2001;22(5):363-9, http://dx.doi.org/10.1007/ s100720100066.",Non-OADS,/arxiv_data1/oa_pdf/e5/cd/cln-71-07-370.PMC4946526.pdf
"2001;24(4):512-6, http://dx.doi.org/10.1002/mus.1034.",Non-OADS,/arxiv_data1/oa_pdf/e5/cd/cln-71-07-370.PMC4946526.pdf
"2008;38(2):947-56, http://dx.doi.org/10.1002/mus.21016.",Non-OADS,/arxiv_data1/oa_pdf/e5/cd/cln-71-07-370.PMC4946526.pdf
"2008;38(2):957-63, http://dx.doi.org/10.1002/mus.21053.",Non-OADS,/arxiv_data1/oa_pdf/e5/cd/cln-71-07-370.PMC4946526.pdf
"2010;41(2):219-26, http://dx.doi.org/10.1002/mus.21609 13.",Non-OADS,/arxiv_data1/oa_pdf/e5/cd/cln-71-07-370.PMC4946526.pdf
"2011;43(1):14-8, http://dx.doi.org/10.1002/mus.21883.",Non-OADS,/arxiv_data1/oa_pdf/e5/cd/cln-71-07-370.PMC4946526.pdf
"2013;71(12):955-8, http://dx.doi.org/10.1590/0004-282X20130180.",Non-OADS,/arxiv_data1/oa_pdf/e5/cd/cln-71-07-370.PMC4946526.pdf
"2000;55(1):16-23, http://dx.doi.org/10.1212/WNL.55.1.16.",Non-OADS,/arxiv_data1/oa_pdf/e5/cd/cln-71-07-370.PMC4946526.pdf
"2010;74(18):1434-40,http://dx.doi.org/10.1212/WNL.0b013e3181dc1b1e.",Non-OADS,/arxiv_data1/oa_pdf/e5/cd/cln-71-07-370.PMC4946526.pdf
"1997;84(3):223-43, http://dx.doi.org/10.1006/clin.1997.4412.",Non-OADS,/arxiv_data1/oa_pdf/e5/cd/cln-71-07-370.PMC4946526.pdf
"2007;48(3):360-70, http://dx.doi.org/10.3349/ymj.2007.48.3.360.",Non-OADS,/arxiv_data1/oa_pdf/e5/cd/cln-71-07-370.PMC4946526.pdf
"2012;46(2):166-73, http://dx.doi.org/10.1002/mus.23398.",Non-OADS,/arxiv_data1/oa_pdf/e5/cd/cln-71-07-370.PMC4946526.pdf
"2008;35(1):40-50, http://dx.doi.org/10.1016/j.jpainsymman.2007.02.041.",OADS,/arxiv_data1/oa_pdf/e5/cd/cln-71-07-370.PMC4946526.pdf
"2006;7(3): 110-4, http://dx.doi.org/10.1097/01.cnd.0000202223.39994.c0.",Non-OADS,/arxiv_data1/oa_pdf/e5/cd/cln-71-07-370.PMC4946526.pdf
"2008;37(2):141-9, http://dx.doi.org/10.1002/ mus.20950.",Non-OADS,/arxiv_data1/oa_pdf/e5/cd/cln-71-07-370.PMC4946526.pdf
"2011; 69(2A):176-9, http://dx.doi.org/10.1590/S0004-282X2011000200006.",Non-OADS,/arxiv_data1/oa_pdf/e5/cd/cln-71-07-370.PMC4946526.pdf
"2009;67(2A):203-8, http://dx.doi.org/10.1590/S0004-282X2009000200006.",Non-OADS,/arxiv_data1/oa_pdf/e5/cd/cln-71-07-370.PMC4946526.pdf
"2011;7:151-60, http://dx.doi.org/10.2147/NDT.S8915.",Non-OADS,/arxiv_data1/oa_pdf/e5/cd/cln-71-07-370.PMC4946526.pdf
"2014;50(4):493-500, http://dx.doi.org/10.1002/ mus.24213.",Non-OADS,/arxiv_data1/oa_pdf/e5/cd/cln-71-07-370.PMC4946526.pdf
"2014;34(6):942-9, http://dx.doi.org/10.1007/s11596-014-1378-x.",Non-OADS,/arxiv_data1/oa_pdf/e5/cd/cln-71-07-370.PMC4946526.pdf
"Anti-angiogenic DOI: 10.6061/clinics/2016(07)08Copyright &2016 CLINICS â€“This is an Open Access article distributed under the terms of the Creative Commons License (http://creativecommons.org/licenses/by/ 4.0/) which permits unrestricted use, distribution, and reproduction in any medium or format, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e5/77/cln-71-07-399.PMC4946527.pdf
"2000;343(12):864-9, http://dx.doi.org/10.1056/NEJM200009213431207.",Non-OADS,/arxiv_data1/oa_pdf/e5/77/cln-71-07-399.PMC4946527.pdf
"2006;111(1):147-53, http://dx.doi.org/10.1016/j.ijcard.2005.12.002.",OADS,/arxiv_data1/oa_pdf/e5/77/cln-71-07-399.PMC4946527.pdf
"1983;7(4):544-51, http://dx.doi.org/10.1007/BF01655948.",Non-OADS,/arxiv_data1/oa_pdf/e5/77/cln-71-07-399.PMC4946527.pdf
"1998; 66(Suppl 1):S243-5; discussion S7, http://dx.doi.org/10.1016/S0167-5273 (98)00175-2.",Non-OADS,/arxiv_data1/oa_pdf/e5/77/cln-71-07-399.PMC4946527.pdf
"1996;11(3): 335-9, http://dx.doi.org/10.1016/S1078-5884(96)80081-5.",Non-OADS,/arxiv_data1/oa_pdf/e5/77/cln-71-07-399.PMC4946527.pdf
"2009;206(2):328-34, http://dx.doi.org/10.1016/j.atherosclerosis.2009.01.042.",Non-OADS,/arxiv_data1/oa_pdf/e5/77/cln-71-07-399.PMC4946527.pdf
"2013;8(3):e37882, http://dx.doi.org/10.1371/journal.pone.0037882.",Non-OADS,/arxiv_data1/oa_pdf/e5/77/cln-71-07-399.PMC4946527.pdf
"2003;16(3):179-89, http://dx.doi.org/10.1016/ S0895-7967(03)00023-1.",Non-OADS,/arxiv_data1/oa_pdf/e5/77/cln-71-07-399.PMC4946527.pdf
"2012;7(4):e34717, http://dx.doi.org/10.1371/journal.pone.",Non-OADS,/arxiv_data1/oa_pdf/e5/77/cln-71-07-399.PMC4946527.pdf
"1999; 177(4):316-20, http://dx.doi.org/10.1016/S0002-9610(99)00046-X.",OADS,/arxiv_data1/oa_pdf/e5/77/cln-71-07-399.PMC4946527.pdf
"1989;39(3):153-8, http://dx.doi.org/10.1111/j.1440- 1827.1989.tb01494.x.",Non-OADS,/arxiv_data1/oa_pdf/e5/77/cln-71-07-399.PMC4946527.pdf
"1998;124(3):498-502, http://dx.doi.org/10.1016/S0039-6060(98)70095-9.",Non-OADS,/arxiv_data1/oa_pdf/e5/77/cln-71-07-399.PMC4946527.pdf
"2006;20(1):148-56, http://dx.doi.org/10.1007/s10016-005-9436-2.",Non-OADS,/arxiv_data1/oa_pdf/e5/77/cln-71-07-399.PMC4946527.pdf
"2013;6(3):617-23, http://dx.doi.org/10.3400/avd.oa.",Non-OADS,/arxiv_data1/oa_pdf/e5/77/cln-71-07-399.PMC4946527.pdf
"2006;1:14, http://dx.doi.org/10.1186/1750-1172-1-14.",Non-OADS,/arxiv_data1/oa_pdf/e5/77/cln-71-07-399.PMC4946527.pdf
"2015;10(10):e0140473, http://dx.doi.org/10.1371/journal.pone.0140473.",Non-OADS,/arxiv_data1/oa_pdf/e5/77/cln-71-07-399.PMC4946527.pdf
"2015;24(6):1085-97, http://dx.doi.org/10.17219/ acem/33322.",Non-OADS,/arxiv_data1/oa_pdf/e5/77/cln-71-07-399.PMC4946527.pdf
"2005;42(1):107-15, http://dx.doi.org/10.1016/j.jvs.2005.03.",OADS,/arxiv_data1/oa_pdf/e5/77/cln-71-07-399.PMC4946527.pdf
"2013;21(4):3, http://dx.doi.org/10.5455/aim.2013.21.250-252.",Non-OADS,/arxiv_data1/oa_pdf/e5/77/cln-71-07-399.PMC4946527.pdf
"1987;66(1):65-72, http://dx.doi.org/10.1097/00005792- 198701000-00002.",Non-OADS,/arxiv_data1/oa_pdf/e5/77/cln-71-07-399.PMC4946527.pdf
"1997;67(5):264-9, http://dx.doi.org/10.1111/ j.1445-2197.1997.tb01960.x.",Non-OADS,/arxiv_data1/oa_pdf/e5/77/cln-71-07-399.PMC4946527.pdf
"2010; 121(16):1858-61, http://dx.doi.org/ 10.1161/CIRCULATIONAHA.110.942383.",Non-OADS,/arxiv_data1/oa_pdf/e5/77/cln-71-07-399.PMC4946527.pdf
"Determining the accuracies of different MRI sequences currently being used in clinical practice to assess maturing cartilage in children and adolescents is crucial given that arti- cular cartilage thickness tends to reduce during physiologic DOI: 10.6061/clinics/2016(07)09Copyright &2016 CLINICS â€“This is an Open Access article distributed under the terms of the Creative Commons License (http://creativecommons.org/licenses/by/ 4.0/) which permits unrestricted use, distribution, and reproduction in any medium or format, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/09/60/cln-71-07-404.PMC4946528.pdf
"2004;11(12):1389-95, http://dx.doi.org/10.1016/ j.acra.2004.09.003.",OADS,/arxiv_data1/oa_pdf/09/60/cln-71-07-404.PMC4946528.pdf
"2012;4(2):77-97, http://dx.doi.org/10.1177/1759720X11431005.",Non-OADS,/arxiv_data1/oa_pdf/09/60/cln-71-07-404.PMC4946528.pdf
"2014;41(2):354-8, http://dx.doi.org/10.3899/jrheum.131081.",Non-OADS,/arxiv_data1/oa_pdf/09/60/cln-71-07-404.PMC4946528.pdf
"2009;192(5):1209-18, http://dx.doi.org/10.2214/AJR.",Non-OADS,/arxiv_data1/oa_pdf/09/60/cln-71-07-404.PMC4946528.pdf
"2011;44(9):2072-7, http://dx.doi.org/10.1002/1529-0131(200109)44:9o2072::AID-ART357 43.0.CO;2-3.",Non-OADS,/arxiv_data1/oa_pdf/09/60/cln-71-07-404.PMC4946528.pdf
"1999;7(3):265-71, http://dx.doi.org/10.1053/joca.1998.0200.",Non-OADS,/arxiv_data1/oa_pdf/09/60/cln-71-07-404.PMC4946528.pdf
"1994;192(2):485-91, http://dx.doi.org/10.1148/radiology.192.2.8029420.",Non-OADS,/arxiv_data1/oa_pdf/09/60/cln-71-07-404.PMC4946528.pdf
"1996;3(11):919-24,http://dx.doi.org/10.1016/S1076-6332(96)80299-6.",Non-OADS,/arxiv_data1/oa_pdf/09/60/cln-71-07-404.PMC4946528.pdf
"1996;25(1):55-62, http://dx.doi.org/10.1007/s002560050032.",Non-OADS,/arxiv_data1/oa_pdf/09/60/cln-71-07-404.PMC4946528.pdf
"2004;50(3):811-6, http://dx.doi.org/10.1002/art.20191.",Non-OADS,/arxiv_data1/oa_pdf/09/60/cln-71-07-404.PMC4946528.pdf
"2003;54(2):230-6, http://dx.doi.org/10.1203/01.PDR.0000072781.93856.E6.",Non-OADS,/arxiv_data1/oa_pdf/09/60/cln-71-07-404.PMC4946528.pdf
"2001;32(Suppl 1):S110-6, http://dx.doi.org/10.1055/s-0029-1245374.",Non-OADS,/arxiv_data1/oa_pdf/09/60/cln-71-07-404.PMC4946528.pdf
"1995;21(9):1163-76, http://dx.doi.org/10.1016/0301-5629(95)00044-5.",Non-OADS,/arxiv_data1/oa_pdf/09/60/cln-71-07-404.PMC4946528.pdf
"2013; 58(11):3775-90, http://dx.doi.org/10.1088/0031-9155/58/11/3775.",Non-OADS,/arxiv_data1/oa_pdf/09/60/cln-71-07-404.PMC4946528.pdf
"1999;44(12):N261-4, http://dx.doi.org/10.1088/0031-9155/44/ 12/403.",Non-OADS,/arxiv_data1/oa_pdf/09/60/cln-71-07-404.PMC4946528.pdf
"2009;7:12, http://dx.doi.org/10.1186/1546-0096-7-12.",Non-OADS,/arxiv_data1/oa_pdf/09/60/cln-71-07-404.PMC4946528.pdf
"2006;19(17):822-54, http://dx.doi.org/10.1002/nbm.1063.",Non-OADS,/arxiv_data1/oa_pdf/09/60/cln-71-07-404.PMC4946528.pdf
"2006;14(9):914-22, http://dx.doi.org/10.1016/j.joca.2006.03.004.",OADS,/arxiv_data1/oa_pdf/09/60/cln-71-07-404.PMC4946528.pdf
"2004;8(4): 329-53, http://dx.doi.org/10.1055/s-2004-861579.",Non-OADS,/arxiv_data1/oa_pdf/09/60/cln-71-07-404.PMC4946528.pdf
"2000;43(1):126-32, http://dx.doi.org/ 10.1002/(SICI)1522-2594(200001)43:1 o126::AID-MRM15 43.0.CO;2-#.",Non-OADS,/arxiv_data1/oa_pdf/09/60/cln-71-07-404.PMC4946528.pdf
"2000;45(11):304-10, http://dx.doi.org/10.1515/bmte.2000.45.11.304.",Non-OADS,/arxiv_data1/oa_pdf/09/60/cln-71-07-404.PMC4946528.pdf
"2003;50(6):1229-36, http://dx.doi.org/10.1002/mrm.10648.",Non-OADS,/arxiv_data1/oa_pdf/09/60/cln-71-07-404.PMC4946528.pdf
"2004;50(1):94-7, http://dx.doi.org/10.1002/art.11483.",Non-OADS,/arxiv_data1/oa_pdf/09/60/cln-71-07-404.PMC4946528.pdf
"2015;21(3):e210-22, http://dx.doi.org/10.1111/hae.12614.",Non-OADS,/arxiv_data1/oa_pdf/09/60/cln-71-07-404.PMC4946528.pdf
"2011; 31(1):37-62, http://dx.doi.org/10.1148/rg.311105084.",Non-OADS,/arxiv_data1/oa_pdf/09/60/cln-71-07-404.PMC4946528.pdf
"1996;26(10):695-700, http://dx.doi.org/10.1007/BF01383382.",Non-OADS,/arxiv_data1/oa_pdf/09/60/cln-71-07-404.PMC4946528.pdf
"2006;14(Suppl A): A46-75, http://dx.doi.org/10.1016/j.joca.2006.02.026.",OADS,/arxiv_data1/oa_pdf/09/60/cln-71-07-404.PMC4946528.pdf
"2006;14(Suppl A):A76-86, http://dx.doi.org/10.1016/j.joca.2006.03.010.",OADS,/arxiv_data1/oa_pdf/09/60/cln-71-07-404.PMC4946528.pdf
"2006;14(Suppl A):A95-111, http://dx.doi.org/10.10 16/j.joca.2006.02.029.",OADS,/arxiv_data1/oa_pdf/09/60/cln-71-07-404.PMC4946528.pdf
"2006; 65(4):433-41, http://dx.doi.org/10.1136/ard.2005.039370.",Non-OADS,/arxiv_data1/oa_pdf/09/60/cln-71-07-404.PMC4946528.pdf
"2010; 18(4):547-54, http://dx.doi.org/10.1016/j.joca.2009.12.003.",OADS,/arxiv_data1/oa_pdf/09/60/cln-71-07-404.PMC4946528.pdf
"1996;6(2):329- 35, http://dx.doi.org/10.1002/jmri.",Non-OADS,/arxiv_data1/oa_pdf/09/60/cln-71-07-404.PMC4946528.pdf
"2007;57(2):448-54,http://dx.doi.org/10.1002/mrm.21146.",Non-OADS,/arxiv_data1/oa_pdf/09/60/cln-71-07-404.PMC4946528.pdf
"2007;15(11):1326-32, http://dx.doi.org/10.1016/j.joca.2007.04.007.",OADS,/arxiv_data1/oa_pdf/09/60/cln-71-07-404.PMC4946528.pdf
Available from PubMed: http://www.ncbi.nlm.nih.gov/ pubmed/22046518.,Non-OADS,/arxiv_data1/oa_pdf/09/60/cln-71-07-404.PMC4946528.pdf
http://dx.doi.org/10.1155/2011/475684.,Non-OADS,/arxiv_data1/oa_pdf/09/60/cln-71-07-404.PMC4946528.pdf
"1999;42(4):695-703, http://dx.doi.org/10.1002/(SICI) 1522-2594(199910)42:4 o695::AID-MRM11 43.0.CO;2-Z.",Non-OADS,/arxiv_data1/oa_pdf/09/60/cln-71-07-404.PMC4946528.pdf
"2005;34(1):215-20, http://dx.doi.org/10.1093/ije/dyh299.",Non-OADS,/arxiv_data1/oa_pdf/09/60/cln-71-07-404.PMC4946528.pdf
"2006; 17(4):688-90, http://dx.doi.org/10.1093/beheco/ark016.",Non-OADS,/arxiv_data1/oa_pdf/09/60/cln-71-07-404.PMC4946528.pdf
"Intestinal fatty acid-binding protein (I-FABP) has been used as a marker for the detection of intestinal injuries and has been investigated as a candidate marker for the DOI: 10.6061/clinics/2016(07)10Copyright &2016 CLINICS â€“This is an Open Access article distributed under the terms of the Creative Commons License (http://creativecommons.org/licenses/by/ 4.0/) which permits unrestricted use, distribution, and reproduction in any medium or format, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/58/10/cln-71-07-412.PMC4946529.pdf
"2011; 87(10):659-61, http://dx.doi.org/10.1016/j.earlhumdev.2011.05.004.2.",OADS,/arxiv_data1/oa_pdf/58/10/cln-71-07-412.PMC4946529.pdf
"2006;22(1):50-6, http://dx.doi.org/10.1007/s00383-005-1588-1.",Non-OADS,/arxiv_data1/oa_pdf/58/10/cln-71-07-412.PMC4946529.pdf
"1990;117(1 Pt 2):S2-5, http://dx.doi.org/10.1016/S0022-3476(05) 81123-0.",Non-OADS,/arxiv_data1/oa_pdf/58/10/cln-71-07-412.PMC4946529.pdf
"2001;13(2):111-5, http://dx.doi.org/10.1097/00008480- 200104000-00004.",Non-OADS,/arxiv_data1/oa_pdf/58/10/cln-71-07-412.PMC4946529.pdf
"1991;51(1):1-4, http://dx.doi.org/10.1016/0022-4804(91)90061-P. 6.",Non-OADS,/arxiv_data1/oa_pdf/58/10/cln-71-07-412.PMC4946529.pdf
"2011;46(2):527-34, http://dx.doi.org/10.1016/j.mcn.2010.12.007.",OADS,/arxiv_data1/oa_pdf/58/10/cln-71-07-412.PMC4946529.pdf
"1990;117(5):833-5, http://dx.doi.org/10.1016/S0022-3476(05)83354-2.",Non-OADS,/arxiv_data1/oa_pdf/58/10/cln-71-07-412.PMC4946529.pdf
"2007;128(2):115-23, http://dx.doi.org/10.1007/s00418-007-0302-x.",Non-OADS,/arxiv_data1/oa_pdf/58/10/cln-71-07-412.PMC4946529.pdf
"2004;55(4):622-9, http://dx.doi.org/ 10.1203/01.PDR.0000113463.70435.74.",Non-OADS,/arxiv_data1/oa_pdf/58/10/cln-71-07-412.PMC4946529.pdf
"2013;28 (Suppl1): 19-25, http://dx.doi.org/10.1590/S0102- 86502013001300005.",Non-OADS,/arxiv_data1/oa_pdf/58/10/cln-71-07-412.PMC4946529.pdf
"1994;14(6):1017-28, http://dx.doi.org/10.3109/15513819409037698.",Non-OADS,/arxiv_data1/oa_pdf/58/10/cln-71-07-412.PMC4946529.pdf
"J Pediatr Gastroenterol Nutr.2008;47(1):11-8, http://dx.doi.org/10.1097/MPG.0b013e3181788618.",Non-OADS,/arxiv_data1/oa_pdf/58/10/cln-71-07-412.PMC4946529.pdf
"1976;72:248-54, http://dx.doi.org/10.1016/0003-2697(76)90527-3.",Non-OADS,/arxiv_data1/oa_pdf/58/10/cln-71-07-412.PMC4946529.pdf
"2003;53(3):426-33, http://dx.doi.org/10.1203/01.PDR.0000050657.56817.E0.",Non-OADS,/arxiv_data1/oa_pdf/58/10/cln-71-07-412.PMC4946529.pdf
"Surgery.1997;121(3):335-42, http://dx.doi.org/10.1016/S0039-6060(97)90363-9.",Non-OADS,/arxiv_data1/oa_pdf/58/10/cln-71-07-412.PMC4946529.pdf
"2013;10(1):24-8, http://dx.doi.org/10.4103/0189-6725.109381.",Non-OADS,/arxiv_data1/oa_pdf/58/10/cln-71-07-412.PMC4946529.pdf
"2009;44(9):1730-5, http://dx.doi.org/10.1016/j.jpedsurg.2009.01.007.",OADS,/arxiv_data1/oa_pdf/58/10/cln-71-07-412.PMC4946529.pdf
"2008;43(2):308-14, http://dx.doi.org/10.1016/j.jpedsurg.2007.10.022.",OADS,/arxiv_data1/oa_pdf/58/10/cln-71-07-412.PMC4946529.pdf
"2000;31(2):162-9, http://dx.doi.org/10.1097/00005176- 200008000-00013.",Non-OADS,/arxiv_data1/oa_pdf/58/10/cln-71-07-412.PMC4946529.pdf
"1977;11(8):906-9, http://dx.doi.org/10.1203/00006450-197708000-00011.",Non-OADS,/arxiv_data1/oa_pdf/58/10/cln-71-07-412.PMC4946529.pdf
"1995; 30(8):1138-42, http://dx.doi.org/10.1016/0022-3468(95)90006-3.",Non-OADS,/arxiv_data1/oa_pdf/58/10/cln-71-07-412.PMC4946529.pdf
"2013;22(2):69-75, http://dx.doi.org/10.1053/j.sempedsurg.2013.01.002.",OADS,/arxiv_data1/oa_pdf/58/10/cln-71-07-412.PMC4946529.pdf
"1993; 28(3):367-70; discussion 370-1., doi: http://dx.doi.org/10.1016/0022-3468 (93)90233-B.",Non-OADS,/arxiv_data1/oa_pdf/58/10/cln-71-07-412.PMC4946529.pdf
"2003; 36(7):529-35, http://dx.doi.org/10.1016/S0009- 9120(03)00096-1.",Non-OADS,/arxiv_data1/oa_pdf/58/10/cln-71-07-412.PMC4946529.pdf
"J Biol Chem.1996;271(23):13317-23, http://dx.doi.org/10.1074/jbc.",OADS,/arxiv_data1/oa_pdf/58/10/cln-71-07-412.PMC4946529.pdf
"2006;21(2):113-8, http://dx.doi.org/10.1590/S0102- 86502006000200011.",Non-OADS,/arxiv_data1/oa_pdf/58/10/cln-71-07-412.PMC4946529.pdf
"2014;56(2):207-10, http://dx.doi.org/10.1111/ ped.12223.",Non-OADS,/arxiv_data1/oa_pdf/58/10/cln-71-07-412.PMC4946529.pdf
"2001;100(2):192-6, http://dx.doi.org/10.1006/jsre.2001.6237.",Non-OADS,/arxiv_data1/oa_pdf/58/10/cln-71-07-412.PMC4946529.pdf
"1996;110(2):339-43, http://dx.doi.org/10.1053/gast.1996.v110.pm8566578.",Non-OADS,/arxiv_data1/oa_pdf/58/10/cln-71-07-412.PMC4946529.pdf
"2010;45(4):735-40, http://dx.doi.org/10.1016/ j.jpedsurg.2009.09.024.",OADS,/arxiv_data1/oa_pdf/58/10/cln-71-07-412.PMC4946529.pdf
"The current study evaluated the peripartum factors associated with the necessity for neonatal r esuscitation in the delivery room DOI: 10.6061/clinics/2016(07)05Copyright &2016 CLINICS â€“This is an Open Access article distributed under the terms of the Creative Commons License (http://creativecommons.org/licenses/by/ 4.0/) which permits unrestricted use, distribution, and reproduction in any medium or format, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8c/f2/cln-71-07-381.PMC4946531.pdf
"2011;11(Suppl 3):S12, http://dx.doi.org/10.1186/1471-2458-11-S3-S12.",Non-OADS,/arxiv_data1/oa_pdf/8c/f2/cln-71-07-381.PMC4946531.pdf
"2011;11(Suppl 3):S10,http://dx.doi.org/10.1186/1471-2458-11-S3-S10.3.",Non-OADS,/arxiv_data1/oa_pdf/8c/f2/cln-71-07-381.PMC4946531.pdf
"2005;365:891-900, http://dx.doi.org/10.1016/S0140-6736(05)71048-5.",OADS,/arxiv_data1/oa_pdf/8c/f2/cln-71-07-381.PMC4946531.pdf
"2009;107(Suppl 1):S5-19, http://dx.doi.org/10.1016/j.ijgo.2009.07.016.",OADS,/arxiv_data1/oa_pdf/8c/f2/cln-71-07-381.PMC4946531.pdf
"2005;83:409-17, http://dx.doi.org/10.1590/S0042-9686200 5000600008.",Non-OADS,/arxiv_data1/oa_pdf/8c/f2/cln-71-07-381.PMC4946531.pdf
"2012;28(3):559-72, http://dx.doi.org/10.1590/S0102-311X2012000300016.",Non-OADS,/arxiv_data1/oa_pdf/8c/f2/cln-71-07-381.PMC4946531.pdf
"BMC Pregnancy Child- birth 2009;9(Suppl 1):S6, http://dx.doi.org/10.1186/1471-2393-9-S1-S6.",Non-OADS,/arxiv_data1/oa_pdf/8c/f2/cln-71-07-381.PMC4946531.pdf
"1996;49:1373-9, http://dx.doi.org/10.1016/S0895-4356 (96)00236-3.",Non-OADS,/arxiv_data1/oa_pdf/8c/f2/cln-71-07-381.PMC4946531.pdf
"2007;26(30):5512-28, http://dx.doi.org/ 10.1002/sim.3148.",Non-OADS,/arxiv_data1/oa_pdf/8c/f2/cln-71-07-381.PMC4946531.pdf
"2004;104(1):11-9, http://dx.doi.org/10.1097/01.AOG.0000 127035.64602.97.",Non-OADS,/arxiv_data1/oa_pdf/8c/f2/cln-71-07-381.PMC4946531.pdf
"2002;187(3):721-7, http://dx.doi.org/10.1067/ mob.2002.125886.",Non-OADS,/arxiv_data1/oa_pdf/8c/f2/cln-71-07-381.PMC4946531.pdf
"2008;198:703(6).e1-5, http://dx.doi.org/10.1016/j.ajog.",OADS,/arxiv_data1/oa_pdf/8c/f2/cln-71-07-381.PMC4946531.pdf
"2010;95(5):F326-30, http://dx.doi.org/10.1136/adc.2009.174532.",Non-OADS,/arxiv_data1/oa_pdf/8c/f2/cln-71-07-381.PMC4946531.pdf
"2012;129(5):e1238-43, http://dx.doi.org/10.1542/peds.2011-3134.",Non-OADS,/arxiv_data1/oa_pdf/8c/f2/cln-71-07-381.PMC4946531.pdf
"2001;30(6):1233-41, http://dx.doi.org/10.1093/ije/ 30.6.1233.",Non-OADS,/arxiv_data1/oa_pdf/8c/f2/cln-71-07-381.PMC4946531.pdf
"1992;82(3):378-82, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/8c/f2/cln-71-07-381.PMC4946531.pdf
"2009;169(7):787-97, http://dx.doi.org/ 10.1093/aje/kwp024.",Non-OADS,/arxiv_data1/oa_pdf/8c/f2/cln-71-07-381.PMC4946531.pdf
"2008;28(Suppl 3):S14-8, http://dx.doi.org/10.1038/jp.2008.145.",Non-OADS,/arxiv_data1/oa_pdf/8c/f2/cln-71-07-381.PMC4946531.pdf
"2010;20:289-94, http://dx.doi.org/10.1016/j.ogrm.2010.06.005.",OADS,/arxiv_data1/oa_pdf/8c/f2/cln-71-07-381.PMC4946531.pdf
"2006;117(5): 1712-21, http://dx.doi.org/10.1542/peds.2005-2215.",Non-OADS,/arxiv_data1/oa_pdf/8c/f2/cln-71-07-381.PMC4946531.pdf
"1997;24(2):121-3, http://dx.doi.org/10.1111/j.1523- 536X.1997.tb00352.x.",Non-OADS,/arxiv_data1/oa_pdf/8c/f2/cln-71-07-381.PMC4946531.pdf
"2009;107(Suppl 1):S21-45, http://dx.doi.org/10.1016/j.ijgo.2009.07.017.",OADS,/arxiv_data1/oa_pdf/8c/f2/cln-71-07-381.PMC4946531.pdf
"2000;12(2):123-7, http://dx.doi.org/10.1097/00001703-2 00004000-00011.27.",Non-OADS,/arxiv_data1/oa_pdf/8c/f2/cln-71-07-381.PMC4946531.pdf
http://www2.datasus.gov.b r/DATASUS/index.php?area=0205.,OADS,/arxiv_data1/oa_pdf/8c/f2/cln-71-07-381.PMC4946531.pdf
"Cad Saude Publica 2014;30(Suppl 1):S1-15, http://dx.doi.org/10.1590/0102-311X00133213.",Non-OADS,/arxiv_data1/oa_pdf/8c/f2/cln-71-07-381.PMC4946531.pdf
"DOI: 10.6061/clinics/2016(07)01Copyright &2016 CLINICS â€“This is an Open Access article distributed under the terms of the Creative Commons License (http://creativecommons.org/licenses/by/ 4.0/) which permits unrestricted use, distribution, and reproduction in any medium or format, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/45/ff/cln-71-07-361.PMC4946532.pdf
"2012;6:207-19, http://dx.doi.org/10.2147/BTT.S23907.",Non-OADS,/arxiv_data1/oa_pdf/45/ff/cln-71-07-361.PMC4946532.pdf
"2012; 56(4):908-43, http://dx.doi.org/10.1016/ j.jhep.2011.12.001.",OADS,/arxiv_data1/oa_pdf/45/ff/cln-71-07-361.PMC4946532.pdf
DisponÃ­vel em http://globocan.iarc.fr/ Pages/fact_sheets_population.aspx 4.,Non-OADS,/arxiv_data1/oa_pdf/45/ff/cln-71-07-361.PMC4946532.pdf
"2011;54(6):1898-900, http://dx.doi.org/10.1002/hep.24684.5.",Non-OADS,/arxiv_data1/oa_pdf/45/ff/cln-71-07-361.PMC4946532.pdf
"2012; 379(9822):1245-55, http://dx.doi.org/10.1016/S0140-6736(11)61347-0.",Non-OADS,/arxiv_data1/oa_pdf/45/ff/cln-71-07-361.PMC4946532.pdf
DisponÃ­vel em: http://www.endocrino.org.br/sindrome-metabolica/ 7.,Non-OADS,/arxiv_data1/oa_pdf/45/ff/cln-71-07-361.PMC4946532.pdf
"2002;97(3):734-44, http://dx.doi.org/10.1111/j.1572-0241.2002.05557.x.",Non-OADS,/arxiv_data1/oa_pdf/45/ff/cln-71-07-361.PMC4946532.pdf
"2010;25(5):951-6, http://dx.doi.org/10.1111/j.1440-1746.2009.06203.x.",Non-OADS,/arxiv_data1/oa_pdf/45/ff/cln-71-07-361.PMC4946532.pdf
"2001;34(4):603-5, http://dx.doi.org/10.1016/S0168-8278(01)00025-3.",Non-OADS,/arxiv_data1/oa_pdf/45/ff/cln-71-07-361.PMC4946532.pdf
"2009;54(12):2712-21, http://dx.doi.org/10.1007/s10620-009-1015-x.",Non-OADS,/arxiv_data1/oa_pdf/45/ff/cln-71-07-361.PMC4946532.pdf
"2004;99(11):1382-92, http://dx.doi.org/10.1111/j.1360-0443.2004.00884.x.Table 4 -Number and size of hepatocellular carcinoma nodules diagnosed in cirrhotic patients by ultrasonography.",Non-OADS,/arxiv_data1/oa_pdf/45/ff/cln-71-07-361.PMC4946532.pdf
"The ABI is associated with DOI: 10.6061/clinics/2016(07)04Copyright &2016 CLINICS â€“This is an Open Access article distributed under the terms of the Creative Commons License (http://creativecommons.org/licenses/by/ 4.0/) which permits unrestricted use, distribution, and reproduction in any medium or format, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1e/43/cln-71-07-375.PMC4946533.pdf
"2005;112(8):1121-7, http://dx.doi.org/10.1161/CIR CULATIONAHA.104.512988.",Non-OADS,/arxiv_data1/oa_pdf/1e/43/cln-71-07-375.PMC4946533.pdf
"2004;43 (11):2009-14, http://dx.doi.org/10.1016/j.jacc.2004.01.038.",OADS,/arxiv_data1/oa_pdf/1e/43/cln-71-07-375.PMC4946533.pdf
"2009;157(1):177-84, http://dx.doi.org/10.1016/j.ahj.2008.08.011.",Non-OADS,/arxiv_data1/oa_pdf/1e/43/cln-71-07-375.PMC4946533.pdf
"2002;40(1):27-33, http://dx.doi.org/10.1016/S0735-1097(02)01938-1.",Non-OADS,/arxiv_data1/oa_pdf/1e/43/cln-71-07-375.PMC4946533.pdf
"2005;111(16):2042-9, http://dx.doi.org/10.1161/01.CIR.0000162477.70955.5F.",Non-OADS,/arxiv_data1/oa_pdf/1e/43/cln-71-07-375.PMC4946533.pdf
"2004;25(12):1021-8, http://dx.doi.org/10.1016/j.ehj.2004.04.023.",OADS,/arxiv_data1/oa_pdf/1e/43/cln-71-07-375.PMC4946533.pdf
"2006;113(23):2713-23, http://dx.doi.org/10.1161/CIRCULATIONAHA.105.",Non-OADS,/arxiv_data1/oa_pdf/1e/43/cln-71-07-375.PMC4946533.pdf
"2005;165(19):2214-20, http://dx.doi.org/10.1001/archinte.165.19.2214.",Non-OADS,/arxiv_data1/oa_pdf/1e/43/cln-71-07-375.PMC4946533.pdf
"1998;339(9):584-90, http://dx.doi.org/10.1056/NEJM199808273390903.",Non-OADS,/arxiv_data1/oa_pdf/1e/43/cln-71-07-375.PMC4946533.pdf
"2005;25(7):1463-9, http://dx.doi.org/10.1161/01.ATV .",Non-OADS,/arxiv_data1/oa_pdf/1e/43/cln-71-07-375.PMC4946533.pdf
"2009;8(2):91-7, http://dx.doi.org/10.1097/HPC.0b013e3181a84613.",Non-OADS,/arxiv_data1/oa_pdf/1e/43/cln-71-07-375.PMC4946533.pdf
"2001;344(21):1608-21, http://dx.doi.org/10.1056/ NEJM200105243442108.",Non-OADS,/arxiv_data1/oa_pdf/1e/43/cln-71-07-375.PMC4946533.pdf
"2008;300(2):197-208, http://dx.doi.org/10.1001/jama.",Non-OADS,/arxiv_data1/oa_pdf/1e/43/cln-71-07-375.PMC4946533.pdf
"2006;17(10):2937-44, http://dx.doi.org/10.1681/ ASN.2006040368.",Non-OADS,/arxiv_data1/oa_pdf/1e/43/cln-71-07-375.PMC4946533.pdf
"2013;31(7):1281-357, http://dx.doi.org/10.1097/01.hjh.",Non-OADS,/arxiv_data1/oa_pdf/1e/43/cln-71-07-375.PMC4946533.pdf
"2012;110(11):1692-8, http://dx.doi.org/10.1016/j.amjcard.2012.07.038.",OADS,/arxiv_data1/oa_pdf/1e/43/cln-71-07-375.PMC4946533.pdf
"1978;9(4):369-74, http://dx.doi.org/10.1161/01.STR.9.4.369.",Non-OADS,/arxiv_data1/oa_pdf/1e/43/cln-71-07-375.PMC4946533.pdf
"2009;49(1):45-7, http://dx.doi.org/10.1016/j.ypmed.2009.04.015.",OADS,/arxiv_data1/oa_pdf/1e/43/cln-71-07-375.PMC4946533.pdf
"2012;60(3):631-8, http://dx.doi.org/10.1161/HYPERTENSIONAHA.112.191510.",Non-OADS,/arxiv_data1/oa_pdf/1e/43/cln-71-07-375.PMC4946533.pdf
"2003;14(4):279-84, http://dx.doi.org/10.1097/ 01.mca.0000071769.74379.49.",Non-OADS,/arxiv_data1/oa_pdf/1e/43/cln-71-07-375.PMC4946533.pdf
"1992;94(2-3):93-107, http://dx.doi.org/10.1016/ 0021-9150(92)90234-8.",Non-OADS,/arxiv_data1/oa_pdf/1e/43/cln-71-07-375.PMC4946533.pdf
"1992;123(2):521-3, http://dx.doi.org/10.1016/0002-8703(92)90671-H. 27.",Non-OADS,/arxiv_data1/oa_pdf/1e/43/cln-71-07-375.PMC4946533.pdf
"2005;65(9):1382-7, http://dx.doi.org/10.1212/01.wnl.0000183057.96792.a8.",Non-OADS,/arxiv_data1/oa_pdf/1e/43/cln-71-07-375.PMC4946533.pdf
"2010;30(7):1347-53, http://dx.doi.org/10.1161/ATVBAHA.110.206433.",Non-OADS,/arxiv_data1/oa_pdf/1e/43/cln-71-07-375.PMC4946533.pdf
"Therefore, the aim of the current study was to evaluate the role of multidetector computed tomography (MDCT) DOI: 10.6061/clinics/2016(07)07Copyright &2016 CLINICS â€“This is an Open Access article distributed under the terms of the Creative Commons License (http://creativecommons.org/licenses/by/ 4.0/) which permits unrestricted use, distribution, and reproduction in any medium or format, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/84/0c/cln-71-07-392.PMC4946534.pdf
"2004;16(3):209-14, http://dx.doi.org/10.1053/j.semtcvs.2004.08.007.",Non-OADS,/arxiv_data1/oa_pdf/84/0c/cln-71-07-392.PMC4946534.pdf
"2004;5(1):59 â€“68, http://dx.doi.org/10.1016/j.prrv.2003.09.009.",OADS,/arxiv_data1/oa_pdf/84/0c/cln-71-07-392.PMC4946534.pdf
"1979; 34(1):96 â€“101, http://dx.doi.org/10.1136/thx.34.1.96.",Non-OADS,/arxiv_data1/oa_pdf/84/0c/cln-71-07-392.PMC4946534.pdf
"2005;99(4):508 â€“10, http://dx.doi.org/10.1016/j.rmed.2004.08.014.",OADS,/arxiv_data1/oa_pdf/84/0c/cln-71-07-392.PMC4946534.pdf
"1984;86(4):611-5, http://dx.doi.org/10.1378/chest.86.4.611.",Non-OADS,/arxiv_data1/oa_pdf/84/0c/cln-71-07-392.PMC4946534.pdf
"2008;247(3):632-48, http://dx.doi.org/10.1148/ radiol.2473062124.",Non-OADS,/arxiv_data1/oa_pdf/84/0c/cln-71-07-392.PMC4946534.pdf
"1979;72(6):917-25, http://dx.doi.org/10.1093/ ajcp/72.6.917.",Non-OADS,/arxiv_data1/oa_pdf/84/0c/cln-71-07-392.PMC4946534.pdf
"1990;154(2):241-9, http://dx.doi.org/10.2214/ajr.154.2.2105007.9 .",Non-OADS,/arxiv_data1/oa_pdf/84/0c/cln-71-07-392.PMC4946534.pdf
"1997;17(3): 725â€“45, http://dx.doi.org/10.1148/radiographics.17.3.9153708.",Non-OADS,/arxiv_data1/oa_pdf/84/0c/cln-71-07-392.PMC4946534.pdf
"2011;40(1):e39 â€“42, http://dx.doi.org/10.1016/ j.ejcts.2011.01.080.",OADS,/arxiv_data1/oa_pdf/84/0c/cln-71-07-392.PMC4946534.pdf
"2012;18(1):51 â€“5, http://dx.doi.org/10.5761/atcs.cr.11.01835.",Non-OADS,/arxiv_data1/oa_pdf/84/0c/cln-71-07-392.PMC4946534.pdf
"2006;95(3):190 â€“4, http://dx.doi.org/10.1177/145749690 609500312.",Non-OADS,/arxiv_data1/oa_pdf/84/0c/cln-71-07-392.PMC4946534.pdf
"2007; 42(10):1776 â€“9, http://dx.doi.org/10.1016/j.jpedsurg.2007.07.028.",OADS,/arxiv_data1/oa_pdf/84/0c/cln-71-07-392.PMC4946534.pdf
"2004;183(1):183 â€“8, http://dx.doi.org/10.2214/ajr.183.",Non-OADS,/arxiv_data1/oa_pdf/84/0c/cln-71-07-392.PMC4946534.pdf
"1998;18(1):165 â€“87, http://dx.doi.org/10.1148/radiographics.18.1.9460115.",Non-OADS,/arxiv_data1/oa_pdf/84/0c/cln-71-07-392.PMC4946534.pdf
"1997;169(3):679 â€“82, http://dx.doi.org/10.2214/ ajr.169.3.9275876.",Non-OADS,/arxiv_data1/oa_pdf/84/0c/cln-71-07-392.PMC4946534.pdf
"2013;43(5):946 â€“51, http://dx.doi.org/10.1093/ejcts/ezs484.",Non-OADS,/arxiv_data1/oa_pdf/84/0c/cln-71-07-392.PMC4946534.pdf
"2008;56(3):154 â€“7, http://dx.doi.org/10.1055/s-2007-965572.",Non-OADS,/arxiv_data1/oa_pdf/84/0c/cln-71-07-392.PMC4946534.pdf
"1998; 179(4):884 â€“9, http://dx.doi.org/10.1016/S0002-9378(98)70183-8.",Non-OADS,/arxiv_data1/oa_pdf/84/0c/cln-71-07-392.PMC4946534.pdf
"2006;5(4):424 â€“6, http://dx.doi.org/10.1510/icvts.2006.128611.",Non-OADS,/arxiv_data1/oa_pdf/84/0c/cln-71-07-392.PMC4946534.pdf
"2010;19(9):561 â€“5, http://dx.doi.org/10.1016/j.hlc.2010.05.008.",OADS,/arxiv_data1/oa_pdf/84/0c/cln-71-07-392.PMC4946534.pdf
"2009;73(5):938 â€“42, http://dx.doi.org/10.1253/circj.CJ-08-0914.",Non-OADS,/arxiv_data1/oa_pdf/84/0c/cln-71-07-392.PMC4946534.pdf
"2010;45(4):811 â€“21, http://dx.doi.org/10.1016/ j.jpedsurg.2009.12.013.",OADS,/arxiv_data1/oa_pdf/84/0c/cln-71-07-392.PMC4946534.pdf
"In the USA, 20.5 million people were estimated to haveQ1 DOI: 10.6061/clinics/2016(07)02Copyright &2016 CLINICS â€“This is an Open Access article distributed under the terms of the Creative Commons License (http://creativecommons.org/licenses/by/ 4.0/) which permits unrestricted use, distribution, and reproduction in any medium or format, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/85/cc/cln-71-07-365.PMC4946535.pdf
"1999;117(3):632-9, http://dx.doi.org/10.1016/S0016-5085(99)70456-7.",Non-OADS,/arxiv_data1/oa_pdf/85/cc/cln-71-07-365.PMC4946535.pdf
"1959;79(3):514-36, http://dx.doi.org/10.1001/archsurg.1959.",Non-OADS,/arxiv_data1/oa_pdf/85/cc/cln-71-07-365.PMC4946535.pdf
"1993;38(4):680-3, http://dx.doi.org/10.1007/ BF01316800.",Non-OADS,/arxiv_data1/oa_pdf/85/cc/cln-71-07-365.PMC4946535.pdf
"1976;5(4):335-41, http://dx.doi.org/10.1093/ije/5.4.335.",Non-OADS,/arxiv_data1/oa_pdf/85/cc/cln-71-07-365.PMC4946535.pdf
"1970;283(25):1358-64,http://dx.doi.org/10.1056/NEJM197012172832502.",Non-OADS,/arxiv_data1/oa_pdf/85/cc/cln-71-07-365.PMC4946535.pdf
"1970;283(2):53-&, http://dx.doi.org/10.1056/ NEJM197007092830201.",OADS,/arxiv_data1/oa_pdf/85/cc/cln-71-07-365.PMC4946535.pdf
"2000; 45(12):2392-8, http://dx.doi.org/10.1023/A:1005647226746.",Non-OADS,/arxiv_data1/oa_pdf/85/cc/cln-71-07-365.PMC4946535.pdf
"1995; 108(4):A1053-A, http://dx.doi.org/10.1016/0016-5085(95)28512-1.",Non-OADS,/arxiv_data1/oa_pdf/85/cc/cln-71-07-365.PMC4946535.pdf
"1952;135(3):394-405, http://dx.doi.org/10.1097/ 00000658-195203000-00011.",Non-OADS,/arxiv_data1/oa_pdf/85/cc/cln-71-07-365.PMC4946535.pdf
"2005;2(9):423-33, http://dx.doi.org/10.1038/ncpgasthep0257.",Non-OADS,/arxiv_data1/oa_pdf/85/cc/cln-71-07-365.PMC4946535.pdf
"2002;17(6):702-7, http://dx.doi.org/10.1046/j.1440-1746.2002.02758.x.",Non-OADS,/arxiv_data1/oa_pdf/85/cc/cln-71-07-365.PMC4946535.pdf
"1985;149(4):551-7, http://dx.doi.org/10.1016/S0002-9610(85)80055-6.",Non-OADS,/arxiv_data1/oa_pdf/85/cc/cln-71-07-365.PMC4946535.pdf
"2004;159(7):702-6, http://dx.doi.org/10.1093/aje/kwh090.",Non-OADS,/arxiv_data1/oa_pdf/85/cc/cln-71-07-365.PMC4946535.pdf
"2015;28(2):113-6,http://dx.doi.org/10.1590/S0102-67202015000200007.",Non-OADS,/arxiv_data1/oa_pdf/85/cc/cln-71-07-365.PMC4946535.pdf
"1988;8(4):904-6, http://dx.doi.org/10.1002/hep.",Non-OADS,/arxiv_data1/oa_pdf/85/cc/cln-71-07-365.PMC4946535.pdf
"2006;20(6):981-96, http://dx.doi.org/10.1016/j.bpg.2006.05.004.",OADS,/arxiv_data1/oa_pdf/85/cc/cln-71-07-365.PMC4946535.pdf
"1999;341(6):427-34, http://dx.doi.org/10.1056/NEJM199908053410607.",Non-OADS,/arxiv_data1/oa_pdf/85/cc/cln-71-07-365.PMC4946535.pdf
"2014;49(8): 1001-6, http://dx.doi.org/10.3109/00365521.2014.920912.",Non-OADS,/arxiv_data1/oa_pdf/85/cc/cln-71-07-365.PMC4946535.pdf
"1998;43(6):1285-91, http://dx.doi.org/10.1023/A:1018816109905.",Non-OADS,/arxiv_data1/oa_pdf/85/cc/cln-71-07-365.PMC4946535.pdf
"2015;10(9), http://dx.doi.org/10.1371/journal.pone.0137660.",Non-OADS,/arxiv_data1/oa_pdf/85/cc/cln-71-07-365.PMC4946535.pdf
"2009;54(12):2736-41, http://dx.doi.org/10.1007/s10620-008-0682-3.",Non-OADS,/arxiv_data1/oa_pdf/85/cc/cln-71-07-365.PMC4946535.pdf
"DOI: 10.6061/clinics/2016(07)06Copyright &2016 CLINICS â€“This is an Open Access article distributed under the terms of the Creative Commons License (http://creativecommons.org/licenses/by/ 4.0/) which permits unrestricted use, distribution, and reproduction in any medium or format, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/44/11/cln-71-07-387.PMC4946536.pdf
"1996;17(5):53-80, http://dx.doi.org/10.2307/30142367.",Non-OADS,/arxiv_data1/oa_pdf/44/11/cln-71-07-387.PMC4946536.pdf
Available at: http://www.cdc.gov/ncidod/ dhqp/pdf/isolation2007.pdf.,OADS,/arxiv_data1/oa_pdf/44/11/cln-71-07-387.PMC4946536.pdf
"2013;26:(3):423-9, http://dx.doi.org/10.2478/s13382-013-0095-1.",Non-OADS,/arxiv_data1/oa_pdf/44/11/cln-71-07-387.PMC4946536.pdf
"2015; 89(3):197-201, http://dx.doi.org/10.1016/j.jhin.2014.11.011.",OADS,/arxiv_data1/oa_pdf/44/11/cln-71-07-387.PMC4946536.pdf
"2010; 44(2):482-7, http://dx.doi.org/10.1590/S0080-62342010000200034.",Non-OADS,/arxiv_data1/oa_pdf/44/11/cln-71-07-387.PMC4946536.pdf
"1995;16(1):43-55, http://dx.doi.org/10.1016/0169- 8141(94)00075-E. 8.",Non-OADS,/arxiv_data1/oa_pdf/44/11/cln-71-07-387.PMC4946536.pdf
"1995;23(4):225-36,http://dx.doi.org/10.1016/0196-6553(95)90067-5.",Non-OADS,/arxiv_data1/oa_pdf/44/11/cln-71-07-387.PMC4946536.pdf
"2013;16(3):786-97, http://dx.doi.org/10.1590/S1415-790X2013000300021.",Non-OADS,/arxiv_data1/oa_pdf/44/11/cln-71-07-387.PMC4946536.pdf
Available from: http://presrepublica.jusbrasil.com.br/legislacao/109606/ lei-6932-81.,Non-OADS,/arxiv_data1/oa_pdf/44/11/cln-71-07-387.PMC4946536.pdf
Available from: http://dx.doi.org/ 10.1590/S0104-42302007000200002.,Non-OADS,/arxiv_data1/oa_pdf/44/11/cln-71-07-387.PMC4946536.pdf
Available from: http://portal.mte.gov.br/data/files/8A7C812D36A280000138812EAFCE19E1/NR -32%20(atualizada%202011).pdf 15.,Non-OADS,/arxiv_data1/oa_pdf/44/11/cln-71-07-387.PMC4946536.pdf
"2015;43(7):769-72, http://dx.doi.org/10.1016/j.ajic.2015.03.021.",OADS,/arxiv_data1/oa_pdf/44/11/cln-71-07-387.PMC4946536.pdf
"2013;47(3):686-93, http://dx.doi.org/10.1590/S0080-623420130000300023.",Non-OADS,/arxiv_data1/oa_pdf/44/11/cln-71-07-387.PMC4946536.pdf
"2014;35(1):70-7, http://dx.doi.org/10.1590/1983-1447.2014.01.40930.",Non-OADS,/arxiv_data1/oa_pdf/44/11/cln-71-07-387.PMC4946536.pdf
"2014;35(5):547-55, http://dx.doi.org/10.1086/675835.",Non-OADS,/arxiv_data1/oa_pdf/44/11/cln-71-07-387.PMC4946536.pdf
"2011; 48(12):1533-9, http://dx.doi.org/10.1016/j.ijnurstu.2011.06.009.",OADS,/arxiv_data1/oa_pdf/44/11/cln-71-07-387.PMC4946536.pdf
"2012;16S:e386, http://dx.doi.org/10.1016/j.ijid.2012.05.507.",OADS,/arxiv_data1/oa_pdf/44/11/cln-71-07-387.PMC4946536.pdf
"Rev Epidemiol Control Infect.2014;4(1):12-7, http://dx.doi.org/10.17058/reci.v4i1.4052.",Non-OADS,/arxiv_data1/oa_pdf/44/11/cln-71-07-387.PMC4946536.pdf
"2010;44(2): 482-7, http://dx.doi.org/10.1590/S0080-62342010000200034.",Non-OADS,/arxiv_data1/oa_pdf/44/11/cln-71-07-387.PMC4946536.pdf
"2012;40(6):e221-3, http://dx.doi.org/10.1016/j.ajic.2011.12.012.",OADS,/arxiv_data1/oa_pdf/44/11/cln-71-07-387.PMC4946536.pdf
"2012;36(1):118-24, http://dx.doi.org/10.1590/S0100-55022012000100016.",Non-OADS,/arxiv_data1/oa_pdf/44/11/cln-71-07-387.PMC4946536.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a7/e4/rjw124.PMC4946538.pdf
Case Rep Orthop 2014; 2014 :619490. http://dx.doi.org/10.1155/ 2014/619490 .,Non-OADS,/arxiv_data1/oa_pdf/a7/e4/rjw124.PMC4946538.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e7/6f/ofv130.01.PMC4946539.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fa/38/ofv130.03.PMC4946540.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e4/7d/ofv130.11.PMC4946541.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/db/62/ofv131.22.PMC4946542.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/bf/3e/ofv130.05.PMC4946543.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e0/15/ofv131.36.PMC4946544.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c1/56/ofv131.37.PMC4946545.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/94/e1/ofv130.06.PMC4946546.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ca/3f/ofv130.08.PMC4946547.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e0/ba/ofv130.09.PMC4946548.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7f/f9/ofv131.68.PMC4946549.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/ by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in anymedium, provided the original work is not altered or transformed in any way, and that the workis properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3c/c8/ofv133.06.PMC4946550.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/ by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in anymedium, provided the original work is not altered or transformed in any way, and that the workis properly cited.",Non-OADS,/arxiv_data1/oa_pdf/93/89/ofv133.14.PMC4946551.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/ by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in anymedium, provided the original work is not altered or transformed in any way, and that the workis properly cited.",Non-OADS,/arxiv_data1/oa_pdf/be/37/ofv133.26.PMC4946552.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/75/b1/ofv130.04.PMC4946553.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/ by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in anymedium, provided the original work is not altered or transformed in any way, and that the workis properly cited.",Non-OADS,/arxiv_data1/oa_pdf/90/e9/ofv133.28.PMC4946554.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/ by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in anymedium, provided the original work is not altered or transformed in any way, and that the workis properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d4/d2/ofv133.60.PMC4946555.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/47/ee/ofv130.10.PMC4946556.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5a/bf/ofv131.23.PMC4946557.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/65/9a/ofv131.27.PMC4946558.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/ by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in anymedium, provided the original work is not altered or transformed in any way, and that the workis properly cited.",Non-OADS,/arxiv_data1/oa_pdf/09/bb/ofv133.34.PMC4946559.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/ by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in anymedium, provided the original work is not altered or transformed in any way, and that the workis properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4d/88/ofv133.42.PMC4946560.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/27/be/ofv131.61.PMC4946561.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/df/c3/ofv131.66.PMC4946562.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/ by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in anymedium, provided the original work is not altered or transformed in any way, and that the workis properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c4/21/ofv133.51.PMC4946563.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c7/0c/rjw125.PMC4946623.pdf
"Allen Spinal Cord Atlas, http://mousespinal.brain- map.org/ 71.",Non-OADS,/arxiv_data1/oa_pdf/2f/c1/10.1177_1744806916629065.PMC4946630.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a4/ca/main.PMC4946644.pdf
This is of particular concern because one of the strongest predictors of vaccine uptake is healthcare provider (HCP) recommendation and a lack of HCP recommendation has been listed as a reason for non-Contents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/pvrPapillomavirus Research http://dx.doi.org/10.1016/j.pvr.2016.05.005 2405-8521/ &2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/a4/ca/main.PMC4946644.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a4/ca/main.PMC4946644.pdf
"The contents are solely the responsibility of the au- thors and does not necessarily represent the of ï¬cial views of the Department of Veterans Affairs or the National Institutes of Health,including the National Cancer Institute and the National Instituteof Nursing Research.References [1] Centers for Disease Control and Prevention, Genital HPV infection â€”CDC Fact Sheet, Atlanta, GA. Retrieved from: âŒ©http://www.cdc.gov/std/HPV/STDFact- HPV.htm âŒª,2 0 1 4 .",Non-OADS,/arxiv_data1/oa_pdf/a4/ca/main.PMC4946644.pdf
"Retrieved from: âŒ©http://www.cancer.gov/about-cancer/causes-prevention/risk/infectious- agents/hpv-fact-sheet âŒª,2 0 1 5 .",Non-OADS,/arxiv_data1/oa_pdf/a4/ca/main.PMC4946644.pdf
"Retrieved from: âŒ©http://www.fda.gov/NewsEvents/Newsroom/PressAnnounce ments/ucm426485.htm âŒª,2 0 1 4 .",Non-OADS,/arxiv_data1/oa_pdf/a4/ca/main.PMC4946644.pdf
"Retrieved from: âŒ©http://www.the- nation.com/article/virginity-or-death/ âŒª, 2005.",Non-OADS,/arxiv_data1/oa_pdf/a4/ca/main.PMC4946644.pdf
"Available: âŒ©http://ecdc.europa.eu/en/publications/Publications/20120905_ GUI_HPV_vaccine_update.pdf âŒª,2 0 1 2 .M.L.",Non-OADS,/arxiv_data1/oa_pdf/a4/ca/main.PMC4946644.pdf
"(26,27)Pragmin -speciï¬c siRNAs (target sequences 50-GTCACAGGCCAAGATAGAA-30(6)and 50-CTGTTTTCTT CTGTAATTATA-30designed using siDirect version 2.0; http://sidirect2.rnai.jp) were used to knock down humanPragmin expression.",OADS,/arxiv_data1/oa_pdf/db/a7/CAS-107-0972.PMC4946704.pdf
[Cited 12-20-2013] Available from URL: http://www.fda.gov/downloads/ Drugs/DrugSafety/UCM380607.pdf 41 Goldman JM.,Non-OADS,/arxiv_data1/oa_pdf/3c/c6/CAS-107-1029.PMC4946706.pdf
"(7,8) Using iPCR, we detected eight retroviral common integra- tion sites, Evi5,Ccnd3 ,Cbfa2t3 h ,Gï¬1,Ikzf1,Pecam1 ,Mycn , andPim1 (Table S1), which have already been identiï¬ed by retrovirus-tagged mouse mutagenesis studies using various types of genetically engineered mice (Retrovirus and Trans- poson tagged Cancer Gene Database, http://variation.osu.edu/rtcgd/).",OADS,/arxiv_data1/oa_pdf/fe/a6/CAS-107-0890.PMC4946715.pdf
"For immuno- histochemical analyses, the avidin â€“biotin complex method with peroxidase was used, and quantitative analyses were under-taken both for areas and integrated density as described (22) except for ImageJ was used (https://imagej.nih.gov/ij/) as asoftware (previously NIH image was used).",OADS,/arxiv_data1/oa_pdf/48/e6/CAS-107-0908.PMC4946728.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e7/29/ehw132.PMC4946749.pdf
https://www.medicines.org.uk/ emc/medicine/29837 .20.,Non-OADS,/arxiv_data1/oa_pdf/e7/29/ehw132.PMC4946749.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/99/e0/ehw164.PMC4946750.pdf
Available at: http://www.bevital.no/.,Non-OADS,/arxiv_data1/oa_pdf/f5/c9/NEURIMMINFL2016009167.PMC4946773.pdf
Available at: https://www.fhi.no/globalassets/dokumenterfiler/ rapporter/rin2014norsk.pdf.,Non-OADS,/arxiv_data1/oa_pdf/f5/c9/NEURIMMINFL2016009167.PMC4946773.pdf
"This article is available under a Creative Commons License 4.0 (Attribution-Non-Commercial), as described at http://creativecommons.org/licenses/by-nc/4.0eISSN: 1529-7268 http://www.biolreprod.orgISSN: 0006-3363 1 Article 123",Non-OADS,/arxiv_data1/oa_pdf/47/51/i0006-3363-94-6-123.PMC4946803.pdf
"This article is available under a Creative Commons License 4.0 (Attribution-Non-Commercial), as described at http://creativecommons.org/licenses/by-nc/4.0eISSN: 1529-7268 http://www.biolreprod.orgISSN: 0006-3363 1 Article 125",Non-OADS,/arxiv_data1/oa_pdf/1b/91/i0006-3363-94-6-125.PMC4946804.pdf
"This article is available under a Creative Commons License 4.0 (Attribution-Non-Commercial), as described at http://creativecommons.org/licenses/by-nc/4.0eISSN: 1529-7268 http://www.biolreprod.orgISSN: 0006-3363 1 Article 134",Non-OADS,/arxiv_data1/oa_pdf/7a/d9/i0006-3363-94-6-134.PMC4946805.pdf
"This article is available under a Creative Commons License 4.0 (Attribution-Non-Commercial), as described at http://creativecommons.org/licenses/by-nc/4.0eISSN: 1529-7268 http://www.biolreprod.orgISSN: 0006-3363 1 Article 136",Non-OADS,/arxiv_data1/oa_pdf/72/5b/i0006-3363-94-6-136.PMC4946806.pdf
"This article is available under a Creative Commons License 4.0 (Attribution-Non-Commercial), as described at http://creativecommons.org/licenses/by-nc/4.0eISSN: 1529-7268 http://www.biolreprod.orgISSN: 0006-3363 1 Article 139",Non-OADS,/arxiv_data1/oa_pdf/51/3a/i0006-3363-94-6-139.PMC4946807.pdf
"This article is available under a Creative Commons License 4.0 (Attribution-Non-Commercial), as described at http://creativecommons.org/licenses/by-nc/4.0eISSN: 1529-7268 http://www.biolreprod.orgISSN: 0006-3363 1 Article 140",Non-OADS,/arxiv_data1/oa_pdf/c1/b2/i0006-3363-94-6-140.PMC4946808.pdf
Nuffield Department of Primary Care Health Sciences; 2009 Available from:  http://www.cebm.net/index.aspx?o=1025  19.,Non-OADS,/arxiv_data1/oa_pdf/43/54/1679-4508-eins-13-1-117.PMC4946819.pdf
Available from: http://www.thomsonhc.,Non-OADS,/arxiv_data1/oa_pdf/4f/89/1679-4508-eins-13-1-122.PMC4946820.pdf
"The full terms of this license are available at https://www.dovepress.com/ terms.php and incorporate the Creative Commons Attribution â€“ Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/b2/89/mder-9-199.PMC4946827.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Pulse oximetry screening: a review of diagnosing  critical congenital heart disease in newborns Melissa S Engel1 Lazaros K Kochilas2 1Division of Neonatology, University  of Minnesota, Minneapolis, MN,   2Childrenâ€™s Healthcare of Atlanta,   Emory University, Atlanta, GA, USA Correspondence: Melissa Engel   Division of Neonatology, University of  Minnesota, Sixth Floor East Building, 2450  Riverside Avenue, Minneapolis, MN 55454,  USA  T el +1 612 636 9704   Fax +1 612 624 8176   Email wayn0020@umn.ed uAbstract:  Congenital heart disease (CHD) is one of the most common birth defects, with an  incidence of nine out of every 1,000 live births.",Non-OADS,/arxiv_data1/oa_pdf/b2/89/mder-9-199.PMC4946827.pdf
Submit your manuscript here:  http://www.dovepress.com/medical-devices-evidence-and-research-journa l Medical Devices: Evidence and Research 2016:9submit your manuscript | www.dovepress.co m Dove press Dove press Dove pres s 203Pulse oximetry screening for CCHD,Non-OADS,/arxiv_data1/oa_pdf/b2/89/mder-9-199.PMC4946827.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by/4.0/.,Non-OADS,/arxiv_data1/oa_pdf/31/81/mder-9-185.PMC4946828.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/31/81/mder-9-185.PMC4946828.pdf
"php and incorporate the Creative Commons Attribution â€“ Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/31/81/mder-9-185.PMC4946828.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Medical Devices: Evidence and Research 2016:9 185â€“198Medical Devices: Evidence and Research Dovepress submit your manuscript | www.dovepress.com Dovepress 185 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/MDER.S90461 Bioresorbable vascular scaffolds technology:  current use and future developments Giuseppe Giacchi Luis Ortega-Paz Salvatore Brugaletta Kohki IshidaManel SabatÃ© Cardiology Department, Clinic  Cardiovascular Institute, Hospital Clinic, August Pi and Sunyer Biomedical Research Institute (IDIBAPS), University of Barcelona,  Barcelona, SpainAbstract: Coronary bioresorbable vascular scaffolds are a new appealing therapeutic option in  interventional cardiology.",Non-OADS,/arxiv_data1/oa_pdf/31/81/mder-9-185.PMC4946828.pdf
"Poly- l-lactide and poly- d,l-lactide are hydrolyzed Correspondence: Salvatore Brugaletta Cardiology Department, Clinic Cardiovascular Institute, Hospital Clinic, August Pi and Sunyer Biomedical Research Institute (IDIBAPS), University of Barcelona, Carrer/Villarroel 170, 08036 Barcelona, SpainTel +34 93 227 9305Fax 34 93 227 9305Email sabrugal@clinic.ub.esJournal name: Medical Devices: Evidence and Research Article Designation: REVIEWY ear: 2016V olume: 9Running head verso: Giacchi et alRunning head recto: Coronary scaffolds: current use and future developmentsDOI: http://dx.doi.org/10.2147/MDER.S90461",Non-OADS,/arxiv_data1/oa_pdf/31/81/mder-9-185.PMC4946828.pdf
Data available from: http://www.abbottvas cular.com/int/products/coronary-intervention/absorb-bioresorbable-scaffold.html?reie0e2vs4i.,OADS,/arxiv_data1/oa_pdf/31/81/mder-9-185.PMC4946828.pdf
Data available from: https://clinicaltrials.gov/ ct2/show/record/NCT01759290.,OADS,/arxiv_data1/oa_pdf/31/81/mder-9-185.PMC4946828.pdf
Data available from: https://clinicaltrials.gov/ct2/ show/record/NCT01023789?term=NCT01023789&rank=1.,OADS,/arxiv_data1/oa_pdf/31/81/mder-9-185.PMC4946828.pdf
Data available from: http://www.tctmd.com/show.,OADS,/arxiv_data1/oa_pdf/31/81/mder-9-185.PMC4946828.pdf
"Medical Devices: Evidence and Research 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Medical Devices: Evidence and Research Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/medical-devices-evidence-and-research-journalMedical Devices: Evidence and Research is an international, peer- reviewed, open access journal that focuses on the evidence, technology, research, and expert opinion supporting the use and application of   medical devices in the diagnosis, monitoring, treatment and management of clinical conditions and physiological processes.",Non-OADS,/arxiv_data1/oa_pdf/31/81/mder-9-185.PMC4946828.pdf
Data available from: http://www.abbottvascular.com/ int/products/coronary-intervention/absorb-bioresorbable-scaffold.html?ebm0vu6jemi.,Non-OADS,/arxiv_data1/oa_pdf/31/81/mder-9-185.PMC4946828.pdf
Data available from: https://clinicaltrials.gov/ct2/ show/NCT02632292?term= absorb+ gt1&rank= 1.,OADS,/arxiv_data1/oa_pdf/31/81/mder-9-185.PMC4946828.pdf
Available  from: http://www.tctmd.com/list.aspx?fid=1046680.,Non-OADS,/arxiv_data1/oa_pdf/31/81/mder-9-185.PMC4946828.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution â€“ Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/1c/eb/ndt-12-1705.PMC4946829.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 1705â€“1710Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1705ORIGINAL RESEARCHopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NDT .S10707 4 Cortical spreading depression produces a  neuroprotective effect activating mitochondrial  uncoupling protein-5 Emanuela Viggiano1,2 Vincenzo Monda1 Antonietta Messina1 Fiorenzo Moscatelli3 Anna Valenzano3 Domenico Tafuri4 Giuseppe Cibelli3 Bruno De Luca1 Giovanni Messina1,3 Marcellino Monda1 1Department of Experimental  Medicine, Section of Human  Physiology and Unit of Dietetics and  Sports Medicine, Second University  of Naples, Naples, 2Department  of Medicine, University of Padua,   Padua, 3Department of Clinical and  Experimental Medicine, University of  Foggia, Foggia, 4Department of Motor  Sciences and Wellness, University of  Naples â€œParthenopeâ€, Naples, ItalyAbstract:  Depression of electrocorticogram propagating over the cortex surface results in  cortical spreading depression (CSD), which is probably related to the pathophysiology of  stroke, epilepsy, and migraine.",Non-OADS,/arxiv_data1/oa_pdf/1c/eb/ndt-12-1705.PMC4946829.pdf
"In fact, CSD increased the  expressions of HIF-1, iNOS,20 nNOS,21,22 mitogen-activated protein kinase (MAPK),23  heat shock proteins (hsp27, hsp70),24â€“28 and heme oxygenase-1 (HO-1).29 These genes are also activated during hypoxia/ischemia and play a pivotal role  in neuroprotection during ischemia, suggesting their involvement in CSD-induced  neuroprotection.30â€“34 Recently it was demonstrated that the expression of the UCP-2 Correspondence: Giovanni Messina Department of Clinical and Experimental  Medicine, University of Foggia, Via L  Pinto, 71122 Foggia, Italy Tel +39 81 566 5804 Fax +39 81 566 5844 Email gianni.messina@unina2.i t Journal name: Neuropsychiatric Disease and Treatment Article Designation: ORIGINAL RESEARCH Y ear: 2016 Volume: 12 Running head verso: Viggiano et al Running head recto: CSD increases UCP-5 DOI: http://dx.doi.org/10.2147/NDT.S107074",Non-OADS,/arxiv_data1/oa_pdf/1c/eb/ndt-12-1705.PMC4946829.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/1c/eb/ndt-12-1705.PMC4946829.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/1c/eb/ndt-12-1705.PMC4946829.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution â€“ Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/37/e4/ndt-12-1687.PMC4946830.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 1687â€“1703Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1687Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NDT .S10647 9 A new look at an old drug: neuroprotective  effects and therapeutic potentials of lithium salts Liliana Dellâ€™Osso Claudia Del Grande Camilla Gesi Claudia Carmassi Laura Musetti Department of Clinical and  experimental Medicine, University  of Pisa, Pisa, italyAbstract:  Increasing evidence highlights bipolar disorder as being associated with impaired  neurogenesis, cellular plasticity, and resiliency, as well as with cell atrophy or loss in specific  brain regions.",Non-OADS,/arxiv_data1/oa_pdf/37/e4/ndt-12-1687.PMC4946830.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/37/e4/ndt-12-1687.PMC4946830.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/37/e4/ndt-12-1687.PMC4946830.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution â€“ Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/26/b8/ppa-10-1197.PMC4946831.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2016:10 1197â€“1203Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  1197OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S11016 7 The impact of pharmacist-managed clinic on  medication adherence and health-related quality  of life in patients with cOPD: a randomized  controlled study chuanwei Xin Zhongni Xia cheng Jiang Mengmeng lin gonghua li Department of Pharmacy, Zhejiang  Academy of Traditional chinese  Medicine, T ongde hospital of Zhejiang  Province, hangzhou, Peopleâ€™s republic  of chinaIntroduction:  COPD is rapidly becoming one of the most challenging health problems  worldwide, which is characterized by not fully reversible airflow limitation.",Non-OADS,/arxiv_data1/oa_pdf/26/b8/ppa-10-1197.PMC4946831.pdf
"It is estimated to become the fifth leading cause of disease burden in 2020. correspondence: gonghua li Department of Pharmacy, Zhejiang  Academy of Traditional chinese  Medicine, Tongde hospital of Zhejiang  Province, gucui road 234 of hangzhou,  Peopleâ€™s republic of china Tel +86 571 8997 2240 email xyaoshi9@163.co m Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Xin et al Running head recto: Impact of pharmacist-managed clinic on medication adherence DOI: http://dx.doi.org/10.2147/PPA.S110167",Non-OADS,/arxiv_data1/oa_pdf/26/b8/ppa-10-1197.PMC4946831.pdf
Available from: http://www.goldcopd.org /.,Non-OADS,/arxiv_data1/oa_pdf/26/b8/ppa-10-1197.PMC4946831.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/26/b8/ppa-10-1197.PMC4946831.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution â€“ Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/fa/46/opth-10-1265.PMC4946832.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 1265â€“1273Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1265Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S10106 0 history of falling and visual ability among  independently living elderly in sweden Jeanette KÃ¤llstrand- eriksson1 Cathrine hildingh1 Boel Bengtsson2 1school of health and Welfare,   halmstad University, halmstad,   2Department of Clinical sciences  in MalmÃ¶, Ophthalmology, lund  University, MalmÃ¶, swedenPurpose:  The aim of this study was to assess the performance-based visual ability among  independently living elderly subjects and to investigate whether there was any association  between visual ability and falls.",Non-OADS,/arxiv_data1/oa_pdf/fa/46/opth-10-1265.PMC4946832.pdf
"Keywords:  elderly, falls, independently living, visual ability Introduction Falls and fall injuries among older people are considered a major problem with negative  consequences for both the individual and society.1,2 The number of falls is estimated to  increase in many countries throughout the world since the aging population is increasing  with at least one-third of elderly persons living in the community suffering a fall each  year.3,4 The Swedish National Institute of Public Health estimates that deterioration in  quality of life caused by accidental falls costs the society almost twice as much as do direct  costs such as health care and rehabilitation.3 A major systematic review has identified  as many as 400 potential risk factors for falling, and visual impairment was considered  one of the most predictive for falling among independently living elderly people.1 Research has indicated that visual ability is of considerable importance for both  quality of life and social functioning, and its loss or limitation can be a threat to Correspondence: Jeanette KÃ¤llstrand- eriksson school of health and Welfare, halmstad  University, Box 823, s-301 18 halmstad,  sweden Tel +46 35 16 79 49 email jeanette.kallstrand_eriksson@hh.s e Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: KÃ¤llstrand-Eriksson et al Running head recto: History of falling and visual ability among elderly in Sweden  DOI: http://dx.doi.org/10.2147/OPTH.S101060",Non-OADS,/arxiv_data1/oa_pdf/fa/46/opth-10-1265.PMC4946832.pdf
"Available from: http://www.icoph.org/ downloads/visualstandardsreport.pd f. Accessed March 2, 2016.",Non-OADS,/arxiv_data1/oa_pdf/fa/46/opth-10-1265.PMC4946832.pdf
Available from: http://www.who.int/ classifications /icd/en /.,OADS,/arxiv_data1/oa_pdf/fa/46/opth-10-1265.PMC4946832.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/fa/46/opth-10-1265.PMC4946832.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/fa/46/opth-10-1265.PMC4946832.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution â€“ Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/06/a3/ndt-12-1711.PMC4946833.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 1711â€“1714Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1711ORIGINAL RESEARCHopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NDT .S10717 8 Risk factors for suicide among patients with  schizophrenia: a cohort study focused on  cerebrospinal fluid levels of homovanillic acid  and 5-hydroxyindoleacetic acid Daniel Neider Leif H LindstrÃ¶m Robert BodÃ©n Department of Neuroscience,   Psychiatry, Uppsala University, Uppsala  University Hospital, Uppsala, SwedenBackground:  The objective of this study was to investigate the association between  5-hydroxyindoleacetic acid (5-HIAA) and homovanillic acid (HVA) in cerebrospinal fluid  (CSF), bullying, and later suicide among patients with schizophrenia.",Non-OADS,/arxiv_data1/oa_pdf/06/a3/ndt-12-1711.PMC4946833.pdf
"Results from studies on HVA and 5-HIAA in patients with schizophrenia spectrum  disorders are contradictory and many are hampered by short follow-up periods.9,10 Patients  with a diagnosis of schizophrenia have been shown to have low HVA and normal 5-HIAA  levels compared to healthy volunteers,11 and patients with a poor function (frequency of  social contacts, employment duration, symptomatology and duration of rehospitalization)  on a 5-year-up follow-up were found to have a low quotient of HVA/5-HIAA.12Correspondence: Daniel Neider Department of Neuroscience, Psychiatry,  Uppsala University, Uppsala University  Hospital, Entrance 10, 75185 Uppsala,  Sweden Fax +46 18 2600 65 Email d aniel.neider@akademiska.s e Journal name: Neuropsychiatric Disease and Treatment Article Designation: ORIGINAL RESEARCH Y ear: 2016 Volume: 12 Running head verso: Neider et al Running head recto: Risk factors for suicide among patients with schizophrenia DOI: http://dx.doi.org/10.2147/NDT.S107178",Non-OADS,/arxiv_data1/oa_pdf/06/a3/ndt-12-1711.PMC4946833.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/06/a3/ndt-12-1711.PMC4946833.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/06/a3/ndt-12-1711.PMC4946833.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution â€“ Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/be/bb/ndt-12-1715.PMC4946846.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 1715â€“1723Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1715OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S10675 2A meta-analysis on the efficacy and safety of  st Johnâ€™s wort extract in depression therapy in  comparison with selective serotonin reuptake  inhibitors in adults Y ong-hua cui1 Yi Zheng1,2 1Department of Pediatrics, Beijing  anâ€™ding hospital, capital Medical  University, Beijing, Peopleâ€™s republic  of china; 2Beijing institutes of Brain  Disorders, Beijing, Peopleâ€™s republic  of chinaObjective:  The aim of the study was to investigate the efficacy and safety of St Johnâ€™s wort  extract and selective serotonin reuptake inhibitors (SSRIs) in the treatment of depression.",Non-OADS,/arxiv_data1/oa_pdf/be/bb/ndt-12-1715.PMC4946846.pdf
"However, these antidepressants may cause multiple side effects,  such as nausea, insomnia, and sexual dysfunction.4 Thirty-eight percent of patients  with long-term use of SSRIs have experienced at least one side effect, with sexual  dysfunction, sleepiness, and weight gain being the most common.5 Well-defined extracts from St Johnâ€™s wort ( Hypericum perforatum ), namely, St Johnâ€™s  wort extract (Neurostan), have been used to treat depression for more than a 100 years correspondence: Yi Zheng Department of Pediatrics, Beijing  anâ€™ding hospital, capital Medical  University, No 5, ankang hutong,  Xicheng District, Beijing 100088,  Peopleâ€™s republic of china Tel +86 10 5830 3181 Fax +86 10 5830 3078 email zhengyi160122@163.co m Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Cui and Zheng Running head recto: St Johnâ€™s wort extract for depression DOI: http://dx.doi.org/10.2147/NDT.S106752",Non-OADS,/arxiv_data1/oa_pdf/be/bb/ndt-12-1715.PMC4946846.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/be/bb/ndt-12-1715.PMC4946846.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/be/bb/ndt-12-1715.PMC4946846.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution â€“ Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/e0/1b/tcrm-12-1093.PMC4946848.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2016:12 1093â€“1094Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  1093LeTTeRopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TCRM.S11244 2 Correlation between obesity and chronic kidney  disease: is obstructive sleep apnea an interfering  factor?",Non-OADS,/arxiv_data1/oa_pdf/e0/1b/tcrm-12-1093.PMC4946848.pdf
"In conclusion, we believe that implement - ing OSA screening in clinical practice when dealing with obesity and CKD is very  important and may help future research in acquiring evidence for complementary  therapeutic treatments based on sleep, since OSA can act as a possible aggravating  factor in CKD.Correspondence: Camila Hirotsu Department of Psychobiology, Universidade  Federal de SÃ£o Paulo, Rua NapoleÃ£o de  Barros, 925 Zipcode 04024-002 - 1st florr,  SÃ£o Paulo, Brazil Tel +55 11 5908 7193 Fax +55 11 5572 5092 email milahirotsu@gmail.co m Journal name: Therapeutics and Clinical Risk Management Article Designation: Letter Y ear: 2016 Volume: 12 Running head verso: Santos-Camilo et al Running head recto: Correlation between obesity and chronic kidney disease DOI: http://dx.doi.org/10.2147/TCRM.S112442",Non-OADS,/arxiv_data1/oa_pdf/e0/1b/tcrm-12-1093.PMC4946848.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/e0/1b/tcrm-12-1093.PMC4946848.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/e0/1b/tcrm-12-1093.PMC4946848.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by/4.0/.,Non-OADS,/arxiv_data1/oa_pdf/49/1a/dmso-9-207.PMC4946854.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/49/1a/dmso-9-207.PMC4946854.pdf
"php and incorporate the Creative Commons Attribution â€“ Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/49/1a/dmso-9-207.PMC4946854.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016:9 207â€“211Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Dovepress submit your manuscript | www.dovepress.com Dovepress 207 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DMSO.S106221The relationship between the presence of lower  urinary tract symptoms and waist circumference Maria Clara EugÃªnia de  Oliveira   Larissa Ramalho Dantas Varella   Priscylla Helouyse melo Angelo   Maria Thereza Albuquerque Barbosa Cabral Micussi Physical Therapy Department, Federal  University of Rio Grande do Norte,  Natal, Rio Grande do Norte, BrazilPurpose: The aim of the study is to evaluate the pressure of the pelvic floor muscles (PFM)  according to waist circumference (WC) and correlate the presence of urinary tract symptoms  (UTS) with WC.",Non-OADS,/arxiv_data1/oa_pdf/49/1a/dmso-9-207.PMC4946854.pdf
"These muscles have the role of supporting the pelvic organs, assisting in the sexual function, and maintaining urinary Correspondence: Maria Thereza  Albuquerque Barbosa Cabral Micussi   Physical Therapy Department, Federal University of Rio Grande do Norte, Avenida Senador Salgado Filho, 3000, Lagoa Nova, Natal, RN 59078-970, Brazil   Tel +55 84 3342 2016   Email therezamicussi@yahoo.com.brJournal name: Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 9Running head verso: Oliveira et alRunning head recto: Presence of lower urinary tract symptoms and WCDOI: http://dx.doi.org/10.2147/DMSO.S106221",Non-OADS,/arxiv_data1/oa_pdf/49/1a/dmso-9-207.PMC4946854.pdf
"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/diabetes-metabolic-syndrome-and-obesity-targets-and-therapy-journal Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy is  an international, peer-reviewed open-access journal committed to   the rapid publication of the latest laboratory and clinical findings   in the fields of diabetes, metabolic syndrome and obesity research.",Non-OADS,/arxiv_data1/oa_pdf/49/1a/dmso-9-207.PMC4946854.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 211 Presence of lower urinary tract symptoms and WC 26.,Non-OADS,/arxiv_data1/oa_pdf/49/1a/dmso-9-207.PMC4946854.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by/4.0/.,Non-OADS,/arxiv_data1/oa_pdf/8f/66/amep-7-377.PMC4946855.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/8f/66/amep-7-377.PMC4946855.pdf
"php and incorporate the Creative Commons Attribution â€“ Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/8f/66/amep-7-377.PMC4946855.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Advances in Medical Education and Practice 2016:7 377â€“380Advances in Medical Education and Practice Dovepress submit your manuscript | www.dovepress.com Dovepress 377 LETTER open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AMEP .S110449 Good teacher, good tutor LucÃ©lio B Couto Gustavo S RomÃ£o Reinaldo B Bestetti Department of Medicine, University  of RibeirÃ£o Preto, RibeirÃ£o Preto,  BrazilDear editor We have read with great interest the paper by Kassab et al1, who have essentially shown  that good teachers will be good tutors in a problem-based learning (PBL) environment.",Non-OADS,/arxiv_data1/oa_pdf/8f/66/amep-7-377.PMC4946855.pdf
"Costabile Romano, 2201, RibeirÃ£o Preto 14096-900, BrazilEmail: rbestetti44@gmail.comJournal name: Advances in Medical Education and Practice Article Designation: LETTERY ear: 2016V olume: 7Running head verso: Couto et alRunning head recto: Good teacher, good tutorDOI: http://dx.doi.org/10.2147/AMEP .S110449",Non-OADS,/arxiv_data1/oa_pdf/8f/66/amep-7-377.PMC4946855.pdf
Available from: http://books.nap.edu/html/howpeople1.,Non-OADS,/arxiv_data1/oa_pdf/8f/66/amep-7-377.PMC4946855.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here: http://www.dovepress.com/advances-in-medical-education-and-practice-journalAdvances in Medical Education and Practice is an international, peer-  reviewed, open access journal that aims to present and publish research on Medical Education covering medical, dental, nursing and allied   health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/8f/66/amep-7-377.PMC4946855.pdf
"Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Advances in Medical Education and Practice 2016:7submit your manuscript | www.dovepress.com Dovepress Dovepress Dovepress 380 Couto et al Dove Medical Press encourages responsible, free and frank academic debate.",Non-OADS,/arxiv_data1/oa_pdf/8f/66/amep-7-377.PMC4946855.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by/4.0/.,Non-OADS,/arxiv_data1/oa_pdf/95/fd/tacg-9-093.PMC4946856.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/95/fd/tacg-9-093.PMC4946856.pdf
"php and incorporate the Creative Commons Attribution â€“ Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/95/fd/tacg-9-093.PMC4946856.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).The Application of Clinical Genetics 2016:9 93â€“100The Application of Clinical Genetics Dovepress submit your manuscript | www.dovepress.com Dovepress 93 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TACG.S103975Utilization of genetic testing among children with  developmental disabilities in the United States Bridget Kiely Sujit Vettam Andrew Adesman Division of Developmental and  Behavioral Pediatrics, Department of Pediatrics, Steven and Alexandra Cohen Childrenâ€™s Medical Center of New Y ork, New Hyde Park, NY, USAPurpose: Several professional societies recommend that genetic testing be routinely included  in the etiologic workup of children with developmental disabilities.",Non-OADS,/arxiv_data1/oa_pdf/95/fd/tacg-9-093.PMC4946856.pdf
"3   Children younger than 5â€“6 years of age, in whom intelligence quotient and adaptive Correspondence: Andrew Adesman Division of Developmental andBehavioral Pediatrics, Departmentof Pediatrics, Steven and AlexandraCohen Childrenâ€™s Medical Center ofNew York, 1983 Marcus Avenue, Suite 130, Lake Success, New York, NY 11042, USA Tel +1 516 802 6100Email AAdesman@Northwell.eduJournal name: The Application of Clinical Genetics Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 9Running head verso: Kiely et alRunning head recto: Genetic testing among children with developmental disabilitiesDOI: http://dx.doi.org/10.2147/TACG.S103975",Non-OADS,/arxiv_data1/oa_pdf/95/fd/tacg-9-093.PMC4946856.pdf
"The Application of Clinical Genetics 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress The Application of Clinical Genetics Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/the-application-of-clinical-genetics-journalThe Application of Clinical Genetics is an international, peer-reviewed  open access journal that welcomes laboratory and clinical findings in the field of human genetics.",Non-OADS,/arxiv_data1/oa_pdf/95/fd/tacg-9-093.PMC4946856.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes   from published authors.Dovepress 100 Kiely et al 27.,Non-OADS,/arxiv_data1/oa_pdf/95/fd/tacg-9-093.PMC4946856.pdf
Available from: http://www.cdc.gov/nchs/data/slaits/PathwaysFAQ.pdf.,OADS,/arxiv_data1/oa_pdf/95/fd/tacg-9-093.PMC4946856.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution â€“ Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/48/70/dddt-10-2255.PMC4946857.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 2255â€“2262Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2255Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S9144 1 An appraisal of golimumab in the treatment  of severe, active nonradiographic axial  spondyloarthritis Julien Paccou RenÃ©-Marc Flipo Department of Rheumatology, Lille  University Hospital, Lille, FranceAbstract:  Golimumab (SimponiÂ®) is a fully human tumor necrosis factor Î± inhibitor (TNFi)  antibody administered subcutaneously.",Non-OADS,/arxiv_data1/oa_pdf/48/70/dddt-10-2255.PMC4946857.pdf
"Keywords:  axial spondyloarthritis, nonradiographic axial spondyloarthritis, ankylosing  spondylitis, golimumab, tumor necrosis factor Î± inhibitor, therapy Introduction The Assessment in Spondyloarthritis International Society (ASAS) has recently  developed new criteria for the classification of spondyloarthritis (SpA) with the aim  of achieving earlier diagnosis and in the process has introduced the concept of pre - dominantly axial versus peripheral disease.1,2 Patients presenting with persisting back  pain for .3 months and an age of onset ,45 years are classified as having axial SpA  (axSpA) in the presence of either sacroiliitis (on radiographs or magnetic resonance  imaging [MRI] scans) and at least one additional typical SpA feature (imaging arm) or  HLA-B27 positivity and two additional SpA characteristics (clinical arm).1 Depending  on radiographic evidence indicating the presence or absence of permanent structural  sacroiliac joint changes, patients are further classified as having either ankylosing  spondylitis (AS) or nonradiographic axSpA (nr-axSpA).3 More recently, the American College of Rheumatology, the Spondylitis Association  of America, and the Spondyloarthritis Research and Treatment Network teamed up Correspondence: Julien Paccou Department of Rheumatology, Lille  University Hospital, Lille 2, 59037 Lille,  France Tel +33 3 2044 6926 Fax +33 3 2044 5462 email julien.paccou@chru-lille.f r Journal name: Drug Design, Development and Therapy Article Designation: Review Y ear: 2016 Volume: 10 Running head verso: Paccou and Flipo Running head recto: Golimumab for the treatment of nr-axSpA DOI: http://dx.doi.org/10.2147/DDDT.S91441",Non-OADS,/arxiv_data1/oa_pdf/48/70/dddt-10-2255.PMC4946857.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/48/70/dddt-10-2255.PMC4946857.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/48/70/dddt-10-2255.PMC4946857.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution â€“ Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/29/83/copd-11-1553.PMC4946858.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 1553â€“1567International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1553RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/COPD.S5432 8 Brazilian studies on pulmonary function in COPD  patients: what are the gaps?",Non-OADS,/arxiv_data1/oa_pdf/29/83/copd-11-1553.PMC4946858.pdf
"Data from studies published in various regions of the world show that  COPD is underdiagnosed.1 In Brazil, Queiroz et al6 reported 71.4% COPD underdiagnosis in individuals with  risk factors who were treated in public primary care facilities, while Santos et al7  found that among patients with COPD, 80% had not received a prior diagnosis of the Correspondence: Pedro Lopes de Melo Biomedical Instrumentation Laboratory,  Institute of Biology and Faculty of  engineering, State University of Rio de  Janeiro, PavilhÃ£o Haroldo Lisboa da  Cunha â€“ Sala 104, 524 Rua SÃ£o Francisco  Xavier, MaracanÃ£, Rio de Janeiro,  RJ 20550-013, Brazil Tel +55 21 2334 0705 email plopes@uerj.b r Journal name: International Journal of COPD Article Designation: Review Y ear: 2016 Volume: 11 Running head verso: Lopes and Melo Running head recto: Brazilian studies on pulmonary function in COPD DOI: http://dx.doi.org/10.2147/COPD.S54328",Non-OADS,/arxiv_data1/oa_pdf/29/83/copd-11-1553.PMC4946858.pdf
"Adapted from Faria et al,59 under creative  commons license: http://creativecommons.org/licenses/by/2.0 /.",Non-OADS,/arxiv_data1/oa_pdf/29/83/copd-11-1553.PMC4946858.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/29/83/copd-11-1553.PMC4946858.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/29/83/copd-11-1553.PMC4946858.pdf
Available from: http://eur-lex.europa.eu/legal-content/EN/ ALL/?uri =CELEX%3A52008DC068 9.,Non-OADS,/arxiv_data1/oa_pdf/29/83/copd-11-1553.PMC4946858.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution â€“ Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/c8/43/dddt-10-2239.PMC4946859.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 2239â€“2253Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2239Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S10972 1 Thymoquinone subdues tumor growth and  potentiates the chemopreventive effect of  5-fluorouracil on the early stages of colorectal  carcinogenesis in rats Osama adnan Kensara1,* adel galal el-shemi2,3,* amr Mohamed Mohamed2,4 Bassem refaat2 shakir idris2 Jawwad ahmad2 1Department of clinical nutrition,   Faculty of applied Medical sciences,   Umm al-Qura University, holy  Makkah, saudi arabia; 2Department  of laboratory Medicine, Faculty of  applied Medical sciences, Umm  al-Qura University, holy Makkah,   saudi arabia; 3Department of  Pharmacology, Faculty of Medicine,   assiut University, assiut, egypt;   4Department of animal Medicine,   Faculty of Veterinary Medicine, assiut  University, assiut, egypt *These authors contributed equally  to this workAbstract:  Colorectal cancer (CRC) is one of the most prevalent cancers and has a high mor - tality rate.",Non-OADS,/arxiv_data1/oa_pdf/c8/43/dddt-10-2239.PMC4946859.pdf
"In this  aspect, 5-fluorouracil (5-FU)-based therapy, either alone or in combination with other  cytotoxic agents (eg, irinotecan, leucovorin, or oxaliplatin), remains the standard correspondence: adel galal el-shemi Department of laboratory Medicine,  Faculty of applied Medical sciences,  Umm al-Qura University, PO Box 7607,  holy Makkah, saudi arabia Tel +966 509655135 Fax +966 12 527 0000 ext 4242 email agshemi@uqu.edu.s a  Bassem refaat Department of laboratory Medicine,  Faculty of applied Medical sciences,  Umm al-Qura University, PO Box 7607,  holy Makkah, saudi arabia  email bassem.refaat@yahoo.co.u k Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Kensara et al Running head recto: Thymoquinone enhances 5-FU against the early stages of CRC DOI: http://dx.doi.org/10.2147/DDDT.S109721",Non-OADS,/arxiv_data1/oa_pdf/c8/43/dddt-10-2239.PMC4946859.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/c8/43/dddt-10-2239.PMC4946859.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/c8/43/dddt-10-2239.PMC4946859.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p  and incorporate the Creative Commons Attribution â€“ Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/72/b2/ceg-9-151.PMC4946860.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Ferumoxytol versus placebo in iron deficiency  anemia: efficacy, safety, and quality of life in  patients with gastrointestinal disorders David C Ford1 Naomi V Dahl2 William E Strauss2 Charles F Barish3 David J Hetzel4 Kristine Bernard2 Zhu Li2 Lee F Allen2 1Toronto Digestive Disease  Associates, Inc, Vaughan Endoscopy  Clinic, Vaughan, ON, Canada; 2AMAG  Pharmaceuticals, Inc, Waltham,  MA,   3Wake Gastroenterology, Wake  Research Associates, Raleigh,   NC, USA; 4Department of  Gastroenterology, Royal Adelaide  Hospital, Adelaide, SA, Australia Correspondence: William E Strauss   Medical Affairs, AMAG Pharmaceuticals,  Inc, 1100 Winter Street, Waltham,  MA 02451, USA   T el +1 617 498 7789   Fax +1 617 902 2420   Email wstrauss@amagpharma.co mIntroduction:  Iron deficiency anemia (IDA) is common in patients with gastrointestinal (GI)  disorders and can adversely affect quality of life.",Non-OADS,/arxiv_data1/oa_pdf/72/b2/ceg-9-151.PMC4946860.pdf
"Clinical and Experimental Gastroenterology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-and-experimental-gastroenterology-journa lClinical and Experimental Gastroenterology is an international, peer- reviewed, open access journal, publishing all aspects of gastroenterology  in the clinic and laboratory, including: Pathology, pathophysiology  of gastrointestinal disease; Investigation and treatment of gastointes - tinal disease; Pharmacology of drugs used in the alimentary tract; Immunology/genetics/genomics related to gastrointestinal disease.",Non-OADS,/arxiv_data1/oa_pdf/72/b2/ceg-9-151.PMC4946860.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/72/b2/ceg-9-151.PMC4946860.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution â€“ Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/b9/a6/ijn-11-3131.PMC4946861.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 3131â€“3143International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3131OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S10854 9 green synthesis of multifunctional silver and gold  nanoparticles from the oriental herbal adaptogen:  siberian ginseng ragavendran abbai1,* ramya Mathiyalagan1,* Josua Markus1 Yeon-Ju Kim2 chao Wang2 Priyanka singh2 sungeun ahn2 Mohamed el-agamy Farh2 Deok chun Yang1,2 1ginseng Bank, graduate school  of Biotechnology, 2Department of  Oriental Medicinal Biotechnology,   college of life sciences, Kyung hee  University, Y ongin, republic of Korea *These authors contributed equally  to this workAbstract:  Pharmacologically active stem of the oriental herbal adaptogen, Siberian ginseng,  was employed for the ecofriendly synthesis of Siberian ginseng silver nanoparticles (Sg-AgNPs)  and Siberian ginseng gold nanoparticles (Sg-AuNPs).",Non-OADS,/arxiv_data1/oa_pdf/b9/a6/ijn-11-3131.PMC4946861.pdf
"Usually, their mass  production is performed through various physical and chemical methods, which correspondence: Yeon-Ju Kim;  Deok chun Yang ginseng Bank, graduate school of  Biotechnology, college of life sciences,  Kyung hee University, 1 seocheondong,  giheunggu, Yongin si, gyeonggido,  17104, republic of Korea Tel +82 31 201 2100 Fax +82 31 205 2688 email dcyang@khu.ac.k r;  yeonju kim@khu.a c.kr Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Abbai et al Running head recto: Multifunctional nanoparticles from Siberian ginseng DOI: http://dx.doi.org/10.2147/IJN.S108549",Non-OADS,/arxiv_data1/oa_pdf/b9/a6/ijn-11-3131.PMC4946861.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/b9/a6/ijn-11-3131.PMC4946861.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/b9/a6/ijn-11-3131.PMC4946861.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by/4.0/.,Non-OADS,/arxiv_data1/oa_pdf/d2/8d/jaa-9-135.PMC4946862.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/d2/8d/jaa-9-135.PMC4946862.pdf
"php and incorporate the Creative Commons Attribution â€“ Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/d2/8d/jaa-9-135.PMC4946862.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Asthma and Allergy 2016:9 135â€“143Journal of Asthma and Allergy Dovepress submit your manuscript | www.dovepress.com Dovepress 135 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JAA.S98172A review of the clinical efficacy and safety of   MP-AzeFlu, a novel intranasal formulation of  azelastine hydrochloride and fluticasone propionate,  in clinical studies conducted during different allergy seasons in the US Bruce M Prenner Allergy Associates Medical Group,   Inc., San Diego, CA, USAAbstract:  A novel intranasal formulation of azelastine HCl (AZE, an antihistamine) and  fluticasone propionate (FP , a corticosteroid) in a single spray (MP-AzeFlu [DymistaÂ®]) was  studied in four randomized, double-blind, placebo-controlled trials of patients with seasonal  allergic rhinitis conducted in the US.",Non-OADS,/arxiv_data1/oa_pdf/d2/8d/jaa-9-135.PMC4946862.pdf
"1 In the US, the prevalence of AR is now estimated at 60â€“90  million individuals or ~ 30% of the population, and the prevalence continues to  increase at a steady rate.2,3 Global climate changes resulting in elevated levels of Correspondence: Bruce M Prenner   Allergy Associates Medical Group, Inc.,  2655 Camino Del Rio North, Suite 120, San Diego, CA 92108, USA   Tel +1 619 229 2355   Email prenner@aaamg.comJournal name: Journal of Asthma and Allergy Article Designation: REVIEWY ear: 2016V olume: 9Running head verso: PrennerRunning head recto: Efficacy of MP-AzeFlu across different allergy seasonsDOI: http://dx.doi.org/10.2147/JAA.S98172",Non-OADS,/arxiv_data1/oa_pdf/d2/8d/jaa-9-135.PMC4946862.pdf
Available from: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guid-ances/ucm071293.pdf.,Non-OADS,/arxiv_data1/oa_pdf/d2/8d/jaa-9-135.PMC4946862.pdf
"Journal of Asthma and Allergy 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Asthma and Allergy Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/journal-of-asthma-and-allergy-journalThe Journal of Asthma and Allergy is an international, peer-reviewed  open access journal publishing original research, reports, editorials and commentaries on the following topics: Asthma; Pulmonary physi-ology; Asthma related clinical health; Clinical immunology and the immunological basis of disease; Pharmacological interventions and new therapies.",Non-OADS,/arxiv_data1/oa_pdf/d2/8d/jaa-9-135.PMC4946862.pdf
Available from: http://www.ema.europa.eu/docs/en   _GB/document_library/Scientific_guideline/2009/09/WC500003554.pdf.,Non-OADS,/arxiv_data1/oa_pdf/d2/8d/jaa-9-135.PMC4946862.pdf
Available at: http://www.nosneezes.com.,Non-OADS,/arxiv_data1/oa_pdf/d2/8d/jaa-9-135.PMC4946862.pdf
2014. http://www.mysanantonio.com/business/health-care/article/Cedar-and-allergy-symptoms-hit-highest-levels-of-5150578.php.,Non-OADS,/arxiv_data1/oa_pdf/d2/8d/jaa-9-135.PMC4946862.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by/4.0/.,Non-OADS,/arxiv_data1/oa_pdf/83/d0/imcrj-9-187.PMC4946863.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/83/d0/imcrj-9-187.PMC4946863.pdf
"php and incorporate the Creative Commons Attribution â€“ Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/83/d0/imcrj-9-187.PMC4946863.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).International Medical Case Reports Journal 2016:9 187â€“191International Medical Case Reports Journal Dovepress submit your manuscript | www.dovepress.com Dovepress 187 Case Repo Rt open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IMCRJ.S107926Long-lasting corneal endothelial graft rejection  successfully reversed after dexamethasone  intravitreal implant Giuseppe Giannaccare Michela Fresina alberto pazzaglia piera Versura ophthalmology Unit, Department of  experimental, Diagnostic and specialty Medicine (DIM es), alma Mater  studiorum University of Bologna,  santâ€™orsola -Malpighi t eaching  Hospital, Bologna, ItalyAbstract: Graft rejection is the most significant complication corneal transplantation and the lead- ing indication for overall corneal transplantation.",Non-OADS,/arxiv_data1/oa_pdf/83/d0/imcrj-9-187.PMC4946863.pdf
"The optimal route of administration of corticosteroid remains unknown and many different approaches, such as systemic, topical,  subconjunctival, Correspondence: Giuseppe Giannaccare ophthalmology Unit, DIMes Department, alma Mater studiorum University of Bologna, santâ€™orsola-Malpighi teaching Hospital, Via pelagio palagi 9, Bologna 40138, Italytel +39 051 214 2845email giuseppe.giannaccare@gmail.comJournal name: International Medical Case Reports Journal Article Designation: Case ReportY ear: 2016V olume: 9Running head verso: Giannaccare et alRunning head recto: Dexamethasone intravitreal implant in corneal graft rejectionDOI: http://dx.doi.org/10.2147/IMCRJ.S107926",Non-OADS,/arxiv_data1/oa_pdf/83/d0/imcrj-9-187.PMC4946863.pdf
"International Medical Case Reports Journal 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress International Medical Case Reports Journal Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/international-medical-case-reports-journal-journalThe International Medical Case Reports Journal is an international,  peer-reviewed open-access journal publishing original case reports from all medical specialties.",Non-OADS,/arxiv_data1/oa_pdf/83/d0/imcrj-9-187.PMC4946863.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 191 Dexamethasone intravitreal implant in corneal graft rejection  12.,Non-OADS,/arxiv_data1/oa_pdf/83/d0/imcrj-9-187.PMC4946863.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p  and incorporate the Creative Commons Attribution â€“ Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/d0/0d/cmar-8-085.PMC4946864.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Treatment challenges for community oncologists  treating postmenopausal women with endocrine- resistant, hormone receptor-positive, human  epidermal growth factor receptor 2-negative  advanced breast cancer William J Gradishar Division of Hematology/Oncology,   Department of Medicine,   Northwestern University Feinberg  School of Medicine, Chicago, IL, USA Correspondence: William J Gradishar   Northwestern University Feinberg School  of Medicine, NMH/Arkes Family Pavilion  Suite 850, 676 N Saint Clair, Chicago, IL  60611, USA   T el +1 312 695 6180   Email w-gradishar@northwestern.ed uAbstract:  Community-based oncologists are faced with challenges and opportunities when  delivering quality patient care, including high patient volumes and diminished resources;  however, there may be the potential to deliver increased patient education and subsequently  improve outcomes.",Non-OADS,/arxiv_data1/oa_pdf/d0/0d/cmar-8-085.PMC4946864.pdf
"Cancer Management and Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/cancer-management-and-research-journa lCancer Management and Research is an international, peer-reviewed  open access journal focusing on cancer research and the optimal use of  preventative and integrated treatment interventions to achieve improved  outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/d0/0d/cmar-8-085.PMC4946864.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/d0/0d/cmar-8-085.PMC4946864.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution â€“ Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/4c/9f/copd-11-1569.PMC4946865.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 1569â€“1578International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  1569OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S10899 3 associations of autophagy with lung diffusion  capacity and oxygen saturation in severe COPD:  effects of particulate air pollution Kang-Yun lee1,2,* ling-ling Chiang1,3,* shu-Chuan ho1,3 Wen-T e liu1â€“3 Tzu-Tao Chen1 Po-hao Feng1,2 Chien-ling su1,3 Kai-Jen Chuang4,5 Chih-Cheng Chang1,2 hsiao-Chi Chuang1â€“3 1Division of Pulmonary Medicine,   Department of Internal Medicine,   shuang ho hospital, 2Department of  Internal Medicine, school of Medicine,   3school of respiratory Therapy,   4Department of Public health, school  of Medicine, College of Medicine,   5school of Public health, College of  Public health and nutrition, Taipei  Medical University, Taipei City, Taiwan *These authors contributed equally  to this workAbstract:  Although traffic exposure has been associated with the development of COPD,  the role of particulate matter ,10 Î¼m in aerodynamic diameter (PM10) in the pathogenesis of  COPD is not yet fully understood.",Non-OADS,/arxiv_data1/oa_pdf/4c/9f/copd-11-1569.PMC4946865.pdf
"Kumar et al3 further showed that the risk of acute exacerbation Correspondence:  hsiao-Chi Chuang Taiwan CardioPulmonary research  group, school of respiratory Therapy,  College of Medicine, Taipei Medical  University, 250 Wuxing street,  Taipei City 110, Taiwan Tel +886 2 2736 1661 ext 3515 Fax +886 2 2739 1143 email r92841005@ntu.edu.t w Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Lee et al Running head recto: PM10-related pathogenesis of COPD DOI: http://dx.doi.org/10.2147/COPD.S108993",OADS,/arxiv_data1/oa_pdf/4c/9f/copd-11-1569.PMC4946865.pdf
"Daily  concentrations of PM10 were obtained from the Environ - mental Protection Administration, Taiwan ( http://taqm.epa.",OADS,/arxiv_data1/oa_pdf/4c/9f/copd-11-1569.PMC4946865.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/4c/9f/copd-11-1569.PMC4946865.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/4c/9f/copd-11-1569.PMC4946865.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/Fate decision of MSCs Q Chen et al 1139 Cell Death and Differentiation",Non-OADS,/arxiv_data1/oa_pdf/da/07/cdd2015168a.PMC4946886.pdf
The Kaplan â€“Meier plotting tool (http://kmplot.com/analysis/)51was used to evaluate the risk-free survival of breast cancer patients expressing low or high levels of Tip60.,Non-OADS,/arxiv_data1/oa_pdf/85/04/cdd2015173a.PMC4946888.pdf
"Tip60 expression was scored using the Jetset best probe set.52Pre- processed and normalized gene expression and copy number data, as well asrecurrence information, were downloaded from the corresponding TCGA breastcancer repository (version 3 July 2012; http://tcga-data.nci.nih.gov/tcga/tcgaHome2.jsp).",OADS,/arxiv_data1/oa_pdf/85/04/cdd2015173a.PMC4946888.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies this paper on Cell Death and Differentiation website (http://www.nature.com/cdd)p53-independent tumor suppression by Tip60 C Bassi et al 1208 Cell Death and Differentiation",Non-OADS,/arxiv_data1/oa_pdf/85/04/cdd2015173a.PMC4946888.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies this paper on Cell Death and Differentiation website (http://www.nature.com/cdd)ANXA1 promotes in ï¬‚uenza virus propagation S Arora et al 1256 Cell Death and Differentiation",Non-OADS,/arxiv_data1/oa_pdf/7c/5e/cdd201619a.PMC4946891.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/4.0/Cell non-autonomy in apoptosis M Eroglu and WB Derry 1118 Cell Death and Differentiation",Non-OADS,/arxiv_data1/oa_pdf/e5/7d/cdd201641a.PMC4946894.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/Targeted gene delivery to breast cancer cells K Mann and M Kullberg 228 Cancer Gene Therapy (2016), 221 â€“228 Â© 2016 Nature America, Inc.",Non-OADS,/arxiv_data1/oa_pdf/f4/6c/cgt201621a.PMC4946976.pdf
"Accessed on February 24, 2014.Available from: http://www.uspreventiveservicestaskforce.org/Page/ Name/methods-and-processes .",OADS,/arxiv_data1/oa_pdf/a0/4c/198_2016_Article_3525.PMC4947102.pdf
"For the decision whether or not to start drug treatment, the Osteoporosis Choice PET was developed at the Mayo Clinic in the US(http://shareddecisions.mayoclinic.org/decision-aids-for- chronic-disease/other-decision-aids/ ) and conveys the pros and cons of treatment using an estimate of the patient â€™sr i s k of bone fracture.",Non-OADS,/arxiv_data1/oa_pdf/5e/00/198_2016_Article_3555.PMC4947108.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), whichpermits any noncommercial use, distribution, and reproduction inany medium, provided you give appropriate credit to the original author(s) and the source, prov ide a link to the Creative Commons license, and indicate if changes were made.Osteoporos Int (2016) 27:2489 â€“2496 2495",Non-OADS,/arxiv_data1/oa_pdf/5e/00/198_2016_Article_3555.PMC4947108.pdf
Available from http://www.platformouderenzorg.nl/uploads/files/guidelines/ osteoporoseenfractuurpreventie.pdf 22.,Non-OADS,/arxiv_data1/oa_pdf/5e/00/198_2016_Article_3555.PMC4947108.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the originalauthor(s) and the source, provide a link to the Creative Commonslicense, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/1c/2f/40256_2016_Article_170.PMC4947114.pdf
Available at: http://www.dsld.nlm.nih.gov/ dsld/rptQSearch.jsp?item=omega-3&db=adsld .,OADS,/arxiv_data1/oa_pdf/1c/2f/40256_2016_Article_170.PMC4947114.pdf
Available at: http://health.gov/dietsupp/ch1.htm .,Non-OADS,/arxiv_data1/oa_pdf/1c/2f/40256_2016_Article_170.PMC4947114.pdf
Available at: http://www.accessdata.fda.gov/scripts/cder/ob/ .,Non-OADS,/arxiv_data1/oa_pdf/1c/2f/40256_2016_Article_170.PMC4947114.pdf
Available at: http://clinicaltrials.gov/ct2/show/ NCT02104817?term=strength ?and?omega-3&rank=3 .,Non-OADS,/arxiv_data1/oa_pdf/1c/2f/40256_2016_Article_170.PMC4947114.pdf
Available at: http://pi.lilly.com/us/ foreo-pi.pdf .,Non-OADS,/arxiv_data1/oa_pdf/2e/ff/198_2016_Article_3534.PMC4947115.pdf
http://abstracts.ects-ibms2015.org/ectsibms/ 0001/ectsibms0001p362.htm 72.,Non-OADS,/arxiv_data1/oa_pdf/2e/ff/198_2016_Article_3534.PMC4947115.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per-mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/0b/1a/40256_2016_Article_165.PMC4947116.pdf
9.https://www.medicines.org.uk/emc/ 10.,Non-OADS,/arxiv_data1/oa_pdf/0b/1a/40256_2016_Article_165.PMC4947116.pdf
49.https://www.clinicaltrials.gov/ct2/show/NCT02079805 50.,Non-OADS,/arxiv_data1/oa_pdf/0b/1a/40256_2016_Article_165.PMC4947116.pdf
123. https://clinicaltrials.gov/ct2/show/NCT02085265?term=sartan- ad&rank=1266 C. A.,Non-OADS,/arxiv_data1/oa_pdf/0b/1a/40256_2016_Article_165.PMC4947116.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ï¬nancial interests: The authors declare no competing ï¬nancial interests.,Non-OADS,/arxiv_data1/oa_pdf/ee/b7/ncomms12106.PMC4947183.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Ioannidou, K. et al.",Non-OADS,/arxiv_data1/oa_pdf/ee/b7/ncomms12106.PMC4947183.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ rThe Author(s) 2016NATURE COMMUNICATIONS | DOI: 10.1038/ncomms12106 ARTICLE NATURE COMMUNICATIONS | 7:12106 | DOI: 10.1038/ncomms12106 | www.nature.com/naturecommunications 9",Non-OADS,/arxiv_data1/oa_pdf/ee/b7/ncomms12106.PMC4947183.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all non-commer cial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Journal of Extracellular Vesicles 2016, 5: 31295 - http://dx.doi.org/10.3402/jev.v5.31295 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/78/40/JEV-5-31295.PMC4947197.pdf
"2 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2016, 5: 31295 - http://dx.doi.org/10.3402/jev.v5.31295",OADS,/arxiv_data1/oa_pdf/78/40/JEV-5-31295.PMC4947197.pdf
"Following the overnight incubation, samples were cen- trifuged in a bench-top centrifuge (Eppendorf 5810R) using a swing bucket rotor (S-4-104) at maximum speedNanoparticle analysis of cancer EVs Citation: Journal of Extracellular Vesicles 2016, 5: 31295 - http://dx.doi.org/10.3402/jev.v5.31295 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/78/40/JEV-5-31295.PMC4947197.pdf
"4 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2016, 5: 31295 - http://dx.doi.org/10.3402/jev.v5.31295",OADS,/arxiv_data1/oa_pdf/78/40/JEV-5-31295.PMC4947197.pdf
"To confirm the relative differences in vesicle quantity found among cells secreting various levels of EVs, weemployed a highly pure method of EV enrichment.Nanoparticle analysis of cancer EVs Citation: Journal of Extracellular Vesicles 2016, 5: 31295 - http://dx.doi.org/10.3402/jev.v5.31295 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/78/40/JEV-5-31295.PMC4947197.pdf
"6 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2016, 5: 31295 - http://dx.doi.org/10.3402/jev.v5.31295",OADS,/arxiv_data1/oa_pdf/78/40/JEV-5-31295.PMC4947197.pdf
"Leuk /C30leukaemia, Mel /C30melanoma.Nanoparticle analysis of cancer EVs Citation: Journal of Extracellular Vesicles 2016, 5: 31295 - http://dx.doi.org/10.3402/jev.v5.31295 7 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/78/40/JEV-5-31295.PMC4947197.pdf
"8 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2016, 5: 31295 - http://dx.doi.org/10.3402/jev.v5.31295",OADS,/arxiv_data1/oa_pdf/78/40/JEV-5-31295.PMC4947197.pdf
"(d) Quantiï¬cation of relative EV levels from MCF7, SK-MEL-5 and OVCAR-5 cells by esterase activity.Nanoparticle analysis of cancer EVs Citation: Journal of Extracellular Vesicles 2016, 5: 31295 - http://dx.doi.org/10.3402/jev.v5.31295 9 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/78/40/JEV-5-31295.PMC4947197.pdf
"10 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2016, 5: 31295 - http://dx.doi.org/10.3402/jev.v5.31295",OADS,/arxiv_data1/oa_pdf/78/40/JEV-5-31295.PMC4947197.pdf
"(b) Proportion of small (B150 nm) and large ( /C21150 nm) vesicles to total number of EV secreted by each cell type varies across the NCI-60 panel.Nanoparticle analysis of cancer EVs Citation: Journal of Extracellular Vesicles 2016, 5: 31295 - http://dx.doi.org/10.3402/jev.v5.31295 11 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/78/40/JEV-5-31295.PMC4947197.pdf
"12 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2016, 5: 31295 - http://dx.doi.org/10.3402/jev.v5.31295",OADS,/arxiv_data1/oa_pdf/78/40/JEV-5-31295.PMC4947197.pdf
"Table I. Gene products correlating with small vesicle quantity Gene symbol Gene name Corr Gene product functionFound in exosomes CYTH3 Cytohesin 3 0.496 Guanine nucleotide exchange and phospholipid interaction; membrane traffickingV/X VPS41 Vacuolar protein sorting 41 0.467 Vesicle-mediated protein sorting; formation and fusion of Golgi vesiclesX NPC2 Niemann-Pick disease, type C2 0.429 Mobilizes cholesterol within the late endosome RAB17 Member Ras oncogene family 0.408 GTPase; recruitment of effectors for vesicle formation, tethering and fusionV/X SNX24 Sorting nexin 24 0.39 Phosphatidylinositol binding and intracellular trafficking SNX9 Sorting nexin 9 0.388 Involved in endocytosis and intracellular vesicle trafficking V/XAP1S2 Adaptor-related protein complex 1 0.388 Recruitment of clathrin to membranes and recognition of sorting signals within the cytosolic tails of transmembrane cargo molecules ALS2 Amyotrophic lateral sclerosis 2 (juvenile)0.383 GTPase regulator, associates with Rab5 on early endosomal compartments to mediate endosomal dynamics ZFYVE9 Zinc finger, FYVE domain containing 90.372 Early endosome protein; regulates TGF-mediated signalling RAB9A Rab9A, member Ras oncogene family0.366 GTPase involved in transport of proteins between the endosomes and the trans Golgi networkV/X PSAP Prosaposin 0.364 Precursor glycoprotein; cleavage products involved lysosomal degradation of sphingolipidsV/X ERAS ES cell expressed Ras 0.363 GTPase; activates the phosphatidylinositol 3-kinase signal transduction pathway SFT2D2 SFT2 domain containing 2 0.36 Fusion of retrograde transport vesicles derived from an endocytic compartment with the Golgi complexV/X STX7 Syntaxin 7 0.36 Mediates the endocytic trafficking from early endosomes to late endosomes and lysosomesV/X GNS Glucosamine ( N-acetyl)-6-sulfatase 0.357 Lysosomal enzyme involved in catabolism of heparin, heparan sulphate and keratan sulphateV/X RAB5B Rab5B, member Ras oncogene family0.356 GTPase likely involved in vesicular trafficking V/X CD63 CD63 0.353 Tetraspanin; plays a role in vesicular protein trafficking V/X SH3BP4 SH3-domain binding protein 4 0.351 Cargo-specific control of clathrin-mediated endocytosis; binds GTPase complexesV/X MRAS Muscle Ras oncogene homolog 0.35 Membrane-associated GTPase; signal transduction HGS Hepatocyte growth factor- regulated tyrosine kinase substrate0.349 May regulate trafficking to early and late endosomes by recruiting clathrin; interacts with ESCRT-0 to sort ubiquitinated membraneproteins into MVBV/X SGSH N-sulfoglucosamine sulfohydrolase 0.349 Lysosomal degradation of heparan sulphate X ARHGDIA Rho GDP dissociation inhibitor (GDI) alpha0.348 Regulation of signalling through Rho GTPases V/X ARL8A ADP-ribosylation factor-like 8A 0.348 GTP binding, regulation of lysosomal motility V/X SMURF1 SMAD-specific E3 ubiquitin protein ligase 10.346 Ubiquitin ligase V/X ATP6V0D2 V-ATPase Subunit D 2 0.345 Transporter involved in receptor-mediated endocytosis, protein degradation and coupled transportV/X RASAL2 Ras protein activator like 2 0.338 Activator of Ras superfamily of small GTPases KIF13A Kinesin family member 13A 0.336 Motor protein necessary for the steady-state distribution of late endosomes/lysosomes and vesicle transport to the plasmamembraneX GOLGA4 Golgi autoantigen, golgin subfamily a, 40.335 Rab6-regulated membrane-tethering events in the Golgi apparatus, delivery of transport vesicles containing GPI-linked proteinsX V, exosome classification based on FunRich Vesiclepedia database; X, based on ExoCarta database cross-reference.Nanoparticle analysis of cancer EVs Citation: Journal of Extracellular Vesicles 2016, 5: 31295 - http://dx.doi.org/10.3402/jev.v5.31295 13 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/78/40/JEV-5-31295.PMC4947197.pdf
"14 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2016, 5: 31295 - http://dx.doi.org/10.3402/jev.v5.31295",OADS,/arxiv_data1/oa_pdf/78/40/JEV-5-31295.PMC4947197.pdf
"Recyclessynaptic vesicle membranes from the presynaptic surfaceV GIPC1 GIPC PDZ domain containing family, member0.342 Scaffolding protein that regulates cell surface receptor expression and traffickingV RAB32 Rab32, member Ras oncogene family0.342 Small GTP-binding proteins of the Rab family, involved in vesicle and granule targetingV ATP2B4 ATPase, Ca /C27/C27 transporting, plasma0.34 Hydrolyses ATP coupled with the transport of calcium out of the cell V SEC23A Sec23 homolog A 0.337 Component of the COPII coat; responsible for vesicle budding from the ERV V, microvesicle classification based on FunRich Vesiclepedia database.Nanoparticle analysis of cancer EVs Citation: Journal of Extracellular Vesicles 2016, 5: 31295 - http://dx.doi.org/10.3402/jev.v5.31295 15 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/78/40/JEV-5-31295.PMC4947197.pdf
"16 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2016, 5: 31295 - http://dx.doi.org/10.3402/jev.v5.31295",OADS,/arxiv_data1/oa_pdf/78/40/JEV-5-31295.PMC4947197.pdf
"Conflict of interest and funding The authors declare no conflict of interest.Nanoparticle analysis of cancer EVs Citation: Journal of Extracellular Vesicles 2016, 5: 31295 - http://dx.doi.org/10.3402/jev.v5.31295 17 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/78/40/JEV-5-31295.PMC4947197.pdf
"18 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2016, 5: 31295 - http://dx.doi.org/10.3402/jev.v5.31295",OADS,/arxiv_data1/oa_pdf/78/40/JEV-5-31295.PMC4947197.pdf
Available from: http://discover.nci.nih.gov/cellminer/analysis.do 52.,OADS,/arxiv_data1/oa_pdf/78/40/JEV-5-31295.PMC4947197.pdf
"2014;3:24858, doi: http://dx.doi.org/ 10.3402/jev.v3.24858 65.",Non-OADS,/arxiv_data1/oa_pdf/78/40/JEV-5-31295.PMC4947197.pdf
"2003;423:541 /C15.Nanoparticle analysis of cancer EVs Citation: Journal of Extracellular Vesicles 2016, 5: 31295 - http://dx.doi.org/10.3402/jev.v5.31295 19 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/78/40/JEV-5-31295.PMC4947197.pdf
"20 (page number not for citation purpose)Citation: Journal of Extracellular Vesicles 2016, 5: 31295 - http://dx.doi.org/10.3402/jev.v5.31295",OADS,/arxiv_data1/oa_pdf/78/40/JEV-5-31295.PMC4947197.pdf
"Patient/methods Seven patients (5 males, 10 females; mean age 74.2 years, range 61 to 77 years) with ET were included in the study (Table 1).Freely available online Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services1",Non-OADS,/arxiv_data1/oa_pdf/8f/2a/tre-06-378-7522-1.PMC4947198.pdf
"M + 8 Gabapentin Yes Abbreviations: ET, Essential Tremor; F, Female; M, Male.Gironell A, Marin-Lahoz J Ethosuximide for Essential Tremor Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services2",Non-OADS,/arxiv_data1/oa_pdf/8f/2a/tre-06-378-7522-1.PMC4947198.pdf
"1Before assessments were taken before drug intake on the test day.Ethosuximide for Essential Tremor Gironell A, Marin-Lahoz J Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services3",Non-OADS,/arxiv_data1/oa_pdf/8f/2a/tre-06-378-7522-1.PMC4947198.pdf
"doi: 10.1002/ mds.870070206Gironell A, Marin-Lahoz J Ethosuximide for Essential Tremor Tremor and Other Hyperkinetic Movements http://www.tremor journal.or gThe Center for Digital Research and ScholarshipColumbia Universit y Libraries/Information Services4",Non-OADS,/arxiv_data1/oa_pdf/8f/2a/tre-06-378-7522-1.PMC4947198.pdf
"The disposition of the study participants within the pools is shown in supple- mental Figure 1, http://links.lww.com/HJH/A590.",Non-OADS,/arxiv_data1/oa_pdf/2f/18/jhype-34-788.PMC4947533.pdf
The Lustgarten Foundation and Cablevision are also partners in the curePC public awareness campaign (http://www.curePC.org).,Non-OADS,/arxiv_data1/oa_pdf/d7/a2/mpa-44-1178.PMC4947540.pdf
"The study was supported by MedViz (http://medviz.uib.no/), an interdisciplinary research cluster from Haukeland University Hospital,University of Bergen, and Christian Michelsen Research AS.",OADS,/arxiv_data1/oa_pdf/ea/fb/mpa-44-1266.PMC4947543.pdf
Available at: http://www.genet.sickkids.on.ca/app.,Non-OADS,/arxiv_data1/oa_pdf/ea/fb/mpa-44-1266.PMC4947543.pdf
"Available at: http://www.cff.org/UploadedFiles/aboutCFFoundation/AnnualReport/2012-Annual-Report.pdf .Accessed May 9, 2014.",Non-OADS,/arxiv_data1/oa_pdf/ea/fb/mpa-44-1266.PMC4947543.pdf
Available at: http://www.stard-statement.org/.,Non-OADS,/arxiv_data1/oa_pdf/ea/fb/mpa-44-1266.PMC4947543.pdf
Information sources and search strategy Searches were undertaken by a professional systematic review company â€“ the York Health Economic Consortium (http://www.yhec.co.uk/.).,OADS,/arxiv_data1/oa_pdf/0d/54/jhype-34-600.PMC4947544.pdf
"No difference was found in blood pressure reduction between those offering additional help and those not, for either SBP (additional help /C03.37, 95% CI /C00.22 to /C06.52 vs. no additional help /C03.85, 95% CI /C02.08 to/C0563) or DBP (additional help /C02.18, 95% CI /C00.45 to /C03.91 vs. no additional help /C02.58, 95% CI 0.95 to /C06.11) (see supplementary Figs 1 and 2, http://links.lww.com/ HJH/A580.",Non-OADS,/arxiv_data1/oa_pdf/0d/54/jhype-34-600.PMC4947544.pdf
"No significant difference was found when comparing interventions by duration for SBP (6 months or longer /C04.35, 95% CI /C02.10 to /C06.60 vs. less than 6 months /C03.19, 95% CI /C01.07 to /C05.32) or DBP (6 months or longer /C03.16, 95% CI /C00.83 to /C06.49 vs. less than 6 months /C03.94, 95% CI 0.37 to /C03.35; see supple- mentary Figs 3 and 4, http://links.lww.com/HJH/A580).",Non-OADS,/arxiv_data1/oa_pdf/0d/54/jhype-34-600.PMC4947544.pdf
"No significant difference was found for SBP when compar- ing those interventions which included a theoretical basis ( /C03.02, 95% CI /C00.79 to /C05.24) vs. no theoretical basis ( /C04.41, 95% CI /C02.26 to /C05.5), but theoretical basis recorded no reduction for DBP (no theoretical basis 0.90, 95% CI 0.02 to /C01.82), whereas a significant fall was found for no theoretical basis ( /C03.94, 95% CI /C02.53 to /C05.36; see supplementary Figs 7 and 8, http://links.lww.com/HJH/ A580).Digital interventions in adults with hypertension Journal of Hypertension www.jhypertension.com 603",Non-OADS,/arxiv_data1/oa_pdf/0d/54/jhype-34-600.PMC4947544.pdf
PROSPERO 2014; See http://www.crd.york.ac.uk/PROSPERO/display_record.,Non-OADS,/arxiv_data1/oa_pdf/0d/54/jhype-34-600.PMC4947544.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ J Med Ethics 2016; 42:449. doi:10.1136/medethics-2014-102540corr1 Lipworth W, Axler R. J Med Ethics 2016; 42:445 â€“449.",Non-OADS,/arxiv_data1/oa_pdf/9a/3d/medethics-2014-102540corr1.PMC4947598.pdf
Available from: http://clinical-trial.gov/ct2/show/record/NCT01309802.,Non-OADS,/arxiv_data1/oa_pdf/f7/b5/AMS-12-24344.PMC4947604.pdf
Available from: http://clinicaltrials.gov/ct2/show/record/NCT02165111.,Non-OADS,/arxiv_data1/oa_pdf/f7/b5/AMS-12-24344.PMC4947604.pdf
Available from: http://www.ginasthma.org.,Non-OADS,/arxiv_data1/oa_pdf/89/8f/AMS-12-24402.PMC4947605.pdf
"(Accessed November 25, 2009, at http://www.ginasthma.org/Guidelineitem.as-p?l1=2&l2=1&intId=987).",Non-OADS,/arxiv_data1/oa_pdf/89/8f/AMS-12-24402.PMC4947605.pdf
http://apps.who.int/iris/bitstream/10665/43894/   1/9789241596657_eng.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ca/85/AMS-12-24452.PMC4947606.pdf
FRAX Polish population: http://shef.ac.uk/FRAX/ 20.,Non-OADS,/arxiv_data1/oa_pdf/80/ee/AMS-12-26009.PMC4947612.pdf
Website: http://elisaanalysis.com/ 30.,Non-OADS,/arxiv_data1/oa_pdf/ca/ae/AMS-12-26063.PMC4947613.pdf
http://imagej.nih.gov/ij/.,OADS,/arxiv_data1/oa_pdf/42/ca/AMS-12-27560.PMC4947616.pdf
"The criteria used for this division were con-sistent with the guidelines of the Polish Forum for Prevention of Cardiovascular Diseases, updated  in 2012 (http://www.pfp.edu.pl).",Non-OADS,/arxiv_data1/oa_pdf/a8/8b/AMS-12-27873.PMC4947617.pdf
"To view a copy of this license, visit http:// creativecommons.org/licenses/by-nc-sa/4.0/ Supplementary Information accompanies this paper on the Oncogene website (http://www.nature.com/onc)MIR31HG functions as an oncogenic lncRNA in PDAC H Yang et al 3657 Â© 2016 Macmillan Publishers Limited Oncogene (2016) 3647 â€“3657",Non-OADS,/arxiv_data1/oa_pdf/21/84/onc2015430a.PMC4947634.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies this paper on Cell Death and Differentiation website (http://www.nature.com/cdd)Control of cell adhesion by agrin A Anselmo et al 1330 Cell Death and Differentiation",Non-OADS,/arxiv_data1/oa_pdf/6d/fd/cdd201610a.PMC4947663.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies this paper on Cell Death and Differentiation website (http://www.nature.com/cdd)Autophagy-dependent rescue of class II CFTR mutants A Tosco et al 1393 Cell Death and Differentiation",Non-OADS,/arxiv_data1/oa_pdf/2e/5b/cdd201622a.PMC4947669.pdf
Available at http://cancer.sanger.ac.uk/cosmic/gene/analysis?ln=BRAF (2014).,Non-OADS,/arxiv_data1/oa_pdf/70/42/bjc2016106a.PMC4947692.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Chemoradiation impacts anti-tumour immunity 260 www.bjcancer.com | DOI:10.1038/bjc.2016.166,Non-OADS,/arxiv_data1/oa_pdf/2a/14/bjc2016166a.PMC4947695.pdf
"To view a copy of this license, visit http:// creativecommons.org/licenses/by-nc-sa/4.0/ Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Tumour and immune cell dynamics in PSA bounce 202 www.bjcancer.com | DOI:10.1038/bjc.2016.171",Non-OADS,/arxiv_data1/oa_pdf/1c/99/bjc2016171a.PMC4947697.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Prognostic implication of tumour budding BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2016.173 163,Non-OADS,/arxiv_data1/oa_pdf/4d/b1/bjc2016173a.PMC4947698.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)CIMP status and metastatic colorectal cancer BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2016.176 171,Non-OADS,/arxiv_data1/oa_pdf/7b/84/bjc2016176a.PMC4947699.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Cardiorespiratory fitness in lymphoma survivors BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2016.180 187,Non-OADS,/arxiv_data1/oa_pdf/91/ee/bjc2016180a.PMC4947700.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)WBP5 induces MDR of SCLC through Hippo pathway BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2016.186 251,Non-OADS,/arxiv_data1/oa_pdf/23/0c/bjc2016186a.PMC4947702.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)FAK inhibitors in non-small cell lung cancer BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2016.190 211,Non-OADS,/arxiv_data1/oa_pdf/7b/8b/bjc2016190a.PMC4947704.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER OSMR associates with EMT in cervical carcinoma 222 www.bjcancer.com | DOI:10.1038/bjc.2016.199,Non-OADS,/arxiv_data1/oa_pdf/a4/0d/bjc2016199a.PMC4947707.pdf
To view please visit the journalonline (http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/69/2e/bmjgast-2016-000094.PMC4947709.pdf
http://www.ncbi.nlm.nih.gov/ pubmed/2777045 6.,Non-OADS,/arxiv_data1/oa_pdf/69/2e/bmjgast-2016-000094.PMC4947709.pdf
http://www.ncbi.nlm.nih.gov/ pubmed/22986437 39.,Non-OADS,/arxiv_data1/oa_pdf/69/2e/bmjgast-2016-000094.PMC4947709.pdf
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3504311&tool=pmcentrez&rendertype=abstract 40.,OADS,/arxiv_data1/oa_pdf/69/2e/bmjgast-2016-000094.PMC4947709.pdf
http://www.graphpad.com.,Non-OADS,/arxiv_data1/oa_pdf/69/2e/bmjgast-2016-000094.PMC4947709.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2016-011443).,Non-OADS,/arxiv_data1/oa_pdf/52/38/bmjopen-2016-011443.PMC4947712.pdf
"Toview, please visit the journal online (http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/52/38/bmjopen-2016-011443.PMC4947712.pdf
2013. http://www.europeristat.com 2.,Non-OADS,/arxiv_data1/oa_pdf/52/38/bmjopen-2016-011443.PMC4947712.pdf
http://statline.cbs.nl/Statweb/publication/?VW=T&DM=SLNL&PA= 37230ned&HD=150313-1001 (accessed Mar 2015).,OADS,/arxiv_data1/oa_pdf/52/38/bmjopen-2016-011443.PMC4947712.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/46/36/bmjopen-2015-010919.PMC4947714.pdf
"The Cochrane Collaboration, 2011. http://www.cochrane-handbook.org 29.",Non-OADS,/arxiv_data1/oa_pdf/46/36/bmjopen-2015-010919.PMC4947714.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2016- 011632).,Non-OADS,/arxiv_data1/oa_pdf/4e/fb/bmjopen-2016-011632.PMC4947715.pdf
"Cochrane Collaboration, 2011. http://www.cochrane-handbook.org 18.",OADS,/arxiv_data1/oa_pdf/d2/11/bmjopen-2016-012229.PMC4947717.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2015- 010691).,Non-OADS,/arxiv_data1/oa_pdf/da/59/bmjopen-2015-010691.PMC4947718.pdf
"Randomisation We used a web-based computer-generated randomisation sequence prepared centrally via the â€˜Sealed Envelope â€™ website (https://http://www.sealedenvelope.com), and 2 Levett KM, et al.BMJ Open 2016; 6:e010691.",OADS,/arxiv_data1/oa_pdf/da/59/bmjopen-2015-010691.PMC4947718.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2016-011604).,Non-OADS,/arxiv_data1/oa_pdf/30/10/bmjopen-2016-011604.PMC4947720.pdf
"Queensland Government Department of Health, Surgical Skin Disinfection Guideline, 2015. https://www.health.qld.gov.au/ publications/clinical-practice/guidelines-procedures/diseases-infection/governance/skin-disinfection.pdf (accessed 5 Jul 2016).",Non-OADS,/arxiv_data1/oa_pdf/30/10/bmjopen-2016-011604.PMC4947720.pdf
"Queensland Centre for Healthcare Related Infection Surveillance and Prevention and Tuberculosis Prevention, Guideline for SurgicalSkin Disinfection, 2012. http://citeseerx.ist.psu.edu/viewdoc/ download?doi=10.1.1.269.2004&rep=rep1&type=pdf (accessed 5 Jul 2016).",Non-OADS,/arxiv_data1/oa_pdf/30/10/bmjopen-2016-011604.PMC4947720.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2015-010243).,Non-OADS,/arxiv_data1/oa_pdf/62/dd/bmjopen-2015-010243.PMC4947721.pdf
"31â€“36 Coronary risk scores (P-12) â–¸The risk of cardiovascular diseases can be calculated using classical scoring systems such as the Framingham risk score (USA).37The scoring is available in the literature or can be cal- culated automatically in the internet when the personal clinicalvariables of the individuals, such as age, gender, total andhigh-density lipoprotein cholesterol levels, smoking status andhypertension/blood pressure information, are entered (http://cvdrisk.nhlbi.nih.gov/).",Non-OADS,/arxiv_data1/oa_pdf/62/dd/bmjopen-2015-010243.PMC4947721.pdf
http://www.ncbi.nlm.nih.gov/mesh/?term=personalized+medicine(accessed 20 Jun 2014).,OADS,/arxiv_data1/oa_pdf/62/dd/bmjopen-2015-010243.PMC4947721.pdf
https://www.genome.gov/pages/policy/personalizedmedicine/dhhsreportpersonalizedhealth.pdf (accessed 01 Jul 2014).,OADS,/arxiv_data1/oa_pdf/62/dd/bmjopen-2015-010243.PMC4947721.pdf
"CASyMReport: 1st CASyM open stakeholder consultation conference,Lyon, March 2013. https://www.casym.eu/index.php?index=90(accessed 03 Jul 2014).",Non-OADS,/arxiv_data1/oa_pdf/62/dd/bmjopen-2015-010243.PMC4947721.pdf
"Newsweek , 13 Jul 2009. http://www.newsweek.com/id/204227 (accessed 4 Jul2014).",Non-OADS,/arxiv_data1/oa_pdf/62/dd/bmjopen-2015-010243.PMC4947721.pdf
2013. http://www.fda.gov/iceci/ enforcementactions/warningletters/2013/ucm376296.htm (accessed21 Dec 2013).,Non-OADS,/arxiv_data1/oa_pdf/62/dd/bmjopen-2015-010243.PMC4947721.pdf
http://mediacenter.23andme.com/press-releases/ 23andme-inc-provides-update-on-fda-regulatory-review/ (accessed 21 Dec 2013).,Non-OADS,/arxiv_data1/oa_pdf/62/dd/bmjopen-2015-010243.PMC4947721.pdf
Ecancermedicalscience 2014;8:400. http://ecancer.org/ journal/8/400-development-of-interactive-empowerment-services-in- support-of-personalised-medicine.php 75.,OADS,/arxiv_data1/oa_pdf/62/dd/bmjopen-2015-010243.PMC4947721.pdf
PwC Medical Technology Innovation Scorecard Highlights 2013. http://www.pwc.com/InnovationScorecard (accessed 14 Nov 2014).,Non-OADS,/arxiv_data1/oa_pdf/62/dd/bmjopen-2015-010243.PMC4947721.pdf
Checking up on Taiwan healthcare â€”Market challenges and opportunities 2012. https://www.pwc.tw/en_TW/tw/industries/publications/assets/healthcare-en.pdf (accessed 18 Dec 2014).,Non-OADS,/arxiv_data1/oa_pdf/62/dd/bmjopen-2015-010243.PMC4947721.pdf
"Submitted to the EuropeanCommission, Research Executive Agency, Marie Curie Actions(Intra-European Fellowships for Career Development) on 05.06.2014. http://cordis.europa.eu/result/rcn/150015_en.html (accessed 30 Jun 2016).",Non-OADS,/arxiv_data1/oa_pdf/62/dd/bmjopen-2015-010243.PMC4947721.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ BMJ Open 2016; 6:e010327corr1.,Non-OADS,/arxiv_data1/oa_pdf/21/5a/bmjopen-2015-010327corr1.PMC4947722.pdf
"Secondary obesity and overweight, 2015. http://www.who.int/mediacentre/factsheets/fs311/en/ (accessed Apr 2016).",Non-OADS,/arxiv_data1/oa_pdf/1f/e9/bmjdrc-2016-000200.PMC4947725.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ BMJ Open 2016; 6:e010224corr1.,Non-OADS,/arxiv_data1/oa_pdf/9f/a9/bmjopen-2015-010224corr1.PMC4947726.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2016-011705).,Non-OADS,/arxiv_data1/oa_pdf/2a/90/bmjopen-2016-011705.PMC4947727.pdf
"To this end, we created an ACP websitecalled PREPARE (http://www.prepareforyourcare.org)to prepare diverse English-speaking and Spanish-speaking older adults for medical decision-making.Here, we describe the study protocol for a randomisedcontrolled efficacy trial of PREPARE in a safety-netsetting.",Non-OADS,/arxiv_data1/oa_pdf/2a/90/bmjopen-2016-011705.PMC4947727.pdf
"â€ Intervention and control conditions As previously described, PREPARE is an easy-to-use, patient-centred, interactive website that is available inEnglish or Spanish, is written at a ï¬fth grade reading level, includes voice-overs of all text for the reading-impaired and closed-captioning of all videos forthe hearing impaired (http://www.prepareforyourcare.",Non-OADS,/arxiv_data1/oa_pdf/2a/90/bmjopen-2016-011705.PMC4947727.pdf
Overview of Race and Hispanic Origin : 2010. http://www.census.gov/prod/cen2010/briefs/c2010br-02.pdf(accessed December 2015).,OADS,/arxiv_data1/oa_pdf/2a/90/bmjopen-2016-011705.PMC4947727.pdf
The Institute for Healthcare Advancement: http://www.iha4health.,Non-OADS,/arxiv_data1/oa_pdf/2a/90/bmjopen-2016-011705.PMC4947727.pdf
http://www.census.gov/topics/ population/language-use.html (accessed Jan 2016).,OADS,/arxiv_data1/oa_pdf/2a/90/bmjopen-2016-011705.PMC4947727.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2016-011686).,Non-OADS,/arxiv_data1/oa_pdf/9d/1e/bmjopen-2016-011686.PMC4947728.pdf
http://www.phac-aspc.gc.ca/fluwatch/ 14-15/w22_15/assets/pdf/fw2015-22-eng.pdf (accessed Feb 2016).,OADS,/arxiv_data1/oa_pdf/9d/1e/bmjopen-2016-011686.PMC4947728.pdf
"2014/15 Influenza Surveillance Report Week 15, April 5 â€“18, 2015. http://www.health.alberta.ca/documents/ Influenza-Surveillance-2015-15.pdf (accessed Feb 2016).",Non-OADS,/arxiv_data1/oa_pdf/9d/1e/bmjopen-2016-011686.PMC4947728.pdf
http://www.albertahealthservices.ca/assets/healthinfo/Diseases/hi-dis-flu-prov-hlsl.pdf (accessed Feb 2016).,Non-OADS,/arxiv_data1/oa_pdf/9d/1e/bmjopen-2016-011686.PMC4947728.pdf
http://www.cdc.gov/eval/guide/introduction/index.htm (accessed Feb2016).,OADS,/arxiv_data1/oa_pdf/9d/1e/bmjopen-2016-011686.PMC4947728.pdf
http://www.phac-aspc.gc.ca/fluwatch/14-15/def14-15-eng.php (accessed Feb 2016).,Non-OADS,/arxiv_data1/oa_pdf/9d/1e/bmjopen-2016-011686.PMC4947728.pdf
http://getdata-graph-digitizer.com/).,OADS,/arxiv_data1/oa_pdf/db/22/bmjopen-2016-011325.PMC4947730.pdf
http://www.njrcentre.org.uk/njrcentre/default.,Non-OADS,/arxiv_data1/oa_pdf/db/22/bmjopen-2016-011325.PMC4947730.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2015-010781).,Non-OADS,/arxiv_data1/oa_pdf/02/b7/bmjopen-2015-010781.PMC4947731.pdf
2011. http://www.shpr.se/Libraries/Documents/%C3%85rsrapport_2011_avseende_verksamhets%C3%A5ret_2011.sflb.ashx (accessed 27 Oct 2011).,OADS,/arxiv_data1/oa_pdf/02/b7/bmjopen-2015-010781.PMC4947731.pdf
Toview these files please visit the journal online (http://dx.doi.org/10.1136/ rmdopen-2016-000249).,Non-OADS,/arxiv_data1/oa_pdf/d5/dc/rmdopen-2016-000249.PMC4947732.pdf
To view please visit the journal online (http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/d5/dc/rmdopen-2016-000249.PMC4947732.pdf
2006. http://www.has-sante.fr/portail/upload/docs/ application/pdf/osteoporose_synthese.pdf 13.,Non-OADS,/arxiv_data1/oa_pdf/d5/dc/rmdopen-2016-000249.PMC4947732.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2015-009809).,Non-OADS,/arxiv_data1/oa_pdf/e5/b6/bmjopen-2015-009809.PMC4947733.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/e5/b6/bmjopen-2015-009809.PMC4947733.pdf
2010. http://www.ohri.ca/programs/clinical_ epidemiology/oxford.asp 46.,Non-OADS,/arxiv_data1/oa_pdf/e5/b6/bmjopen-2015-009809.PMC4947733.pdf
Funding This paper presents independent research funded by the Lung Alliance Netherlands (http://www.longalliantie.nl).,Non-OADS,/arxiv_data1/oa_pdf/30/a2/bmjopen-2016-011519.PMC4947734.pdf
"Competing interests All authors have completed the Unified Competing Interest form at http://www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author), and AHMS, DK, MT, SH, PLS, GvB, MPMHR-vM, LMAG, NHC, TvdM, GMA, PNRD and JCCMitV declare that they have not had relationships with any company that might have an interest inthe submitted work in the previous 3 years and no non-financial interests that may be relevant to the submitted work.",Non-OADS,/arxiv_data1/oa_pdf/30/a2/bmjopen-2016-011519.PMC4947734.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/30/a2/bmjopen-2016-011519.PMC4947734.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2016- 011453).,Non-OADS,/arxiv_data1/oa_pdf/27/7e/bmjopen-2016-011453.PMC4947735.pdf
2015. http://www.stigmaindex.org/ 2.,Non-OADS,/arxiv_data1/oa_pdf/27/7e/bmjopen-2016-011453.PMC4947735.pdf
http://www.who.int/mental_health/ evidence/WHOQOL-HIV BREF.pdf.,OADS,/arxiv_data1/oa_pdf/27/7e/bmjopen-2016-011453.PMC4947735.pdf
http://www.who.int/mental_health/evidence/WHOQOL-HIVBREF.pdf 62.,OADS,/arxiv_data1/oa_pdf/27/7e/bmjopen-2016-011453.PMC4947735.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2016-012376).,Non-OADS,/arxiv_data1/oa_pdf/25/b9/bmjopen-2016-012376.PMC4947737.pdf
2015. http://www.mentalhealthcommission.ca/English/article/77031/september-17-2015-mental-health-commission-canada-releases-comprehensive-report-suppor (accessed 10 Feb2016).,Non-OADS,/arxiv_data1/oa_pdf/25/b9/bmjopen-2016-012376.PMC4947737.pdf
2015.https://www.cadth.ca/resources/finding-evidence/grey-matters(accessed 12 Feb 2016).,Non-OADS,/arxiv_data1/oa_pdf/25/b9/bmjopen-2016-012376.PMC4947737.pdf
2015. http://tech.cochrane.org/our-work/ cochrane-author-support-tool/covidence (accessed 10 Feb 2016).,OADS,/arxiv_data1/oa_pdf/25/b9/bmjopen-2016-012376.PMC4947737.pdf
2016. http://eenet.ca/(accessed 10 Feb 2016).,OADS,/arxiv_data1/oa_pdf/25/b9/bmjopen-2016-012376.PMC4947737.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ BMJ Open 2016; 6:e012293corr1.,Non-OADS,/arxiv_data1/oa_pdf/ea/94/bmjopen-2016-012293corr1.PMC4947738.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2015-010884).,Non-OADS,/arxiv_data1/oa_pdf/d4/11/bmjopen-2015-010884.PMC4947739.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2015-010837).,Non-OADS,/arxiv_data1/oa_pdf/75/cf/bmjopen-2015-010837.PMC4947740.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ rmdopen-2015-000235).,Non-OADS,/arxiv_data1/oa_pdf/b0/f5/rmdopen-2015-000235.PMC4947741.pdf
Ethics approval http://lacohortedesir.fr.,Non-OADS,/arxiv_data1/oa_pdf/b0/f5/rmdopen-2015-000235.PMC4947741.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2016-011419).,Non-OADS,/arxiv_data1/oa_pdf/78/0b/bmjopen-2016-011419.PMC4947743.pdf
http://www.who.int/mental_health/suicide-prevention/en/ (accessed30 May 2015).,Non-OADS,/arxiv_data1/oa_pdf/78/0b/bmjopen-2016-011419.PMC4947743.pdf
http://www.cdc.gov/violenceprevention/suicide/index.html (accessed 30 May 2015).,Non-OADS,/arxiv_data1/oa_pdf/78/0b/bmjopen-2016-011419.PMC4947743.pdf
Specified Report of Vital Statistics: Age-Adjusted Death Rates by suicides ( Japanese).http://www.mhlw.go.jp/toukei/saikin/hw/jinkou/tokusyu/suicide04/(accessed 30 May 2015).,Non-OADS,/arxiv_data1/oa_pdf/78/0b/bmjopen-2016-011419.PMC4947743.pdf
http://www.nimh.nih.gov/health/topics/suicide-prevention/index.shtml (accessed 30 May 2015).,Non-OADS,/arxiv_data1/oa_pdf/78/0b/bmjopen-2016-011419.PMC4947743.pdf
http://www.city.niigata.lg.jp/iryo/kokoro/jisatsu/jittaihaaku.html (accessed 30 May 2015).13.,Non-OADS,/arxiv_data1/oa_pdf/78/0b/bmjopen-2016-011419.PMC4947743.pdf
http://www.city.osaka.lg.jp/shisei_top/category/ 1756-0-0-0-0.html (accessed 30 May 2015).,Non-OADS,/arxiv_data1/oa_pdf/78/0b/bmjopen-2016-011419.PMC4947743.pdf
http://www.city.osaka.lg.jp/shobo/page/0000267911.html (accessed 30 May 2015).,Non-OADS,/arxiv_data1/oa_pdf/78/0b/bmjopen-2016-011419.PMC4947743.pdf
http://www8.cao.go.jp/jisatsutaisaku/whitepaper/en/w-2015/summary.html (accessed 20Apr 2016).,OADS,/arxiv_data1/oa_pdf/78/0b/bmjopen-2016-011419.PMC4947743.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2015-010641).,Non-OADS,/arxiv_data1/oa_pdf/9d/dd/bmjopen-2015-010641.PMC4947747.pdf
"98-11,1998. http://fhs.mcmaster.ca/hug/wp9811.htm 61.",Non-OADS,/arxiv_data1/oa_pdf/9d/dd/bmjopen-2015-010641.PMC4947747.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2015- 010726).,Non-OADS,/arxiv_data1/oa_pdf/b3/e8/bmjopen-2015-010726.PMC4947748.pdf
"2010. http://neuropathology-web.org/chapter3/chapter3dGmh.html 29. de Kieviet JF, Pouwels PJW, Lafeber HN, et al.",Non-OADS,/arxiv_data1/oa_pdf/b3/e8/bmjopen-2015-010726.PMC4947748.pdf
http://www.news-medical.net/health/ Biomarker-What-is-a-Biomarker.aspx.,Non-OADS,/arxiv_data1/oa_pdf/b3/e8/bmjopen-2015-010726.PMC4947748.pdf
Secondary Introduction and Overview of the Sensory Profile 2.Pearson Clinical Assessment Webinar Archive 2014. http://mfile.akamai.com/23543/wmv/citrixvar.download.akamai.com/23543/www/442/808/8068365212672442808/3-8068365212672442808- 147478595dc.asx?,Non-OADS,/arxiv_data1/oa_pdf/b3/e8/bmjopen-2015-010726.PMC4947748.pdf
2007. http://www.canchild.ca/en/ measures/gmfcs_expanded_revised.asp 71.,Non-OADS,/arxiv_data1/oa_pdf/b3/e8/bmjopen-2015-010726.PMC4947748.pdf
2014. http://www.health.vic.gov.au/neonatalhandbook/conditions/bronchopulmonary-dysplasia.htm81.,Non-OADS,/arxiv_data1/oa_pdf/b3/e8/bmjopen-2015-010726.PMC4947748.pdf
2013. http://www.apa.org/pi/about/publications/caregivers/practice-settings/assessment/tools/family-impact.aspx 90.,Non-OADS,/arxiv_data1/oa_pdf/b3/e8/bmjopen-2015-010726.PMC4947748.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2015-010247).,Non-OADS,/arxiv_data1/oa_pdf/1c/5a/bmjopen-2015-010247.PMC4947751.pdf
Retrieved from http://www.R-project.org/.,Non-OADS,/arxiv_data1/oa_pdf/1c/5a/bmjopen-2015-010247.PMC4947751.pdf
http://www.who.int/tobacco/global_report/2013/en/ 5.,Non-OADS,/arxiv_data1/oa_pdf/a8/e7/openhrt-2015-000358.PMC4947752.pdf
Nordic Medico-Statistical Committee 100:2013 (accessed 2 Dec 2015).http://www.nowbase.org/~/media/Projekt%20sites/Nowbase/Publikationer/Helse/Health%20Statistics%202013.ashx 9.,OADS,/arxiv_data1/oa_pdf/a8/e7/openhrt-2015-000358.PMC4947752.pdf
http://www.kaypahoito.fi 16.,Non-OADS,/arxiv_data1/oa_pdf/a8/e7/openhrt-2015-000358.PMC4947752.pdf
http://www.stat.fi/til/ksyyt/2014/ksyyt_2014_2015-12-30_tie_001_en.html 31.,OADS,/arxiv_data1/oa_pdf/a8/e7/openhrt-2015-000358.PMC4947752.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2015-010493).,Non-OADS,/arxiv_data1/oa_pdf/65/69/bmjopen-2015-010493.PMC4947753.pdf
Using medication reconciliation to prevent errors 2006. http://www.jointcommission.org/sentinel_event_alert_issue_35_using_medication_reconciliation_to_prevent_errors/ (accessed 2 Feb2016).,OADS,/arxiv_data1/oa_pdf/48/0a/bmjopen-2016-012200.PMC4947755.pdf
http://www.ntocc.org/Portals/0/PDF/Resources/ PolicyPaper.pdf 22.,Non-OADS,/arxiv_data1/oa_pdf/48/0a/bmjopen-2016-012200.PMC4947755.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2016- 011534).,Non-OADS,/arxiv_data1/oa_pdf/c5/b6/bmjopen-2016-011534.PMC4947756.pdf
doi:10.1136/bmjopen-2016- 011139 â–¸Prepublication history for this paper is available online.To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2016-011139).,Non-OADS,/arxiv_data1/oa_pdf/74/de/bmjopen-2016-011139.PMC4947758.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ 6 Hill A-M, et al.BMJ Open 2016; 6:e011139.",Non-OADS,/arxiv_data1/oa_pdf/74/de/bmjopen-2016-011139.PMC4947758.pdf
"Adelaide: Australian Orthopaedic Association, 2015. https://aoanjrr.sahmri.com/ 2.",Non-OADS,/arxiv_data1/oa_pdf/74/de/bmjopen-2016-011139.PMC4947758.pdf
2015. http://www.who.int/mediacentre/ factsheets/fs344/en/ 37.,Non-OADS,/arxiv_data1/oa_pdf/74/de/bmjopen-2016-011139.PMC4947758.pdf
2015. http://www.profane.eu.org/fesi.html 44.,Non-OADS,/arxiv_data1/oa_pdf/74/de/bmjopen-2016-011139.PMC4947758.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2015-010527).,Non-OADS,/arxiv_data1/oa_pdf/51/77/bmjopen-2015-010527.PMC4947759.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2016-011385).,Non-OADS,/arxiv_data1/oa_pdf/38/2a/bmjopen-2016-011385.PMC4947760.pdf
http://www.jaif.or.jp/cms_admin/wp-content/uploads/understanding/annual/47th/47-s3_endo-e.pdf (accessed1 Aug 2016).,Non-OADS,/arxiv_data1/oa_pdf/6a/29/bmjopen-2016-011641.PMC4947762.pdf
Hypertension Treatment Guidelines 2014. http://www.jpnsh.jp/data/jsh2014/jsh2014v1_1.pdf (accessed 1 Aug 2016).,Non-OADS,/arxiv_data1/oa_pdf/6a/29/bmjopen-2016-011641.PMC4947762.pdf
2011. http://mhlw-grants.niph.go.jp/niph/search/NIDD00.do?resrchNum=201021008B (accessed 1 Aug 2016).,Non-OADS,/arxiv_data1/oa_pdf/6a/29/bmjopen-2016-011641.PMC4947762.pdf
doi:10.1136/bmjopen-2016- 011242 â–¸Prepublication history for this paper is available online.To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2016-011242).,Non-OADS,/arxiv_data1/oa_pdf/73/c8/bmjopen-2016-011242.PMC4947763.pdf
http://www.pcori.org (accessed 30 Sep 2015).,Non-OADS,/arxiv_data1/oa_pdf/73/c8/bmjopen-2016-011242.PMC4947763.pdf
